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Staphylococcus aureus continues to be a clinical burden globally due to its 
ability to rapidly adapt to antibiotic stress. The overwhelming majority of 
clinical MRSA (methicillin-resistant Staphylococcus aureus) isolates exhibit a 
low-level β-lactam resistance (oxacillin MIC 2-4 μg/ml). Yet, these are 
capable of developing high-level resistance to oxacillin (MIC ≥256 μg/ml) by 
an unknown mechanism(s). Therefore, an experimental system to explore 
underlying molecular basis of high-level resistance was developed here.  
The aim of the project was to construct genetically amenable MRSA strains 
by introducing plasmid-borne and single copy chromosomal mecA into well-
characterised, methicillin sensitive genetic background SH1000 which 
allowed to mimic the resistance phenotype identical to the naturally occurring 
MRSA clinical isolates. The progression of resistance and whole genome 
sequencing data revealed single nucleotide polymorphisms in c-di-AMP 
phosphodiesterase (gdpP) to be responsible for high-level resistance when 
plasmid-borne mecA was used. When, single copy mecA was introduced 
mutations in either rpoB (RNA polymerase β subunit) or rpoC (RNA 
polymerase β’ subunit) were found associated with increased resistance 
properties. 
The impact of the genetic mutations (rpoB and rpoC) responsible for high-
level resistance were examined at the transcriptional level using RNA-seq. 
Introduction of mecA induces metabolic stress resulting in substantial gene 
expression compared to SH1000 but is reversed upon acquisition of 
rpoB/rpoC mutations. These findings suggested that expression of high-level 
resistance requires not only elevated amounts of cellular PBP2A but also 
normalised gene expression. Collectively, this study offers some important 
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1 Chapter 1 
Introduction 
1.1 Staphylococcus aureus 
Staphylococcus aureus is a Gram-positive, facultative anaerobic coccal 
bacterium, approximately 0.5-1.5 µm in diameter, known for an array of 
diseases in both the community and the hospital settings. Staphylococcal cell 
division occurs in multiple planes (Tzagoloff and Novick, 1977) resulting in 
either a single cell following separation or if cells do not separate, form pairs, 
tetrads and ‘bunch of grapes’ like formation. This irregular grape-like 
structure, after which it was named, from the Greek, staphyle (bunch of 
grapes) and kokkos (granules), was first discovered from post-operative 
wound by Sir Alexander Ogoston in 1880. S. aureus is a commensal, non-
spore forming, non-motile opportunistic pathogen able to colonise all 
mammalian species causing minor to life-threatening infections given the 
right circumstances. Preferably, it commonly colonises in the upper 
respiratory tract, particularly anterior nares (Stapleton and Taylor, 2007). 
Infections caused by S. aureus include, infections of skin (cellulitis and 
impetigo), bacteraemia, food poisoning, endocarditis, mastitis (mammary 
gland infection), pneumonia, toxic shock syndrome (TSS) and osteomyelitis 
(bone infection) (Boucher and Corey, 2008; Choi et al., 1989; Richards et al., 
1999).  
S. aureus produces circular, glistening, smooth and raised colonies on solid 
culture medium. The distinctive golden colour of S. aureus colonies is due to 
the carotenoid, staphyloxanthin, involved in oxidative stress resistance 
mechanism (Clauditz et al., 2006).  
1.1.1 Staphylococcus aureus infections and epidemiology 
A large number of staphylococci species is known to infect humans and 
other mammals and in some cases birds. S. aureus plays the most 
significant role in causing infections and diseases in humans compared to 
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other major pathogenic staphylococci include, S. saprophyticus, S. 
hemolyticus and S. lugdunesis (Couto et al., 2001). It is estimated that about 
30% of the human population are transient carriers and 10% to 20% of are 
long-term carriers (Lowy, 1998). Most commonly, patients suffering from 
cancer, type l diabetes, circulatory system diseases, intravenous drug users 
and surgical patients are at high risk for staphylococcal infections (Archer, 
1998; Lowy, 1998). Nine out of ten patients suffering from atopic dermatitis 
were found to be colonised with S. aureus (Abeck and Mempel, 1998). S. 
aureus is the most prevalent causative agent of joint infections (septic 
arthritis) by producing proteolytic enzymes leading to induction of pro-
inflammatory cytokines (Sharff et al., 2013). S. aureus-induced pneumonia is 
highly life threatening with 50% mortality among infections in Europe (Kumar 
et al., 2009). Staphylococcal pneumonia is associated with cytotoxins such 
as PVL, enhancing bacterial virulence which contributes to neutrophil cell 
lysis (Löffler et al., 2010).  
S. aureus infections have increasingly been reported throughout the world, 
mainly in United States, China, Canada, Europe and parts of the Western 
Pacific (Chuang and Huang, 2013; Diekema et al., 2001).  Because of the 
complex medical issues of the infected patients, the treatment of these 
infections has become increasingly difficult, imposing a higher burden on 
healthcare resources (Chu et al., 2005), coupled with increasing morbidity 
and mortality. During 2016/2017, more than 12,500 cases of S. aureus-
induced infections were reported in England, representing a 24.6% and 7.7 
increase from 2011/2012 and 2015/2016, respectively (Public Health 
England Reports, 2017).  
1.2 Staphylococcal metabolism: an overview 
S. aureus is a highly adaptive commensal which possess a number of genes 
that allow the bacterium to grow and divide in the wide range of 
environments from aerobic to anaerobic during the course of an infection 
(Park et al., 1992). The ability to grow and divide in a variety of niches  is 
provided by the metabolic capability of the bacterium which supplies 
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essential nutrients to ATP-producing pathways, both in the presence and 
absence of oxygen (Hall and Ji, 2013).  
Under aerobic and anaerobic growth conditions, S. aureus grows well using 
oxygen and nitrate/nitrite, respectively as terminal electron acceptors (Fuchs 
et al., 2007; Somerville and Proctor, 2009). S. aureus utilises menaquinone 
for transfer of electrons regardless of oxygen availability (Lester and Crane, 
1959). NADH dehydrogenase transfers electrons to menaquinone from 
NADH by hydrolysing NADH to NAD+ under aerobic condition (Somerville 
and Proctor, 2009). The electrons are then transferred to oxygen through 
cascade of cytochrome oxidases from menaquinone which drives out 
protons across the membrane and generates water. Protons exterior to the 
membrane maintain electrochemical gradient and pH (Somerville and 
Proctor, 2009). In order to generate new ATP, protons return to the 
cytoplasm through the ATP synthase complex, however disruption of the 
electron transfer chain results in anaerobic or fermentative growth phenotype 
(Fuchs et al., 2007; Somerville and Proctor, 2009). Under anaerobic growth 
conditions, S. aureus ferment sugars and amino acids and enhances 
dissimilatory nitrate reduction in order to maintain redox poise of the cell 
(Fuchs et al., 2007; Hall and Ji, 2013). 
1.3 S. aureus cell division 
Cell division is a highly coordinated and controlled process which permits 
continual growth and division without affecting physiology of the cells 
(Errington et al., 2003). The main structural component of the cell wall which 
is peptidoglycan, must be continuously synthesised in a timely manner 
(Turner et al., 2014). Peptidoglycan makes up to 55% of the total cell wall 
mass (Heijenoort, 2001) which protects cells from osmotic shock as well as 
withstands internal turgor (Macheboeuf et al., 2006). S. aureus cell division 
machinery (divisome) comprises of two groups of proteins that coordinate 
division and peptidoglycan insertion (Figure 1.1). One of the most important 
divisome component is a mammalian protein tubulin homologue FtsZ which 
recruits other division proteins such as FtsA, in a sequential order to the 




Figure 1.1 S. aureus divisome and cell cycle 
A) Schematic illustrating cell division machinery from S. aureus. CM, cytoplasmic 
membrane. Taken from (Bottomley, 2011). 
B) Model of S. aureus cell cycle and peptidoglycan insertion. Cell division begins with an 
increase in cell size followed by continuous insertion of peptidoglycan to the midcell to 
form a septum with uniform thickness. Following completion of the septum, the daughter 





recruited for Z-ring formation (Chaudhuri et al., 2009; Steele et al., 2011). 
The remaining cell division components are recruited to the midcell after Z-
ring formation as late cell division proteins such as, FtsL, DivlC, DivlB, FtsW, 
GpsB, and PBPs, which are required for peptidoglycan remodelling and 
degradation (Chaudhuri et al., 2009; Pinho et al., 2000, 2001a).  
Splitting of the cell into two hemispherical daughter cells is then enabled by 
the addition of cell wall hydrolases (e.g. autolysins). There are approximately 
20 putative PG hydrolases but their roles are largely unknown (Wheeler et 
al., 2015). 
1.3.1 Peptidoglycan synthesis in Staphylococcus aureus 
Peptidoglycan is the major constituent of the bacterial cell wall which 
provides cell-shape as well as enabling resistance to intracellular turgor 
pressure (Sauvage et al., 2008). Insertion of the new peptidoglycan is 
mediated by penicillin binding proteins (PBPs) on the exterior of the 
cytoplasmic membrane following the cooperative activity of a number of 
other proteins involved in its building block synthesis in the cytoplasm (De 
Jonge et al., 1992).  
Staphylococcal peptidoglycan consists glycan chains of alternating 
disaccharides, N-acetylmuramic acid (MurNAc) and N-acetylglucosamine 
(GlcNAc) linked by short stem peptides attached to MurNAc (Figure 1.2) 
(Ghuysen, 1968; Vollmer et al., 2008a). GlcNAc-MurNAc units are 
crosslinked by β-1, 4 glycosidic bonds through a PBP-mediated 
transglycosylation (TGase) reaction (Vollmer, 2008). S. aureus forms ~6 
disaccharide long GlcNAc-MurNAc polymers (Vollmer, 2008), crosslinked 
covalently by the pentapeptide stem consists of L-alanine, D-glutamine, L-
lysine and a D-alanyl-D-alanyl moiety to the MurNAc residue through PBP-
mediated transpeptidation (TPase) reaction (Pinho et al., 2013; Vollmer, 
2008a; Vollmer et al., 2008). This flexible crosslinking of glycan units occurs 
between D-alanine at the 4th residue from one side chain and L-lysine at the 
position 3 on the other side chain through a pentaglycine bridge (Figure 1.2) 
(Pinho et al., 2013; Vollmer et al., 2008a). S. aureus peptidoglycan has a 
6 
 
high degree of crosslinking from 72% to over 93% of crosslinked 
peptidoglycan (Vollmer et al., 2008a).  
Synthesis of peptidoglycan occurs in three different stages which takes place 
in three different locations in the cell (Figure 1.3). During the first stage in the 
cytoplasm, nucleotide sugar-linked precursors UDP-N-acetylglucosamine 
(UDP-GlcNAc) and UDP-N-acetylmuramic acid (UDP-MurNAc) are 
synthesised from fructose-6-phosphate. Subsequently, amino acids are 
added by Mur ligases to UDP-MurNAc resulting in UDP-MurNAc 
pentapeptide. The second stage occurs to the cytoplasmic membrane, UDP-
MurNAc pentapeptide precursor is linked to the transport lipid, bactoprenol 
forming lipid l. Subsequently, GlcNAc is added from UDP-GlcNAc to lipid l, 
forming lipid ll. The subsequent addition of pentaglycine bridge to the 3rd 
position at L-lysine, resulting in Lipid ll-Gly5, is catalysed by FemABX-like 
proteins. Lipid ll-Gly5 is then flipped across the cell membrane by FtsW for 
peptidoglycan incorporation through PBPs. During the final stage, PBPs 
catalyse transglycosylation and transpeptidation reactions, resulting in 
respective polymerisation of Lipid ll-Gly5 and crosslinking of flexible 
pentapeptide stem into nascent peptidoglycan (Macheboeuf et al., 2006; 




Figure 1.2 The chemical structure of S. aureus peptidoglycan 
Chemical composition of single peptidoglycan disaccharide pentapeptide with a 
pentaglycine cross bridge unit is illustrated. The glycan polymer consists of N-
acetylmuramic acid and N-acetylglucosamine are linked covalently to the peptide stem via 
lactyl group. A pentaglycine bridge linked to L-lysine at the 3rd position of the side chain is 






Figure 1.3 Peptidoglycan synthesis in S. aureus  
Peptidoglycan precursors are synthesised and assembled in the cytoplasm through a 
series of steps. They are subsequently linked to transport lipid forming lipid l and lipid ll. 
Lipid ll is translocated across the cell membrane via FtsW activity. On the exterior of the 
cell membrane, PBPs catalyse transpeptidation and transglycosylation reactions to 
incorporate substrate (lipid ll) into nascent peptidoglycan. Taken from (Pinho et al., 1998; 




1.3.2 Penicillin binding proteins  
Penicillin binding proteins (PBPs) are a group of enzymes with 
transpeptidation and/or transglycosylation activities, involved in the final 
stages of peptidoglycan metabolism (Goffin and Ghuysen, 1998; Sauvage et 
al., 2008). PBPs have particularly been the subject of interest since their 
discovery as β-lactam targets, as well as their role in the development of β-
lactam resistance in some of the most important pathogens such as 
Streptococcus pneumoniae, Staphylococcus aureus and Enterococci (Zapun 
et al., 2008).  
The PBPs are classified into two major groups based on their molecular 
weight: high molecular weight (HMW) and low molecular weight (LMW), and 
further according to the number of reactions a single enzyme is able to 
catalyse (Table 1.1). Depending on their catalytic activity and the structure, 
HMW PBPs are divided into two classes, class A of bifunctional PBPs and 
class B of monofunctional PBPs (Goffin and Ghuysen, 1998; Sauvage et al., 
2008). Their topology comprises of a two functional domains joined by a β-
rich linker on the exterior of cytoplasmic membrane, a transmembrane 
anchor and a cytoplasmic tail (Goffin and Ghuysen, 1998; Lovering et al., 
2007; Macheboeuf et al., 2006). HMW class A PBPs can have N-terminal 
transglycosylase activity domain and a C-terminal transpeptidase activity 
domain (Goffin and Ghuysen, 1998; Sauvage et al., 2008). Whereas, HMW 
class B PBPs can contain an N-terminal domain with unknown function and a 
C-terminal transpeptidase activity domain (Goffin and Ghuysen, 1998; 
Sauvage et al., 2008). LMW PBPs possess either endopeptidase or 
carboxypeptidase activity to hydrolyse pentapeptide stems into tetrapeptides, 
preventing further peptidoglycan crosslinking (Goffin and Ghuysen, 2002; 
Macheboeuf et al., 2006). Thereby, the level of peptidoglycan crosslinking is 
controlled by LMW PBPs (Morlot et al., 2004). 
The number of native PBPs possessed, varies amongst bacterial species. B. 
subtilis contains 16 PBPs, of which four are class A PBPs (Table 1.1). PBPs 
are involved in sporulation and vegetative peptidoglycan synthesis (Sauvage 
et al., 2008; Scheffers, 2005; Scheffers and Errington, 2004). Six of its 16 
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PBPs are class B (Table 1.1) of which, PBP2b containing transpeptidase 
activity is required for cell division (Daniel et al., 2000). E. coli possesses a 
total of 12 PBPs of which there are three class A (PBP1a, PBP1b and 
PBP1c) and two class B (PBP2 and PBP3) (Table 1.1). PBP1a and PBP1b 
are the main transpeptidases and transglycosylases whilst PBP2 and PBP3 
are monofunctional transpeptidases (Den Blaauwen et al., 2008). PBP2 is 
specific to cell elongation while PBP3 is major constituent of the divisome 
(Den Blaauwen et al., 2008). The seven LMW PBPs are associated with 
peptidoglycan maturation or recycling and cell separation (Sauvage et al., 
2008; Vollmer et al., 2004, 2008b). The different modes of growth and cell 
shape of bacteria might reflect the number of PBPs that they possess.  
In S. aureus, the cell does not elongate therefore, peptidoglycan is mainly 
synthesised at the septum during cell division (Figure 1.1 B) (Lund et al., 
2018; Pinho and Errington, 2003; Pinho et al., 2013), making S. aureus a 
minimalist model for studying cell division. It produces only four native PBPs 
(Table 1.1). S. aureus strains susceptible to β-lactam antibiotics contain two 
HMW class B PBPs, PBP1 and PBP3 of which PBP1 is essential for growth 
and survival (Pereira et al., 2009). Both enzymes are important of their 
transpeptidase activity. Depletion of PBP1 halts cell division and causes 
rapid loss in viability (Pereira et al., 2007). However, inactivation of the 
transpeptidase activity of PBP1 showed no alterations in peptidoglycan 
composition, signifying its function independent of its functional 
transpeptidase domain (Pereira et al., 2007, 2009). Its unique HMW class A 
PBP, PBP2 localises to the septum (Pinho and Errington, 2003), required for 
its transpeptidase and transglycosylase activities and deletion of this enzyme 
is lethal to the cell (Pinho et al., 2001a). Dispersed localisation of bifunctional 
PBP2 was observed when S. aureus cells were treated with oxacillin unlike 
in MRSA where transpeptidase activity of native PBP2 was taken over by 
PBP2A – a non-native HMW class A PBP, in the presence of oxacillin (Pinho 
and Errington, 2005; Tan et al., 2012a). Moreover, inhibition of substrate 
synthesis also delocalises PBP2, resembling the results found with oxacillin 
treatment, suggesting the importance of transpeptidation substrates for 
PBP2 recruitment to the septum (Pinho and Errington, 2005). Moreover, in 
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the presence of functional PBP2A, PBP2 localises to the septum explaining 
the essentiality of the transpeptidase activity of PBP2A for substrate 
recognition (Pinho and Errington, 2005; Pinho et al., 2001a). The methicillin 
resistance determinant, PBP2A is an acquired PBP encoded by the mecA 
gene in MRSA. This β-lactam insensitive transpeptidase undertakes the 
normal function of native PBPs in the presence of low-levels of all available 
β-lactam antibiotics (Pinho et al., 2001b). However, high-level resistance is 
only conferred by the presence of transglycosylase activity of native PBP2 
(Pinho et al., 2001a). Inactivation of PBP3 showed no significant alteration in 
peptidoglycan composition or growth defects except significant decrease in 
autolytic rate (Pinho et al., 2000), suggesting the importance of PBP3 in cell 
division but not for cell survival as the transpeptidase activity of PBP3 may 
have thought to be taken over by PBP1 and/or PBP2 (Pinho et al., 2000). 
The exact role of PBP3 is yet to be identified. S. aureus encodes only one 
LMW PBP, PBP4 which unlike E. coli PBP5, has a transpeptidase activity 
necessary to achieve high degree of peptidoglycan crosslinking (Wyke et al., 
1981). Loss of PBP4 is associated with reduction in the transcription of PBP2 
in both MSSA and MRSA strains resulting in decreased peptidoglycan 
crosslinking (Memmi et al., 2008), suggesting a putative interaction between 
them. However, the expression of PBP2A remained unchanged upon the 
loss of PBP4 (Memmi et al., 2008). These observations suggest the 
cooperative function of PBP4, PBP2 and PBP2A and their structural and 
organisational relationships (Leski and Tomasz, 2005; Memmi et al., 2008). 
Moreover, inactivation of PBP4 in MRSA is associated with significant 
reduction in oxacillin resistance suggesting the role of PBP4 in in mediating 





Species PBPs Classification Molecular function References 
Staphylococcus 
aureus 
PBP2 (pbp2) HMW Class A Essential for cell division 




HMW Class B 
Require for PG 
synthesis 
(Pinho et al., 
2001b) 
PBP1 (pbpA) 
Essential for cell growth 
and survival 
(Pereira et al., 
2009) 
PBP3 (pbpC) 
Involved in septum 
formation 
(Pinho et al., 
2000) 
PBP4 (pbp4) LMW 
Involved peptidoglycan 
crosslinking 




HMW Class A 
Important for the 
assembly of division 
septum 
(Scheffers and 
Errington, 2004)  
PBP4 (pbpD) 
Require for synthesis 
and remodelling of PG 
(Sauvage et al., 
2007)  
PBP2c (pbpF) Require for cell growth (Scheffers, 2005)  
PBP2d 
(pbpG) 
Involved in cell growth 
(Mcpherson and 
Popham, 2003)  
PBP3 (pbpC) 
HMW Class B 
Involved in cell division 




Required for spore 
morphogenesis 




Involved in cell division 




Involved in rod shape 
formation 
(Wei et al., 2003)  
PbpH (pbpH) Involved in PG synthesis (Wei et al., 2003)  
PBP4b (yrrR) 
Involved in spore PG 
synthesis 
(Scheffers and 




Cell separation and 
peptidoglycan 
maturation 











PBP5* (dacB) Spore cortex synthesis 
(Popham et al., 
1999) 
PBP4* (pbpE) Involved in sporulation (Scheffers, 2005) 




HMW Class A 
Essential for cell growth 
and survival 




Essential for cell growth 
and survival 




Involved in PG synthesis 
(Schiffer and 
Höltje, 1999)  
PBP2 (pbpA) 
HMW Class B 
Required for cell shape 
(Schiffer and 
Höltje, 1999)  
PBP3 (ftsi) 
Essential for PG 
synthesis in the absence 
of PBP1b 




Cell separation and 
peptidoglycan 
maturation 


















(Sauvage et al., 
2008) 
PBP7 (pbpG) 
Cell separation and 
peptidoglycan 
maturation 
(Vollmer et al., 
2004) 
PBP4b (yefw) Not determined 





(Henderson et al., 
1997) 
Table 1.1 Classification of PBPs 




1.4 PBP-based antibiotic resistance 
A multi-layered mesh of highly crosslinked peptidoglycan protects the cell 
from environmental stresses as well as contributing to resistance and 
virulence essential for survival and pathogenicity (McCallum et al., 2010). 
The Gram-positive bacterial cell wall also consists of wall teichoic acids 
covalently linked to the peptidoglycan, lipoteichoic acids attached to the 
cytoplasmic membrane and other membrane associated proteins including 
peptidoglycan-anchored surface proteins and extracellular proteins. All of 
these components make the cell envelope an attractive target for numerous 
antibiotics which either block or disrupt peptidoglycan synthesis (Figure 1.4) 
(McCallum et al., 2010). For continual cell growth and division, peptidoglycan 
precursor synthesis, polymerisation, cell wall degradation and turnover are 
essential processes.  
As mentioned above, the last enzymatic reactions of peptidoglycan synthesis 
are carried out by PBPs. Any perturbation of cell wall metabolism caused by 
an inhibition of PBPs is lethal for growth and survival. The two major classes 
of cell wall antibiotics include β-lactams and glycopeptides. β-lactam 
antibiotics, such as penicillin, methicillin and oxacillin target native PBPs of 
S. aureus by inhibiting transpeptidase activity, hindering access to their 
substrate (Goffin and Ghuysen, 1998). Glycopeptides, such as vancomycin 
and teicoplanin target the D-ala-D-ala terminus of the lipid ll and 
uncrosslinked nascent peptidoglycan exterior to the cytoplasm, thereby 
blocking PBP reactions (Reynolds, 1989). However, various means of 
antibiotic resistance have been emerged and investigated, such as decrease 
affinity to the antibiotic by utilising non-native PBPs or degradation of the 








Figure 1.4 S. aureus peptidoglycan synthesis and cell wall active antibiotics targets 
Red blocked arrows indicate inhibition of enzymatic reactions; red half-moon arrows 
indicate inhibition of cell wall synthesis; red arrows indicate pentaglycine bridge cleavage 





1.4.1 β-lactam resistance in Staphylococcus aureus 
There are two main mechanisms acquired by S. aureus to become resistant 
to the β-lactams. One is enzyme-mediated resistance conferred by 
penicillinase (β-lactamase) production which hydrolyses the β-lactam class 
of antibiotics, such as penicillin (Sabath, 1982). The second and broader 
mechanism is the expression of mecA encoding the additional PBP, PBP2A 
with decreased affinity for β-lactams, maintaining cell wall biosynthesis in the 
presence of β-lactams (Hartman and Tomasz, 1984; Lim and Strynadka, 
2002; Reynolds and Brown, 1985) with the help of native bifunctional PBP, 
PBP2 for its transglycosylase activity (Pinho et al., 2001b). 
A distinctive feature of methicillin-resistant S. aureus (MRSA) is their 
heterogeneous resistance expression, meaning that individual strains can 
produce a subpopulations with different levels of higher resistance (Tomasz 
et al., 1991). Resistance levels also varies between different MRSA lineages, 
ranging from an oxacillin MIC of <0.5 to >1000 µg/ml (McCallum et al., 2010). 
1.5 The history of MRSA 
In the early 1940s penicillin was first introduced to treat patients with S. 
aureus bacteraemia but penicillin resistant S. aureus (PRSA) were isolated 
as soon as 1942 (Rammelkamp and Maxon, 1942). The development of 
penicillin resistance was mediated by an enzyme, penicillinase/β-lactamase 
encoded by blaZ which cleaves the β-lactam ring and inhibits the action of 
antibiotic (Bondi and Dietz, 1945; Sabath, 1982). 
In response to the spread and emergence of penicillin resistance, a 
semisynthetic β-lactam named methicillin, resistant to penicillinase was 
developed and introduced into the clinic in 1959 (Jevons, 1961; Lowy, 2003). 
One year later after the introduction of methicillin to treat S. aureus mediated 
infections, an MRSA isolate was recovered from a patient diagnosed with 
osteomyelitis and septic arthritis (Jevons et al., 1963). Later, a large 
proportion of cases were reported in hospital followed by community settings. 
The outcomes of MRSA mediated infections are worse than the outcomes 
from MSSA (Cosgrove et al., 2003). A rapid spread of MRSA was noted as 
17 
 
soon as its first appearance in a new setting, accounting for an increasing 
cases of nosocomial infections (Couto et al., 1995; Panlilio et al., 1992). The 
notorious ability of S. aureus to develop and acquire antibiotic resistance 
mechanisms makes it a major healthcare problem (Figure 1.5). Currently, 
MRSA mediated infections account for significantly high morbidity and 
mortality rates (Dantes et al., 2013; Klein et al., 2007). Even though 
methicillin is no longer produced commercially or used clinically, the term 
MRSA has continued to be used. In addition, methicillin resistance means 
resistance to nearly all available β-lactams (Stryjewski and Corey, 2014).  
In order to identify the genetic determinants of methicillin resistance, the 
chromosomal localisation of mec gene complex encoding novel penicillin-
binding protein (PBP2A) (Katayama et al., 2000) was determined by 
Sjöström et al (1975). Later, it was confirmed that mec was only found on a 
chromosomal region of MRSA and not MSSA (Stewart and Rosenblum, 
1980). Using the penicillin-binding assay, several researchers also identified 
the novel low affinity PBP2A encoded by mecA in MRSA strains (Brown and 
Reynolds, 1980; Hartman and Tomasz, 1984; Utsui and Yokota, 1985). 
mecA is encoded on a mobile genetic element found in all MRSA called 
staphylococcal cassette chromosome (SCCmec) (Katayama et al., 2000). 






Figure 1.5 Timeline illustrating the introduction of antibiotics and subsequent 
emergence of antibiotic resistance in S. aureus 
PRSA, Penicillin-resistant S. aureus; MRSA, Methicillin-resistant S. aureus; VISA, 
Vancomycin-intermediate S. aureus; VRSA, Vancomycin-resistant S. aureus; CA-MRSA, 




1.5.1 Signalling and regulation of β-lactam resistance 
The variable phenotypic expression of methicillin resistance is regulated by 
the mecI and mecR1 regulatory elements (Archer and Bosilevac, 2001). The 
regulatory components, mecI and mecR1 are encoded within the mec gene 
complex adjacent to the mecA on SCCmec element which integrates in the 
chromosome (Ito et al., 2001). The mec regulatory genes, mecR1 and mecI 
are structurally and functionally similar to the blaZ regulatory components, 
blaR1 and blaI (Figure 1.6) which in response to β-lactam antibiotics induces 
the expression of mecA or blaZ, respectively (Gregory et al., 1997; Lowy, 
2003).   
Exposure to β-lactams enables the activation of a signal-transduction protein, 
MecR1. Its extracellular penicillin-binding domain (PBD) senses the 
presence of antibiotic which then allows the activation of its cytoplasmic 
domain (Zhang et al., 2001). The cytoplasmic metalloproteinase domain 
(MPD) of MecR1 has a protease activity. Its activation results in direct or 
indirect cleavage of MecI repressor therefore, initiating the transcription of 
mecA (Figure 1.7) (Archer and Bosilevac, 2001; Zapun et al., 2008; Zhang et 
al., 2001). Recently, Arêde et al (2012) characterised an anti-repressor 
encoded by mecR2 gene whose function is essential for complete induction 
of mecA enabling optimal β-lactam resistance. In addition to mecR1-mecI, 
the mecR2 gene is localised in an unusual three-component arrangement 
and cotranscribed with mecR1-mecI (Figure 1.7) (Arêde et al., 2012). An 
inefficient mecR1-dependent mecA expression is compensated by mecR2 
which interacts with mecI directly enabling destabilisation of mecI binding to 
the mecA promoter (Arêde et al., 2012, 2013). Mutations or deletions of the 
operator region or the mecI results in constitutive expression of mecA 
(Niemeyer et al., 1996). It was demonstrated that either blaI or mecI must be 
functional in order to repress the expression of mecA suggesting the 
importance of preventing the overproduction of PBP2A (Rosato et al., 2003). 
Unexpectedly, methicillin resistance had no effect upon overexpression of 
mecI in S. aureus strains, suggesting the presence of an additional 
regulatory gene (Oliveira and de Lencastre, 2011).  
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Moreover, it is important to note that not all MRSA strains carry an intact mec 
regulatory system as some strains carries truncated genes or lack mecI 
(Hurlimann-Dalel et al., 1992; Suzuki et al., 1993). Those having a complete 
regulatory system tend to be slow in developing resistance upon exposure to 
methicillin (Ryffel et al., 1992). For example, the N315 strain carries both 
regulatory systems resulting in a tight repression of mecA by both mecI and 
blaI which can lead to inhibition of β-lactam resistance (Hiramatsu, 1995; 
Niemeyer et al., 1996). Yet, the strains with de-repressed mecA expression 
exhibit only low-level resistance in the absence of β-lactam selection. Also, 
the promoter region, mecA, and regulatory genes (mecI and mecR1) are 
highly conserved among MRSA strains (Chambers, 1997). This highlights 
the need for tightly controlled mecA expression. 
The genetic background of the strains also plays an important role in the 
stability of mecA as the composition of mec regulatory system is greatly 
diverse between community-acquired MRSA (CA-MRSA) and hospital-
acquired MRSA (HA-MRSA) strains (Katayama et al., 2005). In some MRSA, 
the penicillinase regulatory system is required as the induction of mecA by 
mecI is slower which could be lethal for the cell in the presence of β-lactam 
antibiotic (Cha et al., 2007; Ryffel et al., 1992). This explains the presence of 
non-functional regulatory elements in many clinical MRSA, resulting in 
constitutive PBP2A production which leads to increased resistance 





Figure 1.6 Structural organisation of SCCmec elements  
The structures of SCCmec elements from representative strains are shown based on their 




Figure 1.7 Regulation of methicillin resistance in S. aureus 
A) In the absence of β-lactams, (I) mecA transcription is prevented by the binding of mecI 
(red triangle) to the mec operator/promoter region.  
B) In the presence of β-lactams, (II) penicillin-binding domain (PBD) of MecR1 detects β-
lactams which (III) triggers the activation of intracellular metalloproteinase domain (MPD) 
resulting in proteolysis of MecI. (IV) β-lactam disrupted cell-wall biosynthesis generates 
dipeptide cell-wall fragments which might be involved in the activation of MPD of MecR1. 
However, how the cell-wall fragments specifically, γ-D-Glu-L-Lys are generated in 
cytoplasm is not understood (Amoroso et al., 2012). (V) MecR2, a second anti-repressor 
is transcribed in the presence of antibiotic leading to MecI proteolysis. (VI) MecI 
degradation causes the transcription of mecA and subsequent production of PBP2A 
resulting in the expression of methicillin resistance.  
Adapted from (Peacock and Paterson, 2015). 
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1.5.2 Characteristics of Staphylococcal cassette chromosome mec 
(SCCmec) 
The evolution of MSSA to MRSA is due to the acquisition of a genetic 
element, staphylococcal cassette chromosome (SCCmec) which encodes for 
methicillin resistance along with the regulatory network which controls its 
expression in Staphylococcus genus. It was first identified and characterised 
in 1999 (Ito et al., 1999). Preliminary work suggested that the evolution of 
SCCmec occurred in multiple stages in the most primitive Staphylococcus 
species, the Staphylococcus sciuri. The study showed that mecA1 encoding 
a penicillin-binding protein in S. sciuri had 80% nucleotide identity to S. 
aureus mecA (Couto et al., 1996; Wu et al., 1996a). Other homologues to 
mecA were also identified namely, mecA of Staphylococcus fleurettii (99% 
identity) and mecA2 of Staphylococcus vitulinus (90% identity) (Schnellmann 
et al., 2006; Tsubakishita et al., 2010), however the structural organisation of 
mecA and its regulatory system was different to that of S. sciuri (Tsubakishita 
et al., 2010). Only recently investigators examined the origin and distribution 
of S. aureus SCCmec elements by using whole genome sequencing and 
SNP analysis approaches which demonstrated that the evolutionary stages 
comprised a possible contribution from several Staphylococcus species 
which included S. sciuri, S. vitulinus and S. fleurettii (Rolo et al., 2017). 
Moreover, iterative phylogenetic tree inferred the level of relatedness 
between SCC elements and SCCmec which suggested that SCCmec was 
assembled through series of recombination events involving at least three 
species even before the introduction of β-lactam antibiotics (Rolo et al., 
2017). 
SCCmec integrates into the S. aureus genome near the origin of replication 
at the 3’ end of the orfX gene at the attachment site sequence attB in all 
cases (Figure 1.8) (Katayama et al., 2003a; Noto et al., 2008). The 
integration of SCCmec is mediated by ccr-based recombination at the attB 
site of the genome and the circularised SCCmec specific attS site (Ito et al., 
1999; Katayama et al., 2000). This generates new pair of sites called attL 
and attR; which flanks the SCCmec elements. However, upon excision of 
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SCCmec results in regeneration of the original attB and attS sites (Figure 
1.8) (Katayama et al., 2000; Misiura et al., 2013). 
The complete sequence of orfX is maintained upon acquisition of the 
SCCmec without altering its expression during growth (Boundy et al., 2013). 
The molecular function of orfX was not clear until recently, the crystal 
structural analysis revealed its structural homology to ribosomal 
methyltransferase YbeA of E. coli 70 S ribosomal methyltransferase RlmH 
(Ero et al., 2008). OrfX-dependent 70 S ribosome methylation was 
demonstrated to have methyltransferase activity in S. aureus (Boundy et al., 
2013).  
SCCmec elements contain three basic genetic elements and share 
structurally similar backbone, that consists of (I) a mec gene complex 
carrying mecA and its regulators, surrounding ORFs and insertion 
sequences, (II) a cassette chromosome recombinase (ccr) gene complex 
containing ccrAB and or ccrC ensuring the mobility of SCCmec and 
surrounding ORFs and (III) the joining region (J region) (Ito et al., 2009; Liu 
et al., 2016a; Turlej et al., 2011). See mec organisation diagram for structural 
organisation of genetic components (Figure 1.6). Moreover, it may also carry 
housekeeping genes inside J regions as well as transposons and plasmids 
(Katayama et al., 2000). Currently, SCCmec elements are classified into I to 
XI types on the basis of the nature of ccr and mec gene complexes (Table 
1.2) (Liu et al., 2016a). They are further classified into different subtypes 
based on the location and DNA segments of the J regions (Liu et al., 2016a).  
1.5.2.1 The ccr gene complex 
The ccr gene complex contains ccr gene(s) and surrounded ORFs. The ccr 
genes encoded DNA recombinases catalyse precise site and orientation-
specific integration as well as excision of the SCCmec elements into and 
from staphylococcal chromosome (Katayama et al., 2000). Based on 
phylogenetic analysis, there are three distinct ccr genes; ccrA, ccrB and ccrC 
have been identified in S. aureus (Ito et al., 2009). These are further 
classified into 8 allotypes based on allelic variation in ccr (Ito et al., 2009; Liu 
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et al., 2016a). Type 1 comprises of ccrA1 and ccrB1 genes, type 2 comprises 
of ccrA2 and ccrB2 genes, type 3 carries ccrA3 and ccrB3 genes, type 4 
comprises of ccrA4 and ccrB4 genes, type 5 contains the ccrC1 gene, type 6 
comprises of ccrA5 and ccrB3 genes, type 7 carries ccrA1 and ccrB6 genes, 
and type 8 comprises of ccrA1 and ccrB3 genes (Figure 1.6) (Table 1.2) (Liu 
et al., 2016a). The types of ccr genes were defined based on frequency of 
DNA sequence similarities in different S. aureus (Ito et al., 2009). 
1.5.2.2 The mec gene complex 
Apart from mecA and its regulatory genes, the mec gene complex is 
composed of insertion sequences (IS) and hypervariable region (HVR). 
Based on the differences in IS and the location and integrity of regulatory 
genes, the mec gene complex was classified into 5 classes (Table 1.2). The 
class A mec gene complex contains intact mecR1 and mecI regulatory genes 
upstream of mecA, insertion sequence IS431 downstream of mecA and HVR 
(Ito et al., 2009). The class B mec gene complex carries IS1272 upstream of 
mecA resulting in truncated mecR1 and IS431 downstream of mecA and 
HVR (Ito et al., 2009). The class C mec gene complex is divided into two 
classes based on the orientation of IS431: class C1 and C2. Both classes 
contain truncated mecR1 due to IS431 upstream of mecA and HVR and 
IS431 to the downstream of mecA. IS431 of class C1 has the same 
orientation upstream and downstream of mecA while class C2 carries IS431 
flanking mecA and regulatory components is in the opposite orientation to 
class C1 (Ito et al., 2009). The class D mec gene complex comprises of a 
partly deleted mecR1 with no IS431 downstream of mec complex (Ito et al., 
2009; Katayama et al., 2001). The class E mec gene complex has recently 
been identified from livestock MRSA isolate which contains blaz, mecA, 







Figure 1.8 Schematic representation of SCCmec transposition 
Circularised SCCmec (dark blue) integrates into the S. aureus genome (yellow), 
specifically to the attB site at the 3’ end of the orfX gene. MRSA chromosome shows the 
integration of linearised SCCmec in the chromosome generating attL and attR sites. Upon 
excision of SCCmec from the chromosome creates circularised SCCmec. Integration and 
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Table 1.2 Types of SCCmec and their composition 





1.5.2.3 The joining (J) regions 
Besides, mec and ccr gene complexes, the J regions are essential for the 
biological functions of the SCCmec. The J regions are epidemiologically 
significant as they could be use as potential targets for transposons or 
plasmids. The J regions carry additional resistance determinants for a range 
of antibiotics and heavy metals resulting in a multidrug resistance phenotype 
(Turlej et al., 2011). Based on the location of J regions in SCCmec, they are 
classified in J1, located at the right side of the cassette; J2, between the mec 
and ccr gene complexes; and J3, located at the left side between the 
chromosomal junction adjoining orfX and the mec complex (Ito et al., 2009; 
Liu et al., 2016a; Turlej et al., 2011).  
1.6 Structural basis of resistance 
The transpeptidation step of peptidoglycan biosynthesis is inhibited by the β-
lactams which act as substrate analogues of the peptidoglycan side chain D-
Ala-D-Ala (Tipper and Strominger, 1965). PBPs require to access 
pentapeptide, specifically D-Ala-D-Ala dipeptides chain for catalysing the 
transpeptidation reaction in order to continue cell wall synthesis. β-lactam 
forms a covalent acyl-enzyme complex between the nucleophilic serine 
residue of the PBP and the antibiotic impeding the transpeptidation reaction 
which results in inhibition of cell wall synthesis (Lim and Strynadka, 2002; 
Peacock and Paterson, 2015). The interaction of PBPs with β-lactam 
antibiotics is shown in Figure 1.9 A. Moreover, the β-lactam occupies the 
deacylating acceptor moiety resulting in slower deacylation of the acyl-
enzyme complex leading to blockage of regeneration of the PBP (Lim and 
Strynadka, 2002; Peacock and Paterson, 2015). This slower rate (k3) of 
regeneration of the PBP renders the enzyme effectively irreversibly 
inactivated. Consequently, loss of peptidoglycan cross-linking results in a 
weaker cell wall formation causing cell death (Peacock and Paterson, 2015). 
However, mechanistic understanding leading to cell death is poorly 
understood. Giesbrecht et al (1998) demonstrated that the penicillin-induced 
cell death results from the high internal turgor pressure leading to 
cytoplasmic leakage due to a weak cell wall.  
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The enzyme kinetic parameters for resistance conferred by PBP2A showed 
that PBP2A has a reduced β-lactam mediated acylation rate compared to the 
native PBPs resulting inefficient formation of acyl-PBP complex as a result of 
poorer fit of β-lactam to the active site (Fuda et al., 2004; Graves-Woodward 
and Pratt, 1998). Therefore, reduced acylation rate (k2) of PBP2A is 
important for developing high-level resistance. Secondly, PBP2A showed 
absence of high affinity (Kd) for β-lactams. The PBP2A crystal structure 
showed that the active-site serine of PBP2A is less accessible compared to 
the susceptible PBPs to β-lactams as the active site is located in a narrow 
cleft (Figure 1.9 B and C) (Lim and Strynadka, 2002). β-lactam sensitive 
PBPs undergo conformational changes to facilitate acylation reaction unlike 
PBP2A (Lim and Strynadka, 2002). However, structural analysis of PBP2A 
showed that the activity of PBP2A is under the control of allosteric site, 
located within the non-penicillin-binding domain (Figure 1.9 C) (Otero et al., 
2013). Nascent peptidoglycan access to this allosteric site by recognition of 
the D-Ala-D-Ala dipeptide stimulates conformational changes allowing 
opening the active site for the transpeptidation reaction (Otero et al., 2013). 
Therefore, poor efficiency for acylation together with restricted access to the 





Figure 1.9 Interaction of S. aureus PBPs with β-lactam and their structures 
A) Diagrammatic representation of the interaction of PBPs with β-lactams (represented by 
penicillin). A reversible, noncovalent pre-acylation Michaelis complex (represented by Kd 
as the dissociation constant) is formed upon interaction. The acyl-PBP intermediate is 
formed from the Michaelis complex measured by a rate constant k2. Deacylation rate 
constant k3 measures the regeneration of PBPs due to hydrolysis of acyl-PBP 
intermediate. Taken from (Lim and Strynadka, 2002). 
B) Structural representation of PBP2 showing the catalytic serine residue (red sphere) of 
transpeptidase domain and the catalytic glutamic acid residue (green sphere) of the 
transglycosylase domain. Taken from (Sauvage et al., 2008). 
C) Crystal structure of MRSA PBP2A showing allosteric site highlighted with yellow 
spheres and the active-site serine highlighted with blue sphere within the transpeptidase 





1.7 The genetic basis of methicillin resistance 
Unlike penicillin resistance in S. aureus which is mediated by plasmid-borne 
β-lactamase (Dyke et al., 1966), methicillin resistance is mediated by the 
acquisition of mecA encoding a fifth low affinity PBP named PBP2A in 
addition to the four native PBPs (Hartman and Tomasz, 1984; Utsui and 
Yokota, 1985). The expression of mecA is often induced by the presence of 
β-lactams maintaining peptidoglycan synthesis while the activity of the 
resident PBPs is inhibited (Fuda et al., 2005). PBP2A is the most abundant 
among all native PBPs of MRSA cell, approximately 800 molecules per cell 
(Pucci and Dougherty, 2002); nonetheless, the level of resistance does not 
fully correlate with the amount of PBP2A (Berger-Bächi and Rohrer, 2002; 
Niemeyer et al., 1996; Ryffel et al., 1994). It has also been demonstrated that 
the amount of native PBPs; approximately 150 to 450 molecules per cell, do 
not alter due to the abundance of PBP2A (Pucci and Dougherty, 2002). The 
acquisition of mecA is a prerequisite for the development of resistance (Kim 
et al., 2013; Mwangi et al., 2013). 
1.7.1 Heterogeneous low-level expression of methicillin resistance 
The level of methicillin resistance of MRSA isolate is diverse according to the 
β-lactam and the culture conditions used. A distinctive feature displayed by 
all MRSA is a heterogeneous expression of methicillin resistance which 
means that the majority of bacterial population is sensitive to low 
concentrations of antibiotic (<5 µg/ml methicillin); however, contains a small 
proportion of cells exhibiting high-level resistance (>50 µg/ml) (Hartman and 
Tomasz, 1986; Tomasz et al., 1991). The frequency at which highly 
resistance subpopulation arises is about 10-4, which is reproducible and 
strain-specific (Tomasz et al., 1991). Earlier studies by Tomasz et al (1991) 
classified MRSA into four classes based on methicillin MICs. Class I, II and II 
contained heterogeneously resistant strains with methicillin MIC 1.5-3, 6-12 
and 50-200 µg/ml, respectively; class IV strains exhibited homogeneous 
high-level resistance to methicillin (MIC ≥800 µg/ml) (Tomasz et al., 1991). 
Most MRSA strains expresses heterogeneous resistance under normal 
growth conditions, however growth in hypertonic media containing sucrose or 
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NaCl or incubation at 30°C appeared to develop homogeneous high-level 
resistance (Sabath and Wallace, 1971). While incubation at 37 to 43°C or 
addition of EDTA (pH 5.2) only favours heterogeneous resistance. Incubation 
of heterogeneously resistant strain in the presence of β-lactam antibiotic 
altered the resistance and selected highly resistant clones (Sabath and 
Wallace, 1971). 
Methicillin resistant variants from pre-MRSA strain N315 were isolated upon 
exposure to 3 µg/ml of methicillin, carried mutations or deletions in their mecI 
gene or at the operator of the mecA gene exhibited class III heterotypic 
resistance pattern (Suzuki et al., 1993). However, deletion of mecI by gene-
replacement with tetL strain showed concomitant constitutive expression of 
mecA accompanied by class III heterogeneous resistance (Kuwahara-Arai et 
al., 1996). This observation demonstrates that the constitutive expression of 
mecA through its derepression and concomitant production of PBP2A can 
make the strain resistant to methicillin but only to the heterogeneous level. 
Consistent with this, 38 epidemic MRSA strains isolated from 20 countries 
had either deletion of the mecI gene or mutations in mecI or mutations in the 
operator region of mecA further supporting the importance of the inactivated 
mecI gene for developing methicillin resistance (Hiramatsu, 1995). 
In an effort to understand the underlying mechanism of heterogeneous 
resistance, earlier evidence suggested that the presence of mec gene 
regulators could not alone be responsible for class I heterogeneity in N315 
as inactivation of mecI leaves N315 strain heterogeneously resistant as well 
as PBP2A remains inducible; therefore, it is likely that other factor(s) are 
involved in the heterogeneous expression of resistance (Hiramatsu, 1995).  
1.7.2 Factors influencing methicillin resistance levels 
To investigate the genes responsible for the heterogeneity, transposon 
mutagenesis was carried out using homogeneously resistant MRSA strains. 
This approach identified several genes involved in peptidoglycan synthesis 
which led to change from homogeneously resistant to either susceptible or 
heterogeneously resistant (Berger-Bächi et al., 1992; Berger Bachi, 1983; 
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Kornblum et al., 1986). Subsequently, De Lencastre and Tomasz (1994) 
identified 14 independent loci, auxiliary (aux) factors or fem (factors essential 
for methicillin resistance) responsible for the decrease in methicillin 
resistance of MRSA strains, evidently, unlinked to SCCmec and mecA but 
influencing methicillin resistance (Berger-Bächi et al., 1992; De Lencastre 
and Tomasz, 1994; De Lencastre et al., 1999).  
The characterised fem or aux factors have shown to be housekeeping genes 
and present in the genomes of all wild-type S. aureus strains. Their activity 
influence the expression of resistance (Berger-Bächi and Rohrer, 2002). 
Many of these chromosomal genes are directly or indirectly involved in 
peptidoglycan biosynthesis and turnover or have regulatory functions (Table 
1.3). However, none of them has been shown to alter mecA expression 
(Berger-Bächi and Rohrer, 2002; Roemer et al., 2013). Tightly controlled cell 
wall synthesising processes, such as stem peptide synthesis (femD/glmM), 
addition of lysine to the stem peptide (murE/femF), glutamine reduction of 
precursor stem peptide (femC/glnR) are all required for the expression of 
methicillin resistance (Berger-Bächi and Rohrer, 2002). It is also shown that 
the inhibition of the pentaglycine side chain synthesis through mutated femA, 
femB and femhB, leads to hypersusceptibility as PBP2A strictly requires 
pentaglycine side chain to mediate resistance (Berger-Bächi and Rohrer, 
2002; Rohrer et al., 1999). 
Moreover, teichoic acids have also been implicated in methicillin resistance 
as they are linked to peptidoglycan while lipoteichoic acids are anchored to 
membrane glycolipids. Teichoic acids regulate autolytic activities (Wecke et 
al., 1997) through modulating their charge by addition of phosphate groups 
carrying negative charge and alanine carrying positive charge. Alteration in 
transfer of alanine into teichoic acids through the dlt operon leads to 
increased negative charge influencing cell wall metabolism through altered 
autolytic activities, therefore increases methicillin resistance (Nakao et al., 
2000). Increase in negative charge of the membrane surface have also been 
shown to influence the binding of antimicrobial peptides to the surface 
(Peschel et al., 2001). Other cellular processes involving protein secretion 
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(spsB) and cell division (ftsA and ftsZ) as well as signal transduction systems 
(pknB/SAV1220) were also identified  in contributing to methicillin resistance 
when a specific gene transcript of COL and USA300 isolates were targeted 
using a plasmid library containing an inducible antisense interference 
fragment (Lee et al., 2011; Roemer et al., 2013). This observation 
demonstrated that methicillin resistance is multifactorial where the 
coordinated activity of a network of processes contributes in providing 
resistance in addition to the expression of mecA.  
The cell wall two-component system (TCS) vraSR of S. aureus senses cell 
surface damage through cell wall active antibiotics and subsequently induces 
a cell wall stress stimulon (CWSS) comprising a number of genes including, 
murZ, fmtA, tarA and pbp2 (Jordan et al., 2008; Kuroda et al., 2003). 
Mutations in vraSR have been shown to severely affect the cell wall stress 
response resulting in hypersusceptibility not only to vraSR inducing agents 
but also β-lactam antibiotics (Gardete et al., 2006; Kuroda et al., 2003). 
Consistent with this, oxacillin efficacy was restored in an animal infection 
model against USA300 lacking vraSR (Jo et al., 2011). 
Besides the genetic background of MRSA, the levels of methicillin resistance 
also strongly influenced by the environmental factors such as osmolarity, 
temperature, pH, visible light, the composition of growth media and the 









Addition of the first glycine to the peptide stem, 
inactivation lethal 
(Rohrer et al., 
1999) 
femA 
Addition of the 2nd and 3rd glycine to the peptide stem, 
inactivation disrupts methicillin resistance 
(Strandén et al., 
1997) 
femB 
Addition of the 4th and 5th glycine to the peptide stem, 
inactivation reduces methicillin resistance  
(Henze et al., 
1993) 
femC (glnR) 
Glutamine synthetase repressor, inactivation reduces 
methicillin resistance 
(Gustafson et al., 
1994) 
femD (glmM) 
Phosphoglucosamine mutase, inactivation reduces 
methicillin resistance 
(Jolly et al., 1997) 
femE 
Function unknown; inactivation reduces methicillin 
resistance 
(de Lencastre et 
al., 1994) 
femF (murE) 
Catalyses incorporation of lysine into the peptide stem; 
inactivation reduces methicillin resistance 
(Ornelas-Soares 
et al., 1994) 
fmtA 





Cell surface protein, inactivation reduces methicillin 
resistance 
(Wu and de 
Lencastre, 1999) 
fmtC (mprF) 










Penicillin-binding protein 2, functional transglycosylase 
domain of PBP2 is needed for methicillin resistance 
(Pinho et al., 
2001b) 
sigB 
Transcription factor, inactivation reduces methicillin 
resistance 
(Wu et al., 
1996b) 
hmrA 
Putative aminohydrolase; overexpression increases 
methicillin resistance 
(Kondo et al., 
2001) 
hmrB 
Homologue of acyl carrier protein; overexpression 
increases methicillin resistance 
(Kondo et al., 
2001) 
dlt operon 
Transfer of D-alanine into teichoic acids; inactivation 
increases methicillin resistance 
(Nakao et al., 
2000) 
glmS 
Glucosamine-6-phosphate synthase, required for 
methicillin resistance 
(Lee et al., 2011) 
murA 
Transferase; converts UDP-GlcNAc to UDP-GlcNAc-
enoylpyruvate, required for methicillin resistance 
(Lee et al., 2011) 
murB 
Reductase; converts UDP-GlcNAc-enoylpyruvate to 
UDP-MurNAc, required for methicillin resistance 
(Lee et al., 2011) 
glyS 
Glycine tRNA synthetase, required for methicillin 
resistance 
(Lee et al., 2011) 
gatD 
Glutamine amidotransferase, required for methicillin 
resistance 
(Figueiredo et al., 
2012) 
murT Mur ligase homolog, required for methicillin resistance 




Proposed lipid II translocase, required for methicillin 
resistance 





Proposed lipid II translocase, required for methicillin 
resistance 
(Lee et al., 2011) 
pbp1 (pbpA) PBP with transpeptidation activity (Lee et al., 2011) 
pbp4 
PBP with transpeptidation activity, required for 
methicillin resistance 
(Memmi et al., 
2008) 
ftsA Divisome component, required for methicillin resistance (Lee et al., 2011) 
ftsZ 
Bacterial ortholog of tubulin, Divisome component, 
required for methicillin resistance 
(Lee et al., 2011) 
tarO 
Forms first precursor in WTA synthesis, required for 
methicillin resistance 
(Maki et al., 
1994) 
tarA 
Forms second intermediate in WTA synthesis, required 
for methicillin resistance 
(Wang et al., 
2013) 
tarB 
Forms third intermediate in WTA synthesis, required for 
methicillin resistance 
(Wang et al., 
2013) 
tarD WTA synthesis, required for methicillin resistance 
(Wang et al., 
2013) 
tarL Required for poly ribitol-phosphate extension of WTA (Lee et al., 2011) 
tarI WTA synthesis, required for methicillin resistance 
(Wang et al., 
2013) 
tarS Glycosyltransferase, required for methicillin resistance 
(Brown et al., 
2012) 
ltaS 
Lipoteichoic acid synthase, required for methicillin 
resistance 




Eukaryotic-like serine/threonine kinase, required for 
methicillin resistance 
(De Lencastre et 
al., 1999) 
spsB Signal peptidase I, required for methicillin resistance (Lee et al., 2011) 
vraSR 
Two component signal transduction sensor of cell wall 
stress, inactivation reduces resistance 
(Kuroda et al., 
2003) 
prsA 
Required for post-translational maturation of PBP2A, 
Inactivation increases susceptibility to ceftaroline 
(Jousselin et al., 
2016) 




1.7.3 Homogeneous high-level expression of methicillin resistance 
The mechanism of heterogeneity is particularly intriguing because 
homogeneous high-level resistance arises from S. aureus isolates exhibiting 
heterotypic resistance upon exposure to a β-lactam antibiotic (Hartman and 
Tomasz, 1986). The majority of CA-MRSA exhibit heterogeneous resistance 
such as USA300 while HA-MRSA exhibit homogeneously high-level 
resistance such as COL. Such isolates expressing high-level resistance 
exhibited uniformly stable expression of resistance with little variation in 
colony size to heterogeneous population (Tomasz et al., 1991). Early 
research to examine the transition from heterogeneous to homogeneous 
resistance suggested that the development of stable high-level resistance 
required the acquisition of genetic mutations at non-mec and non-fem loci 
(Ryffel et al., 1994). Selection of homogeneous resistance did not revert to 
heterogeneous resistance following growth in drug-free medium indicating 
the selection of mutations driving the stability and not the induction of 
resistance pathway (Finan et al., 2002; Ryffel et al., 1994).  
Consistent with this hypothesis, introduction of mecA into a strain carrying a 
chromosomal mutation or naturally occurring homogeneously resistant strain 
with inactivated mecA reproduced homogeneously high-level resistance 
(Chambers, 1997; Ryffel et al., 1994). This demonstrates that the 
chromosomally encoded determinant does not function in the absence of 
mecA to express homogeneous high-level resistance. Mwangi et al (2013) 
demonstrated that introduction of plasmid-borne mecA into an MSSA 
background display relatively low resistance, however, is capable of 
developing homogenously high-level resistance upon exposure to a β-lactam 
antibiotic. Genome sequencing of such a highly resistant population 
identified a nonsense mutation in relA resulting in induction of the stringent 
response (Gandara et al., 2018) through constitutive (p)ppGpp production 
(Mwangi et al., 2013). Moreover, introduction of SCCmec into an MSSA 
strain led to the subsequent development of the mutation in relA with 
concomitant (p)ppGpp accumulation (Kim et al., 2013). Using a similar 
methodological approach, Pozzi et al (2012) identified that the 
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homogeneously high-level resistance phenotype was associated with a 
nonsense mutation in gdpP, encoding a recently identified c-di-AMP 
phosphodiesterase (Corrigan et al., 2011). Also, disruption of gdpP was 
implicated in β-lactam and glycopeptide-mediated high-level resistance and 
tolerance (Griffiths and O’Neill, 2012).  
Conversion of heterogeneous to homogeneous resistance in N315 strain is 
promoted by the acquisition of mutations in the rpoB gene, encoding the 
RNA polymerase β-subunit (Aiba et al., 2013). The effect of rpoB mutation 
was reversed upon replacing amino acid substitutions to wildtype suggesting 
the rpoB mutations being the major cause for heterogeneous to 
homogeneous conversion (Aiba et al., 2013). Mutations of rpoB are also 
implicated in the conversion from hVISA to VISA phenotype (Matsuo et al., 
2011; Watanabe et al., 2011). In addition, selection of high-level resistance in 
historic early MRSA isolates identified mutations in 27 genes and 3 
intergenic sequences representing a range of functional diversity (Dordel et 
al., 2014). These mutations were identified in agreement with previous 
research including, rpoB (Aiba et al., 2013), relA (Mwangi et al., 2013) and 
17 different genes sufficient to confer homogeneous high-level resistance 
(Dordel et al., 2014). Transcriptional profiling comparing both heterogeneous 
and subsequent homogeneously resistant population demonstrated that the 
β-lactam mediated SOS response is associated with development of 
homogeneous expression of resistance by the selection of chromosomal 
mutations (Cuirolo et al., 2009). It is important to note that each of the 
aforementioned mutations associated with elevated resistance, accompanied 
an increase in the cellular levels of PBP2A. Also, when repressed, reduction 
of mecA transcription prevents the conversion from heterogeneous to 
homogeneous resistance signifying the requirement for increased mecA 
transcription and concomitant increase in the quantity of PBP2A for 
conversion (Finan et al., 2002).  
In the absence of antibiotics, the chemical structures of peptidoglycan from 
heterogeneously resistant, USA300 (Müller et al., 2015) and susceptible 
strains are indistinguishable from highly resistant strains COL (De Jonge et 
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al., 1992) while in the presence of methicillin poorly cross-linked 
peptidoglycan was produced (de Jonge and Tomasz, 1993) possibly by 
functional PBP2A which is required in increased amounts for high-level 
resistance. 
1.8 Current treatments for MRSA infections  
One of the major problems in the fight against resistant pathogens is the 
difficulty in identifying novel suitable antimicrobial agents. The evolutionary 
perfection of bacterial resistance mechanisms has threatened the 
effectiveness of every antibiotic ever introduced disregarding the molecular 
target of the drug or its chemical class (Payne et al., 2007). The introduction 
of penicillin gave rise to many other new β-lactam related class of antibiotics 
for the treatment of infections.  
1.8.1 New β-lactam antibiotics targeting PBP2A 
Development of novel β-lactam antibiotics with high affinity for PBP2A 
targeting its transpeptidase activity should help for the treatments of MRSA-
associated infections. This includes a newer class of cephalosporin β-
lactams such as ceftobiprole and ceftaroline; for their broad spectrum activity 
against both gram-positive and gram-negative bacteria, including MRSA 
(Barbour et al., 2009; Saravolatz et al., 2011). Compared to other β-lactams, 
ceftaroline and ceftobiprole have lower MIC values against MRSA due to 
their significantly high affinity for PBP2A (Davies et al., 2007; Kosowska-
Shick et al., 2010). Structural studies of ceftaroline-PBP2A complex have 
shown that it binds to an allosteric site and activates the binding of a second 
ceftaroline molecule to the active site of PBP2A resulting in acyl-enzyme 
complex (Villegas-estrada et al., 2008). It is not clear whether ceftobiprole 
acts in a similar way. Resistance to ceftaroline has already been reported 
among MRSA isolates (Otero et al., 2013). Nonsense mutations have been 
identified in transpeptidase domain as well as the allosteric domain of 
PBP2A, presumably lowering the affinity of ceftaroline binding (Fishovitz et 
al., 2014; Otero et al., 2013). These mutations have been characterised to 
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disrupt the salt bridges required for the allosteric activation of PBP2A activity 
(Fishovitz et al., 2014).  
1.8.2 Vancomycin 
The vancomycin group of antibiotics are a class of glycopeptide antibiotics. 
Vancomycin targets the cell wall biosynthesis specifically, the D-Ala-D-ala 
terminus of the pentapeptide stem of the peptidoglycan precursors (Barna 
and Williams, 1984). Vancomycin has become the drug of choice for due to 
its broad-spectrum activity against MRSA. However, S. aureus isolates with 
decreased susceptibility to vancomycin were reported in Japan (Chambers, 
1997) rendering it sufficient for vancomycin treatment failures in some cases. 
Complete resistance to vancomycin was first discovered in enterococci 
(Murray, 2000) due to the acquisition of the transposon Tn1546 encoding the 
vanA operon (Arthur et al., 1993). The first appearance of S. aureus isolate 
with complete vancomycin resistance (MIC ≥16 µg/ml) also carried the vanA 
operon, originally detected in a vancomycin resistant enterococci (VRE) 
(Chang et al., 2003). 
Vancomycin disrupts the late-stages of peptidoglycan biosynthesis by 
blocking the penultimate D-Ala-D-Ala dipeptide residues through formation of 
non-covalent hydrogen bonds, therefore inhibiting cell wall synthesis (Barna 
and Williams, 1984). Mutations in two-component systems, such as walKR 
and graSR have also implicated in reduced susceptibility to vancomycin 
(Meehl et al., 2007). Also, mutations in RNA polymerase subunit β (rpoB) 
and β’ (rpoC) are also commonly associated with reduced susceptibility to 
vancomycin, leading to increased cell wall thickness and prolonged doubling 
time (Matsuo et al., 2011, 2015).   
1.8.3 Teicoplanin  
Similar to vancomycin, teicoplanin is a glycopeptide antibiotic active against 
both MSSA and MRSA as well as other gram-positive cocci. Unlike 
vancomycin, teicoplanin has a longer half-life and can be administered 
intramuscularly (Chambers, 1997), however it is less effective than 
vancomycin. Moreover, treatment with teicoplanin has 25% less clinical 
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success rate compared to vancomycin (Chambers, 1997). Emergence of 
teicoplanin resistance has been reported during therapy and it is also 
possible to select teicoplanin resistant mutants in vitro (Kaatz et al., 1990). 
Mutations in sigB operon was shown to be preferred mutation site 
contributing to the development of teicoplanin resistance in the rsbU mutant 
(Bischoff and Berger-Bachi, 2001). Also, mutations in other genetic loci such 
as yvqF/vraSR, trfAB, tcaA were implicated in reduced susceptibility to 
teicoplanin (Kato et al., 2010). 
1.8.4 Fluoroquinolones  
Fluoroquinolones, such as ciprofloxacin, pefloxacin and ofloxacin have 
shown potent activity against staphylococcal infections. Fluoroquinolones 
primarily targets topoisomerase IV in staphylococci, unlike DNA gyrase in E. 
coli (Ng et al., 1996). Clinically significant levels of resistance have been 
documented due to the acquisition of mutation in the grlA gene encoding the 
A subunit of topoisomerase IV (Ferrero et al., 1995). Additionally, mutations 
in DNA gyrase subunit A are also implicated in fluoroquinolone resistance 
suggesting it as a secondary target of fluoroquinolone (Ferrero et al., 1995). 
As a result of the ability of S. aureus to develop resistance to monotherapy of 
fluoroquinolone, combination of rifampicin and fluoroquinolone has been 
used as the development of resistance is less likely (Kaatz et al., 1989).   
1.8.5 Rifampicin 
Rifampicin is a highly potent antistaphylococcal agent with an MIC of ≤0.05 
µ/ml. Rifampicin inhibits protein synthesis by directly blocking RNA 
polymerase which disrupts transcription elongation of RNA (Campbell et al., 
2001). Mutations in the target of rifampicin, rpoB (RNA polymerase subunit 
β) alone confers high-level resistance if rifampicin is used as monotherapy, 
therefore is subject to use in combination with another antibiotic active 
against S. aureus to which it also is susceptible (Chambers, 1997). Such 
rifampicin combination regimens include nafcillin or vancomycin for the 
treatment of serious infections caused by MRSA (Chambers, 1997). 
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1.8.6 Mupirocin  
Mupirocin, also known as pseudomonic acid A is an antibacterial agent 
produced by Pseudomonas fluorescens which is effective against 
staphylococci and streptococci (Morton et al., 1995). Mupirocin acts by 
inhibiting bacterial isoleucyl-tRNA synthetase, thereby disrupting protein 
synthesis (Hughes and Mellows, 1978). Mupirocin is a topical antibacterial 
agent with higher success rate in eradicating colonised staphylococci 
(Morton et al., 1995). Two types of mupirocin resistance have been 
discovered. First and very common is low to intermediate level resistance 
caused by mutations in target enzyme with MICs from 8 to 256 µg/ml (Morton 
et al., 1995). Second, high-level resistance (MIC = >500 µg/ml) is mediated 
by the acquisition of a non-native plasmid encoding isoleucyl-tRNA 
synthetase which renders mupirocin ineffective (Morton et al., 1995).  
1.8.7 Alternative to antibiotics 
Finally, the developments of new antimicrobial agents have been variably 
successful therefore, S. aureus vaccine candidates are also currently being 
investigated. S. aureus capsular polysaccharide protein conjugate was 
clinically trailed with haemodialysis patients which showed encouraging 
results, however inconclusive (Shinefield et al., 2002). Other vaccine 
candidates such as enterotoxins or surface adhesins directed to S. aureus 
virulence were also proposed to be developed (Lowy, 2003).  
An active immunisation strategy using a staphylococcal surface protein, IsdB 
was tested which resulted in a failure during the phase II/III trial (Bagnoli et 
al., 2012; Kuklin et al., 2006). Even though IsdB is conserved and expressed 
in different S. aureus strains as an important virulence factor, it was reported 
that as an antigen, IsdB vaccine was unable to generate complete protection 
in mouse models with lethal infection (Kuklin et al., 2006; Stranger-Jones et 
al., 2006). In order to improve the efficacy of the vaccine, a combination of 
four surface proteins including IsdA, IsdB, SdrD and SdrE showed high 
levels of protective immunity compared to single component against 
infections with diverse human S. aureus isolates (Stranger-Jones et al., 
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2006). These four proteins bind to haemoglobin on the staphylococcal 
surface which is required for iron uptake from heme compounds of hosts 
(Mazmanian and al., 2003).  
1.9 Aims of the study 
Several research have been carried out in an attempt to understand the 
molecular basis of methicillin resistance which revealed a number of 
essential genes for developing resistance, however how mecA interacts with 
division machinery and confer resistance is not well understood. Therefore, 
the aim of the study was to investigate the underlying mechanism of high-
level methicillin resistance and studying the localisation of PBP2A. This study 
employed a combination of next generation sequencing techniques at 
genomic and transcriptional level coupled with protein labelling. This 
approach allowed to the tracking of the evolutionary progression of 
resistance from low-level to high-level resistance.  
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2 Chapter 2 
Materials and methods 
2.1 Growth media 
All bacterial growth media were prepared in distilled water (dH2O) and 
sterilised by autoclaving at 121ºC for 20 min, 103 kilopascals, unless 
otherwise stated. 
2.1.1 Brain heart infusion (BHI) 
Brain heart infusion (Sigma)  37 g /l 
2.1.2 BHI agar 
Brain heart infusion agar (Sigma)  52 g/l   
2.1.3 Lysogeny broth (LB) 
Tryptone (Oxoid)    5 g/l 
Yeast extract (Oxoid)   10 g/l 
NaCl      5 g/l 
2.1.4 LB agar 
Tryptone (Oxoid)    5 g/l 
Yeast extract (Oxoid)   10 g/l 
NaCl      5 g/l 
 
1.5% (w/v) Sigma Bacteriological agar was added to make LB agar. 
2.1.5 LK broth 
Tryptone (Oxoid)    5 g/l 
Yeast extract (Oxoid)   10 g/l 
KCl      5 g/l 
2.1.6 LK agar 
Tryptone (Oxoid)   5 g/l 
Yeast extract (Oxoid)  10 g/l 
KCl     5 g/l 
 




Antibiotics used in this study are listed in Table 2.1. Stock solutions were 
filter sterilised using 0.2 µm pore size filter and stored at -20ºC until needed. 
Antibiotics stock solutions were added to agar plates after media was cooled 
to 55ºC. Antibiotic stock solutions were thawed and added to liquid media 





S. aureus working 
concentration 
(µg/ml) 




Ampicillin (Amp) 100 - 100 dH2O 
Chloramphenicol 
(Cm) 










50 50 - dH2O 
Lincomycin (Lin) 25 25 - 
95% (v/v) 
ethanol 
Methicillin (Met) 10 5 - dH2O 
Oxacillin (Ox) 10 5 - dH2O 
Tetracycline 
(Tet) 
5 5 - 
50% (v/v) 
ethanol 
Table 2.1 List of antibiotics used in this study 
2.3 Bacterial strains and plasmids 
2.3.1 Staphylococcus aureus strains 
All strains of Staphylococcus aureus listed in Table 2.2 were stored at -80ºC 
in Microbank (Pro-lab Diagnostics) bead vials. Strains were grown on BHI 
agar plate containing appropriate antibiotic where required to maintain 
selection of resistance markers. Agar plates were stored at 4ºC for two 
weeks and for long-term storage single colony was stocked in bead stocks 
and stored at -80ºC. 
Liquid cultures were grown in a sterile universal tube inoculated with a single 
colony and incubated overnight at 37ºC on a shaker at 250 rpm.  
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Strain Characteristic(s) Reference 
SH1000 Functional rsbU+ derivative of 8325-4 
(Horsburgh et al., 
2002) 
RN4220 Restriction deficient transformation recipient  
(Kreiswirth et al., 
1983) 
SJF4978 
8325-4 pmecA HeR; 8325-4 carrying pmecA expression 
heterogeneous resistance to oxacillin; CmR 
(Pozzi et al., 
2012) 
SJF4979 
8325-4 pmecA HoR; 8325-4 carrying pmecA expression 
homogenous resistance to oxacillin; CmR 
(Pozzi et al., 
2012) 
SJF4981 
SH1000 pmecA; SH1000 carrying pRB474 pmecA 




SH1000 pmecA -TI1*; SH1000 carrying pRB474 pmecA 




SH1000 pmecA -TI2*; SH1000 carrying pRB474 pmecA 




SH1000 pmecA -TI3*; SH1000 carrying pRB474 pmecA 




SH1000 pmecA -TR1†; SH1000 carrying pRB474 pmecA 




SH1000 pmecA -TR2†; SH1000 carrying pRB474 pmecA 




SH1000 pmecA -TR3†; SH1000 carrying pRB474 pmecA 




SH1000 pmecA -TIR1‡; SH1000 carrying pRB474 
pmecA expressing high-level resistance to oxacillin 
(Trained-Intermediate to Resistant); CmR 
This study 
SJF4987 
SH1000 pmecA -TIR2‡; SH1000 carrying pRB474 
pmecA expressing high-level resistance to oxacillin 
(Trained-Intermediate to Resistant); CmR 
This study 
SJF4988 
SH1000 pmecA - TIR3‡; SH1000 carrying pRB474 
pmecA expressing high-level resistance to oxacillin 
(Trained-Intermediate to Resistant); CmR 
This study 
SJF4993 
SH1000 pRB474 pmecA cured; SJF4991 from which 
pRB474 pmecA removed  
This study 
SJF4995 
SH1000 pRB474 pmecA+; SJF4993 with pRB474 
pmecA reintroduced; CmR 
This study 
SJF5015 ANG1959; SEJ1 ΔgdpP::KanR; marked gdpP deletion 
(Corrigan et al., 
2011) 
SJF5025 SJF5015; SH1000 ΔgdpP::KanR; marked gdpP deletion This study 
SJF5026 






RN4220 lysA::pmecA; EryR, LinR. Single copy expression 
of mecA under its own promoter from lysA locus 
This study 
SJF4996 
SH1000 lysA::pmecA; EryR, LinR. Single copy expression 
of mecA under its own promoter from lysA locus 
This study 
SJF4998 
SH1000 lysA::pmecA -TI1* (Trained-Intermediate); EryR, 
LinR. Expressing low-level resistance to oxacillin 
This study 
SJF4999 
SH1000 lysA::pmecA -TI2* (Trained-Intermediate); EryR, 
LinR. Expressing low-level resistance to oxacillin 
This study 
SJF5001 
SH1000 lysA::pmecA -TI4* (Trained-Intermediate); EryR, 
LinR. Expressing low-level resistance to oxacillin 
This study 
SJF5002 
SH1000 lysA::pmecA -TI4* (Trained-Intermediate); EryR, 
LinR. Expressing low-level resistance to oxacillin 
This study 
SJF5000 
SH1000 lysA::pmecA -TR1* (Trained-Resistant); EryR, 
LinR. Expressing high-level resistance to oxacillin 
This study 
SJF5003 
SH1000 lysA::pmecA -TR2* (Trained-Resistant); EryR, 
LinR. Expressing high-level resistance to oxacillin 
This study 
SJF5004 
SH1000 lysA::pmecA -TR3* (Trained-Resistant); EryR, 
LinR. Expressing high-level resistance to oxacillin 
This study 
SJF5005 
SH1000 lysA::pmecA -TR4* (Trained-Resistant); EryR, 
LinR. Expressing high-level resistance to oxacillin 
This study 
SJF5006 
SH1000 lysA::pmecA -TIR1* (Trained-Intermediate to 




SH1000 lysA::pmecA -TIR2* (Trained-Intermediate to 




SH1000 lysA::pmecA -TIR3* (Trained-Intermediate to 
Resistant); EryR, LinR. Expressing high-level resistance 
to oxacillin 
This study 
SJF5009 RN4220 lysA::kan; empty vector at lysA This study 
SJF5010 SJF5003; SH1000 lysA::kan empty vector at lysA This study 
SJF5011 
SJF5010; SH1000 lysA::pmecA+; EryR, LinR. pmecA 
reintroduced at lysA locus replaced with empty vector 
This study 
SJF4997 
SJF4993; SH1000 pRB474-pmecA-cured lysA::pmecA. 
EryR, LinR. 
This study 
SJF5024 SJF5010; SH1000 lysA::kan pRB474-pmecA. CmR. This study 
8325-4 Restriction deficient derivative of 8325 
(Kreiswirth et al., 
1983) 
SJF5035 
8325-4 lysA::pmecA; EryR, LinR. Single copy expression 
of mecA under its own promoter from lysA locus 
This study 
SJF5031 
SH1000 lysA::pmecA -TR5* (Trained-Resistant); EryR, 
LinR. Expressing high-level resistance to oxacillin 
This study 
SJF5032 
SH1000 lysA::pmecA -TR6* (Trained-Resistant); EryR, 
LinR. Expressing high-level resistance to oxacillin 
This study 
SJF5033 
SH1000 lysA::pmecA -TR7* (Trained-Resistant); EryR, 
LinR. Expressing high-level resistance to oxacillin 
This study 
SJF5034 
SH1000 lysA::pmecA -TR8* (Trained-Resistant); EryR, 




SJF315 COL; HA-MRSA (type l SCCmec). 
(Shafer and 
Iandolo, 1979) 
SJF4821 MRSA252; HA-MRSA (type ll SCCmec) 
(Enright et al., 
2000) 
SJF5041 Mu50; HA-MRSA (VISA clinical isolate) 
(Hiramatsu et al., 
1997a) 
SJF5042 Mu3; HA-MRSA (hVISA clinical isolate) 
(Hiramatsu et al., 
1997b) 
SJF4703 USA300_FPR3757; CA-MRSA (type lV SCCmec). (Fey et al., 2013) 
SJF5043 MW2; CA-MRSA (type lV SCCmec) 
(Baba et al., 
2002) 
SJF5036 
AJ1008 – AR1089, with kanA near rpoBC, KanR. 
Complementation strain for rpoB and rpoC allele. 
(Villanueva et al., 
2016) 
SJF5037 
MV42 – AR1089, ermB near rpoB+, EryR. Erythromycin 
cassette inserted near rpoB genomic region. 
(Villanueva et al., 
2016) 
SJF5044 








SJF315 (COL), rpoB+, KanR. Complemented to carry 
WT rpoB allele. 
This study 
SJF5046 
SJF5003, SH1000 lysA::pmecA rpoB-H929Q KanR, EryR, 








SJF5048 Newman rpoB-H929Q, KanR.  This study 
SJF5050 
Newman lysA::pmecA rpoB-H929Q, KanR, EryR, LinR. 
Expressing high-level resistance to oxacillin. 
This study 
SJF5021 
RN4220 lysA::eYFP-PBP2A, EryR, LinR. eYFP-PBP2A 
fusion at lysA locus. 
This study 
SJF5022 
SH1000 lysA::eYFP-PBP2A, EryR, LinR. eYFP-PBP2A 
fusion at lysA locus. 
This study 
SJF5023 
SJF4993, SH1000 pRB474-pmecA-cured lysA::eYFP-
PBP2A, EryR, LinR. eYFP-PBP2A fusion at lysA locus of 
multicopy mecA cured background. 
This study 
SJF5066 
SJF5010, mecA-cured-rpoB (H929Q) lysA::eYFP-
PBP2A, EryR, LinR. eYFP-PBP2A fusion at lysA locus of 
single copy mecA-cured-rpoB (H929Q) background. 
This study 
SJF5018 
RN4220 lysA::PBP2A-SNAP EryR, LinR. PBP2A-SNAP 
fusion at lysA locus. 
This study 
SJF5020 
SH1000 lysA::PBP2A-SNAP EryR, LinR. PBP2A-SNAP 
fusion at lysA locus. 
This study 
SJF5027 
SJF4993, pRB474-pmecA-cured lysA::PBP2A-SNAP, 
EryR, LinR. PBP2A-SNAP fusion at lysA locus of multi 
copy mecA cured background. 
This study 
SJF5028 
SJF5010, mecA-cured-rpoB (H929Q) lysA::PBP2A-
SNAP, EryR, LinR. PBP2A-SNAP fusion at lysA locus of 





SJF5025, ΔgdpP::KanR lysA::PBP2A-SNAP, EryR, LinR. 
PBP2A-SNAP fusion at lysA locus of gdpP mutant. 
This study 
SJF5051 





SH1000 srrAB::tet. Tetracycline marked srrAB deletion 
strain. 
This study 
Table 2.2 S. aureus strains used in this study 
CmR, chloramphenicol resistant; EryR, erythromycin resistant; KanR, kanamycin resistant; 
LinR, lincomycin resistant; Tet R, tetracycline resistant. 
2.3.2 Escherichia coli strains 
E. coli strains listed in Table 2.3 were grown and stored similar to S. aureus 
strains using LB broth and agar instead of BHI growth media. 
Strain Characteristic(s) Reference 
DH5α 
E. coli, fhuA2Δ(argF-lacZ)U169 phoA glnV44 Φ80Δ 
(lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 hsdR17 
New England 
Biolabs 
SJF4983 DH5α E. coli pVP01-pmecA; AmpR. This study 
SJF5065 DH5α E. coli pVP02-orfX; AmpR. This study 
SJF5017 DH5α E. coli pMK-RQ_eYFP-PBP2A, KanR. This study 
SJF5019 DH5α E. coli pVP03_eYFP-PBP2A, AmpR. This study 
SJF5012 DH5α E. coli pVP04_PBP2A-SNAP, AmpR. This study 
SJF5013 DH5α E. coli pMA-T_CLIP-tag, AmpR. This study 
SJF5014 DH5α E. coli pVP05_PBP2A-CLIP, AmpR. This study 
SJF5029 DH5α E. coli pVP06_PBP2A-CLIP, AmpR. This study 
Table 2.3 E. coli strains used in this study 
AmpR, ampicillin resistant marker; KanR, kanamycin resistant marker. 
2.3.3 Plasmids  
Plasmids listed in Table 2.4 were purified using GeneJET Plasmid Miniprep 
kit (Thermo Fischer Scientific). See section 2.9.2 for details.  
Plasmid Characteristic(s) Reference 
pRB474 
Low copy E. coli-Staphylococcus shuttle vector. 




2,867 bp EcoRI fragment containing mecA from 
pSAmecA5 subcloned into the EcoRI site of 
pRB474 
(Pozzi et al., 





Derivative of pMUTIN which contains promoterless 
transcriptional lacZ fusion, non-replicating in gram 
positive bacteria; AmpR (E. coli), EryR, LinR (S. 
aureus) 
(Vagner et al., 
1998) 
pGM068 





pGM068, insertion vector carrying mecA under its 




pGM068 including 3’ orfX fragment, insertion vector 
carrying mecA under its native promoter; AmpR (E. 




High copy E. coli shuttle vector for eYFP-PBP2A 




pGM068, insertion vector carrying eYFP upstream 
of mecA under its native promoter; AmpR (E. coli), 




pGM068, insertion vector carrying mecA under its 
native promoter and C-terminal SNAP-tag; AmpR 
(E. coli), EryR, LinR (S. aureus) 
This study 
pMA-T_CLIP-tag 
High copy E. coli shuttle vector for CLIP-tag 




pGM068, insertion vector carrying mecA under its 
native promoter and C-terminal CLIP-tag; AmpR (E. 




pGM068, insertion vector carrying mecA under its 
native promoter and C-terminal CLIP-tag; AmpR (E. 




E. coli-S. aureus shuttle vector containing ftsZ-
snap and lacI gene under Pspac; AmpR (E. coli), 
EryR, LinR (S. aureus) 
Fabien Grein 
Table 2.4 Plasmids used in this study 
AmpR, ampicillin resistant; CmR, chloramphenicol resistant; EryR, erythromycin resistant; 
LinR, lincomycin resistant. 
2.4 Buffers and solutions 
All buffers and solutions were prepared using dH2O and stored at room 
temperature. Solutions were sterilised by autoclaving when required.  
2.4.1 Phage buffer 
MgSO4   1 mM 
CaCl2    4 mM 
Tris-HCl pH 7.8  50 mM 
NaCl    0.6% (w/v) 
Gelatin   0.1% (w/v) 
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2.4.2 Phosphate buffered saline (PBS) 
NaCl    8 g/l 
Na2HPO4   1.4 g/l 
KCl    0.2 g/l 
KH2PO4   0.2 g/l 
 
The pH was adjusted to 7.4 with NaOH. 
2.4.3 TAE (50X) 
Tris base   242 g/l 
Glacial acetic acid  5.7% (v/v) 
Na2EDTA pH 8.0  0.05 M 
 
1x TAE working solution was made by diluting 50x stock solution with dH2O. 
2.4.4 TBSI 
Tris-HCl pH 7.5  50 mM 
NaCl    0.1 M 
 
EDTA-free protease cocktail inhibitor (Roche) was dissolved in buffer prior to 
use. 
2.4.5 Fixative preparation 
2.4.5.1 Preparation of 16% (w/v) paraformaldehyde 
2.4.5.1.1 100 mM sodium phosphate buffer (pH 7.0) 
1 M NaH2PO4     42.3 ml 
1 M Na2HPO4     57.7 ml 
 
The final volume was adjusted to 1:1.  
2.4.5.1.2 16% (w/v) paraformaldehyde 
Paraformaldehyde     8 g 
100 mM sodium phosphate buffer (pH 7.0) 50 ml 
 
In 40 ml 100 mM sodium phosphate buffer (pH 7.0), 8 g of paraformaldehyde 
was added and the solution was heated to 60°C with vigorous mixing. While 
heating and mixing the solution, ≥5 M NaOH solution was added dropwise 




PBS      2 ml 
16% (w/v) paraformaldehyde  0.5 ml 
2.4.6 SDS-PAGE solutions 
2.4.6.1 SDS-PAGE reservoir buffer (10X) 
Tris    30.3 g/l 
Glycine   144 g/l 
SDS    10 g/l 
 
1x SDS-PAGE working solution was made using dH2O. 
2.4.6.2 SDS-PAGE loading buffer (5x) 
Glycerol   50% (v/v) 
Tris-HCl pH 6.8  250 mM 
SDS    10% (w/v) 
DTT    0.5 M 
Bromophenol blue  0.5% (w/v) 
2.4.6.3 Coomassie Blue stain 
Coomassie Blue  0.1% (w/v) 
Glacial acetic acid  10% (v/v) 
Methanol   5% (v/v) 
2.4.6.4 Coomassie destain 
Glacial acetic acid  10% (v/v) 
Methanol   5% (v/v) 
2.4.7 Western blotting solutions 
2.4.7.1 Blotting buffer 
Glycine   11.26 g/l 
Tris    2.4 g/l 
Ethanol   20% (v/v) 
 
Blotting buffer was stored in 4ºC room. 
2.4.7.2 TBST (20x) 
Tris    48.4 g/l 
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Tween-20   2% (v/v) 
NaCl    20 g/l 
The pH was adjusted to 7.6. 1x TBST working buffer was made using 1:20 
dilution with dH2O. 
2.4.7.3 Blocking buffer 
5% (w/v) dried semi-skimmed milk powder was added to 1x TBST buffer 
prior to use. 
2.5 Chemicals and enzymes 
All chemicals and enzymes were of analytical grade quality and were 
purchased from Fischer Scientific, MP Biomedicals or Roche unless 
otherwise stated. All restriction enzymes, ligases, DNA polymerases, Gibson 
master mix and appropriate buffers were purchased from Fermentas, New 
England Biolabs or Bioline. Concentrations of stock solutions and storage 
conditions are shown in Table 2.5. 
Stock solution Concentration Solvent Storage 
Ammonium persulfate (APS) 10% (w/v) dH2O -20ºC 
Lysostaphin (Sigma) 5 mg/ml 
20 mM Sodium 
acetate pH 5.2 
-20ºC 
Pronase (Sigma)  10 mg/ml TES pH 8.0 -20ºC 
Table 2.5 List of chemical stock solutions used in this study 
2.6 Centrifugation 
The following list of centrifuges were used to harvest samples: 
 Eppendorf microcentrifuge 5424, capacity to 24 x 1.5-2 ml microfuges, 
maximum speed of 21,130 x g (14,800 rpm). 
 Sigma centrifuge 4K15C, capacity up to 16 x 50 ml falcon tubes, and 
maximum speed of 5,525 rcf (5,100 rpm). 
 Avanti High Speed J25I centrifuge, Beckman Coulter: 
 JA-10.5, capacity up to 6 x 400 ml; maximum speed of 18, 500 rcf 
(10,000 rpm) 




Centrifugation was carried out at room temperature unless otherwise stated. 
2.7 Determination of bacterial cell density 
2.7.1 Optical density measurements 
Spectrophotometric measurements were taken at 600 nm (OD600) to 
determine the bacterial yield of a culture using a Biochrom WPA Biowave 
DNA spectrophotometer. 1:10 dilution was made using sterile culture media 
whenever necessary. 
2.8 Determination of antibiotic minimum inhibitory concentration 
(MIC) 
2.8.1 Determination of MIC by Etest 
An overnight culture was diluted to an OD600 of ~2 using fresh culture media. 
The diluted bacterial culture was inoculated on BHI agar plated using cotton 
swab. An antibiotic Etest strip was then placed onto the pre-inoculated BHI 
agar plate using tweezers. Etest strips were stored at 4ºC fridge. Plates were 
incubated overnight at 37ºC developing zone of inhibition around the strip 
following incubation. The antibiotic Etests used in this study were oxacillin 
(Oxoid), Penicillin G (Oxoid), Cefoxitin (Liofilchem) and Rifampicin 
(Liofilchem). For anaerobic MICs, plates were supplied with 2 mM NaNO3 
and incubated in anaerobic jar at 37ºC until visible growth was observed. 
2.8.2 Determination of MIC by Microdilution method 
An overnight culture was diluted to an OD600 of ~2 using fresh culture media. 
The desired test antibiotic was diluted to 2X the top concentration desired. 
100 μl of BHI broth was dispensed into all wells of the 96 well microtitre 
plate. Subsequently, 100 μl of test antibiotic solution was pipetted into the 
wells of column 1. The antibiotics was mixed thoroughly by pipetting up and 
down without introducing bubbles. 100 μl of antibiotic-media mixture was 
withdrew from column 1 and added to column 2 followed by thorough mixing 
with pipette. Similarly, the mixture was transferred to column 3 and the 
procedure was repeated to column 10. Pipette tips were changed with every 
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transfer to prevent cross-contamination. Next, 100 μl of mixture was 
discarded from column 10. Then, 5 μl of bacteria was inoculated into wells in 
columns 1 to 11. Column 12 was not inoculated as it was sterility control and 
blank for reading plates. The plates were incubated at 37ºC for 12-18 hours. 
For anaerobic MICs, BHI broth was supplied with 2 mM NaNO3 and 
incubated in anaerobic jar at 37ºC until visible growth was observed in 
column 11 (positive control). The readings were measured with a Perkin 
VICTOR x3 2030 plate reader.  
2.9 DNA purification techniques 
2.9.1 Genomic DNA extraction 
Extraction and purification of S. aureus genomic DNA was carried out using 
a Qiagen DNeasy Blood and Tissue kit. 1 ml of an overnight culture was 
spun at 14,000 rpm for 5 min. The cell pellet was resuspended in 190 µl of 
dH2O and 10 µl of Lysostaphin (5 mg/ml) was added, followed by 1-hour 
incubation at 37ºC. Genomic DNA was isolated in accordance with the 
manufacturer’s instructions.    
2.9.2 Plasmid purification 
Plasmid purification from E. coli was carried out using a GeneJET Plasmid 
Miniprep kit. Manufacturer’s instructions were followed. 
2.9.3 Gel extraction of DNA 
DNA was separated using TAE agarose gel (1% w/v) stained with ethidium 
bromide (0.5 µg/ml). UV transilluminator was used to visualise DNA bands. 
The required band was excised from the gel using a clean scalpel. GeneJET 
Gel Extraction kit was used to purify DNA from agarose gel slice. 
Manufacturer’s instructions were followed.  
2.9.4 Purification of PCR products 
To purify DNA fragments from PCR reactions, GeneJET PCR Purification kit 
was used in accordance with manufacture guidelines.  
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2.9.5 Ethanol precipitation 
Following purification of DNA, 0.1 volume of 3 M sodium acetate pH 6.2 and 
2.5x volume of 95% (v/v) ethanol were added to the sample. The purified 
DNA sample was spun at 14,000 rpm for 30 min at room temperature. The 
supernatant was discarded and the pellet was washed in 1 ml 70% (v/v) 
ethanol and centrifuged at 14,000 rpm for 15 min. the supernatant was 
discarded and the pellet was dried under laminar flow to remove ethanol. 
The pellet was then resuspended in an appropriate volume of sterile dH2O 
(sdH2O). 
2.10 In vitro DNA manipulation techniques 
2.10.1 Primer design 
For PCR amplification, primers were synthesised by Eurofins MWG Operon, 
usually 20-35 nucleotides. Primers were designed based on the DNA 
sequences of S. aureus 8325 or plasmids or fluorescent proteins. For Gibson 
assembly, primers were designed to be ~50 nucleotides long. For cloning, a 
suitable restriction sites were introduced at the 5’ end of primers followed by 
additional bases for efficient restriction digestions at these sites. Primers 
were resuspended in sdH2O. For stock and working solutions, primers were 
diluted to 100 and 10 µM and stored at -20ºC, respectively. Primers used in 
this study are listed in Table 2.6.  
2.10.2 PCR amplification 
2.10.2.1 Phusion polymerase 
Phusion High Fidelity Master Mix (Thermo Scientific) was used for PCR 
amplification where 3’-5’ proofreading activity is required. A final reaction 
volume contained: 
Phusion High Fidelity Master Mix (2x)  25 µl 
Forward primer (10 µM)    2.5 µl 
Reverse primer (10 µM)    2.5 µL 
Template DNA     50-100 ng 
sdH2O      up to 50 µl 
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PCR amplification was carried out in Veriti Thermal Cycler (Applied 
Biosystems). Pre-heated lid (105ºC) was used under the following reaction 
conditions: 
1x Initial denaturation  98ºC  30 s 
30x  Denaturation   98ºC  10 s 
 Annealing   55-62ºC 10 s 
 Extension   72ºC  15-30 s/kb 
1x Final extension  72ºC  3-5 min 
 
2.10.2.2 Taq polymerase 
PCR amplification was performed using DreamTaq Green Master Mix 
(Thermo Scientific). This was used when accurate amplification was not 
needed. Reaction volume was prepared as follows: 
DreamTaq Green Master Mix (2x)  25 µl 
Forward primer (10 µM)    2.5 µl 
Reverse primer (10 µM)    2.5 µL 
Template DNA     50-100 ng 
sdH2O      up to 50 µl 
PCR amplification was carried out in Veriti Thermal Cycler (Applied 
Biosystems). Pre-heated lid (105ºC) was used under the following reaction 
conditions: 
1x Initial denaturation  95ºC  1 min 
30x  Denaturation   95ºC  30 s 
 Annealing   50-60ºC 30 s 
 Extension   72ºC  1 min/kb 
1x Final extension  72ºC  5-7 min 
2.10.2.3 High-Fidelity DNA polymerase 
For difficult and long amplification, Q5 High-Fidelity DNA Polymerase 2x 
Master Mix (NEB) was used for PCR reactions. Reaction volume was 
prepared as follows: 
Q5 High-Fidelity Master Mix (2x)   25 µl 
Forward primer (10 µM)    2.5 µl 
Reverse primer (10 µM)    2.5 µL 
Template DNA     50-100 ng 
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sdH2O      up to 50 µl 
PCR amplification was carried out in Veriti Thermal Cycler (Applied 
Biosystems). Pre-heated lid (105ºC) was used under the following reaction 
conditions: 
1x Initial denaturation  98ºC  30 s 
30x  Denaturation   98ºC  5-10 s 
 Annealing   50-72ºC 10-30 s 
 Extension   72ºC  20-30 s/kb 
1x Final extension  72ºC  2 min 
 
PCR products were analysed by agarose gel electrophoresis (section 
2.10.6). 
 
Primer Sequence (5’-3’) Application Source 
pmecA_F1 TGACGATTCCAATGACGAAC 












Amplifies mecA and 







Amplifies mecA and 







Amplifies mecA and 







Amplifies mecA and 




































Amplification of mecA 










Amplification of mecA 











Amplifies upstream of 

















































































































Gibson forward primer 






Gibson reverse primer 

















































































































of srrAB. Reverse 
primer. 
This study 
Table 2.6 Primers used in this study 
 
2.10.2.4 Colony PCR screening of E. coli 
The PCR reaction mixture was prepared as described above, without the 
addition of template DNA. Using a sterile pipette tip, a single colony from an 
agar plate was introduced into the PCR reaction mixture. The PCR reaction 
was performed according to the protocol described above. 
2.10.3  Restriction endonuclease digestion 
Restriction digestion of DNA was performed using restriction enzymes (NEB) 
according to the manufacturer’s instructions, using the buffers provided. The 
reaction mixture was incubated at 37ºC for between 2 to 16 h. Digested DNA 
was separated using agarose gel electrophoresis and purified for 
downstream experiments.  
2.10.4  DNA ligation 
Plasmid DNA and insert were prepared for ligation reaction by restriction 
digestion or PCR amplification and purified as described above. The ligation 
reaction was prepared in a total of 10 μl volume as follows: 
Linearised plasmid DNA   50 ng 
Insert DNA     3-fold excess of plasmid DNA 
T4 DNA ligase    0.5 μl (200 U) 
T4 DNA ligase buffer (10x)   1 μl 
sdH2O     up to 10 μl 
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The reaction mixture was incubated overnight at 16ºC. The ligated products 
were transformed to competent E. coli cells. 
2.10.5  Gibson assembly 
Plasmid DNA was prepared by restriction endonuclease digestion (section 
2.10.3). Inserts were prepared by PCR amplification using Gibson assembly 
primers (section 2.10.2). Purified DNA fragments were added to reaction 
mixture. The assembly was performed in a final volume of 10 µl: 
Plasmid DNA    50 ng 
Insert      3-fold excess of plasmid DNA 
Gibson assembly Master Mix (2x)  5 µl 
sdH2O     up to 10 μl 
The reaction was performed at 50ºC for 1 h. Ligated DNA fragments were 
diluted to 1:3 using sdH2O. Assembled plasmid was used to transform 
competent E. coli cells. 
2.10.6  Agarose gel electrophoresis 
1% (w/v) agarose gel was used to separate DNA fragments stained with 0.5 
µg/ml ethidium bromide, in 1x TAE buffer. DNA samples were mixed with 6x 
DNA loading dye (Thermo Scientific) before loading into the wells of the gel. 
To resolve DNA probes, 120 V for 30 min was applied at room temperature. 
DNA bands were visualised using an UV transilluminator and photograph 
was taken using UVi Tec Digital camera and UVi Doc Gel documentation 
system. The size of DNA bands was compared with the fragments of DNA 
ladder (Table 2.7). 
2.10.7 DNA sequencing 
Purified PCR products were sequenced by GATC Biotech. Sequencing 
results were analysed using SnapGene software. 
2.10.8 Determining DNA concentration 
DNA concentration in a sample was measured using NanoDrop 3300 
spectrophotometer and operating software v.2.9.1. The blank measurement 
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was taken for 1 µl buffer used for DNA elution. 1 µl of the sample was loaded 
onto the lever to measure DNA concentration at 260 nm. 
 
Marker DNA fragment size (kb) 
















Table 2.7 DNA fragments used as size markers for agarose gel electrophoresis 
 
2.11 RNA purification techniques 
2.11.1 Total RNA extraction 
Extraction and purification of S. aureus total RNA was carried out using a 
Qiagen RNeasy Plus Mini kit. Using fresh bacterial culture with the OD600 
~0.05, culture was grown in fresh media until it reaches OD600 ~0.5. 8 ml of 
Qiagen RNAprotect Bacteria Reagent was added to 8 ml of culture in a 50 ml 
tube and incubated for 5 mins at room temperature. Cells were recovered by 
centrifugation at 4000 rpm for 10 min at 4°C. Pellets can be stored at -70°C 
for future. 200 µl of TE buffer (30 mM Tris-HCl, 1 mM EDTA, pH 8.0) and 200 
µl proteinase K solution was added to the RNAprotect Bacteria Reagent 
treated pellet and vortexed. Tubes were incubated for 1 hour at 37°C in a 
waterbath. The cell suspension was mixed by vortexing every 10 min for at 
least 10 s. Following centrifugation as above, pellet was resuspended in 700 
µl of RLT buffer containing β-mercaptoethanol. Cells were then disrupted 
using MP Biomedicals FastPrep 24 Homogeniser (3x, speed 6.5, 30 s). Cells 
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were incubated on ice for 5 min between each cycle. The samples were 
centrifuged for 30 s at 13,000 rpm to separate lysing matrix. Supernatant 
was harvested in a gDNA eliminator column and spun for 30 s at 10,000 rpm. 
An equal volume of 100% ethanol was added to flow-through and the spin 
column was discarded. 700 µl of mixture was transferred to RNeasy Mini 
Spin Column and centrifuged for 30 s at 10,000 rpm. Flow-through was 
discarded. This step was repeated until all mixture was passed through the 
column. 700 µl of RW1 buffer was added to the column and spun for 30 s at 
13,000 rpm. Flow-through was discarded. 500 µl of RPE buffer was added to 
the column and spun as before. This step was repeated two more times. 
Column was placed in a new collection tube and centrifuged for 90 s at 
13,000 rpm to remove any remaining buffer. To elute RNA from the 
membrane, spin column was placed in a clean microfuge tube and 40 µl of 
nuclease-free water was added onto the membrane and the tube was 
incubated at room temperature for 1 min before spinning at 13,000 rpm for 1 
min. To improve the yield, flow-through was transferred to the membrane 
and spun as before. RNA concentration was measured using NanoDrop. 
RNA samples were stored at -4°C for a month or -70°C for longer period.  
2.12 Protein analysis 
2.12.1 Preparation of whole cell lysate 
S. aureus cells were grown to an OD600 ~1 in 100 ml BHI. Cells were 
collected by centrifugation for 10 min at 5,000 rcf in a pre-chilled centrifuge. 
The cell pellet was resuspended in PBS and spun as before. This step was 
performed two more times. The pellet was resuspended on 500 µl PBS and 
added to pre-chilled lysing matrix tubes containing 0.1 mm acid-washed 
glass beads (Sigma). Cells were broken using an MP Biomedicals FastPrep 
24 Homogeniser (12x, speed 6.5, 30 s). Samples were incubated on ice 
between each cycle. FastPrep beads were separated by a brief spin for 30 s 
at 13,000 rpm. The supernatant was stored at -20°C until needed.  
65 
 
2.12.2 Preparation of membrane fraction 
S. aureus cultures were grown to an OD600 ~1 in 1 l BHI. Cells were collected 
by centrifugation at 5,000 rcf for 10 min at 4°C. Cells were resuspended 
using PBS and centrifuged at 5,000 rpm for 10 min at 4°C. This step was 
repeated 2 more times. TBSI resuspended pellet was then added to chilled 
lysing matrix tubes containing 0.1 mm acid washed glass beads (Sigma) and 
disrupted using an MP Biomedicals FastPrep 24 Homogeniser (12x, speed 
6.5, 30 s). Samples were incubated on ice for 5 min between each cycle. The 
supernatant was recovered by centrifugation for 10 min at 3,500 rpm at 4°C. 
To remove any remaining glass beads or unbroken cells, supernatant was 
transferred to 15 ml Falcon tube and spun at 5,000 rcf for 10 min at 4°C. The 
supernatant was then centrifuged twice for 10 min at 15,000 rcf at 4°C to 
sediment cell wall material. The supernatant was transferred to new 
centrifuge tube and membrane fractions were sedimented by centrifugation 
at 70,000 rcf for 60 min at 4°C. The pellet was resuspended in PBS and 
stored at -20°C. 
2.12.3 Bradford protein assay 
In order to determine concentration of unknown protein, first different known 
concentration (0, 1.6, 4, 8 and 12 µg) of bovine serum albumin (BSA) were 
prepared using 800 µl of PBS and standard curve was plotted (Figure 2.1). 
BSA and PBS solution was transferred into a spectrophotometer cuvette 
(Fisherbrand). 200 µl of BioRad Protein Assay Dye was added to each 
sample and mixed by pipetting. The absorbance at 595 nm was measured 
after 5 min incubation at room temperature. The sample containing 0 µg of 
BSA was used as a blank to calibrate spectrophotometer to zero. Protein 
concentration was calculated based on the dilution factor used and the 





Figure 2.1 Standard curve for Bradford Protein Assay 
The linear regression method was used for estimation of the concentration of protein 
samples. The trend line equation is also shown. 
 
2.12.4 SDS-PAGE 
Laemmli SDS-PAGE was used to analyse membrane fractions and cell 
lysates. Composition of resolving gel is as follows: 
SDS-PAGE 10% (w/v) resolving gel 
 dH20      4 ml 
1.5 M Tris-HCl pH 8.8   2.5 ml 
10% (w/v) SDS    100 µl 
30% (w/v) acrylamide/bis (37.5:1)  3.5 ml 
10% (w/v) APS    100 µl 
TEMED     20 µl 
N,N,N’N’-tetramethyl-ethylenediamine (TEMED) and ammonium persulfate 
(APS) were added to the gel solution immediately before use. The 
components were mixed gently using a pipette without introducing air 
bubbles. The mixture was loaded between the glass plates of a gel casting 
apparatus (BioRad). To isolate gel from air, 100% (v/v) isopropanol was 
added on top of the gel. Isopropanol was drained using filter paper once gel 
was solidified. Composition of stacking gel is as follows: 
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SDS-PAGE 4% (w/v) stacking gel 
dH20      3.6 ml 
0.5 M Tris-HCl pH 6.8   750 µl 
10% (w/v) SDS    50 µl 
30% (w/v) acrylamide/bis (37.5:1)  650 µl 
10% (w/v) APS    50 µl 
TEMED     20 µl 
Mixed stacking gel components were loaded on top of solidified resolving 
gel. To create sample loading wells, a plastic comb was inserted in to the 
stacking gel. The gel was transferred to BioRad tank containing 1x SDS-
PAGE reservoir buffer after it had solidified. To prepare samples, 5x SDS-
PAGE loading buffer was mixed with samples and incubated for 5 min at 
100ºC and appropriate amount of sample was loaded in the wells. 6 µl of 
Color Prestained Protein Standard, Broad Range (NEB) was also loaded as 
a protein size marker (Table 2.8). Proteins were separated by 
electrophoresis at 120 V until the loading dye reached the base of the glass 
plate.  
Protein size marker Molecular mass (kDa) 
Color Prestained Protein 














Table 2.8 Protein size markers 
2.12.5 Coomassie straining 
SDS-PAGE gel was submerged in Coomassie Blue stain following 
electrophoresis for between 30 min to 1 hour in order to visualise protein 
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bands. Subsequently, gel was then destained in Coomassie destain solution 
overnight on shaker until the background was clear. The protein standards of 
known molecular mass were used for comparison of molecular sizes of 
proteins. 
2.12.6 Western blotting 
Following separation of protein samples by SDS-PAGE (section 2.12.4), the 
gel was soaked in blotting buffer for 10 min. Nitrocellulose membrane (GE 
Healthcare) was cut to the same size as gel and soaked in blotting buffer for 
10 min. Using the Mini-Protean Tetra cell system (BioRad), proteins were 
transferred to the membrane from the gel by wet transfer in ice-cold blotting 
buffer. The power was set to 100 V for 90 min. Subsequently, the membrane 
was rinsed with 1x TBST and then the blot was blocked in blocking buffer for 
1 h at room temperature with gentle shaking. The membrane was then rinsed 
and washed three times in TBST for 10 min at room temperature. The 
membrane was incubated with blocking buffer containing appropriate dilution 
of primary antibodies overnight at 4°C with gentle shaking. To remove the 
primary antibody solution, the membrane was rinsed and washed three times 
with TBST for three times for 10 min as before. The membrane was then 
incubated with blocking buffer containing 1:10,000 horseradish peroxidase 
(HRP) conjugated anti-rabbit IgG secondary antibodies (Sigma) for 1 h at 
room temperature with gentle shaking. To remove unbound antibodies, the 
membrane was rinsed and washed with TBST for three times as before. In 
order to detect proteins bound to the membrane, the blot was covered with 
Clarity Western ECL blotting substrates (BioRad) and incubated for 3 min in 
dark room at room temperature. The excess substrate was then removed 
and the blot was scanned using ChemiDoc MP Systems (BioRad) for 
chemiluminescent detection.  
2.12.7 Gel-based analysis of penicillin binding proteins 
For the detection of penicillin binding proteins, membrane fraction was 
isolated (section 2.12.2). Approximately 25 µg of total protein was incubated 
with 30 µM Bocillin FL (ThermoFisher) at 37°C for 30 min. Subsequently, 5x 
69 
 
SDS-PAGE loading buffer was added and incubated for 5 min at 100°C. The 
proteins were separated by SDS-PAGE gel electrophoresis and visualised 
with ChemiDoc MP Systems (BioRad). 
2.13 Transformation techniques 
2.13.1 Transformation of E. coli 
2.13.1.1 Transformation of electrocompetent E. coli 
A 50 µl of E. coli NEB5α electrocompetent cells (NEB) was defrosted on ice. 
1 ng of Gibson assembly mix or plasmid DNA was added to the cells. The 
mixture was pipetted into a pre-chilled 1 mm electroporation cuvette 
(BioRad). Electroporation was carried out at 25 µF, 1.75 kV and 200 Ω using 
a GenePulser Xcell Electroporation system (BioRad). To recover cells, 1 ml 
of LB was immediately added to the cuvette. E. coli cells were incubated for 
1 h at 37°C with shaking at 250 rpm. 100-150 µl of cells were spread on LB 
agar plates containing appropriate antibiotics. The plates were incubated for 
24-48 hours at 37°C until colonies appeared. 
2.13.2 Transformation of S. aureus 
2.13.2.1 Preparation of electrocompetent S. aureus cells 
A single colony of RN4220 S. aureus was inoculated to 400 ml of BHI and 
incubated for 10-12 h at 37°C with shaking at 250 rpm. Using overnight 
culture, fresh 400 ml of BHI was inoculated with a starting OD600 of 0.1. Cells 
were incubated at 37°C with shaking at 250 rpm until the OD600 reaches 0.4-
0.6. Cells were harvested by centrifugation at 5,000 rcf for 10 min at room 
temperature. Pellets were resuspended in 25 ml sdH2O and spun as before. 
This step was repeated three times. Subsequently, pellets were resuspended 
in 20 ml 10% (v/v) glycerol and centrifuged as before for 10 min. This step 
was repeated twice. Then, 10 ml of 10% (v/v) glycerol was used to 
resuspend the pellet and tubes were incubated at room temperature for 30 
min. The cells were centrifuged as before for 10 min. The pellet was 
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resuspended in 200 µl 10% (v/v) glycerol. From this, 50 µl of aliquots were 
prepared and stored at -80°C. 
2.13.2.2 Transformation of electrocompetent S. aureus 
An aliquot of 50 µl electrocompetent RN4220 S. aureus cells was thawed at 
room temperature and ~1 µg plasmid DNA was added to the cells. The 
mixture was pipetted to a pre-chilled 1 mm electroporation cuvette (BioRad). 
Electroporation was carried out at 25 µF, 2.3 kV and 100 Ω using a 
GenePulser Xcell Electroporation system (BioRad). To recover cells, 1 ml of 
BHI was immediately added to the cuvette. Cells were incubated for 3 h at 
37°C with shaking at 250 rpm. 100-150 µl of cells were spread on BHI agar 
plates containing appropriate antibiotics. The plates were incubated for 24-48 
hours at 37°C until colonies appeared. 
2.14 Phage techniques 
2.14.1 Bacteriophage 
In order to perform phage transduction of S. aureus, bacteriophage Φ11 was 
used (Mani et al., 1993). 
2.14.2 Preparation of phage lysate 
The donor strain of S. aureus was grown overnight. 200 µl of the overnight 
culture was mixed with 5 ml phage buffer, 5 ml BHI and 100 µl of a phage 
lysate stock (Φ11). The mixture was incubated overnight at 25°C, until it was 
clear. Subsequently, the lysate was filter-sterilised using 0.2 µm pore filter 
(Merck) and stored at 4°C.  
2.14.3 Phage transduction 
Recipient S. aureus strain was inoculated in 50 ml LK and incubated at 37°C 
overnight, 250 rpm. The overnight culture was centrifuged at 5,000 rcf at 
room temperature for 10 min. The pellet was resuspended in fresh 3 ml LK. 
500 µl of recipient strain was mixed with 1 ml LK, 10 µl 1 M CaCl2 and 500 µl 
phage lysate. The tubes were incubated without shaking at 37°C for 25 min 
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and then with shaking for 15 min. 1 ml ice cold 0.02 M sodium citrate was 
added to the mixture and incubated the tube for 5 min on ice. The cells were 
centrifuged for 10 min at 5,000 rpm and 4°C. The supernatant was discarded 
and the pellet was resuspended with 1 ml ice cold 0.02 M sodium citrate and 
incubated on ice for 50-100 min. 100-150 µl of cells were spread on LK agar 
plate containing 0.05% (w/v) sodium citrate and appropriate antibiotics for 
selection. Plates were incubated for 24-72 hour at 37°C. Single colonies 
were picked and streaked onto BHI agar plate containing antibiotic for further 
confirmation.  
2.15 Microscopy imaging  
2.15.1 Fixing of cells for imaging 
Cell pellets were resuspended with 0.5 ml PBS. 0.5 ml of freshly prepared 
fixative (section 2.4.5) was added to the cells incubated at room temperature 
for 30 min. After fixation, cells were washed twice with sdH2O by 
centrifugation (14,000 rcf, 1 min, room temperature) and resuspension. 
2.15.2 Labelling of SNAP fusion proteins 
For conventional microscopy, strains producing SNAP fusions were grown to 
an OD600 ~0.05 (early exponential phase). 1 ml of cell culture was incubated 
with 0.5 to 1 µM SNAP substrate, SNAP-Cell TMR-Star for 10 min at 37°C. 
After labelling, the cells were washed with PBS by centrifugation for 1 min at 
10,000 rpm at room temperature and resuspended. The cells were then fixed 
for imaging. 
2.15.3 Conventional fluorescence microscopy 
DeltaVision deconvolution microscope (Applied, precision, GE Healthcare) 
was used to acquire fluorescence images. All the images obtained were 
deconvolved using SoftWoRx v.3.5.1 software. Appropriate wavelengths and 
filters used for imaging of fluorophores are listed in Table 2.9. Brightness and 












FITC 492/20 528/38 eYFP 
RD-TR-PE/TxRED 555/28 617/73 TMR-Star 
Table 2.9 DeltaVision filter sets used for imaging 
2.16 Rate of respiration 
2.16.1 Clark-type oxygen electrode 
Clark-type oxygen electrode (Rank Bros Ltd) was used to measure rate of 
respiration. The apparatus contains an electrode operating at a polarising 
voltage of 0.6 V separated by a chamber with an oxygen-permeable Teflon 
membrane. The reduction in the oxygen concentration was measured at the 
cathode which creates a potential difference. The potential difference is 
measured by LabTrax-4 and LabScribe2 software (World Precision 
Instruments). The temperature of the chamber was maintained at 37°C and 
stirred at a constant rate. Prior to experiment, the chamber was calibrated to 
a 100% to 0% oxygen determined by the addition of sodium dithionate.  
2.16.2 Sample preparation 
50 ml of BHI was inoculated with a single colony and incubated overnight at 
37°C with 250 rpm shaking. Next morning, overnight culture was diluted to 
1:50 in 50 ml fresh BHI and incubated to produce log phase culture for 3 
hours at 37°C with 250 rpm shaking. The cultures were centrifuged at 3,380 
rcf for 10 min at 4°C and supernatant discarded. The pellet was washed 
twice by resuspension in ice-cold 0.02 M PBS followed by centrifugation as 
described above. The washed cell pellet was resuspended in 1 ml ice-cold 
0.02 M PBS and kept on ice until needed.  
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2.16.3 Experimental procedure 
Following electrode calibration, 1950 µl of 0.02 M PBS was added to the 
electrode chamber and the system was left idle for 15 min to stabilise oxygen 
concentration inside the chamber. 50 µl of sample (2.16.2) was added to the 
chamber and allowed to stabilise for 5 min. The chamber was then sealed 
with the lid. After 5 min, 50 µl of 1 M glucose was injected into the chamber 
through the lid to begin respiration. The oxygen consumption was recorded 
and respiration rates were calculated as nmolO2/min.  
2.17 Quantification of extracellular lactate 
2.17.1 Sample preparation 
10 ml of BHI was inoculated with a single colony and incubated overnight at 
37°C with 250 rpm shaking. Overnight culture was used to inoculate fresh 10 
ml BHI and incubated until OD600 reaches ~1. Cells were centrifuged for 10 
min at 5,000 rcf at 4°C.  
2.17.1.1 Deproteinisation procedure 
For deproteinisation, 75 µl of supernatant sample (section 2.17.1) was added 
to a clean microfuge tube. In order to precipitate protein, 30 µl of 4 M ice-cold 
perchloric acid (PCA) was mixed well with sample by vortex. Samples were 
incubated on ice for 5 min and centrifuged at 13,000 rpm for 2 min. The 
supernatant was transferred to the new microfuge tube for the sample 
neutralisation step. Samples were neutralised by adding ice-cold 2 M KOH 
that equals 34 % of the supernatant (e.g. 34 µl of 2 M KOH to 100 µl sample) 
and mixed by vortex briefly. This step neutralised the sample and 
precipitated excess PCA. The tubes were left open to release any CO2 
formation. The pH was adjusted between 6.5 to 8.0. To adjust pH, 0.1 M 
KOH or PCA was used when necessary. Samples were centrifuged at 
13,000 rpm for 15 min and supernatant was collected. L-Lactate Assay Kit 
(Colorimetric/Fluorometric) (Abcam) was used to detect lactate in samples 
and manufacturer’s instructions were followed. 
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2.18 Whole genome sequencing 
Whole genome sequencing was provided by MicrobesNG, University of 
Birmingham. Strains were sent as a bead stock.  
2.18.1 Sample preparation 
For genomic DNA extraction, three beads were washed with extraction buffer 
containing Lysostaphin and RNase A followed by incubation at 37°C for 25 
min. Proteinase K and RNase A was added and further incubated at 65°C for 
5 min. In order to purify genomic DNA, equal volume of SPRI (Solid Phase 
Reversible Immobilisation) beads resuspended in EB buffer was used. DNA 
was quantified in triplicates using Quantit dsDNA HS assay in a plate reader 
(Eppendorf).  
Genomic DNA libraries were prepared using Nextera XT Library Prep Kit 
(Illumina) in accordance with manufacturer’s instructions. Library preparation 
and DNA quantification was carried out on a liquid handling system 
(Hamilton Microlab STAR). Pooled libraries were quantified using Kapa 
Biosystems Library Quantification Kit for illumine on a Roche light cycler 96 
qPCR machine. Libraries were sequenced on the Illumina HiSeq using a 250 
bp paired end protocol. 
Above optimised method is taken from MicrobesNG. 
2.18.2 Data analysis 
Reads were trimmed using Trimmomatic 0.30 with a sliding window cutoff of 
Q15 (Bolger et al., 2014). De novo assembly was performed on samples 
using SPAdes version 3.7 (Bankevich et al., 2012). For contigs annotation, 
Prokka 1.11 was used (Seemann, 2014). NCTC8325 whole genome 
sequence was used as a reference for comparison. 




RNA-Seq for transcriptome analysis was performed by Glasgow Polyomics, 
University of Glasgow. Total RNA was extracted from representative strains 
and sent for sequencing. See section 2.11.1 for RNA extraction method. 
2.19.1 Data analysis 
Total RNA samples of three biological replicates for each strain were subject 
to QC prior to library preparation followed by ribosomal depletion using 
TruSeq stranded total RNA kits (Illumina). The generated raw data was 
compared to NCTC8325 reference sequence for expression quantification 
and transcript annotation. Preliminary bioinformatics support for data 
analysis was provided by Glasgow Polyomics which included expression 





3 Chapter 3 
Expression of high-level methicillin resistance using 
multi copy plasmid-borne mecA 
3.1 Introduction 
Methicillin resistance in staphylococci is a major health problem and is due to 
an acquisition of a non-native penicillin binding protein (PBP2A). PBP2A is 
encoded by mecA, involved in the final assembly of crosslinked 
peptidoglycan in the cell wall (Matthews and Stewart, 1984). This additional 
PBP, confers an intrinsic resistance to all available β-lactams due to its low 
binding affinity (Hartman and Tomasz, 1986). Consequently, production of 
PBP2A allows cells to continue growth and division and enables cell wall 
biosynthesis even in the presence of high concentrations of the antibiotics 
(Aedo and Tomasz, 2016). The central genetic determinant, mecA; is carried 
by a mobile genetic element the staphylococcal chromosomal cassette 
(SCCmec), which incorporates into the chromosome at a unique site (Ito et 
al., 2009). The promoter and gene sequences of mecA among most MRSA 
strains are well conserved (Ryffel et al., 1990), except some of the recently 
identified strains carrying a new mec gene homologue (García-Álvarez et al., 
2011; Kim et al., 2012). However, the carrier SCC has been shown to have 
considerable structural diversity (Ito et al., 2009). 
A distinctive characteristic of most MRSA is the heterotypic expression of 
methicillin resistance under normal growth conditions (Chambers et al., 
1989; Pozzi et al., 2012). Heterogeneous expression is characterised by the 
majority of cells being  susceptible to low concentrations of drug in the 
presence of a β-lactam antibiotic, however, a subpopulation is able to 
develop high-level homogenous resistance (Berger-Bächi and Rohrer, 2002; 
Finan et al., 2002; Kim et al., 2013; Pozzi et al., 2012; Sabath and Wallace, 
1971). This phenomenon of exhibiting heterogeneous or low-level resistance 
of MRSA depends on the genetic background of the strain that acquired 
mecA (Berger-Bächi and Rohrer, 2002). Importantly, one of the most 
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significant observations made is that the high-level homogenous resistance 
will arise from low-level resistance following exposure of a staphylococcal 
population to a β-lactam antibiotic (Finan et al., 2002; Hartman and Tomasz, 
1986). Factors found to be influencing high-level resistance have been 
described in several studies in the past (Berger-Bächi and Rohrer, 2002; 
Matthews and Stewart, 1984). The factors with the most profound effect to 
obtain stable resistance are pH, osmolarity, temperature, visible light and 
growth in the presence of β-lactam antibiotic (Berger-Bächi and Rohrer, 
2002; Matthews and Stewart, 1984; Pozzi et al., 2012). While most MRSA 
isolates exhibit varied resistance, the activity of regulatory genes 
(mecI/mecR) which controls mecA transcription cannot be simply involved 
(Mwangi et al., 2013). However, the molecular basis of transition from low-
level to high-level has not yet been examined systematically. 
In an effort to understand the cause of heterogeneous resistance, 
chromosomal genes affecting methicillin resistance were characterised 
(Berger-Bächi and Rohrer, 2002). Many of them play an important role in cell 
wall biosynthesis (Berger-Bächi and Rohrer, 2002; De Lencastre et al., 1999) 
which has given valuable insight into the physiology of this pathway but none 
of them have shown to affect the production of PBP2A so far (Rohrer et al., 
2003). In addition, oxacillin was found to be associated with mediating the 
accessory gene regulator (Agr) dependent SOS response linked with 
increased expression of mecA during conversion from heterogeneous (HeR) 
to homogeneous resistance (HoR) (Cuirolo et al., 2009). Transcriptional 
profiles of MRSA strains, selected for HeR-HoR phenotype, revealed 
increased expression of the agr global regulatory system together with 
increased mecA expression (Plata et al., 2011). However, HeR cells 
overexpressing of ectopic agr were unable to undergo HeR-HoR transition in 
the presence of oxacillin, indicating the importance of increased mecA 
expression (Cuirolo et al., 2009). However, this observation alone is 
insufficient to explain transition from HeR to HoR resistance as highly 
resistant isolates are not deficient in accessory factors (Pozzi et al., 2012). 
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In an attempt to better understand the underlying mechanism of 
heterogeneous β-lactam resistance, Mwangi et al (2013) developed a model 
system. It was shown that introduction of mecA carried on a multicopy 
plasmid into a methicillin sensitive strain produced a heterogeneous 
population from which a highly resistant homogeneous subpopulation was 
selected upon exposure to β-lactam antibiotic. This subpopulation exhibited 
high-level β-lactam resistance indistinguishable from that of the phenotypes 
of most MRSA isolates (Antignac and Tomasz, 2009). This observation 
indicated that some determinants of methicillin resistance may reside in the 
chromosomal genetic background (Mwangi et al., 2013). Whole genome 
sequencing identified point mutations in the relA gene which encodes for 
synthesis of an alarmone (p)ppGpp during the stringent stress response 
suggesting its role in defining high-level β-lactam resistance (Mwangi et al., 
2013). Similar results were obtained when mecA was transferred via an 
entire SCCmec element into an MSSA strain (Kim et al., 2013). However, 
intracellular levels of (p)ppGpp could be modulated by not only genetic 
changes but also by environmental factors.  
Subsequently, Dordel et al (2014) identified 44 different chromosomal 
mutations associated with high-level resistance using whole genome 
sequencing of laboratory isolated early MRSA lineages expressing 
heterogeneous resistance (De Lencastre et al., 2000). Taken together, the 
influence of these genetic factors on the level of methicillin resistance in 
MRSA should be systematically investigated, as the link between genetic 
determinant and high-level expression of resistance is inconclusive.  
It is plausible that the heterogeneous methicillin resistance is an effect of a 
complex regulatory mechanism capable of producing highly resistant 
subclones, only comparison of transcriptional patterns together with 
proteome analysis of the genomes from low-level resistant parents with 
highly resistant strains may shed some light on the identity of pleiotropic 
regulatory networks. It is therefore essential to elucidate the origin of 
heterogeneous low-level methicillin resistance.  
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3.1.1 Aims of the chapter 
The overall aim of this chapter at the outset was to construct a high-level 
methicillin resistant strain in the genetically amenable background an 
SH1000. Then to use super resolution microscopy approaches to study the 
subcellular localisation and dynamics of PBP2A. The specific aims of this 
chapter were to: 
i. Construct genetically amenable MRSA strain using the SH1000 
background 
ii. Experimental evolution of MRSA strains to isolate highly resistant 
MRSA derivatives  






3.2.1 Construction of a genetically amenable MRSA strain 
Previous studies by Pozzi et al., (2012) and Kim et al., (2013) demonstrated 
that plasmid-borne copies of the mecA could be introduced into an MSSA 
strain to generate low-level methicillin resistance. In order to understand the 
molecular basis of methicillin resistance in Staphylococcus aureus, the 
multicopy shuttle plasmid pRB474 pmecA, carrying mecA was transduced 
into the lab strain SH1000 (Pozzi et al., 2012; Rudkin et al., 2012). SH1000 
was chosen because it is amenable to genetic manipulation. The expression 
of mecA was controlled by its native promoter. A phage lysate was made 
using SJF4978 (8325-4 pmecA HeR) and transduced into SH1000. The 
resulting strain SJF4981 (SH1000 pmecA) was selected using BHI 
chloramphenicol (10 µg/ml) plates.  
SJF4981 (SH1000 pmecA) was verified by using an oxacillin Etest (Oxoid 
M.I.C.E) for detection of MIC and by PCR using primers for mecA 
amplification following isolation of pRB474 pmecA (Figure 3.1 B below).  
8325-4 derived strains are susceptible to oxacillin with MICs ranging from 
0.12 to 0.25 µg/ml (Bæk et al., 2014). To verify susceptibility of SH1000, the 
oxacillin MIC using Etest method was carried out which revealed the SH1000 
MIC to be 0.12 µg/ml (Figure 3.1 A below). Acquisition of plasmid-borne 
mecA by SH1000 produces a low-level resistance with an oxacillin MIC value 
of 0.25 µg/ml (Figure 3.1 A below). This observation verified the functionality 
of mecA expression. In addition, SJF4981 (SH1000 pmecA) grows on BHI 
agar plates containing 10 µg/ml chloramphenicol. Furthermore, the plasmid-
borne mecA was confirmed by PCR, following isolation of pRB474 pmecA 
plasmid from SJF4981 (SH1000 pmecA), using primers pmecA_F1 and 
pmecA_R1 (Figure 3.1 B). PCR and oxacillin MIC results confirmed SJF4981 
(SH1000 pmecA) to have the expected phenotype. This observation is 
similar to previous work (Kim et al., 2013; Peacock and Paterson, 2015; 




Figure 3.1 Construction of an SH1000 pmecA MRSA derivative from an MSSA strain 
A) SJF4981 (SH1000 pmecA) construct was produced by transduction using an 8325-4 
HeR (SJF4978) phage lysate containing pRB474 pmecA plasmid carrying mecA under its 
own promoter. Oxacillin MIC was measured using Etest strip for antibiotic susceptibility 
testing. MICs are listed in brackets.  
B) 1% (w/v) TAE agarose gel showing products of PCR amplification of mecA (lane 1) and 
positive control (COL genomic DNA) (lane 2) using pmecA_F1 (forward) and pmecA_R1 
(reverse) primer. The expected DNA fragment of 2.5 kb is indicated with a black arrow for 
both lanes. Sizes of a DNA ladder are shown in kb. DNA fragments were used as size 





3.2.1.1 Isolation of highly oxacillin resistant derivatives of SH1000 
pmecA 
Transformation of plasmid-borne mecA to SH1000 is accompanied by low-
level oxacillin resistance (Section 3.2.1). To investigate the transition to high-
level resistance to oxacillin, a modified gradient plate technique (Szybalski 
and Bryson, 1952) was used (Figure 3.2 A). Two layers of agar were poured 
into an OmniTray (Thermo Scientific). The bottom layer (slanted) consists of 
plain BHI agar covering the entire OmniTray bottom. The top flat layer 
contains 5 µg/ml methicillin (Figure 3.2 A). A heavy suspension of SJF4981 
(SH1000 pmecA) was spread over the surface of the agar covering the 
whole area of the agar in the OmniTray containing the 0-5 µg/ml methicillin 
gradient (Figure 3.2 A below). Only resistant cells are able to grow in the 
regions of highest methicillin concentration whereas, confluent growth is 
obtained in the regions with less methicillin (Figure 3.2 C and D). This 
method allowed the selection of subsequent mutants exhibiting variable 
resistance levels toward oxacillin, with MICs ranging from <2 µg/ml 
(comparable to those of susceptible isolates) to ≥256 µg/ml in highly resistant 
strains. This approach also showed the progression of resistance in 
experimentally evolved oxacillin resistant strains. This screening was 
repeated twice to select enough spontaneous mutants with variable oxacillin 
MIC. Originally, a total of 42 isolates were selected from two separate 
gradient plates containing 0-5 µg/ml methicillin (See Appendix 1 Table 1). Of 
these 42 strains, a total of ten representative strains were selected for further 
study. An evolutionary lineage from SH1000 is shown in Figure 3.3 and 
associated oxacillin MICs are listed in Table 3.1. 
To determine oxacillin MICs for spontaneous mutants isolated from the 
gradient plate, Etest was performed by spreading, using a cotton swab, a 
small aliquot of overnight cultures diluted to an OD600 of 0.1. Oxacillin Etest 
strips were placed on spread plates for overnight incubation. Most isolates 
produced a low-level of resistance to oxacillin MIC value ranging from 2-4 
µg/ml. However, some isolates exhibited higher oxacillin MIC (≥256 µg/ml). 
Isolates producing low-level resistance (2-4 µg/ml) were further spread on a 
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methicillin gradient plate supplied with up to 20 µg/ml methicillin to select for 
increased resistance. This approach allowed the sequential acquisition of 
resistance to be determined at the molecular level. SJF4986 (SH1000 
pmecA TIR1) was considered to be highly resistant to oxacillin (MIC = ≥256 
µg/ml), as Etest results show partial growth around the Etest strip. All 
representative isolates derived from SJF4981 (SH1000 pmecA) are shown in 
Figure 3.3 along with oxacillin MIC Table 3.1. The presence of pRB474 
pmecA was confirmed by growing isolates on agar plates supplied with 10 
µg/ml chloramphenicol. Moreover, an increase in oxacillin MIC was evidence 





Figure 3.2 Scheme of high-level MRSA selection using plasmid-borne mecA expression and subsequent strain evolution 
A) Schematic representation of antibiotic gradient plate of two layers. Bottom layer consists of plain BHI agar, top layer containing 5/20 µg/ml methicillin.  
B) Resistance properties of SJF4981 (SH1000 pmecA) and its parental MSSA, SH1000 strain.  
C) Use of a gradient plate to select for high-level methicillin resistance.  




Figure 3.3 Lineage of SH1000 showing progression of methicillin resistance 
Oxacillin MICs are listed in brackets for all strains. Ten representative strains were 
selected for further study. *, denotes isolates expressing intermediate oxacillin resistance 
(TI – trained-intermediate), listed in orange boxes; †, denotes isolates expressing high-
level oxacillin resistance (TR – trained-resistant), listed in red boxes; ‡, denotes isolates 
expressing high-level oxacillin resistance following selection on 0-20 µg/ml methicillin 
gradient plate using TI1 strain (TIR – trained-intermediate to resistant), also listed in red 
boxes.   
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Strain Gradient plate Oxacillin MIC 
SH1000  0.12 µg/ml 
Parental strain SH1000 
SH1000 pmecA (SJF4981)  0.25 µg/ml 
Parental strain SH1000 pmecA (SJF4981) 
SH1000 pmecA -TI1* (SJF4984) 0-5 µg/ml methicillin 2 µg/ml 
SH1000 pmecA -TI2* (SJF4989) 0-5 µg/ml methicillin 2 µg/ml 
SH1000 pmecA -TI3* (SJF4992) 0-5 µg/ml methicillin 4 µg/ml 
Parental strain SH1000 pmecA -TI1* (SJF4984) 
SH1000 pmecA -TIR1‡ (SJF4986) 0-20 µg/ml methicillin ≥256 µg/ml 
SH1000 pmecA -TIR2‡ (SJF4987) 0-20 µg/ml methicillin ≥256 µg/ml 
SH1000 pmecA -TIR3‡ (SJF4988) 0-20 µg/ml methicillin ≥256 µg/ml 
Parental strain SH1000 pmecA (SJF4981) 
SH1000 pmecA -TR1† (SJF4985) 0-5 µg/ml methicillin ≥256 µg/ml 
SH1000 pmecA -TR2† (SJF4990) 0-5 µg/ml methicillin ≥256 µg/ml 
SH1000 pmecA -TR3† (SJF4991) 0-5 µg/ml methicillin ≥256 µg/ml 
Parental strain SH1000 pmecA -TR3† (SJF4991) 
SH1000 pRB474 pmecA cured (SJF4993)  0.5 µg/ml 
Parental strain SH1000 pRB474 pmecA cured (SJF4993) 
SH1000 pRB474 pmecA+ (SJF4995)  ≥256 µg/ml 
Table 3.1 List of representative strains 
*, denotes isolates expressing intermediate oxacillin resistance (TI – trained-intermediate); †, 
denotes isolates expressing high-level oxacillin resistance (TR – trained-resistant); ‡, 






3.2.1.2 Removal of plasmid-borne mecA  
From the original screening, a total of 18 isolates were picked expressing 
variable oxacillin resistance with MIC ranging from 1 to ≥256 µg/ml. 
Subsequently, 24 more isolates were selected from second screening 
expressing variable oxacillin resistance (Appendix 1 Table 1).  
The results from section 3.2.1.1 showed a vastly variable oxacillin resistance 
developed from a single clone (SJF4981; SH1000 pmecA TI1) upon 
exposure to an antibiotic gradient. This observation is similar to the MRSA 
isolates found in clinical settings exhibiting large variations in the resistance 
level – this may not be simply due to the level of expression of mecA 
(Hartman and Tomasz, 1986; Sieradzki et al., 2008). Therefore, it was 
important to see whether removal of plasmid-borne mecA leads to 
susceptibility to oxacillin with MIC values identical to that of the parental 
strain SH1000 (oxacillin MIC = 0.12 µg/ml).  
To address this question, a highly resistant strain (SJF4991 - SH1000 
pmecA -TR3) with an oxacillin MIC of ≥256 µg/ml was selected. Initially, 
chloramphenicol selection was used to retain plasmid. Growth of highly 
resistant SJF4991 (SH1000 pmecA -TR3) in the absence of chloramphenicol 
generated a plasmid free derivative of SJF4991 (SH1000 pmecA -TR3). The 
strain was subcultured thirty times without chloramphenicol for the removal of 
pRB474-pmecA. In order to eliminate the possibility of inducing non-specific 
spontaneous mutations in the genome, SJF4991 (SH1000 pmecA -TR3) was 
not grown using curing agents or other procedures such as elevated growth 
temperature (Trevors, 1986) unlike in previous studies (Kim et al., 2013; 
Mwangi et al., 2013).  
The plasmid-free SJF4993 (SH1000 pRB474 pmecA cured) derivative was 
isolated from BHI agar plate and tested for oxacillin sensitivity. SJF4993 
(SH1000 pRB474 pmecA cured) regained susceptibility to oxacillin with an 
MIC value (0.5 µg/ml) similar to that of the parental strain SH1000 Figure 3.2 
D and Figure 3.4 A). The successful removal of mecA was also confirmed by 
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PCR to amplify mecA using primers pmecA_F1 and pmecA_R1, as expected 
this PCR did not yield a product (Figure 3.4 A).  
These observations suggest that mecA is a prerequisite for producing high-
level β-lactam resistance (Finan et al., 2002; Hiramatsu et al., 2002; Lim and 
Strynadka, 2002; Peacock and Paterson, 2015; Walsh, 2000). Reintroduction 
of pRB474 pmecA by phage transduction into SJF4993 (SH1000 pRB474 
pmecA cured) produced a strain SJF4995 (SH1000 pRB474 pmecA+) with 
high-level resistance to oxacillin (MIC = ≥256 µg/ml) indistinguishable from 
that of the original SJF4991 (SH1000 pmecA -TR3) (Figure 3.2 D and Figure 
3.4 B). The presence of plasmid-borne mecA was confirmed by PCR to 
amplify mecA using primers pmecA2_SeqF2 and pmecA2_SeqR1 – yielding 
a product of 838 bp (Figure 3.4 B).  
The findings showed that restoration of high-level oxacillin resistance did not 
require re-training on a methicillin gradient plate. This suggests that once an 
apparent chromosomal mutation(s) has been selected, mecA could be 
removed (SJF4993 - SH1000 pRB474 pmecA cured) and replaced (SJF4995 
- SH1000 pRB474 pmecA+) to give high-level resistance. The evolutionary 
lineages for resultant strains SJF4993 (SH1000 pRB474 pmecA cured) and 





Figure 3.4 Removal and reintroduction of pRB474 pmecA 
A) SH1000 pmecA -TR3 (SJF4991) was cured of pRB474 pmecA resulting in SH1000 
pRB474 pmecA cured (SJF4993) regained susceptibility to oxacillin. 1% (w/v) TAE 
agarose gel showing no products (lane 1 and 2) for mecA fragment, positive control using 
COL genomic DNA (lanes 3 and 4) for mecA and non-template control (lane 5) using 
pmecA2_SeqF2 (forward) and pmecA2_SeqR1 (reverse) primers. The expected DNA 
fragment of 838 bp is indicated with black arrow for both lanes. DNA fragments were used 
as size markers for agarose gel electrophoresis. 
B) Subsequently, reintroduction of pRB474 pmecA restored resistance to oxacillin 
resulting in SH1000 pRB474 pmecA+ (SJF4995). Introduction of mecA was confirmed by 
amplification of mecA fragment (lanes 1 to 6), positive control using COL genomic DNA 
(lane 7) and non-template control (lane 8). DNA fragments were used as size markers for 





3.2.2 Identification of genetic determinants required for high-level 
resistance 
Several studies have shown a connection between development of 
resistance and a compensatory mutation(s) in the genome that support the 
phenotypic expression of resistance (Bæk et al., 2015; Baquero, 2001; Kim 
et al., 2013; Martinez and Baquero, 2000; McCallum et al., 2010; Pozzi et al., 
2012). The results obtained above (section 3.2.1.2) indicate involvement of 
genetic determinant(s) that define the level of oxacillin resistance in highly 
resistant trained derivatives (Table 2.2) of SJF4981. 
3.2.2.1 Disruption of gdpP leads to high-level resistance  
To better understand the selection of high-level resistance and to test the 
hypothesis of the involvement of chromosomal mutations, the genomes of 
untrained-SH1000 pmecA (SJF4981) and its derivatives, trained – 
expressing intermediate (low-level) resistance and trained – highly resistant 
strains (Table 3.1 and Figure 3.3) were sequenced using Illumina MiSeq and 
HiSeq 2500 platforms (MicrobesNG, University of Birmingham). Reads from 
strains were mapped to the fully sequenced reference genome of NCTC8325 
(accession no. NC_007795.1). Variant calling was done using VarScan 
(MicrobesNG, University of Birmingham). A total of 93 mutations were 
identified. These included 5 frameshifts, 33 non-synonymous, 14 
synonymous and 2 nonsense mutations. All identified mutations are listed in 
Appendix 1 Table 2 together with locus tag or gene name and mutation 
strength. From these, 77 of the identified mutations were not considered as 
they were present in all strains including control strain SH1000 pmecA 
(SJF4891).  
When SH1000 pmecA (SJF4981) was compared to its highly resistant 
derivatives, whole genome sequencing identified that all trained - highly 
resistant strains have acquired range of mutations in a gene encoding a 
protein named GdpP (GGDEF domain protein containing 
phosphodiesterase) (Figure 3.5 B and Table 3.2), a recently identified c-di-
AMP phosphodiesterase (Corrigan et al., 2011). Previous studies have 
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reported similar findings associated with different phenotypic observations 
(Banerjee et al., 2010; Corrigan et al., 2011; Greninger et al., 2016; Griffiths 
and O’Neill, 2012; Pozzi et al., 2012).  
In S. aureus, gdpP is part of an operon that contains an upstream gene with 
unknown function and the two downstream genes, rplI, the gene encoding 
50s ribosomal protein L9 and dnaC, the gene encoding DnaC protein that is 
important for DNA replication (Corrigan and Gründling, 2013) (Figure 3.5 A). 
In B. subtilis, the regulation of gdpP expression is controlled by a 
transcription factor σD which is involved in motility, chemotaxis and autolysis 
genes (Luo and Helmann, 2012a). GdpP (655 amino acids) contains two 
transmembrane domains; a degenerate Per-Arnt-Sim (PAS) sensory domain, 
involved in small molecule ligands binding and redox responses; a highly 
modified GGDEF motif that produces neither c-di-GMP nor c-di-AMP (Rao et 
al., 2010); a Desert hedgehog (DHH) domain, a characteristic of 
phosphodiesterases (Pde); and a DHH-associated DHHA1 domain (Figure 
3.5 B) (Corrigan and Gründling, 2013). Two amino acid substitutions were 
identified in GGDEF motif of SJF4987 (SH1000 pmecA TIR2) and SJF4990 
(SH1000 pmecA TR2). There were no mutations identified in either PAS 
motif, DHH or DHHA1 domains (Figure 3.5 B). The GGDEF motif, when 
present in a protein containing phosphodiesterase activity have shown to be 
involved in regulation of phosphodiesterase activity of the protein and not the 
synthesis of c-di-GMP or c-di-AMP (Rao et al., 2010). This observation 
suggests that the GGDEF domain has a regulatory function. The other three 
amino acid substitutions in SJF4991 (SH1000 pmecA TR3), SJF4985 
(SH1000 pmecA TR1) and SJF4998 (SH1000 pmecA TIR3) could be linked 
with preventing the ability of the protein to restore susceptibility to oxacillin 
due to loss of catalytic activity of the protein. 
In addition to altered gdpP, other genetic changes were also identified (Table 
3.2) in strains exhibiting low-level and high-level resistance to oxacillin. 
However, mutations in gdpP were only found in highly resistant strains of 
SH1000 pRB474 pmecA. Other seven genes encoding proteins including 
SAOUHSC_00006, DNA gyrase subunit A gyrA; SAOUHSC_00162, Type I 
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site-specific deoxyribonuclease hsdR; SAOUHSC_00370, Hypothetical 
protein; SAOUHSC_01137, Hypothetical protein; SAOUHSC_01812, 
Hypothetical protein; SAOUHSC_02685, putative uncharacterised protein 
(nirR) and SAOUHSC_02932, Oxygen-dependent choline dehydrogenase 
(betA). These seven mutations were discarded because it is likely that these 
genetic changes were introduced during further training of SH1000 pmecA 
TI1 (SJF4984) using a 0-20 µg/ml methicillin gradient to obtain high-level 
resistance (Table 3.2 and Figure 3.3). It is also possible that one or more 
mutations listed in Table 3.2 may have emerged during passage and not be 
linked to a change in resistance (See Appendix 1 Table 2 for derivation of 
strains).  
The strains listed in Table 3.1 used for whole genome sequencing were also 
used for isolation of pRB474 pmecA. DNA Sequencing (GATC Biotech, 
Germany) of the isolated plasmid (pRB474 pmecA) region containing pmecA 
revealed no mutations in plasmid-borne mecA - strongly suggesting the role 




Figure 3.5 Schematic representation of the GdpP operon and SNP locations 
A) Schematic representation of the genomic region containing the gdpP operon, and the rplI and dnaC genes.  
B) The N-terminus of the GdpP protein contains two transmembrane helices (black boxes), a PAS domain, GGDEF, DHH and DHHA1 domains. Amino 










Locus tag (Gene) Protein 
Parental strain SH1000 (SJF682) 
SH1000 pmecA (SJF4981) 0.25     
Parental strain SH1000 pmecA (SJF4981) 
TI1 (SJF4984)      9045 
            176626 











DNA gyrase subunit A 
Type I site-specific deoxyribonuclease 
Oxygen-dependent choline dehydrogenase 
TI2 (SJF4989)      9045 








DNA gyrase subunit A 
Type I site-specific deoxyribonuclease 
TI3 (SJF4992)      9045 
             176626 











DNA gyrase subunit A 
Type I site-specific deoxyribonuclease 
Hypothetical protein 
Parental strain SH1000 pmecA -TI1 (SJF4984) 
TIR1 (SJF4986)    9045 
             176626 











DNA gyrase subunit A 
Type I site-specific deoxyribonuclease 
Hypothetical protein 
TIR2 (SJF4987)    9045 
            18904 











DNA gyrase subunit A 
c-di-AMP phosphodiesterase 
Type I site-specific deoxyribonuclease 
TIR3 (SJF4988)    9045 
            19903 











DNA gyrase subunit A 
c-di-AMP phosphodiesterase 
Type I site-specific deoxyribonuclease 
Parental strain SH1000 pmecA (SJF4981) 
TR1 (SJF4985)     19852 ≥256 C-A A512E SAOUHSC_00015 (gdpP) c-di-AMP phosphodiesterase 
TR2 (SJF4990)     19188 ≥256 G-C G291R SAOUHSC_00015 (gdpP) c-di-AMP phosphodiesterase 
TR3 (SJF4991)     19270 
                376633 














Table 3.2 Mutations identified by whole genome sequencing in SH1000 pRB474 pmecA derivatives relative to NCTC8325
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3.2.2.2 Inactivation of GdpP results in increased resistance to oxacillin  
The genetic mechanism involving GdpP high-level resistance was further 
investigated to examine whether mutations in gdpP, directly affect oxacillin 
resistance. A strain SEJ1 ΔgdpP::kan (SJF5015) containing a kanamycin 
resistance cassette marked gdpP deletion (Corrigan et al., 2011) was lysed 
using bacteriophage Φ 11. Phage transduction introducing the gdpP deletion 
into SH1000 background resulting in strain SJF5025 (SH1000 ΔgdpP::kan) 
upon selection on agar plate supplied with 50 µg/ml kanamycin. The insertion 
of the gdpP deletion was confirmed by PCR amplification (Figure 3.6 A) and 
verified by genomic DNA sequencing (GATC Biotech, Germany). 
Next, SJF5025 (SH1000 ΔgdpP::kan) was transduced with pRB474 pmecA 
to investigate resistance properties in the presence of gdpP. The resultant 
strain, SJF5026 (SH1000 pmecA ΔgdpP::kan) was isolated using an agar 
plate supplemented with 10 µg/ml chloramphenicol. PCR amplification of 
mecA by using mecA_F and mecA_R primers verified the presence of 
pRB474 pmecA Figure 3.6 B). 
Following this, oxacillin MIC was determined for gdpP deleted strains, 
SJF5025 (SH1000 ΔgdpP::an) and SJF5026 (SH1000 pmecA ΔgdpP::kan) 
using an Etest strip (Figure 3.6 A and B). Oxacillin MICs for SJF5025 (MIC = 
0.25 µg/ml) and SJF5026 (MIC = ≥256 µg/ml) revealed that inactivation of 
gdpP leads to high-level resistance. This is supported by the observations of 
Corrigan et al., 2011 and Griffiths and O’Neill, 2012 who noted increased 





Figure 3.6 Increased oxacillin resistance is caused by inactivation of gdpP 
A) A phage lysate of SEJ1 ΔgdpP::kan (SJF5015) was transduced into SH1000 resulting 
into SH1000 ΔgdpP::kan (SJF5025). The deletion of gdpP in SH1000 ΔgdpP::kan 
(SJF5025) was confirmed by a kanamycin cassette PCR resulting in a product marked 
with a black arrow of 395 bp (Lane 1). The MIC for oxacillin determined by Etest is listed 
in brackets. DNA fragments were used as size markers for agarose gel electrophoresis. 
B) Subsequently, pRB474 pmecA was introduced into SJF5025 (SH1000 ΔgdpP::kan) 
resulting in SJF5026 (SH1000 pmecA ΔgdpP::kan) (lane 2). This was confirmed by mecA 
PCR using primers mecA_F (forward) and mecA_R (reverse). The expected fragment of 
1902 bp is shown with a black arrow. The MIC for oxacillin determined by Etest is listed in 






A notable feature of heterogeneous (low-level) expression of methicillin 
resistance in Staphylococcus aureus is that it is mediated by an optimal level 
of production of PBP2A (Kim et al., 2013). However, the level of resistance 
depends on the background of the strains and varies from borderline 
(oxacillin MIC 2-4 µg/ml) resistance to high-level resistance (Tomasz et al., 
1991). Prior studies have noted the importance of selection of chromosomal 
mutations or genetic rearrangements in developing highly resistant 
populations from populations exhibiting low-level resistance (Chan et al., 
2016; Griffiths and O’Neill, 2012; Kim et al., 2013; Mwangi et al., 2013; Pozzi 
et al., 2012). This is further supported by the genetically amenable 
experimental design demonstrated in this study.  
SH1000, a lab strain expressing mecA under its native promoter on plasmid 
pRB474 produced low-level oxacillin resistance as predicted. Oxacillin 
sensitivity for SH1000 pmecA (MIC 0.25 µg/ml) transductants revealed 
similar observations to previously described studies (Pozzi et al., 2012; 
Ryffel et al., 1994), this expression of low-level resistance is similar to 
parental SH1000 (MSSA) strains as well as most MRSA strains. This 
observation suggests variations in basal resistance due to the background of 
the strains. Resistance to a high-level of oxacillin was obtained upon 
exposure to an antibiotic gradient plate containing 5 µg/ml methicillin 
suggesting a small increment in methicillin exposure is sufficient for the 
selection of high-level oxacillin resistance up to ≥256 µg/ml similar to that of 
clinical MRSA isolates containing SCCmec determinant in the chromosome 
(Finan et al., 2002). The selection of high-level resistance developed in the 
presence of mecA alone, without the additional mec-associated SCC 
element. Therefore, we can rule out any role of SCCmec in leading to high-
level resistance. In addition, highly resistant mutants retained a high-level 
resistance phenotype under drug-free growth conditions once selected. 
Removal of pRB474 pmecA from one of the highly resistant mutant restored 
susceptibility to oxacillin similar to parental SH1000 confirming mecA as a 
prerequisite for conferring high-level resistance. When pRB474 pmecA was 
98 
 
reintroduced into cured methicillin sensitive (formerly highly resistant) strains, 
this restored high-level resistance phenotype without further training on 
antibiotic concentration gradient. Therefore, mecA alone cannot promote 
high-level resistance. These observations indicate that a genetic 
determinant(s) reside in the chromosomal genetic background of bacteria 
which define the level of oxacillin resistance. 
It is interesting that the development of high-level methicillin resistance is a 
consequence of genetic rearrangement(s) in the chromosome. Once a 
chromosomal mutation is selected in a strain expressing high-level 
resistance, mecA could be removed and reintroduced resulting in immediate 
high-level resistance to oxacillin. Therefore, the genetic modification of the 
chromosome was confirmed to be responsible for the high-level resistance 
as if the mecA was removed from a highly resistant strain, it became low-
level resistant and reintroduction of the mecA led to concomitant high-level 
resistance without the need for training.  
Whole genome sequencing identified a number of amino acid substitutions in 
the recently identified SAOUHSC_00015, gdpP (GGDEF domain protein 
containing phosphodiesterase) gene in five out of six highly resistant strains 
(Table 3.2 and Figure 3.5). This observation is consistent with the previously 
described studies in which disruption of the gdpP gene supports expression 
of high-level β-lactam resistance (Griffiths and O’Neill, 2012). However, its 
role in producing high methicillin resistance is yet to be studied. S. aureus 
GdpP, a membrane located signalling protein was recently characterised by 
Corrigan et al., 2011 and shown to have an in vitro cyclic dinucleotide, c-di-
AMP phosphodiesterase activity. GdpP contains two N-terminal 
transmembrane domains, a PAS sensory domain, a GGDEF domain, a DHH 
domain and a DHH-associated DHHA1 domain (Figure 3.5). The GGDEF 
domain is capable of synthesising c-di-GMP nucleotide messenger however 
S. aureus  GdpP lacks critical residues for catalysing cyclic diguanylate 
(Griffiths and O’Neill, 2012). The closest homologue of S. aureus GdpP 
protein is the Bacillus subtilis YybT protein, recently shown to have a strong 
phosphodiesterase activity mediated by DHH/DHHA1 domains (Rao et al., 
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2010). The C-terminal DHH/DHHA1 domains of S. aureus GdpP possess 
phosphodiesterase activity therefore mediates hydrolysis of c-di-AMP 
(Griffiths and O’Neill, 2012; Rao et al., 2010). 
c-di-AMP is a novel secondary messenger molecule synthesised by DacA  
and broken down to phosphadenylyl-adenosine (pApA) by GdpP in S. aureus 
as shown in Figure 3.7 (Corrigan and Gründling, 2013). B. subtilis possess 
three diadenylate cyclase (DAC) domain containing proteins (Witte et al., 
2008), compared to only one in S. aureus (Dengler et al., 2013). The dacA is 
often found in an operon containing YbbR sensory domain protein (Figure 
3.8) which physically interacts with DacA and stimulates cyclase activity 
(Corrigan and Gründling, 2013; Dengler et al., 2013). However, deletion of 
ybbR do not affect oxacillin resistance or c-di-AMP levels in S. aureus 
(Bowman et al., 2016). The dacA operon also contain the 
phosphoglucosamine mutase encoding gene (glmM), GlmM is involved in 
peptidoglycan biosynthesis, which suggests a link between the expression of 
the three-gene (dacA-ybbR-glmM) operon and levels of c-di-AMP resulting in 
concomitant cell wall structures and homeostasis (Corrigan and Gründling, 
2013). 
c-di-AMP has already been characterised in Listeria monocytogenes and 
shown to be involved in a range of cellular processes such as 
immunogenicity and sensing DNA damage (Corrigan and Gründling, 2013; 
Woodward et al., 2010). Corrigan et al., 2011 showed that disruption of gdpP 
leads to increased levels of intracellular c-di-AMP that is capable of changing 
cell wall properties resulting into increased resistance to cell wall targeting 
antibiotics such as oxacillin in a lipoteichoic acid (LTA) negative strain. 
Taking this into consideration, it seems possible that increased resistance is 
due to elevated levels of intracellular c-di-AMP due to GdpP being 
inactivated. However, levels of c-di-AMP have not been measured in highly 
resistant mutants studied in this work. Previous study by Dengler et al., 
(2013) showed that an MRSA carrying a naturally acquired mutation in dacA 
gene resulted in a small decrease in the levels of intracellular c-di-AMP, 
which, however had a pronounced effect on oxacillin resistance as the dacA 
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mutant became heterogeneously resistant from being homogeneously 
resistant and the MIC decreased from >256 µg/ml to 64 µg/ml. The cellular 
levels of c-di-AMP have been shown to have a direct influence on cell 
envelope characteristics. In the gdpP mutant strain with increased 
intracellular c-di-AMP, a highly cross-linked peptidoglycan structure was 
observed (Corrigan et al., 2011). This could be potentially linked with 
increased resistance to oxacillin by strengthening the cell wall. However, this 
remains to be confirmed.  
So far, four c-di-AMP target proteins have been identified in S. aureus 
(Figure 3.8 A); KtrA (SAOUHSC_01034), the potassium transporter-gating 
component; CpaA (SAOUHSC_00946), a predicted proton/cation antiporter; 
PstA (SAOUHSC_00456), a P-ll like signal transduction protein; and KdpD 
(SAOUHSC_2314), a phosphate regulon sensor kinase (Corrigan and 
Gründling, 2013; Corrigan et al., 2013). Three of these proteins (KdpD, KtrA 
and CpaA) are implicated in potassium transport system which provides a 
link between c-di-AMP and ion transport (Corrigan et al., 2013). Very 
recently, OpuCA (SAOUHSC_02744), an ATPase component of the carnitine 
ABC transporter, was identified as c-di-AMP receptor protein (Schuster et al., 
2016). However, individually, none of these genes have shown to be 
essential (Campeotto et al., 2015; Corrigan et al., 2013; Fey et al., 2013; 
Moscoso et al., 2016; Schuster et al., 2016). The varying cellular levels of c-
di-AMP is implicated in an altered ability for potassium ion transport 
(Corrigan et al., 2013) which plays major role in maintaining cell physiology 





Figure 3.7 Synthesis and hydrolysis of c-di-AMP in S. aureus. 
c-di-AMP is synthesised by diadenylyl cyclase (Dac) enzymes using two ATP molecules. 
Phosphodiesterases (PDEs) breaks down c-di-AMP into pApA. GdpP is the only 
characterised PDE containing GGDEF domain. It has been speculated that c-di-AMP bind 
to the specific receptor proteins which affect the activity of effector proteins, resulting into 
a regulation of specific cellular pathways. PPi, inorganic pyrophosphate. Adapted from 





Gries et al., (2013) demonstrated that cells lacking a functional Ktr potassium 
uptake system showed increased membrane potential resulting in increased 
susceptibility to aminoglycosides and cationic antibiotics, thereby altered 
cellular c-di-AMP levels exhibited an important role in regulating potassium 
uptake and concomitant membrane potential (Zeden et al., 2018). The gdpP 
mutant (Corrigan et al., 2011) with increased intracellular c-di-AMP showed 
increase membrane potential whereas, the dacA mutant (Bowman et al., 
2016) with reduced intracellular c-di-AMP showed a reduced membrane 
potential (Zeden et al., 2018). Besides, the dacA mutant (Zeden et al., 2018) 
strain completely lacking cellular c-di-AMP found to have reduced oxacillin 
MIC, indicating the importance of an adequate membrane potential to 
produce high-level antibiotic resistance.  
In an effort to understand β-lactam tolerance in S. aureus, Griffiths and 
O’Neill, (2012) studied the impact of inactivated gdpP by truncation of the 
DHH domain. This resulted in a completely abolished catalytic activity of the 
phosphodiesterase activity of DHH motif. In addition, disruption of the 
GGDEF motif alone was also enough to confer high-level oxacillin 
resistance. Therefore, strains missing both catalytic activity of GGDEF and 
DHH motif are highly oxacillin resistant. However, in the current study, the 
identified substitutions of GdpP are distributed covering most regions of the 
protein including an inter-domain sequence. Therefore, it appears that the 
disruption of GdpP supports high-level β-lactam resistance possibly as a 
result of misfolding or destabilisation of the protein. Consequently, loss of 






Figure 3.8 The c-di-AMP signalling network in S. aureus 
A) In S. aureus, environmental changes (yellow lightning bolt) are sensed by YbbR or yet-
unidentified mechanisms. YbbR interacts with the DacA protein, influencing the cyclase 
activity to synthesise c-di-AMP (yellow circles) from ATP. c-di-AMP binds to recently 
identified receptor proteins (KtrA, CpaA, KdpD, PtsA, OpuCA)  potassium uptake system 
(Corrigan et al., 2013; Schuster et al., 2016). This affects the activity of effector proteins 
directly or indirectly. Phosphodiesterase (PDE) activity of GdpP protein hydrolyses c-di-
AMP into 5’ -pApA, resulting in maintenance of cellular c-di-AMP levels (Corrigan and 
Gründling, 2013; Corrigan et al., 2011). Modified from (Corrigan and Gründling, 2013; 
Corrigan et al., 2011). Blue solid circles denotes 5’ pApA. 
B) It is speculated that the highly resistant SH1000 pmecA (SJF4981) derivatives 
containing mutated gdpP are unable to hydrolyse c-di-AMP, resulting into accumulation of 
intracellular c-di-AMP levels affecting the activity of yet unknown receptor protein directly 
or indirectly to produce high-level oxacillin resistance. Modified from (Corrigan and 





To better understand the role of lack of GdpP activity supporting high-level 
resistance, a marked gdpP mutation was transduced into SH1000 pmecA. 
The resultant gdpP deletion strain exhibited high-level oxacillin resistance. 
However, interestingly no gdpP SNP was identified in one (SH1000 pmecA 
TIR1/SJF4986) of the six highly resistant derivatives selected. The mutation 
was amino acid substitution at residue 54 of SAOUHSC_01812. 
Bioinformatics analysis of SAOUHSC_01812, a hypothetical protein revealed 
to possess a putative DHH/DHHA1 motif, characteristic of 
phosphodiesterases (Pde) and its activity is essential for maintaining 
intracellular c-di-AMP levels. Recently, the function of SAUSA300_1650 
(Pde2), DHH/DHHA1 domain protein; an orthologue of SAOUHSC_01812 
has recently been assessed by using a strain lacking the pde2 gene 
(Bowman et al., 2016). Bowman et al., (2016) demonstrated that Pde2 can 
hydrolyses c-di-AMP and pApA to AMP but preferentially hydrolyses pApA to 
AMP over c-di-AMP. Therefore, similar to the gdpP mutant, the pde2 mutant 
leads to accumulation of pApA and increased cellular c-di-AMP levels which 
has shown to be associated with increased oxacillin resistance (Bowman et 
al., 2016). This observation suggests that the SAOUHSC_01812 contributes 
to c-di-AMP metabolism and oxacillin resistance.  
Moreover, there were six other mutations identified in SH1000 pmecA 
derived strains (Table 3.2) accompanying low-level and high-level resistance 
to oxacillin. These mutations were discarded as it is likely that these 
mutations arose due to passaging to construct highly resistant derivative. 
Several recent studies described a connection between cellular c-di-AMP 
levels and the composition of bacterial cell wall. For instance, Corrigan et al., 
2011 showed 15-fold increase in cellular c-di-AMP caused by inactivation of 
gdpP allowed a S. aureus mutant lacking the essential cell wall polymer, LTA 
to grow normally. This phenotype was accompanied by a reduced cell size 
with increased c-di-AMP level. Mutated gdpP in S. aureus, B. subtilis and L. 
monocytogenes leads to increased β-lactam resistance (Banerjee et al., 
2010; Corrigan et al., 2011; Griffiths and O’Neill, 2012; Luo and Helmann, 
2012; Pozzi et al., 2012; Witte et al., 2013). This evidence further supports 
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the hypothesis of significant physiological changes occur due to 
accumulation of intracellular c-di-AMP. Overproduction of GdpP decreases c-
di-AMP levels in B. subtilis and L. monocytogenes and restores sensitivity to 
cell-wall targeting antibiotics (Luo and Helmann, 2012; Witte et al., 2013).  
Together, these data suggest that the transition from low-level to high-level 
methicillin resistance is associated with c-di-AMP levels by regulating cell 
wall synthesis and allowing cells to cope with membrane and cell-wall 
damage upon exposure to β-lactam antibiotics. Overall, these results 
underscore the potential role of gdpP in β-lactam resistance in S. aureus. 
Further work is required to investigate the role of c-di-AMP and target genes 




4 Chapter 4 
Expression of high-level methicillin resistance using 
single copy chromosomal mecA 
4.1 Introduction 
Since the discovery of first clinical MRSA isolate in 1960 in England (Jevons, 
1961), MRSA has become resistant to nearly all available β-lactam 
(methicillin, nafcillin, dicloxacillin oxacillin, etc.) and cephalosporin antibiotics 
(Katayama et al., 2000). Soon after the occurrence of resistance, various 
hospital-acquired MRSA (HA-MRSA) and community-acquired MRSA (CA-
MRSA) were found disseminated worldwide (Rice, 2006). In addition, MRSA 
has a remarkable ability to acquire resistance to other classes of antibiotics 
such as, vancomycin – an antibiotic of last resort, tetracyclines, macrolides, 
quinolones and aminoglycosides (Hiramatsu et al., 1997a; Tenover et al., 
1998). The appearance of vancomycin-intermediate (VISA) strains is thought 
to be due to an increased cell wall thickness, resulting into restricted access 
of vancomycin to its target (Howden et al., 2010). Whereas, the molecular 
basis of methicillin resistance in S. aureus is yet to be studied. Currently, key 
areas of methicillin resistance research include; the evolution of resistance 
and the effects of genetic factors to the physiology of MRSA.  
The first step for the development of methicillin resistance is the acquisition 
of mecA via a mobile genetic element – staphylococcal cassette 
chromosome mec (SCCmec), integrated into the chromosome of an MSSA 
strain (Hiramatsu, 1995). The composition of SCCmec is highly diverse in 
MRSA (Berglund et al., 2008; Liu et al., 2016a) and its integration into the 
chromosome is driven by site-specific recombinases, ccrA and ccrB 
(Katayama et al., 2000). SCCmec possess three basic genetic elements: the 
mec gene complex, the ccr gene complex, insertion sequences (IS) and the 
junk regions (J region) (Berglund et al., 2008; Liu et al., 2016a). Other than 
mecA, the mec gene complex carries mecA regulatory genes, mecR1 – 
encoding the signal transducer protein MecR1 and mecI – encoding the 
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repressor protein MecI (Archer and Bosilevac, 2001). Based on high diversity 
in the structural organisation and the integrity of genetic content of SCCmec 
elements, they are currently classified into type I to XI and further classified 
into different subtypes (Ito et al., 2009; Liu et al., 2016a). 
The mecA gene encodes for a non-native penicillin binding protein (PBP2A), 
a transpeptidase involved in cell wall biosynthesis (Brown and Reynolds, 
1980; Hartman and Tomasz, 1986). Native PBPs (PBP1, PBP2, PBP3 and 
PBP4) of S. aureus are involved in final assembly of peptidoglycan synthesis 
but have higher affinity for β-lactam antibiotics (Tipper and Strominger, 
1965). Unlike, native PBPs of S. aureus, PBP2A has low affinity for β-lactam 
antibiotics and therefore in the presence of antibiotics, it takes over the 
transpeptidase activities of conventional PBPs and cell can continue to grow 
(Lim and Strynadka, 2002). Even though PBP2A takes over transpeptidase 
activities of native PBPs, previous experiments indicated that 
transglycosylase activity of PBP2 is required for the expression of methicillin 
resistance (Pinho et al., 2001b), suggesting that cell wall synthesis is 
coordinated via convoluted interactions between PBPs.  
Most MRSA strains carry intact regulatory genes, mecI and mecR1, resulting 
into strong repression of mecA (Kuwahara-Arai et al., 1996), however 
truncated mecI and mecR1 results into constitutive expression of mecA 
(Katayama et al., 2001). While mecA is essential for methicillin resistance, 
the majority of MRSA strains only exhibit low-level resistance (MIC = 2-4 
µg/ml) (Ryffel et al., 1994) however these cells are capable of developing 
uniform high-level resistance upon exposure to antibiotics (Finan et al., 2002; 
Sabath and Wallace, 1971; Tomasz et al., 1991). This indicates that 
acquisition of mecA alone cannot impart high-level resistance. It is not 
necessary for the production of PBP2A to increase substantially for the 
expression of high-level resistance, even when it is constitutively expressed 
(Hartman and Tomasz, 1986). Therefore, the quantity of PBP2A does not 
correlate with the variable levels of resistance, indicating other genetic 
determinants other than PBP2A must be responsible for conferring high-level 
resistance (Hartman and Tomasz, 1986).  
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Early research of transposon mutant libraries identified a range of fem 
(factors essential for methicillin resistance) genes and aux (auxiliary factors) 
that are unlinked to mecA but are linked to influence methicillin resistance 
(Berger-Bächi and Rohrer, 2002; Berger-Bächi et al., 1992; De Lencastre 
and Tomasz, 1994). Many of fem genes are directly or indirectly involved in 
peptidoglycan biosynthesis or regulatory processes (Berger-Bächi and 
Rohrer, 2002). However, the mechanistic insights of high-level resistance 
remain to be studied.  
4.1.1 Aims of the chapter 
The overall aim of this chapter was to construct a high-level methicillin 
resistant strain in the genetically amenable background, SH1000 with 
chromosomal expression of mecA under its native promoter. Using super 
resolution microscopy approaches to study the subcellular localisation and 
dynamics of PBP2A. The specific aims of this chapter were to: 
i. Construction of genetically amenable MRSA strain using well defined 
lab strain SH1000 
ii. Experimental evolution of MRSA derivatives and isolation of highly 
resistant MRSA mutants 





4.2.1 Construction of a genetically amenable MRSA train 
Previous studies have demonstrated the importance of compensatory 
mutations acquired by the genetic background in leading to high-level 
resistance. These studies were conducted using plasmid-borne mecA 
expression. 
In order to investigate the effect of a single copy mecA within SH1000 
chromosome on antibiotic resistance, mecA and its native promoter was 
amplified using genomic DNA of COL strain as a template. For chromosomal 
integration of mecA, the suicide vector pMUTIN4 (Vagner et al., 1998) based 
pGM068 lysine insertion plasmid (McVicker et al., 2014) was used to 
integrate mecA under its own promoter (pmecA) downstream of the lysA 
gene. pGM068 contains a truncated 3’ region of a lysA gene encoding the 
terminal enzyme of lysine biosynthesis pathway in S. aureus. This provides a 
region of homology with a chromosomal lysA gene which upon 
transformation in S. aureus results in recombination between 3’ lysA of the 
plasmid and the chromosomal region. This created an insertional duplication 
providing erythromycin resistance without undesired disruption of lysA 
causing lysine auxotrophs. The gel purified pmecA was cloned into the 
BamHl /Sacl site of pGM068 using Gibson assembly resulting in pVP01-
pmecA plasmid (Figure 4.1 A and C) and transformed into E. coli DH5α 
(NEB). Recombinant plasmids were isolated and tested by restriction 
enzyme digest with BamHl/Sacl site producing two bands 7669 bp and 2550 
bp for linear pVP01 backbone and pmecA, respectively (Figure 4.1 C and D) 
and validated by DNA sequencing. The resulting plasmid pVP01-pmecA was 
electroporated into RN4220 resulting into RN4220 lysA::pmecA (SJF4994) 
and transduced into SH1000 creating SH1000 lysA::pmecA (SJF4996). The 
insert pmecA was amplified to confirm integration of the pVP01-pmecA into 
the chromosome (Figure 4.1 C). The correct insertion of plasmid at lysA 
locus was also confirmed by PCR using a forward primer residing in the 
chromosome and a reverse in pmecA insert generating a product of ~4000 




Figure 4.1 Construction of a chromosomal pmecA fusion in S. aureus SH1000 
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A) Diagrammatic illustration of pVP01-pmecA construction. A 2532 bp fragment including the mecA gene and its native promoter (pmecA) was PCR 
amplified from COL genomic DNA using pMUTIN4_OL_FP1 and pMUTIN4_OL_RP1. These primers were designed to regenerate restriction site 
BamHl/Sacl. The pGM068 plasmid was linearised using BamHl/Sacl restriction enzymes. The linearised plasmid backbone and PCR amplified pmecA 
fragments were joined by Gibson assembly, resulting into pVP01-pmecA.  
B) Schematic overview of genomic region of lysA in SH1000 and post integration of pVP01-pmecA resulting into lysA::pmecA (SJF4996). Primer 
binding sites are shown with black arrows. 
C)  pmecA insert was amplified using overlapping primers pMUTIN4_OL_FP1 and pMUTIN4_OL_FR1 creating overhanging strands at both ends of 
the product. The expected band size of 2618 bp for pmecA insert is marked by black arrows (lane 1, 2). DNA fragments were used as size markers for 
agarose gel electrophoresis. 
D) The insertion of pmecA fragment into pGM068 was verified by PCR using pmecA_F1 and pmecA_R1 primers resulting in 2550 bp product marked 
by a black arrow (lane 1, 2). DNA fragments were used as size markers for agarose gel electrophoresis. 
E) pGM068 was digested with BamHl and Sacl enzymes resulting in 7669 bp linear vector backbone and an addition fragment of 1998 bp marked with 
black arrows (lane 1, 2). DNA fragments were used as size markers for agarose gel electrophoresis. 
F) The chromosomal integration of pVP01-pmecA was verified by using forward primer lysA_5’_for and pmecA_R1 resulting in a product of ~4000 bp 
marked by a black arrow (lane 1, 2). DNA fragments were used as size markers for agarose gel electrophoresis. 
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4.2.1.1 Detection of oxacillin susceptibility of SH1000 lysA::pmecA 
The oxacillin MIC by Etest method was compared for SH1000 and its derived 
SH1000 lysA::pmecA (SJF4996). As shown in section 3.2.1, SH1000 is 
susceptible to oxacillin (MIC 0.12 µg/ml) whereas SH1000 lysA::pmecA 
(SJF4996) expresses low-level resistance to oxacillin with an MIC of 2 µg/ml 
(Figure 4.2), similar to most clinical isolates of MRSA with borderline or 
heterogeneous resistance (Gerberding et al., 1991; Varaldo et al., 1993). 
This confirms the introduction of functional single copy expression of 
chromosomal integrated mecA at lysA locus of SH1000 lysA::pmecA 
(SJF4996). The insertion of mecA further verified by PCR (Figure 4.1 F).  
 
4.2.1.2 Isolation of highly oxacillin resistant derivatives of SH1000 
mecA 
The SH1000 lysA::pmecA (SJF4996) strain was trained to produce high-level 
resistance to oxacillin using antibiotic gradient plate technique as described 
in section 3.2.1.1 and Figure 3.2 A. A heavy suspension of SH1000 
lysA::pmecA (SJF4996) was streaked over the surface of the agar containing 
0-5 µg/ml methicillin gradient (Figure 4.3 B). Only resistant cells were able to 
grow towards the region with highest concentration of methicillin.  
From this initial screening, a total of eight spontaneous mutants were 
selected (Figure 4.3 B). Subsequent (trained) mutants exhibited variable 
levels of resistance to oxacillin, with MICs ranging from 2 to ≥256 µg/ml 
(Figure 4.4). Oxacillin susceptibility testing was carried out by using the Etest 
method. Similar to the results obtained in section 3.2.1.1, progression of 
resistance was achieved in experimentally evolved strains. Four isolates 
(SH1000 lysA::pmecA -TI1, SJF4998; SH1000 lysA::pmecA -TI2, SJF4999; 
SH1000 lysA::pmecA -TI3, SJF5001; SH1000 lysA::pmecA -TI4, SJF5002) 
exhibiting low-level (2-4 µg/ml) or intermediate level (<16 µg/ml) resistance 
were picked (Figure 4.4 and Table 4.1). Four isolates (SH1000 lysA::pmecA -
TR1, SJF5000; SH1000 lysA::pmecA -TR2, SJF5003; SH1000 lysA::pmecA -
TR3, SJF5004; SH1000 lysA::pmecA -TR4, SJF5005) exhibiting high-level 
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(≥256 µg/ml) resistance were also found from the first screen (Figure 4.4 and 
Table 4.1). SH1000 lysA::pmecA -TI1 (SJF4998) was further trained on a 
methicillin gradient plate supplied with 20 µg/ml methicillin to select for 
isolates with increased resistance with an MIC of ≥256 µg/ml (oxacillin). The 
resultant trained-intermediate-to-resistant strains were SH1000 lysA::pmecA 
-TIR1 (SJF5006), SH1000 lysA::pmecA -TIR2 (SJF5007) and SH1000 
lysA::pmecA -TIR3 (SJF5007) with oxacillin MIC of ≥256 µg/ml (Table 4.1). 
This methodology allowed the detection of the progression of resistance for 
each strain.  
The evolutionary lineage of SH1000 to SH1000 lysA::pmecA for all derived 






Figure 4.2 Construction and oxacillin MIC of SH1000 and SJF4996 




Figure 4.3 Scheme of high-level MRSA construction using single copy chromosomal insertion of mecA and subsequent strain evolution 
A) SH1000 lysA::pmecA (SJF4996) construct was produced by transduction from RN4220 lysA::pmecA (SJF4994). This led to single copy mecA at the 
lysA locus with mecA expressed under its native promoter. Oxacillin MICs shown in brackets were measured using the Etest strip. 
B) Subsequently, spontaneous mutants exhibiting oxacillin resistance were selected using a gradient plate containing either 0-5 or 0-20 µg/ml of methicillin. 
Strains with low-level resistance were further trained using an antibiotic gradient plate containing 0-20 µg/ml methicillin to select high-level resistance. 





Figure 4.4 Lineage of SH1000 showing progression of methicillin resistance 
Oxacillin MICs are listed in brackets for all strains. *, denotes isolates expressing 
intermediate oxacillin resistance (TI – trained-intermediate) listed in orange boxes; †, 
denotes isolates expressing high-level oxacillin resistance (TR – trained-resistant) listed in 
red boxes; ‡, denotes isolates expressing high-level oxacillin resistance following 
selection on 0-20 µg/ml methicillin gradient plate using TI1 strain (TIR – trained-
intermediate to resistant) also listed in red boxes. Further description of the strains is in 





Strain Gradient plate 
Oxacillin 
MIC 
SH1000  0.12 µg/ml 
Parental strain SH1000 
SH1000 lysA::pmecA (SJF4996)  2 µg/ml 
Parental strain SH1000 lysA::pmecA (SJF4996) 
SH1000 lysA::pmecA -TI1* (SJF4998) 0.5 µg/ml methicillin 2 µg/ml 
SH1000 lysA::pmecA -TI2* (SJF4999) 0.5 µg/ml methicillin 16 µg/ml 
SH1000 lysA::pmecA -TI3* (SJF5001) 0.5 µg/ml methicillin 16 µg/ml 
SH1000 lysA::pmecA -TI4* (SJF5002) 0-20 µg/ml methicillin 16 µg/ml 
Parental strain SH1000 lysA::pmecA -TI1 (SJF4998) 
SH1000 lysA::pmecA -TIR1‡ (SJF5006) 0-20 µg/ml methicillin ≥256 µg/ml 
SH1000 lysA::pmecA -TIR2‡ (SJF5007) 0-20 µg/ml methicillin ≥256 µg/ml 
SH1000 lysA::pmecA -TIR3‡ (SJF5008) 0-20 µg/ml methicillin ≥256 µg/ml 
Parental strain SH1000 lysA::pmecA (SJF4996) 
SH1000 lysA::pmecA -TR1† (SJF5000) 0.5 µg/ml methicillin ≥256 µg/ml 
SH1000 lysA::pmecA -TR2† (SJF5003) 0-20 µg/ml methicillin ≥256 µg/ml 
SH1000 lysA::pmecA -TR3† (SJF5004) 0-20 µg/ml methicillin ≥256 µg/ml 
SH1000 lysA::pmecA -TR4† (SJF5005) 0-20 µg/ml methicillin ≥256 µg/ml 
Parental strain SH1000 lysA::pmecA (SJF4996) 
SH1000 lysA::pmecA -TR5† (SJF5031) 0.5 µg/ml methicillin ≥256 µg/ml 
SH1000 lysA::pmecA -TR6† (SJF5032) 0.5 µg/ml methicillin ≥256 µg/ml 
SH1000 lysA::pmecA -TR7† (SJF5033) 0.5 µg/ml methicillin ≥256 µg/ml 
SH1000 lysA::pmecA -TR4† (SJF5034) 0.5 µg/ml methicillin ≥256 µg/ml 
Parental strain SH1000 lysA::pmecA -TR2† (SJF5003) 
SH1000 lysA::kan cured (SJF5010)  0.5 µg/ml 
Parental strain SH1000 lysA::kan cured (SJF5010) 
SH1000 lysA::pmecA+ (SJF5011)  ≥256 µg/ml 
Table 4.1 List of representative strains 
*, denotes isolates expressing intermediate oxacillin resistance (TI – trained-intermediate); †, 
denotes isolates expressing high-level oxacillin resistance (TR – trained-resistant); ‡, 






4.2.1.3 Removal of a single copy chromosomal mecA 
The vast differences in the level of oxacillin resistance obtained in SH1000 
lysA::pmecA (SJF4996) trained derivatives (Figure 4.4 and Table 4.1) is 
similar to clinical MRSA isolates; this could not be simply due to the level of 
expression of mecA (Hartman and Tomasz, 1986; Sieradzki et al., 2008). 
Therefore, it was hypothesised that excision of chromosomal mecA from one 
of the highly resistant strains would lead to restored oxacillin susceptibility 
identical to that of the parental strain SH1000 (oxacillin MIC = 0.12 µg/ml). 
To address this, SH1000 lysA::pmecA -TR2 (SJF5003) with oxacillin MIC 
≥256 µg/ml was selected for removal of chromosomally integrated pmecA. 
An empty pGM068 suicide vector with kanamycin marker was transduced 
into RN4220 strain resulting in RN4220 lysA::kan (SJF5009). SH1000 
lysA::pmecA -TR2 (SJF5003) was transduced with Φ11 lysate from RN4220 
lysA::kan (SJF5009) and transductants selected on BHI agar plate containing 
kanamycin (50 µg/ml). The resulting strain lost mecA to give SH1000 
lysA::kan (SJF5010). The removal of mecA was confirmed by PCR to amplify 
mecA (Figure 4.5 A). The insertion of empty vector was further verified by 
PCR amplifying the kanamycin cassette (Figure 4.5 A). SH1000 lysA::kan 
(SJF5010) regained susceptibility to oxacillin (MIC 0.5 µg/ml) similar to that 
of the parental strain SH1000 (Figure 4.3 A, Figure 4.4 and Figure 4.5 A). 
These observations further strongly suggest that mecA is a prerequisite for 
developing high-level β-lactam resistance. 
Reintroduction of pVP01-pmecA into mecA cured strain - SH1000 lysA::kan 
(SJF5010) by phage transduction using Φ11 lysate from SJF4994 (RN4220 
lysA::pmecA) produced SH1000 lysA::pmecA+ (SJF5011). This strain 
produced high-level resistance to oxacillin indistinguishable from that of the 
original SH1000 lysA::pmecA -TR2 (SJF5003) (Figure 4.5 B). The 
chromosomal integration of mecA was confirmed by PCR to amplify mecA 
and oxacillin MIC was verified using an Etest for SH1000 lysA::pmecA+ 




Figure 4.5 Removal and reintegration of lysA::pmecA 
A) SH1000 lysA::pmecA -TR2 (SJF5003) was transduced with lysA::kan to replace 
lysA::pmecA. This resulted in oxacillin susceptible SH1000 lysA::kan (SJF5010). 1% (w/v) 
TAE agarose gel shows kan (lane 1, 2) with product size of 395 bp (marked by an arrow) 
using KanR_FW_For (Forward) and KanR_FW_Rev (Reverse) primers. SJF5010 showed 
no band for mecA (lane 1 to 4) using pmecA2_SeqF2 (forward) and pmecA2_SeqR1 
(reverse) primers. mecA positive control using COL genomic DNA showed a product of 
838 bp (lane 5). DNA fragments were used as size markers for agarose gel 
electrophoresis. 
B) Subsequently, reintroduction of lysA::pmecA into SH1000 lysA::kan (SJF5010) resulted 
into SH1000 lysA::pmecA+ (SJF5011). This was confirmed by an oxacillin Etest and PCR 
to amplify mecA using pmecA2_SeqF2 (forward) and pmecA2_SeqR1 (reverse) primers. 
Oxacillin MICs are listed in brackets for both strains. DNA fragments were used as size 




4.2.1.4 Does MecA copy number affect oxacillin resistance level? 
It is interesting to note that removal of mecA in both SJF4993 (SH1000 
pRB474 pmecA cured) as described in section 3.2.1.2 (Figure 3.4 A); as well 
as SJF5010 (SH1000 lysA::kan), resulting in abolition of oxacillin resistance. 
Subsequently, reintroduction of multi copy pRB474-pmecA plasmid into 
SH1000 pRB474 pmecA cured (SJF4993) (Figure 3.4 B); and single copy 
chromosomal mecA reintroduction into SH1000 lysA::kan (SJF5010) 
background exhibited high-level oxacillin resistance upon acquisition of 
mecA. This led to a question as to whether reintroduction of plasmid borne 
mecA into the single copy cured strain (SJF5010) would result in high-level 
resistance to oxacillin, and vice versa? 
SH1000 pRB474 pmecA cured (SJF4993 - multi copy mecA cured) 
background was transduced with a single copy mecA (pVP01-pmecA) 
resulting in SJF4997 (SH1000 pRB474-pmecA-cured lysA::pmecA), also 
SH1000 lysA::kan (SJF5010 - single copy mecA cured) was transduced with 
multi copy mecA (pRB474-pmecA) resulting in SJF5024 (SH1000 lysA::kan 
pRB474-pmecA) (Figure 4.6). Interestingly, SJF4997 (SH1000 pRB474-
pmecA-cured lysA::pmecA developed only low-level resistance to oxacillin 
(MIC = 8 µg/ml; Figure 4.6 A) whereas, SJF5024 (SH1000 lysA::kan 
pRB474-pmecA) retained susceptibility to oxacillin (MIC = 0.5 µg/ml) similar 
to the parental strain SH1000 lysA::kan (SJF5010) (Figure 4.6 B).  
Taken together, these results suggest that the development of high-level 
resistance is specific to the strain background. As a result, mecA cured 
backgrounds do not mutually support high-level resistance suggesting 





Figure 4.6 Reintroduction of mecA into pmecA cured backgrounds 
A) SH1000 pRB474 pmecA cured (SJF4993) was transduced with RN4220 lysA::pmecA 
(SJF4994) phage lysate for chromosomal integration of mecA into the multicopy mecA 
cured background. 1% (w/v) TAE agarose gel shows mecA insertion at the lysA locus 
(lane 1, 2) with product size of ~4000 bp using lysA_5’_For (Forward) and pmecA_R1 
(Reverse) primers. DNA fragments were used as size markers for agarose gel 
electrophoresis. 
B) SH1000 lysA::kan (SJF5010) was transduced with multi copy pRB474-pmecA into the 
single copy mecA cured background (SJF5010). PCR amplification of mecA using 
pmecA2_SeqF2 (forward) and pmecA2_SeqR1 (reverse) primers verified mecA at 838 bp 
indicated with a black arrow. Oxacillin MICs are listed in brackets for all strains. DNA 





4.2.1.5 Are gdpP mutations responsible for elevated antibiotic 
resistance in single copy mecA trained strains? 
In order to investigate whether mutation of gdpP is involved in producing 
high-level resistance in SH1000 lysA::pmecA derivatives (Table 4.1), 
genomic DNA was isolated from these strains. The gdpP gene was amplified 
using primers VP62_F3 and VP63_R3 (see Figure 4.7 A for primer binding 
sites). The PCR products were purified using a GeneJET PCR purification kit 
(Thermo Fischer Scientific). Interestingly, DNA sequencing (GATC Biotech, 
Germany) revealed no alterations in gdpP. 
The insertion of pmecA at lysA was also verified by gene sequencing (GATC 
Biotech, Germany). Genomic DNA was isolated from all SH1000 
lysA::pmecA derivatives (Table 4.1) using primers pmecA2_seqF1 and 
pmecA2_seqR2 (see Figure 4.7 B for construct map). pmecA sequencing 
confirmed no alteration of mecA gene or its native promoter at the lysA locus. 
4.2.2 Identification of chromosomal mutations in highly resistant 
strains  
In order to identify compensatory mutation(s) in highly resistant SH1000 
lysA::pmecA derivatives, full genomes of representative strains (listed in 
Figure 4.4 and Table 4.1) were sequenced using Illumina MiSeq and HiSeq 
2500 platforms (MicrobesNG, University of Birmingham). Reads from strains 
were mapped to the fully sequenced reference genome of NCTC8325 
(accession no. NC_007795.1). Variant calling was done using VarScan 
(MicrobesNG, University of Birmingham). A total of 93 mutations were 
identified. These included 5 frameshifts, 32 non-synonymous, 15 
synonymous and 1 nonsense mutations. All identified mutations are listed in 
Appendix 1 Table 3 together with locus tag or gene name and mutation 
strength. From these, 73 identified mutations were not considered as they 
were present in all strains including control strain SH1000 lysA::pmecA 




The sequencing data for SH1000 lysA::pmecA (SJF4996) was compared 
with its trained isolates (Figure 4.4). Whole genome sequencing identified a 
number of genetic polymorphisms in trained strains with oxacillin MIC from 2 
to ≥256 µg/ml (Table 4.2). However, the single most striking observation to 
emerge from sequencing data was that resistant strains have acquired 
mutations that caused an amino acid substitution in either 
SAOUHSC_00524, rpoB (DNA-directed RNA polymerase subunit β) or 
SAOUHSC_00525, rpoC (DNA-directed RNA polymerase subunit β’) (Figure 
4.8 B and Table 4.2). RpoB and RpoC enzymes are components of RNA 
polymerase (RNAP) holoenzyme. The rpoB and rpoC genes in S. aureus 
share an operon (Figure 4.8 A) with other downstream genes, 50S ribosomal 
protein encoded by rplGB (SAOUHSC_00526), two 30S ribosomal proteins 
encoded by rpsL (SAOUHSC_00527) and rpsG (SAOUHSC_00528) and two 
elongation factors encoded by fusA (SAOUHSC_00529) and tuf 
(SAOUHSC_00530).  
It has been shown that mutations in rpoB are commonly associated with 
rifampicin resistance (Gao et al., 2013). In addition, some studies have also 
noted that alterations in rpoB to be involved in developing resistance to 
methicillin, vancomycin and daptomycin (Matsuo et al., 2011). Moreover, 
mutation in rpoC converts heterogeneously vancomycin-intermediate S. 
aureus (hVISA) into slow VISA which results in increased oxacillin resistance 
(Matsuo et al., 2015; Saito et al., 2014). Nevertheless, how rpo mutations 
lead to high-level resistance is not well studied. 
The positions of the nonsynonymous mutations that were identified in rpoB 
and rpoC are depicted on physical maps with corresponding gene regions 
(Figure 4.8 B). Originally, whole genome sequencing of SH1000 lysA::pmecA 
-TIR3 (SJF5008), a highly oxacillin resistant isolate trained to produce high-
level resistance from expressing low-level resistance did not reveal any 
alterations in either rpoB or rpoC genes. Therefore, the genomic DNA was 
isolated from SH1000 lysA::pmecA -TIR3 (SJF5008) for DNA sequencing of 
rpoB and rpoC genes using sequencing primers (Figure 4.10 C). Reads for 
rpoB and rpoC were mapped to NCTC8325 genomic region corresponding to 
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rpoB and rpoC genes. The sequence alignment identified two amino acid 
substitutions in rpoB at residue 639 and 949 (Figure 4.8 B and Table 4.2). 
This observation further confirms the role of rpo alterations in concomitant 
development of high-level resistance.  
Besides rpo mutations, some resistant strains had also acquired other 
mutations. Two of these mutations in SH1000 lysA::pmecA -TI4 (SJF5002) 
and SH1000 lysA::pmecA -TIR1 (SJF5006) included amino acid substitutions 
in SAOUHSC_00270, a hypothetical protein and SAOUHSC_00269, 
hypothetical protein, respectively (Table 4.2). Four out of seven highly 
resistant strains acquired a point deletion, resulting in disruption of the 
reading frame leading to a frameshift in the gene encoding 
SAOUHSC_00591, a hypothetical protein (Table 4.2). However, it is likely 
that these genetic changes were introduced during passaging and not a 
direct consequence of increased oxacillin resistance as they are not present 
in all highly resistant mutants. Therefore, these mutations were discarded for 
being linked to increased oxacillin resistance. 
For two of the highly resistant strains, SH1000 lysA::pmecA -TIR1 (SJF5006) 
and SH1000 lysA::pmecA -TR2 (SJF5003); whole genome sequencing 
identified 12-bp insertion at genome position 2134372 when compared to the 
genome of NCTC8325 strain. This genomic region maps to 
SAOUHSC_02031 (rsbU), the sigma B regulatory protein. NCTC8325 strain 
carries a deletion in rsbU which is repaired in SH1000 by 11-bp insertion to 
repair defective rsbU of NCTC8325 derived SH1000 (Horsburgh et al., 
2002). Therefore, this means that the SH1000 lysA::pmecA derivatives with 





Figure 4.7 Location of sequencing primers for gdpP and the pmecA insert 
A) Genomic region of gdpP and sequencing primer binding sites.  





Figure 4.8 Physical map depicting SNPs identified in highly resistant SH1000 lysA::pmecA derivatives 
A) Schematic representation of the genomic region of rpoB, rpoC operon, and downstream genes.  
B) Amino acid substitutions identified in resistant derivatives of SJF4996 (SH1000 lysA::pmecA) are indicated with a red box representing highly resistant 









Locus tag (Gene) Protein 
Parental strain SH1000 
SH1000 lysA::pmecA (SJF4996) 2     
Parental strain SH1000 lysA::pmecA (SJF4996) 
TI1 (SJF4998) 2     
TI2 (SJF4999)            525575 16 G-A G1139D SAOUHSC_00524 (rpoB) DNA-directed RNA polymerase subunit β 
TI3 (SJF5001)            529097 16 A-T I1084F SAOUHSC_00525 (rpoC) DNA-directed RNA polymerase subunit β’ 
TI4 (SJF5002)            290628 








DNA-directed RNA polymerase subunit β’ 
TR1 (SJF5000)          528062 







DNA-directed RNA polymerase subunit β’ 
Hypothetical protein 
TR2 (SJF5003)          524946 
                                   590401† 









DNA-directed RNA polymerase subunit β 
Hypothetical protein 
Sigma B regulatory protein 
TR3 (SJF5004)          524946 







DNA-directed RNA polymerase subunit β 
Hypothetical protein 
TR4 (SJF5005)          528644 ≥256 G-C E933Q SAOUHSC_00525 (rpoC) DNA-directed RNA polymerase subunit β’ 
TR5 (SJF5031)*         524087 ≥256 A-C Q643P SAOUHSC_00524 (rpoB) DNA-directed RNA polymerase subunit β 
TR6 (SJF5032)*         524087 ≥256 A-C Q643P SAOUHSC_00524 (rpoB) DNA-directed RNA polymerase subunit β 
TR7 (SJF5033)*         524087 ≥256 A-C Q643P SAOUHSC_00524 (rpoB) DNA-directed RNA polymerase subunit β 
TR8 (SJF5034)*         528065 ≥256 G-C G740R SAOUHSC_00525 (rpoC) DNA-directed RNA polymerase subunit β’ 
Parental strain SH1000 lysA::pmecA -TI1 (SJF4998) 
TIR1 (SJF5006)         289906 
                                   528059 











DNA-directed RNA polymerase subunit β’ 
Sigma B regulatory protein 
TIR2 (SJF5007)         528695 ≥256 G-C G950R SAOUHSC_00525 (rpoC) DNA-directed RNA polymerase subunit β’ 
TIR3 (SJF5008)         524074 








DNA-directed RNA polymerase subunit β 
DNA-directed RNA polymerase subunit β 
Table 4.2 Mutations identified by whole genome sequencing in SH1000 pRB474 pmecA derivatives relative to NCTC8325 
*, DNA sequencing was performed only for the rpoB and rpoC genes; †, frameshift mutation; ‡, 11-bp insertion. Oxacillin MIC listed in µg/ml.
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In order to investigate the effects of this small deletion on high-level 
resistance, a phage lysate from RN4220 lysA::pmecA (SJF4994) was 
transduced into NCTC8325-4 strain, a derivative of 8325 strain with three 
prophages removed (O’Neill, 2010). The transductants were selected on BHI 
agar plate supplied with erythromycin 5 µg/ml and lincomycin 25 µg/ml. The 
resultant strain 8325-4 lysA::pmecA (SJF5035) was further confirmed by 
mecA PCR verification (Figure 4.9). It was hypothesised that if defective 
rsbU is linked with the development of high-level oxacillin resistance then 
8325-4 lysA::pmecA (SJF5035) would exhibit high-level resistance to 
oxacillin upon acquisition of mecA without needing training on methicillin 
gradient plate. However, 8325-4 lysA::pmecA (SJF5035) retained 
susceptibility to oxacillin (MIC = 0.5 µg/ml) comparable to that of its parental 
strain 8325-4 (MIC = 0.12 µg/ml) as shown in Figure 4.9. Therefore, the 
involvement of defective rsbU in developing high-level resistance was ruled 
out. 
In order to assess if the selection of rpo mutations is linked with high-level 
resistance and not a consequence of one-off spontaneous event, SH1000 
lysA::pmecA (SJF4996) was further streaked on methicillin gradient plate 
similar to the method described in section 4.2.1.2 and shown in Figure 4.3. 
Subsequently, four trained strains; SH1000 lysA::pmecA TR5 to TR8 
(SJF5031, SJF5032, SJF5033 and SJF5034) were isolated with increased 
oxacillin resistance (MIC = ≥256 µg/ml) (Table 4.1 and Figure 4.10 A). PCR 
amplification verified the correct insertion of mecA at lysA locus (Figure 4.10 
B). The gene sequencing of mecA revealed no alteration in the sequence. It 
was predicted that these strains may have acquired mutations in either rpoB 
or rpoC. Therefore, genomic DNA was isolated from four strains, SH1000 
lysA::pmecA TR5 to TR8 (SJF5031, SJF5032, SJF5033 and SJF5034) for 
rpoB and rpoC gene sequencing. The genomic region of rpoBC was 
amplified using primers RNAP_F1 and RNAP_R1 producing 7449 bp 
product. Purified PCR products were used for DNA sequencing (GATC 
Biotech, Germany) using primers shown in Figure 4.10 C. Gene sequencing 
reads for rpoBC were mapped to NCTC8325 genome using SnapGene 
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software. The sequencing alignment identified amino acid substitutions in 
either rpoB or rpoC genes of all four strains. These results strongly suggest 
the role of rpoBC in developing high-level oxacillin resistance. Three of the 
strains SH1000 lysA::pmecA TR5 to TR7 (SJF5031, SJF5032 and SJF5033) 
carried same amino acid substitution in the rpoB gene. Whereas, SH1000 
lysA::pmecA TR8 (SJF5034) carried a SNP in the rpoC gene (Table 4.2).  
Interestingly, all strains with SNPs in rpoBC exhibited high-level oxacillin 
resistance and these SNPs are located towards the C-terminal of the protein. 
It has previously been reported that depending on the locations of the SNPs 
in rpoB gene decides the resistance to specific antibiotics. One of the most 
frequent mutations in rpoB is H481Y, associated with producing high-level 
resistance to rifampicin and vancomycin intermediate resistance in S. aureus 
(Matsuo et al., 2011). Two of the mutations in rpoB (N967I and R644H) are 
associated with increased methicillin resistance but do not affect 





Figure 4.9 Construction and oxacillin MIC of 8325-4 lysA::pmecA 
8325-4 was transduced with RN4220 lysA::pmecA (SJF4994) lysate for chromosomal 
integration of mecA at the lysA locus. 1% (w/v) TAE agarose gel shows mecA insertion at 
lysA locus (lane 1) with product size of ~4000 bp using lysA_5’_For (Forward) and 
pmecA_R1 (Reverse) primers. SH1000 lysA::pmecA (SJF4996) genomic DNA was used 
as a template for positive control (lane 2). DNA fragments were used as size markers for 







Figure 4.10 Evolution of SJF4996 derived highly oxacillin resistant rpo mutants and their verification 
A) SJF4996 (Untrained-SH1000 lysA::pmecA) was trained to develop high-level resistance. Subsequently, selection of three isolates 
(SJF5031, SJF5032, SJF5033) acquired rpoB and one (SJF5034) acquired rpoC SNPs. Oxacillin MICs are listed in bracket for each strain. 
B) Schematic overview of the native genomic region of rpoB, C and sequencing primer binding sites.  
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4.2.2.1 Influence of rpo mutations on other β-lactam and rifampicin 
susceptibilities 
In order to investigate whether rpoBC mutations affect susceptibility to other 
antibiotics including rifampicin, β-lactams including cefoxitin and penicillin G, 
Etest was performed to determine the MIC for each strain carrying rpo 
mutations (Table 4.1). Rifampicin was chosen for antibiotic susceptibility 
testing because it has specific inhibitory effects on RNA polymerase which 
inactivates the enzyme at very low concentrations, resulting into inhibition of 
RNA synthesis which stops bacterial growth (Wehrli, 1983). All highly 
resistant strains harbouring rpo mutations were sensitive to rifampicin (Table 
4.3). This observation suggests that the acquired rpoB mutations do not 
support rifampicin resistance.  
Besides oxacillin MIC, cefoxitin and penicillin G MICs were tested using Etest 
method. For cefoxitin, MIC value of ≤4 µg/ml was considered to be sensitive 
and an MIC value of ≥8 µg/ml was considered to be resistant (Wu et al., 
2016). All strains were found to be resistant to cefoxitin apart from SH1000 
(Table 4.3). However, only strains exhibiting high-level oxacillin resistance 
with MIC value of ≥256 µg/ml showed high-level cefoxitin resistance with MIC 
value of ≥256 µg/ml. For penicillin G, MIC value of ≤2 µg/ml was considered 
to be sensitive and an MIC value of ≥2 µg/ml was considered to be resistant 
based on the quality control ranges supplied by Oxoid. All strains exhibiting 
high-level resistance to oxacillin with an MIC value of ≥256 µg/ml showed 
increased resistance to penicillin G with MIC value of ≥4 µg/ml (Table 4.3). 
MIC values for antibiotics used were compared against SH1000 and SH1000 
lysA::pmecA (SJF4996).  
Taken together, these observations suggest that the rpo mutations acquired 
by highly oxacillin resistant SH1000 lysA::pmecA (SJF4996) derivatives 













SH1000   0.12 2 0.064 S 
SH1000 lysA::pmecA  
(SJF4996) 
  2 24 0.75 S 
SH1000 lysA::pmecA - TI2 
(SJF4999) 
rpoB G1139D 16 24 2 S 
SH1000 lysA::pmecA - TI3 
(SJF5001) 
rpoC I1084F 16 24 1.5 S 
SH1000 lysA::pmecA - TI4 
(SJF5002) 
rpoC S852Y 16 16 1 S 
SH1000 lysA::pmecA - TIR1 
(SJF5006) 
rpoC A738T ≥256 ≥256 8 S 
SH1000 lysA::pmecA - TIR2 
(SJF5007) 
rpoC G950R ≥256 ≥256 12 S 





≥256 ≥256 16 S 
SH1000 lysA::pmecA - TR1 
(SJF5000) 
rpoC R739S ≥256 ≥256 8 S 
SH1000 lysA::pmecA - TR2 
(SJF5003) 
rpoB H929Q ≥256 ≥256 12 S 
SH1000 lysA::pmecA - TR3 
(SJF5004) 
rpoB H929Q ≥256 ≥256 6 S 
SH1000 lysA::pmecA - TR4 
(SJF5005) 
rpoC E933Q ≥256 ≥256 16 S 
SH1000 lysA::pmecA - TR5 
(SJF5031) 
rpoB Q643P ≥256 ≥256 12 S 
SH1000 lysA::pmecA - TR6 
(SJF5032) 
rpoB Q643P ≥256 ≥256 12 S 
SH1000 lysA::pmecA - TR7 
(SJF5033) 
rpoB Q643P ≥256 ≥256 8 S 
SH1000 lysA::pmecA - TR8 
(SJF5034) 
rpoC G740R ≥256 ≥256 12 S 
S, Sensitive.  
Table 4.3 Antibiogram of SH1000 derived oxacillin resistant strains 
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4.2.2.2 Mapping rpoB and rpoC mutations to the core RNAP structure 
It is important to examine the impact of rpo mutations (Table 4.3) on the 
physical properties of the RNAP core enzyme and its activity. A single point 
mutation can have pleiotropic effects on the stability and structure of the 
protein. In order to map mutations, the cryoEM structure of E. coli RNA 
polymerase elongation complex (Kang et al., 2017) was used to provide a 
structural framework as the S. aureus crystal structure of RNAP is not 
resolved yet. All mutations identified in rpoB are in conserved residues in E. 
coli, whereas except one of the rpoC residues (S852), the rest are conserved 
in E. coli (Appendix 3). These point mutations are mapped on the E. coli 
RNAP as shown in Figure 4.11 A. All mutations occurred either on the 
surface or towards the surface far from the catalytic center (Nudler, 2009). 
Additionally, none of the mutations were shown to be interacting with the 
nearby RNAP subunit interaction site (Figure 4.11 A). All rpoB mutations 
were mapped on E. coli rpoB to determine if any of the residue resides in the 
rifampicin binding pocket regions (Figure 4.11 B). None of the mutations 
detected in this study are located in the rifampicin binding regions l and ll 
(Campbell et al., 2001; Villanueva et al., 2016). Therefore, all rpoB and rpoC 
mutants are susceptible to rifampicin (Table 4.3).  
Interestingly, each mutation detected in rpoB and rpoC brought a change to 
the physicochemical properties of the amino acids (Pommié et al., 2004). 
The rpoB and rpoC mutations result in amino acid substitutions G1139D and 
G740R which cause the introduction of positive and negative charge, 
respectively as well as substantial change in hydropathy from neutral to 
hydrophilic. Whereas, G639C of rpoB amino acid substitution results into 
hydrophobicity without altering its polarity. D949H and R739S mutations 
brought in charged basic amino acids from acidic and uncharged amino 
acids from a charged basic amino acid, respectively, resulting in neutral 
hydropathy from hydrophilic. The H929Q substitution resulted in loss of 
electrical charge by replacing a neutral basic amino acid with a hydrophilic 
uncharged amino acid. The I1084F substitution did not change polarity but 
replaced an aliphatic amino acid with an aromatic amino acid. The A738T 
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substitution brought in a neutral polar amino acid in place of a hydrophobic 
nonpolar amino acid. The S852Y substitution did not alter polarity but 
substituted an aromatic amino acid with very large molar volume (Pommié et 
al., 2004). Moreover, the Q643P substitution brought in substantial change in 
polarity accompanying a sharp structural variation introducing abrupt 
changes to the direction of the chain (Pommié et al., 2004). All these amino 
acid changes suggest severe effects on the activity and/or interaction of 





Figure 4.11 Location of rpo mutations on E. coli RNAP core enzyme complex 
A) The three-dimensional structure of E. coli RNAP elongation complex (Kang et al., 
2017) was used to map the rpoB and rpoC mutations identified in this study. The core 
RNAP complex consists of two α subunits (grey and pale yellow), β subunit (red) and β’ 
subunit (blue) marked with colour coded molecular surface with reduced transparency. 
The mapped rpoB and rpoC (S. aureus) mutated residues are shown as sticks and 
highlighted with dots (Zoom in section). S. aureus residue numbering was used to label 
structural locations of mutated alleles. *, residue not conserved in E. coli (Appendix 3). 
Figures were generated from Protein Data Bank code 6ALH using PyMOL protein 
modelling software. 
B) All identified rpoB mutations were mapped to the E. coli RpoB structure and are 
marked on the red molecular surface with reduced transparency. Other molecular 
structures of two α and a β’ subunits were hidden. Rifampicin binding pocket regions l and 
ll (Campbell et al., 2001) are marked as orange and cyan lines, respectively and mapped 
mutations are shown as sticks highlighted with dots (magenta). S. aureus residue 
numbering was used to label structural locations of mutated alleles. The figure was 
generated from Protein Data Bank code 6ALH using PyMOL protein modelling software. 
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4.2.2.3 Prevalence of rpo mutations in clinical MRSA isolates 
Previous studies have identified mutations in rpo genes which confer 
antibiotic resistance in laboratory-derived highly resistant isolates (Aiba et al., 
2013; Matsuo et al., 2015; Saito et al., 2014; Villanueva et al., 2016; Zhou et 
al., 2012). In order to investigate the existence of rpo alterations in MRSA 
isolates found in clinical settings and their effect on developing high-level 
resistance to β-lactam antibiotics, a total of seven MRSA isolates were 
selected for protein sequence alignment of RpoB and RpoC using the Clustal 
Omega tool. Multiple sequence alignments of RpoB and RpoC identified non-
synonymous amino acid substitutions in JH9, COL, USA300, MRSA252 and 
Mu50 relative to NCTC8325 (Table 4.4 and Appendix 2).  
In order to verify these results and determine oxacillin susceptibility, the 
genomic DNA from HA-MRSA (COL, MRSA252, Mu50 and Mu3) and CA-
MRSA (USA300 and MW2) strains were isolated and the rpoBC genomic 
region was PCR amplified using RNAP_F1 and RNAP_R1 (Figure 4.10 C). 
The purified products of 7461 bp were used for DNA sequencing (GATC 
biotech, Germany). The sequencing data was aligned with NCTC8325 which 
identified mutations in rpoBC of four strains similar to the results obtained 
from Clustal Omega alignment (Appendix 2). Antibiotic susceptibility tests 
and amino acid substitutions are listed in Table 4.4 
There were no nonsynonymous mutations identified in rpoBC of Mu3 and 
MW2 irrespective of exhibiting high-level and low-level β-lactam resistance, 
respectively. This suggests involvement of an unknown mechanism 
independent of rpo alterations in the development of high-level resistance. In 
addition, USA300 has been reported to be resistant to oxacillin with an MIC 
ranging from 32-48 µg/ml (Bæk et al., 2014) and also carries an amino acid 
substitution in rpoC at residue 857. Mwangi et al., 2007 reported that the JH9 
strain to have four SNPs in rpoB (D471Y, A473S, A477S, A478D) and one in 
rpoC (E854K) but it is susceptible to oxacillin (MIC = 0.75 µg/ml) and 
resistant to vancomycin (MIC = 8 µg/ml) and rifampicin (MIC = 16 µg/ml). 
JH9 was isolated in vivo following multidrug therapy resulting in vancomycin 
intermediate resistance (Mwangi et al., 2007). 
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The direct homologues of S. aureus rpoB and rpoC in B. subtilis, E. coli and 
T. aquaticus are highly conserved. Alignment of S. aureus RpoB with B. 
subtilis, E. coli and T. aquaticus RpoB revealed that three out of five 
substitutions found in RpoB of strains listed in Table 4.3 are conserved 
residues, while two residues are in conservative regions but either with 
strong or weak similar properties (highlighted in green Appendix 3). 
Alignment of S. aureus RpoC with B. subtilis, E. coli and T. aquaticus RpoC 
revealed that four out of seven substitutions found in strains listed in Table 
4.3 are conserved residues, while one resides in conservative region with 
strong similar properties whereas one is found to be in not conserved region 
(highlighted in green Appendix 3). Similarly, alignment of RpoB and RpoC of 
clinical isolates listed in Table 4.4 revealed that not all identified SNPs are 
located in conserved regions of the genes (highlighted in yellow Appendix 3). 
Taken together, these observations suggest that the location of the 
mutations could not simply determine if the level of antibiotic resistance and 
a disruption of either RpoB or RpoC are sufficient to confer high-level 















≥256 ≥256 ≥256 S 
Mu50 rpoB (H481Y) ≥256 ≥256 24 ≥256 
Mu3  ≥256 ≥256 48 S 
USA300 rpoC (R857H) 1 16 0.25 S 
MW2  8 32 32 S 
JH9* 
rpoB (D471Y, A473S, A477S, 
E478D) 
rpoC (E854K) 
0.75 ND ND 16 
S, Sensitive; ND, not done; *, not tested for antibiotic susceptibility testing as the strain was 
not available, data taken from (Mwangi et al., 2007) 




4.2.3 Effect of rpo mutations on growth characteristics of 
representative strains 
The frequent occurrence of rpoB and rpoC mutations have previously been 
shown to be involved in not only the conversion of heterogeneous 
vancomycin resistance to vancomycin intermediate resistance but also 
heterogeneous to homogenous conversion of methicillin resistance (Aiba et 
al., 2013; Matsuo et al., 2011, 2015; Watanabe et al., 2011). This conversion 
is accompanied by a slower growth rate (Aiba et al., 2013; Matsuo et al., 
2011).  
In order to test if rpo mutations have an impact on growth rate of SH1000 
lysA::pmecA (SJF4996) and derived mutants, their growth characteristics in 
liquid medium was examined and compared to the SH1000 in the absence of 
antibiotic. From the strains listed in Table 4.1, Table 4.3 and Table 4.4, WT 
control, SH1000; MRSA control, COL; untrained, SH1000 lysA::pmecA 
(SJF4996); trained rpoB (H929Q), SH1000 lysA::pmecA (SJF5003); trained-
mecA-cured-rpoB (H929Q), SH1000 lysA::kan cured (SJF5010); and trained 
rpoC (G740R), SH1000 lysA::pmecA (SJF5034) strains were selected as 
representatives for growth rate assays. Optical density measurements 
showed the parental strain SJF4996 (mecA only) exhibited a growth rate 
similar to that of SH1000 (Figure 4.12 A). However, both the rpo mutants 
(SJF5003 and SJF5034) including mecA-cured-rpoB mutant (SJF5010) had 
a similar but slower growth rate than the parental strain SJF4996 and 
SH1000. Optical density measurements were used to calculate doubling 
time. SH1000 and untrained, SH1000 lysA::pmecA (SJF4996) doubling time 
was approximately 35 min and 34 min, respectively. Whereas, COL, trained-
rpoB (SJF5003) and trained-mecA-cured-rpoB (SJF5010) required more time 
(~48 min) to double than parent strain. While, trained-rpoC (SJF5034) 
showed the slowest growth rate with doubling time of 55 min. 
The growth rates of the rpo mutants did not show a defect compared to COL 
(Figure 4.12 A). As aforementioned, the COL strain also harbours two SNPs 
in rpoB (A798V, S875L) gene. This observation suggests that the growth 
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defect in rpo mutants is due to the acquisition of mutations in either rpoB 
(SJF5003 and SJF5010) or rpoC (SJF5034).  
Furthermore, the growth characteristics of the representative strains 
(SH1000, COL, SJF4996, SJF5003 and SJF5034) were also tested in the 
presence of oxacillin (Figure 4.12 B). Following inoculation of fresh culture 
into 50 ml pre-warmed BHI, the cultures were grown for one hour and 
oxacillin was added (Figure 4.12 B). 0.5 µg/ml of oxacillin was added to 
SH1000 and SJF4996 cultures and 20 µg/ml of oxacillin was added to COL, 
SJF5003 and SJF5034 cultures after one hour of incubation. Optical density 
measurements showed that SH1000 was unable to grow in the presence of 
oxacillin. Whereas, SJF4996 grew for two hours before cessation but 
showed same doubling time of 35 min as compared to in the absence of 
oxacillin (Figure 4.12 B). The growth rate of rpo mutants (SJF5003 and 
SJF5034) and COL was unaffected in the presence of oxacillin (Figure 4.12 
B). SJF5003 retained same doubling time of 47 min in the presence of 20 
µg/ml oxacillin, whereas SJF5034 and COL needed less time (51 min and 44 
min, respectively) to double in the presence of 20 µg/ml oxacillin compared 
to in the absence of oxacillin. 
These observations suggest that the growth of highly resistant rpo mutants 
remains stable in the presence of oxacillin, similar to the clinical isolate COL. 
Therefore, the acquisition of compensatory mutations in rpoB and rpoC allow 
cells to grow in the presence of oxacillin to cope with antibiotic pressure, 





Figure 4.12 Growth characteristics of rpo mutants relative to SH1000 
A) Growth of representative rpo mutants, SH1000 lysA::pmecA rpoB (H929Q) (SJF5003), 
SH1000 lysA::kan mecA cured rpoB (H929Q) (SJF5010), SH1000 lysA::pmecA rpoC 
(G740R) (SJF5034) was compared to SH1000, COL and a parental strain SH1000 
lysA::pmecA (SJF4996). Bacterial cultures were prepared in triplicate and the error bars 
represent standard deviation of the mean. 
B) Growth of representative rpo mutants, SH1000 lysA::pmecA rpoB (H929Q) (SJF5003) 
and SH1000 lysA::pmecA rpoC (G740R) (SJF5034) was compared to SH1000, COL and 
parent strain SH1000 lysA::pmecA (SJF4996). Bacterial cultures were prepared in 
triplicate and the error bars represent standard deviation of the mean. 0.5 µg/ml of 
oxacillin was added to SH1000 and SJF4996 cultures following one hour of incubation. 20 
µg/ml of oxacillin was added to COL, SJF5003 and SJF5034 cultures following one hour 





4.2.4 Effect of rpo mutations on the level of PBP2A and other PBPs 
In order to test the amount of PBP2A being produced in SH1000; COL; 
SH1000 lysA::pmecA (SJF4996); trained rpoB (H929Q), SH1000 
lysA::pmecA (SJF5003); trained-mecA-cured-rpoB (H929Q), SH1000 
lysA::kan cured (SJF5010); and trained rpoC (G740R), SH1000 lysA::pmecA 
(SJF5034) strains, Western blot using anti-PBP2A antibodies was 
performed. To avoid cross reactivity of antibodies against other cellular 
proteins, crude antiserum containing anti-PBP2A antibodies was incubated 
at room temperature with E. coli whole cell lysate followed by incubation with 
S. aureus SH1000 whole cell lysate for four hours prior to use. To test the 
specificity, blots were probed with polyclonal anti-PBP2A antibodies using a 
range of serum dilutions of 1:5,000; 1:10,000 and 1:15,000 prepared in 
blocking buffer. An intense band was observed at ~76 kDa for PBP2A. 
Similarly, a range of membrane fraction concentrations were tested and ~10 
µg of membrane protein was then used as standard. As an endogenous 
control for membrane proteins, anti-DivlB antibodies were purified to avoid 
cross reactivity using an E. coli whole cell lysate. DivlB was selected as it is 
located in the membrane (Bottomley et al., 2014). To test the specificity, 
blots were probed with anti-DivlB antiserum using a range of serum dilutions 
of 1:5,000; 1:10,000 and 1:15,000 with 10 µg of membrane protein. An 
intense band of reactivity with anti-DivlB was observed at ~50 kDa for DivlB.  
Western blot analysis using anti-PBP2A antibodies identified the expected 
band of ~76 kDa identified in COL, SJF4996, SJF5003, SJF5034 in the 
absence and presence of 20 µg/ml oxacillin (SJF5003 and SJF5034) as 
shown in Figure 4.13 A. In addition, Western blot analysis using anti-DivlB 
identified a band of ~50 kDa with similar intensity for each sample (Figure 
4.13 A, bottom panel), confirming equal amount of membrane fraction used 
for the detection of membrane proteins (~10 µg). As predicted, SH1000 and 
SJF5010 (mecA-cured-rpoB-H929Q) did not show a band for PBP2A. 
whereas, trained-rpo mutants (SJF5003 and SJF5034) produced increased 
amounts of PBP2A compared to SJF4996 (untrained) which produced low-
levels of PBP2A, however similar to the relative amount of PBP2A being 
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produced by COL (Figure 4.13 B). The relative levels of PBP2A was 
calculated for all samples using ImageLab™ (BioRad) software by selecting 
untrained-mecA-only (SJF4996) as a point of reference (=1). Interestingly, in 
the presence of 20 µg/ml oxacillin in SJF5003 (trained-rpoB-H929Q) and 
SJF5034 (trained-rpoC-G740R) showed no difference in the relative levels of 
PBP2A production when compared in the absence of oxacillin (Figure 4.13 A 
and B). Both rpo mutations resulted into up to 2-fold increase in PBP2A 
compared to untrained (SJF4996) parental strain (Figure 4.13 A and B) 
suggesting that each mutation resulted in elevated levels of PBP2A in the 
cell membranes. This observation was in agreement with the results reported 
by other research groups (Dordel et al., 2014).  
The production of PBP2A was also compared in strains carrying multicopy 
mecA (pRB474-pmecA based) untrained-SH1000-pmecA (SJF4981) and 
trained-gdpP (R318L) (SJF4991) alongside single copy mecA strains, 
untrained (SJF4996), trained-rpoB (SJF5003) and trained-rpoC (SJF5034) 
(Figure 4.13 D). For Western blot analysis, whole cell lysate (~10 µg) was 
used instead of membrane fractions. SJF4991 (trained-gdpP) showed 
increased levels of PBP2A compared to parental strain (SJF4981). These 
observations were similar to the single copy mecA expressing, untrained 
(SJF4996) and trained (SJF5003 and SJF5034) strains (Figure 4.13 D). This 
result indicate that increased in the production of PBP2A is required to confer 
high-level oxacillin resistance regardless of how mecA is being expressed.   
The profiles of PBPs in SH1000; COL; untrained, SH1000 lysA::pmecA 
(SJF4996); trained rpoB (H929Q), SH1000 lysA::pmecA (SJF5003); trained-
mecA-cured-rpoB (H929Q), SH1000 lysA::kan cured (SJF5010); and trained 
rpoC (G740R), SH1000 lysA::pmecA (SJF5034) were studied by an SDS-
PAGE gel-based Bocillin-FL labelling. Membrane fractions were isolated 
from each strain grown to an OD600 of ~1. The membrane proteins (~50 µg) 
were incubated with 25 µM Bocillin-FL for 25 min at 37ºC and separated in a 
10% (w/v) SDS-PAGE gel. As expected, four bands were detected 
representing PBP1 (~82.7 kDa), PBP2 (~80 kDa), PBP3 (~77.3 kDa) and 
PBP4 (~48.2 kDa). Due to similar size of PBP1, PBP2 and PBP3, some 
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samples showed brighter bands (Figure 4.13 C). However, there was no 
obvious difference observed in the production of PBPs in the aforementioned 
representative strains. Moreover, both rpo mutants (SJF5003, rpoB-H929Q 
and SJF5034, rpoC-G740R) were grown in the presence of 20 µg/ml of 
oxacillin prior to membrane fraction isolation. However, the presence of 
oxacillin did not alter the production of native PBPs, suggesting rpo 





Figure 4.13 Cellular levels of PBP2A and other PBPs of SJF4996 and its derivatives 
A) Membranes fractions (~10 µg of protein) of COL, SH1000, SJF4996 (untrained-mecA-
only), SJF5003 (trained-rpoB-H929Q), SJF5010 (trained-mecA-cured-rpoB-H929Q) and 
SJF5034 (trained-rpoC-G740R) were probed with anti-PBP2A antibodies at a 1:5000 
dilution (first row). Anti-DivlB antibodies were used as an endogenous control for 
membrane proteins (second row) at a 1:10000 dilution simultaneously. Bands of ~76 kDa 
and 50 kDa, corresponding to PBP2A and DivlB, respectively, are indicated with black 
arrows.  
B) Relative levels of PBP2A for representative strains (COL, SH1000, SJF5003, SJF5010, 
SJF5034) were calculated using ImageLab™ (BioRad) quantitation tool, selecting 
SJF4996 (untrained-mecA-only) as a point of reference (=1). The results of relative 
concentrations of PBP2A are the average of three independent repeats where error bars 
represent standard deviation of the mean (±SEM).  
C) Analysis of penicillin binding protein (PBPs) profiles in representative strains (COL, 
SH1000, SJF4996, SJF5003, SJF5010, SJF5034) by Bocillin-FL labelling. The membrane 
fractions (~50 µg protein) were labelled with 25 µM Bocillin-FL at 37°C for 20 mins. The 
identified bands for PBP1 (~82.7 kDa), PBP2 (~80 kDa), PBP3 (~77.3 kDa) and PBP4 
(~48.2 kDa) are indicated with black arrows.  
D) Whole cell lysate (~10 µg protein) of SH1000, SJF4996 (untrained-mecA-only), 
SJF5003 (trained-rpoB-H929Q), SJF5034 (trained-rpoC-G740R), SJF4981 (untrained-
multicopy mecA), SJF4991 (trained-gdpP mutant), SJF5010 (trained-mecA-cured-rpoB-
H929Q) and COL were probed with anti-PBP2A antibodies at a 1:5000 dilution. Bands of 
~76 kDa are indicated with a black arrow. 
 




4.2.5 Complementation of S. aureus rpoB and rpoC 
To determine if the rpo mutations were the reason for the development of 
high-level β-lactam resistance, mutated rpoBC were complemented with the 
respective a wild type allele. A phage lysate from AJ1008 with a kan insertion 
next to rpoBC was used (Villanueva et al., 2016) (SJF5036). The kanamycin 
resistance gene is in the intergenic region between rpoC and 
SAOUHSC_00526. Phage transduction of both rpo mutants (SJF5003, rpoB-
H929Q and SJF5034, rpoC-G740R) were carried out with selection on agar 
containing kanamycin (50 µg/ml). Kanamycin resistant transductants were 
verified by PCR-based assays for the insertion of the kan next to the rpoBC 
genomic region (Figure 4.14 A). The genomic DNA was isolated from the 
resultant strains SJF5044 (SJF5003, rpoB+), SJF5045 (SJF5034, rpoC+) for 
DNA sequencing to verify replacement of mutated rpoB-H929Q and rpoC-
G740R to wildtype rpoB and rpoC, respectively. This would occur via co-
transduction of kan and the WT rpoBC allele as they are genetically linked. 
Both genetically complemented strains (SJF5044 and SJF5045) regained 
susceptibility to oxacillin with an MIC value of 1 µg/ml (Figure 4.14 B and C). 
Furthermore, the amount of PBP2A production was also determined using 
Western blot showed reduction in the levels of PBP2A similar to that of 
untrained, SH1000 lysA::pmecA (SJF4996) strain (Figure 4.13 A and Figure 
4.14 E). Moreover, COL was transduced using phage lysate from SJF5036 
(AJ1008 with kan near rpoBC (Villanueva et al., 2016)). The resultant 
transductant SJF5049 (COL rpoB+) was verified by PCR based assays 
(Figure 4.14 A) and DNA sequencing confirmed replacement of native rpoB 
(A798V, S875L) to WT rpoB. Surprisingly, the genetically complemented 
SJF5049 (COL rpoB+) became highly sensitive to oxacillin with an MIC of 0.5 
µg/ml (Figure 4.14 D). However, some colonies were seen to grow in the 
zone of inhibition (Figure 4.14 D). Western blot analysis showed reduction in 
the production of PBP2A of SJF5049 (COL rpoB+) compared to its parent 
(Figure 4.14 E). Collectively, these observations further confirm the role of 




Figure 4.14 Correlation between oxacillin resistance and the production of PBP2A 
A) A phage lysate from SJF5036 (AJ1008, AR1089 with kanA near rpoBC (Villanueva et 
al., 2016)) was used to replace mutated rpoB-H929Q (SJF5003), rpoC-G740R (SJF5034) 
and COL to WT rpoB and C regions. The resultant SJF5044 (SJF5003, rpoB+), SJF5045 
(SJF5034, rpoC+) and SJF5049 (COL rpoB+) kanamycin resistant transductants for 
complemented strains were verified by PCR using Kpn_rpoC_nearby5 and 
Pst1_rpoC_nearby (Villanueva et al., 2016) producing a band of 3.5 kb marked by black 
arrows (SJF5044-lane 1, SJF5045-lane 3 and SJF5049-lane 5). SJF5003 (lane 2), 
SJF5034 (lane 4) and COL genomic DNA was used as a positive control, producing a 
product of 2 kb marked by a black arrow. DNA fragments were used as size markers for 
agarose gel electrophoresis. 
B) Oxacillin susceptibility for parental and genetically complemented strains, SJF5003 and 
SJF5044, SJF5034 and SJF5045, COL and SJF5049 (COL rpoB+) were compared using 
the Etest method. Oxacillin MIC are listed in brackets for all strains. 
C) Membranes fractions (~10 µg of protein) of SJF5003 (trained-rpoB-H929Q), SJF5034 
(trained-rpoC-G740R), SJF5044 (SJF5003, rpoB+), SJF5045 (SJF5034, rpoC+), COL and 
SJF5049 (COL rpoB+) were probed with anti-PBP2A antibodies at a 1:5000 dilution. A 
band of ~76 kDa corresponding to PBP2A is indicated with a black arrow. 
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4.2.6 Reconstitution of the high-level resistance in a naïve MSSA 
background 
In order to examine whether the phenotypic expression of high-level oxacillin 
resistance is not SH1000 strain background specific phenomenon, a clinical 
MSSA isolate Newman was chosen for complete reconstitution of the high-
level resistance phenotype. Newman, a clinical strain isolated in 1952 is 
commonly used for genetic manipulation (Duthie and Lorenz, 1952). In order 
to introduce mutation in the rpoB gene of Newman, phage lysate from 
SJF5036 (AJ1008 with kanA near rpoBC (Villanueva et al., 2016)) was 
transduced into SJF5003 (trained-rpoB-H929Q) as described in section 
2.14.3 and resultant transductants were screened for kanamycin as well as 
high-level oxacillin resistance. This would show kanamycin resistance but 
without co-transduction of the WT rpoB allele. Genomic DNA was isolated 
and the insertion of kan nearby rpoBC was confirmed by PCR resulting into 
kanamycin resistance marked rpoB (H929Q) mutant, SH1000 lysA::pmecA 
rpoB-H929Q (SJF5046). A phage lysate from SJF5046 was used to 
transduce the rpoB-H929Q mutation across to Newman. The transductant 
was selected on agar plate containing kanamycin (50 µg/ml). The resultant 
Newman rpoB-H929Q (SJF5048) strain was verified for the insertion of rpoB-
H929Q mutation by DNA sequencing. The PCR based assay confirmed 
insertion of kan next to rpoBC (Figure 4.15 A).  
Subsequently, in order to introduce mecA, SJF5048 (Newman rpoB-H929Q) 
was transduced using a phage lysate from SJF4994 (RN4220 lysA::pmecA). 
Transductants were selected on agar containing erythromycin (5 µg/ml) and 
lincomycin (25 µg/ml). Genomic DNA was isolated from the resultant 
transductant Newman lysA::pmecA rpoB-H929Q (SJF5050) and verified by 
PCR to amplify mecA at the lysA locus (Figure 4.15 B). Oxacillin 
susceptibility of SJF5050 (Newman lysA::pmecA rpoB-H929Q) showed 
increased oxacillin MIC value of ≥256 µg/ml unlike its parental strain 
(oxacillin MIC 0.12 µg/ml) (Figure 4.15 C). Therefore, the successful 
reconstitution of an MRSA phenotype in Newman ensured that development 
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of resistance is not strain specific phenomenon, further emphasising on the 
correlation between rpo mutations and mecA. 
4.2.6.1 Insertion of mecA nearby orfX locus 
The mec gene complex is located within a mobile genetic element, SCCmec 
(Staphylococcal Chromosome Cassette mec), which carries mecA and its 
regulatory genes (Beck et al., 1986). All MRSA isolates possess a mec gene 
complex, specifically located within the 3’ end of orfX (SAOUHSC_00027), 
known as the SCCmec attachment site (attB) (Noto et al., 2008). 
In order to determine whether expression of mecA from the native orfX locus 
could regenerate high-level β-lactam resistance, pMUTIN4 derived (Vagner 
et al., 1998) plasmid was used to introduce mecA and its own promoter 
downstream of the orfX gene. For chromosomal insertion of mecA at orfX 
site, the pVP01-pmecA plasmid was restriction digested using Hindlll/BamHl 
enzymes to cut out 3’ lysA fragment of 1084 bp resulting in a linear plasmid 
backbone. Genomic DNA was isolated from SH1000 to amplify the orfX gene 
including downstream sequence (Figure 4.16 A) and subsequently cloned 
into the linear plasmid using Gibson assembly master mix, resulting into 
pVP02-orfX (Figure 4.16 A). Transformation of plasmid, pVP02-orfX into 
electrocompetent E. coli DH5α (NEB) (SJF5065) was used for amplification 
of plasmid prior to verification. The insertion of orfX fragment and presence 
of intact pmecA was verified by DNA sequencing and PCR-based assays 
(Figure 4.16 B and C). However, transformation of pVP02-orfX into RN4220 
did not produce transformants. Several unsuccessful attempts were made by 





Figure 4.15 Reconstitution of high-level oxacillin resistance in Newman 
A) A phage lysate from SH1000 lysA::pmecA rpoB-H929Q (SJF5046) was used to move 
kanamycin marked rpoB-H929Q (SJF5003) into Newman. The resultant Newman rpoB-
H929Q (SJF5048) kanamycin resistant strain was verified by PCR using 
Kpn_rpoC_nearby5 and Pst1_rpoC_nearby (Villanueva et al., 2016) producing a band of 
3.5 kb marked by a black arrow (lane 1). DNA fragments were used as size markers for 
agarose gel electrophoresis. 
B) Subsequently, a phage lysate from SJF4994 (RN4220 lysA::pmecA) was used to 
transduce SJF5048 (Newman rpoB-H929Q) with mecA insertion at the lysA locus. The 
resultant strain, Newman lysA::pmecA rpoB-H929Q (SJF5050) was verified by PCR using 
lysA_5’_For (Forward) and pmecA_R1 (Reverse) primers producing a band of ~4000 bp 
marked by a black arrow (lane 1). DNA fragments were used as size markers for agarose 
gel electrophoresis. 
C) The introduction of rpoB-H929Q and mecA into Newman resulted in the development 
of high-level resistance. Oxacillin susceptibility of SJF5050 (Newman lysA::pmecA rpoB-
H929Q) and its parental strain Newman were compared using Etest method. Oxacillin 






Figure 4.16 Construction of a suicide vector for pmecA expression from the orfX 
site in S. aureus 
A) Diagrammatic illustration of pVP02-orfX construction. An 811 bp fragment covering 
downstream region of the orfX gene and the intergenic region was PCR amplified from S. 
aureus genomic DNA using orfX_GF2 and orfX_GR2. These primers were designed to 
regenerate the restriction site Hindlll/BamHl. The pVP01-pmecA plasmid was linearised 
using Hindlll/BamHl restriction enzymes. The linearised plasmid backbone and orfX 
fragments were joined by Gibson assembly, resulting into pVP02-orfX. 
B) 1% w/v TAE agarose gel showing product of ~811 bp representing orfX 3’ fragment 
using sequencing primers 5orfX and 3orfX. The expected band is marked by an arrow. 
DNA fragments were used as size markers for agarose gel electrophoresis. 
C) The pmecA insert was amplified using overlapping primers mecA_F and mecA_R 
producing a band of ~1902 bp marked by a black arrow. DNA fragments were used as 





4.2.7 Screen for functional PBP2A fluorescent fusions  
In MRSA, an acquired PBP2A, encoded by the mecA gene is a membrane 
associated protein penicillin binding protein with transpeptidation activity 
(Macheboeuf et al., 2006; Pinho et al., 2001b). It is required for the final 
assembly of peptidoglycan in the presence of β-lactam antibiotics (Sauvage 
et al., 2008), when the activity of native PBPs is inhibited, however the 
presence of PBP2 is still required (Pinho et al., 2001b, 2001a). Previous 
studies have shown that PBP2 mainly localised to the septum throughout the 
cell division (Pinho and Errington, 2005) even when the cells are treated with 
oxacillin (Tan et al., 2012a). However, the subcellular localisation of PBP2A 
is not yet studied. In an effort to understand the localisation of PBP2A in a 
well-defined genetically amenable MRSA background, PBP2A fluorescent 
fusions were constructed with eYFP, CLIP and SNAP. 
4.2.7.1 Construction of S. aureus eYFP-PBP2A strains   
In an attempt to study the localisation of PBP2A, an S. aureus strain 
producing PBP2A fused with eYFP was constructed. N-terminal fusion of 
eYFP joined to PBP2A by a 6-amino acid flexible linker (GSGGGS) was 
constructed using pGM068 (McVicker et al., 2014) integration plasmid. The 
expression of eYFP-PBP2A was under the native promoter of mecA.  
The full-length fragment containing the mecA promoter, eyfp and mecA 
sequences was gene synthesised by GeneArt Gene Synthesis service 
(Invitrogen). The synthetic eYFP-PBP2A encoding fragment was inserted 
into pMK-RQ (KanR), an E. coli shuttle vector. pMK-RQ_eYFP-PBP2A was 
transformed into electrocompetent E. coli DH5α (SJF5017). The eYFP-
PBP2A fragment was PCR amplified using 3mecA_F1 and 3mecA_R1 
primers and PCR purified insert was cloned into BamHl/Sacl cut linearised 
pGM068 lysA plasmid, resulting in pVP03_eYFP-PBP2A (Figure 4.17 A). 
Subsequently, pVP03_eYFP-PBP2A was transformed into electrocompetent 
DH5α E. coli resulting into SJF5019. Next, pVP03_eYFP-PBP2A was 
isolated from SJF5019 using a Plasmid Midiprep Kit (Sigma) followed by 
transformation into RN4220 to create RN4220 lysA::eYFP-PBP2A 
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(SJF5021). Integration of plasmid was confirmed by selection of 
transformants on agar containing erythromycin (5 µg/ml) and lincomycin (25 
µg/ml). The chromosomal lysA region containing eYFP-PBP2A (Figure 4.17 
B) was then moved to SH1000, multicopy copy mecA cured background 
SJF4993 (SH1000 pRB474 pmecA cured) and single copy mecA cured 
background SJF5010 (SH1000 lysA::kan cured) by phage transduction 
creating SJF5022 (SH1000 lysA::eYFP-PBP2A), SJF5023 (pRB474-pmecA-
cured lysA::eYFP-PBP2A) and SJF5066 (mecA-cured-rpoB (H929Q) 
lysA::eYFP-PBP2A), respectively. The insertion of eYFP-PBP2A was verified 
by PCR amplification of pmecA and lysA-mecA fragment (Figure 4.17 C and 
D).  
Based on the observations reported in previous sections 3.2.1.2 and 4.2.1.3, 
removal and subsequent reintroduction of mecA resulted into concomitant 
high-level oxacillin resistance. Therefore, it was predicted that insertion of 
eYFP-PBP2A into multicopy copy mecA cured background SJF4993 
(SH1000 pRB474 pmecA cured) and single copy mecA cured background 
SJF5010 (SH1000 lysA::kan cured) would promote high-level resistance. In 
order to determine oxacillin susceptibility of SJF5022 (SH1000 lysA::eYFP-
PBP2A), SJF5023 (SJF4993, pRB474-pmecA-cured lysA::eYFP-PBP2A) 
and SJF5066 (SJF5010, mecA-cured-rpoB (H929Q) lysA::eYFP-PBP2A) 
Etest was performed which showed that all three strains were sensitive to 
oxacillin with MIC value of 0.25 (SJF5022 and SJF5023) and 0.12 (SJF5066) 
µg/ml (Figure 4.17 E). Furthermore, SJF5022, SJF5023 and SJF5066 were 
grown in BHI broth containing methicillin (2, 4 and 6 µg/ml), showed no 
growth after overnight incubation at 37ºC.  
Taken together, sensitivity to oxacillin would suggest that the eYFP-PBP2A 





Figure 4.17 Construction SH1000 lysA::eYFP-PBP2A using pmecA cured 
backgrounds 
A) Diagrammatic illustration of pVP03_eYFP-PBP2A construction. The full length insert 
comprising native mecA promoter, eYFP joined by a 6-amino acid linker and mecA was 
synthesised by GeneArt (Invitrogen) services cloned into an E. coli shuttle vector pMK-
RQ_eYFP-PBP2A (SJF5017). The plasmid was isolated and an insert was amplified using 
overlapping primers 3mecA_F1 and 3mecA_R1. The PCR product was cloned into BamHl 
and SacI cut integration plasmid, pGM068 by Gibson assembly, resulting in 
pVP03_eYFP-PBP2A (E. coli pVP03_eYFP-PBP2A, SJF5019).  
B) Physical map showing insertion of pVP03-eYFP-PBP2A plasmid at the lysA locus. 
Primer binding sites are also shown with arrows. 
C) Genomic DNA was isolated from SJF5022 (lane 1), SJF5023 (lane 2) and SJF5066 
(lane 3) for PCR verification. 1% w/v TAE agarose gel showing a product of 3207 bp 
representing the insertion of eYFP-PBP2A fragment using sequencing primers 3mecA_F 
and 3mecA_R. The expected band is marked by an arrow. DNA fragments were used as 
size markers for agarose gel electrophoresis. 
D) Genomic DNA was isolated from SJF5022 (lane 1), SJF5023 (lane 2) and SJF5066 
(lane 3) for PCR verification. 1% w/v TAE agarose gel showing a product of ~4000 bp 
representing the insertion of eYFP-PBP2A fragment at lysA locus using sequencing 
primers lysA_5’_For (Forward) and pmecA2_seqR2 (Reverse). The expected band is 
marked by an arrow. DNA fragments were used as size markers for agarose gel 
electrophoresis. 
E) The oxacillin susceptibility of eYFP-PBP2A constructs SJF5022 (SH1000 lysA::eYFP-
PBP2A), SJF5023 (SJF4993, pRB474-pmecA-cured lysA::eYFP-PBP2A) and SJF5066 
(SJF5010, mecA-cured-rpoB (H929Q) lysA::eYFP-PBP2A) was determined using the 
Etest method. Oxacillin MICs are listed in brackets for all strains. 
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4.2.7.2 Construction of S. aureus PBP2A-CLIP strains 
The CLIP-tag (NEB) is a small protein tag (20 kDa) based on a human DNA 
repair enzyme, O6-alkylguanine-DNA-alkyltransferase (AGT) that covalently 
binds with CLIP-tag substrates derived from benzylcytosine (BC) (Keppler et 
al., 2003). The CLIP-tag can be fused to any protein of interest and labelled 
with range of synthetic CLIP-tag substrates conjuncted with a fluorophore.  
The full-length CLIP-tag fragment encoding a flexible linker of 6-amino acids 
(GSGGGS) upstream of CLIP-tag was gene synthesised by GeneArt Gene 
Synthesis service (Invitrogen). The CLIP-tag DNA sequence was codon 
optimised for S. aureus prior to synthesis. The synthetic CLIP-tag fragment 
was supplied in an E. coli shuttle vector, pMA-T_CLIP-tag (AmpR) 
(Invitrogen). pMA-T_CLIP-tag was transformed into electrocompetent E. coli 
DH5α upon arrival (SJF5013). The CLIP-tag fragment together with a linker 
was amplified by PCR using pMA-T_CLIP-tag as a template and overlapping 
VP54_F and VP55_R primers, resulting in a 613 bp product. Simultaneously, 
pmecA fragment was amplified by PCR using overlapping VP49_F and 
VP53_R primers, resulting in a 2579 bp product. Both PCR purified 
fragments were cloned into BamHl/Sacl cut version of pGM068 (TetR) 
plasmid backbones, with tetracycline resistant cassette. This resulted in 
pVP06_PBP2A-CLIP (Figure 4.18 A) creating SJF5029 (pVP06_PBP2A-
CLIP) following transformation into electrocompetent E. coli DH5α. The 
insertion of CLIP-tag was verified by PCR amplification using VP56_F and 
VP57_R primers resulting in a 567 bp product (Figure 4.18 B). The insertion 
of pmecA was verified by PCR amplification using pmecA2_seqF1 and 
pmecA2_seqR2 primers resulting in a 3500 bp product (Figure 4.18 C). 
Subsequently, pVP06_PBP2A-CLIP was isolated from SJF5029 for RN4220 
transformation. However, there was no positive RN4220 transformants 
recovered from agar plate containing tetracycline (5 µg/ml). Several 






Figure 4.18 Construction of pVP06_PBP2A-CLIP 
A) Diagrammatic illustration of pVP06_PBP2A-CLIP construction. Codon optimised, full-
length CLIP-tag sequence along with 6-amino acid flexible linker upstream was 
synthesised by GeneArt (Invitrogen) services and cloned into an E. coli shuttle vector 
pMA-T_CLIP-tag (SJF5013). CLIP-tag fragment was amplified from using pMA-T_CLIP-
tag (SJF5013) as a template with VP54_F and VP55_R primers. The pmecA fragment 
was amplified using VP49_F and VP53_R primers. Both fragments were PCR purified and 
cloned into BamHl and SacI cut integration plasmid, pGM068 (TetR) by Gibson assembly, 
resulting in pVP06_PBP2A-CLIP. 
B) The insertion of CLIP-tag into pVP06_PBP2A-CLIP of SJF5029 was verified by PCR 
using VP56_F and VP57_R primers producing a band of 567 bp marked by a black arrow. 
DNA fragments were used as size markers for agarose gel electrophoresis. 
C) The insertion of pmecA into pVP06_PBP2A-CLIP of SJF5029 was verified by PCR 
using pmecA2_seqF1 and pmecA2_seqR2 primers producing a band of 3500 bp marked 






4.2.7.3 Construction of S. aureus PBP2A-SNAP strains 
Similar to CLIP-tag (NEB), the SNAP-tag (NEB) is a highly engineered, small 
protein (20 kDa) tag based on a human DNA repair enzyme, O6-
alkylguanine-DNA-alkyltransferase (AGT). However, SNAP-tag covalently 
binds to benzylguanine (BG) substrates (Keppler et al., 2003). The SNAP-tag 
can be fused to any protein of interest and labelled with range of synthetic 
SNAP-tag substrates conjuncted with a fluorophore without affecting the 
reaction with SNAP-tag. 
The full-length SNAP-tag fragment was PCR amplified from pCQ11-FtsZ-
SNAP (Fabien Grein) as a template using VP51_F and VP52_R. the 
overlapping primers were designed to insert a flexible linker of 6-amino acids 
(GSGGGS) upstream of SNAP-tag. Simultaneously, pmecA fragment was 
amplified by PCR using overlapping VP49_F and VP50_R primers, resulting 
in a 2588 bp product. Both fragments were PCR purified and cloned into 
BamHl/Sacl cut version of pGM068 plasmid backbones, with 
erythromycin/lincomycin for S. aureus; resulting in pVP04_PBP2A-SNAP 
(Figure 4.19 A). The plasmid was transformed into E. coli DH5α 
electrocompetent strain (NEB), creating SJF5012. The insertion of SNAP-tag 
was verified by PCR amplification using VP51_F and VP52_R primers 
resulting in a 558 bp product (Figure 4.19 B). The insertion of pmecA was 
verified by PCR amplification using pmecA2_seqF1 and pmecA2_seqR2 
primers resulting in a 3500 bp product (Figure 4.19 C). pVP04_PBP2A-
SNAP was isolated from SJF5012 and transformed into electrocompetent 
RN4220. The transformants were selected on agar plate containing 
erythromycin (5 µg/ml) and lincomycin (25 µg/ml). Genomic DNA was 
isolated from positive transformants to verify the integration of 
pVP04_PBP2A-SNAP at the lysA locus. PCR amplification using lysA_5’_For 
and pmecA2_SeqR2 primers produced a ~4000 bp product. A phage lysate 
from RN4220 lysA::PBP2A-SNAP (SJF5018) was used to move lysA region 
containing PBP2A-SNAP (Figure 4.19 D) into SH1000; multicopy copy mecA 
cured background, SJF4993 (SH1000 pRB474 pmecA cured); single copy 
mecA cured background, SJF5010 (SH1000 lysA::kan cured) and a gdpP 
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mutant, (SJF5025) by phage transduction creating SJF5020 (SH1000 
lysA::PBP2A-SNAP), SJF5027 (pRB474-pmecA-cured lysA::PBP2A-SNAP), 
SJF5028 (mecA-cured-rpoB (H929Q) lysA::PBP2A-SNAP) and SJF5030, 
(ΔgdpP::kan lysA::PBP2A-SNAP), respectively.  
In order to determine the oxacillin susceptibility of PBP2A-SNAP strains, the 
oxacillin Etest method was performed. SJF5020 (SH1000 lysA::PBP2A-
SNAP) remained sensitive to oxacillin (0.5 µg/ml) whereas, reintroduction of 
mecA via PBP2A-SNAP fusion into mecA cured backgrounds, SJF5027 
(pRB474-pmecA-cured lysA::PBP2A-SNAP), SJF5028 (mecA-cured-rpoB 
(H929Q) lysA::PBP2A-SNAP) only showed sensitivity (oxacillin MIC = 1 
µg/ml) or intermediate resistance to oxacillin (MIC = 8 µg/ml), respectively 
(Figure 4.19 F). Similar to SJF5027, PBP2A-SNAP in the gdpP mutant 
background (SJF5030) remained sensitive to oxacillin (MIC = 1 µg/ml) 
(Figure 4.19 F). The detection of intermediate level resistance (SJF5028) to 
oxacillin suggests that the C-terminal SNAP fused to PBP2A is likely to be 




Figure 4.19 Construction of SH1000 lysA::PBP2A-SNAP fusion 
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A) Diagrammatic illustration of pVP04_PBP2A-SNAP construction. SNAP-tag was amplified with pCQ11-FtsZ-SNAP (Fabien Grein) as a template 
using overlapping primers VP51_F and VP52_R primers producing 604 bp fragment. Primers were designed to insert a flexible linker (6-amino acids) 
upstream of SNAP. The pmecA fragment was PCR amplified using VP49_F and VP50_R producing 2588 bp fragment. The purified PCR products 
were cloned into BamHl/SacI cut pGM068 by Gibson assembly, resulting in pVP04_PBP2A-SNAP (E. coli pVP04_PBP2A-SNAP, SJF5012).  
B) Physical map showing insertion of pVP04_PBP2A-SNAP plasmid at the lysA locus. Primer binding sites are also shown with arrows. 
C) The insertion of the SNAP-tag in pVP04_PBP2A-SNAP (lane 1) was verified by PCR using VP51_F and VP52_R primers producing a band of 558 
bp marked by a black arrow. DNA fragments were used as size markers for agarose gel electrophoresis. 
D) The insertion of pmecA in pVP04_PBP2A-SNAP (lane 1) was verified by PCR using pmecA2_seqF1 and pmecA2_seqR2 primers producing a band 
of 3500 bp marked by a black arrow. DNA fragments were used as size markers for agarose gel electrophoresis. 
E) Genomic DNA was isolated from RN4220 PBP2A-SNAP (SJF5018) (lane 1) for PCR verification. 1% w/v TAE agarose gel showing a product of 
~4000 bp representing the insertion of PBP2A-SNAP at the lysA locus using sequencing primers lysA_5’_For (Forward) and pmecA2_SeqR2 
(Reverse). The expected band is marked by an arrow. DNA fragments were used as size markers for agarose gel electrophoresis. 
F) Oxacillin susceptibility of SH1000 lysA::PBP2A-SNAP (SJF5020); SJF4993, pRB474-pmecA-cured lysA::PBP2A-SNAP (SJF5027); SJF5010, mecA-
cured-rpoB (H929Q) lysA::PBP2A-SNAP (SJF5028) and SJF5025, ΔgdpP::kan lysA::PBP2A-SNAP (SJF5030) was determined using the Etest 
method. Oxacillin MICs are listed in brackets for all strains. 
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4.2.7.3.1 Localisation of PBP2A-SNAP in S. aureus in the absence of 
oxacillin 
The subcellular localisation of S. aureus PBP2A was visualised using 
fluorescence microscopy of SJF5020 (SH1000 lysA::PBP2A-SNAP) and 
SJF5028 (mecA-cured-rpoB (H929Q) lysA::PBP2A-SNAP). The cells were 
grown to an OD600 0.5 in the absence of oxacillin. To optimise the labelling 
conditions, different concentrations (0.25 and 0.5 µM) of SNAP-Cell TMR-
Star (NEB) substrate was tested but did not produce a fluorescence signal. 
Therefore, the collected cells were incubated with 1 µM SNAP-Cell TMR-Star 
at 37ºC for 30 min for labelling. SNAP-Cell TMR-Star is a cell permeable 
substrate based on 6-carboxytetramethylrhodamine. It is a red fluorescent 
dye which covalently binds to SNAP-tag fusion proteins.  
Previous studies have shown that PBP2 localises at the septum (Pinho and 
Errington, 2003) and that PBP2A takes over its transpeptidase activity in the 
presence of oxacillin (Pinho and Errington, 2005; Pinho et al., 2001b). This 
suggests that PBP2A is recruited at the septum. SH1000 was labelled as a 
control which showed no signal with the same contrast for SJF5020 and 
SJF5028 (Figure 4.20 A). Preliminary data from the raw images of SJF5020 
showed cytoplasmic signal whereas, deconvolution revealed a collection of 
patches distributed around the cell surface (Figure 4.20 B). In SJF5028, in 
the presence of rpoB (H929Q) mutation, a bright signal at the septum was 
observed, this was further highlighted by deconvolution which reduced the 
cytoplasmic signals (Figure 4.20 C). However, not all cells in the field 
showed septal localisation of PBP2A-SNAP. Based on preliminary data, this 
observation suggests that PBP2A is able to localise at the midcell in the 
absence of oxacillin when the cells have acquired an rpoB mutation. 
However, this experiment was a trial to optimise for a brighter fluorescence 







Figure 4.20 Localisation of PBP2A-SNAP TMR-Star in the absence of oxacillin 
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A) SH1000 labelled with 1 µM SNAP-Star showed no signal. The images are average 
intensity projections of z-stacks images acquired at 250 nm z-intervals. The same contrast 
was adjusted for all images 
B) PBP2A-SNAP in SJF5020 (SH1000 lysA::PBP2A-SNAP) was labelled with 1 µM 
SNAP-Cell TMR-Star for 30 mins. The images are z-stack images with average intensity 
projections are acquired at 250 nm z-intervals. Same contrast was adjusted for all raw and 
deconvolved images separately. 
C) For SJF5028 (mecA-cured-rpoB (H929Q) lysA::PBP2A-SNAP), PBP2A-SNAP was 
labelled with 1 µM SNAP-Cell TMR-Star for 30 mins. Some cells showed a brighter signal 
at the septum marked by a white arrowhead. The z-stack images with average intensity 
projections are acquired at 250 nm z-intervals. Same contrast was adjusted for all raw and 





4.2.7.3.2 Localisation of PBP2A-SNAP in S. aureus in the presence of 
oxacillin 
The localisation of the PBP2A-SNAP fusion was visualised using 
fluorescence microscopy with SJF5020 (SH1000 lysA::PBP2A-SNAP) and 
SJF5028 (mecA-cured-rpoB (H929Q) lysA::PBP2A-SNAP. The cells were 
grown in BHI to an OD600 0.5 (early-exponential phase). and then SJF5020 
(SH1000 lysA::PBP2A-SNAP; oxacillin MIC = 0.5 µg/ml) was sub-cultured 
into fresh BHI broth containing 0.2 µg/ml of oxacillin. SJF5028 (mecA-cured-
rpoB (H929Q) lysA::PBP2A-SNAP; oxacillin MIC = 8 µg/ml) was sub-cultured 
into fresh BHI containing 2 µg/ml of oxacillin. During the experiment, it was 
noted that in the presence of 0.2 µg/ml of oxacillin, SJF5020 grew slower 
than in the absence of oxacillin, suggesting a severe growth defect due to 
PBP2A-SNAP fusion (results not shown). SJF5028 also grew slower in the 
presence of 2 µg/ml oxacillin (results not shown).  
Following incubation with oxacillin, the cells were then collected and labelled 
with 1 µM SNAP-Cell TMR-Star for 30 mins and incubated at 37ºC. The 
labelled cells were washed and then fixed with paraformaldehyde. The cells 
were then washed and resuspended in dH2O. The samples were examined 
using deconvolution fluorescence microscopy. A control (SH1000) did not 
show fluorescence (Figure 4.21 A). Preliminary data from the raw images of 
SJF5020 showed cytoplasmic localisation in the presence of oxacillin 
whereas, deconvolution revealed that some cells appeared to have 
increased signal distributed around cell surface (Figure 4.21 B). Moreover, 
SJF5020 appeared to have increased cell size compared to cells grown 
without oxacillin (Figure 4.20 B). 
In SJF5028, in the presence of the rpoB (H929Q) mutation, a bright signal at 
the septum was observed, this was further highlighted by deconvolution 
which reduced the cytoplasmic signals (Figure 4.21 C). A number of cells 
showed brighter PBP2A-SNAP signal at the septum compared to the cells 
grown in the absence of oxacillin (Figure 4.20 C). Based on preliminary data, 
this observation suggests that PBP2A is able to localise at the midcell more 
effectively in the presence of oxacillin when the cells have acquired a rpoB 
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mutation. However, this experiment was a trial to optimise for a brighter 
fluorescence substrate and requires further tests to verify the findings. 
Further localisation study is needed to determine differences in cell size with 









Figure 4.21 Localisation of PBP2A-SNAP TMR-Star in the presence of oxacillin 
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A) SH1000 labelled with 1 µM SNAP-Star showed no signal. The images are average 
intensity projections of z-stacks images acquired at 250 nm z-intervals. The same contrast 
was adjusted for all images 
B) SJF5020 (SH1000 lysA::PBP2A-SNAP) was grown in the presence of 0.2 µg/ml of 
oxacillin (MIC = 0.5 µg/ml). PBP2A-SNAP was labelled with 1 µM SNAP-Cell TMR-Star 
for 30 mins. The images are z-stack images with average intensity projections are 
acquired at 250 nm z-intervals. Same contrast was adjusted for all raw and deconvolved 
images separately. 
C) SJF5028 (mecA-cured-rpoB (H929Q) lysA::PBP2A-SNAP) grown in the presence of 2 
µg/ml of oxacillin (MIC = 8 µg/ml) was labelled with 1 µM SNAP-Cell TMR-Star for 30 
mins. Some cells showed a brighter signal at the septum marked by a white arrowhead. 
The z-stack images with average intensity projections are acquired at 250 nm z-intervals. 






An expression of heterogeneous methicillin resistance in S. aureus is a 
characteristic feature capable of developing a stable high-level 
homogeneous resistance upon exposure to β-lactam antibiotics (Matthews 
and Stewart, 1984). The introduction of plasmid-borne mecA into clinical 
MSSA leads to low-level resistance (Kim et al., 2013; Murakami et al., 1987; 
Pozzi et al., 2012) which was able to develop homogeneous high-level 
resistance upon selection with antibiotic exposure. However, it is difficult to 
study the underlying mechanism of developing high-level resistance using 
clinical MSSA and MRSA strains as it limits the experimental genetic 
manipulation. Therefore, similar to the naturally occurring MRSA carrying 
chromosomally located mecA gene on SCCmec element; in this study, an 
MSSA strain with constitutive expression of single copy mecA under its 
native promoter was constructed using a genetically amenable lab strain, 
SH1000 (SJF4996), exhibiting low-level of resistance to oxacillin (MIC = 2 
µg/ml). Highly oxacillin resistant spontaneous mutants were selected upon 
exposure to ≥5 µg/ml of methicillin, similar to the results obtained in section 
3.2.1.1 (see section 4.2.1.2). However, when single copy chromosomal 
mecA was removed (SJF5010) and replaced with plasmid-borne mecA 
(SJF5024) did not result into high-level resistance (Figure 4.6). This 
observation suggested the importance of the chromosomal background 
contributing to the development of high-level resistance.     
Prior studies have noted considerable increase in the production of PBP2A 
(Aedo and Tomasz, 2016; Dordel et al., 2014; Pozzi et al., 2012) was 
associated with the expression of high-level resistance yet Murakami et al., 
(1987) demonstrated that strains exhibiting low-level resistance produced 
large amount of PBP2A similar to those produced by highly resistant strains. 
This data suggested an apparent noncorrelation between the amount of 
PBP2A being produced and the MIC, implicating an existence of different 
genetic determinants responsible for varied resistance pattern. To further 
examine the correlation between the amount of PBP2A and resistance, 
Katayama et al., (2003) introduced plasmid-borne mecA into naïve (i.e., 
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MSSA strains that have not carried mecA previously) and experienced (i.e., 
MRSA strains that have SCCmec removed) hosts, showing diminished 
amounts of PBP2A in naïve compared to experienced strains. Also, upon re-
acquisition of mecA into experienced the strains exhibited high-level 
resistance accompanied by increased production of PBP2A (Antignac and 
Tomasz, 2009), highlighting the importance of the genetic background in 
regulating β-lactam resistance. Similar results were obtained in this study 
with highly resistant derivatives (SJF5003 and SJF5034) of SJF4996 
(SH1000 lysA::pmecA) produced up to 3-fold more PBP2A even in the 
presence of oxacillin, comparable to clinical isolate COL (Figure 4.13 A and 
B). 
It has been proposed that additional compensatory mutations in the genome 
played a prominent role in supporting high-level resistance (Hartman and 
Tomasz, 1986; Murakami et al., 1987). To better understand the role of 
genetic determinants in causing high-level resistance from low-level 
resistance, four clones of MRSA (De Lencastre et al., 2000) carrying type l 
SCCmec element containing inactive form of regulatory genes, mecI and 
mecR1 (Hiramatsu et al., 1992) were grown in the presence of oxacillin to 
obtain homogeneously and highly resistant populations (Dordel et al., 2014). 
Genome comparisons with their parental strains revealed a number of 
functionally diverse genetic determinants influencing high-level resistance. 
Functional categorisation of these genes included guanine metabolism 
(guaA, prsA, hpt and relA2), transcription (rpoB and rpoC), ribosome 
structure or translation (metS, lysS, cysS, valS, gcp, rpsM and sua-5) (Dordel 
et al., 2014). Most of these genes have been shown to be involved in 
inducing the stringent stress response resulting in the development of high-
level resistance (Kim et al., 2013; Mwangi et al., 2013). Kim et al (2013) 
proposed that mutations in genes involved in nutrient uptake, maintaining 
bacterial metabolism or in transcription systems (RNA polymerase) lead to 
constitutive expression of relA which would be predicted to activate 
production of (p)ppGpp, invoking the stringent response and concomitant 
high-level resistance (Figure 4.22). However, the correlation between 
specific mutations carried by MRSA isolates resulting in a common 
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consequence remains to be determined. This is because not all highly 
resistant clones of MRSA carry an altered relA system. 
In this study, it has been shown that mecA is essential for resistance, yet 
chromosomal genes influence the level of expression of resistance. This is 
because when chromosomal mecA of highly oxacillin resistant mutant 
(SJF5003, MIC = ≥256 µg/ml) was replaced with kanamycin resistance gene 
kan, it regained susceptibility (SJF5010, MIC = 0.5 µg/ml) however, 
subsequent reintroduction of mecA produced high-level resistance 
(SJF5011, MIC = ≥256 µg/ml) without further training indicating the 
contribution of genetic determinant which defines the level of resistance. 
The comparison of full genome sequences of highly resistant strains (Table 
4.1) Table 4.2 versus low-level resistant parental strain (SJF4996) identified 
mutations in either rpoB or rpoC genes (Table 4.2). Acquisition of either rpo 
mutations not only conferred resistance to oxacillin but also to other β-
lactams such as cefoxitin and penicillin G (Table 4.3). However, all strains 
carrying highly resistant strains remained sensitive to rifampicin. Rifampicin 
resistance is most commonly associated with mutations in rpoB, one of the 
most frequent mutations in rpoB (H481Y) promotes rifampicin as well as 
vancomycin resistance (Matsuo et al., 2011). The identification of rpo 
mutations in this study is not coincidental as rpo mutations are also identified 
in clinical MRSA isolates associated with resistance to specific antibiotics 
(Table 4.4). Alignment of the RpoB and RpoC sequences from clinical MRSA 
isolates, COL, Mu50, Mu3, MW2, USA300, JH9, MRSA252; with the Clustal 
Omega program revealed number of alterations highlighted in green 
(Appendix 2). The mutations identified in both rpoB and rpoC of JH9 were 
previously reported by Mwangi et al (2007). The rpoB mutations of COL were 
previously reported by Dordel et al (2014) and Hiramatsu et al (2013), and 
further verified using DNA sequencing along with other clinical MRSA isolate 






Figure 4.22 Schematic model for stringent response mediated high-level resistance 
in S. aureus 
Mutations identified (Dordel et al., 2014; Kim et al., 2013) involved in diverse cellular 
functions could trigger stringent stress response by increasing cellular ppGpp which 
controls biosynthetic activities through direct interaction with ribosomal protein and its 
regulation, resulting into increased production of PBP2A and antibiotic resistance. Taken 
from (Dordel et al., 2014). 
HD, hydrolase; SYN, synthetase; TGS, a domain containing three enzyme activities, 
threonyl-tRNA synthetase (ThrRS), GTPase and guanosine 3’, 5’ -bis(diphosphate) 3’ -
pyrophosphohydrolase (SpoT); ACT, domain containing three enzyme activities, aspartate 





Genetic complementation of rpoB and rpoC in representative strains 
SJF5003 (trained, SH1000 lysA::pmecA rpoB-H929Q) and SJF5034 (trained, 
SH1000 lysA::pmecA rpoC-G740R) not only restored oxacillin susceptibility 
(MIC = 1 µg/ml) in SJF5044 (SJF5003, rpoB+) and SJF5045 (SJF5034, 
rpoC+), respectively but also diminished the production of PBP2A (Figure 
4.14 E) similar to the parental strain SJF4996 (Figure 4.13 A). These results 
were not specific to the strains constructed in this study as replacing COL 
rpoB (A798V and S875L) to WT rpoB (NCTC8325) resulted into not only 
restoration of oxacillin susceptibility comparable to the parental strain 
SJF4996 (oxacillin MIC = 2 µg/ml) but also reduction in the amount of cellular 
PBP2A being produced (Figure 4.14 and F). Another possible explanation is 
that COL carries type l SCCmec which contains truncated mecA regulatory 
genes mecI and mecRI (Deurenberg et al., 2007), resulting in derepression 
of the mecA gene, therefore constitutive production of PBP2A (Figure 4.14 F) 
however, this can be reversed by replacing rpoB to WT (NCTC8325), 
resulting into decreased production of PBP2A (Figure 4.14 F). Therefore, the 
rpo mutations can be considered ‘regulatory mutations’. Moreover, 
introduction of mecA and rpoB (H929Q) mutation into Newman strain 
produced highly oxacillin resistant clones (SJF5050). Collectively, these 
observations confirm the importance of mutations in either RNA polymerase 
subunits for the conversion of low-level to high-level homogeneous 
methicillin resistance.  
Recent studies by Aiba et al (2013) demonstrated that two point mutations in 
rpoB (N967I and R644H) were able to cause heterogeneous to 
homogeneous resistance in N315 upon selection with imipenem. N315 is a 
hospital-acquired MRSA which carries type ll SCCmec element containing a 
functional mecI (mecA repressor gene), resulting in strongly repressed mecA 
expression (Hiramatsu et al., 1992). Both rpoB mutants had prolonged 
doubling time and thickened cell wall accompanied by increased amount of 
cellular PBP2A. Similar features were noted for rpoB (H481Y) mutation 
which raises rifampicin and vancomycin resistance (Katayama et al., 2009; 
Matsuo et al., 2011). Transcriptional analysis of rpoB (N967I) mutant relative 
to the parental strain showed decrease in expression of cidABC and increase 
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in the expression of IrgAB (Aiba et al., 2013). Disruption of lrgAB operon is 
associated with decreased antibiotic tolerance (Groicher et al., 2000) and 
inactivation of cid operon causes increased tolerance to antibiotics (Rice et 
al., 2003). This suggests the expression of cid and lrg is modulated by rpoB 
mutations. 
rpoB mutations have also been identified in the progression of vancomycin 
resistance from hetero-VISAslow-VISAVISA accompanied by rifampicin 
resistance (Matsuo et al., 2011; Watanabe et al., 2011). Slow-VISA is a 
novel phenotype associated with prolonged doubling time (Saito et al., 2014). 
Not only rpoB mutations have shown to be a frequent underlying cause for 
antibiotic resistance but also mutations in rpoC (P440L) showed increase 
vancomycin resistance (Matsuo et al., 2015). The revertants of rpoC (P440L) 
mutant showed increased susceptibility to vancomycin accompanied by 
decreased doubling time with reduced cell wall thickness (Matsuo et al., 
2015). Surprisingly, a number of revertants had acquired different rpoC 
mutations that were considered to be compensatory, suggesting its influence 
on the overall gene expression profile (Matsuo et al., 2015). Taken together, 
it is plausible that rpo mutations lead to changes in the way RNA polymerase 
subunits interact with each other which influences diverse transcriptional 
regulation, supporting elevated resistance. Therefore, the next chapter 
moves on to discuss the impact of rpoB (H929Q) and rpoC (G740R) 




5 Chapter 5 
The role of rpoB and rpoC mutations in S. aureus high-
level methicillin resistance 
5.1 Introduction 
Early research by Hartman and Tomasz (1986) and Sabath and Wallace 
(1971) in the study of the molecular basis of expression of methicillin 
resistance strongly suggested the involvement of genetic determinants in the 
conversion of low-level to high-level resistance. With the technological 
advancements in recent years, several studies using whole genome 
sequencing have revealed a number of genetic factors required for high-level 
β-lactam resistance.  
Mwangi et al (2013) identified a nonsense mutation in relA by introducing 
plasmid-borne mecA into an MSSA strain to reproduce high-level β-lactam 
resistance. Inactivation of relA is predicted to result in constitutive production 
of (p)ppGpp, leading to the stringent stress response (Mwangi et al., 2013). 
Similar observations were noted when an entire SCCmec element was 
introduced into an MSSA strain (Kim et al., 2013). Furthermore, Griffiths and 
O’Neill (2012) and Pozzi et al (2012) identified mutations in gdpP required for 
conversion of heterogeneous to homogeneous methicillin resistance. 
Disruption in gdpP is associated with reduced phosphodiesterase activity, 
resulting into increased intracellular c-di-AMP (Corrigan et al., 2011). 
Mutations in gdpP were also found to be associated with resistance to other 
broad-spectrum β-lactams such as, ceftobiprole and ceftaroline (Chan et al., 
2016). Aiba et al (2013) reported a mutation in the rpoB gene implicated in 
the conversion from low-level to high-level homogeneous resistance by 
altering the expression of autolysis genes, resulting in reduced autolytic 
activity associated with a prolonged doubling time. Similarly, nonsense 
mutations in relA and rpoB were identified along with other mutations in 25 
genes found to be associated with the development of high-level resistance 
(Dordel et al., 2014).  
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Moreover, systematic tracking of evolution in the JH lineage in vivo, identified 
35 point mutations between JH1 (first) and JH9 (last) isolates associated with 
multidrug resistance (Mwangi et al., 2007). Characterisation of compensatory 
mutations have led us to one step towards understanding the genomic 
changes leading to high-level resistance. However, it is important to examine 
the role of chromosomal mutations on not only of the genomic level but also 
their effect on bacterial physiology via alterations in the transcriptional and 
translational capacity. To better understand the transcriptional changes 
caused by mutations for the conversion of JH1 to multidrug resistant JH9, 
transcriptional profiling revealed 224 differentially expressed genes; where 
48 genes were found to be controlled by vraR (Kuroda et al., 2003), and 
other 32 genes were controlled by yycF (Dubrac and Msadek, 2004) and 244 
genes positively regulated by the agr (Liang et al., 2005) locus. These three 
transcriptional regulators agr, vraR and yycF also appear to be involved in 
increased tolerance to vancomycin (Mwangi et al., 2007). Additionally, the 
expression of many genes are affected by nonsynonymous mutations in 
rpoB that causes pleiotropic effects that are responsible for rifampicin 
resistance in B. subtilis (Maughan et al., 2004). The impacts of rpoB H481Y 
and relA F128Y mutations on global gene expression revealed significant 
upregulation in genes associated with agr activity as well as genes involved 
in capsule biosynthesis (Gao et al., 2013). 
Investigating proteins induced by oxacillin in MSSA, Singh et al., (2001) 
revealed nine proteins were produced in elevated amounts, these include, 
MsrA (methionine sulfoxide reductase), signal transduction proteins encoded 
by the agr locus, GreA (transcription elongation factor) and GroES (heat 
shock protein). Comparison of proteomic profiles of MSSA and MRSA in the 
absence of methicillin showed only the FemA protein with an elevated 
amount (Cordwell et al., 2002; Lee et al., 2015). FemA is characterised as a 
factor essential for the expression of methicillin resistance in S. aureus. 
(Berger-Bächi et al., 1989). Another report exploring proteome profiles in 
MSSA and MRSA identified a total of ten proteins with an elevated amount in 
MRSA compared to MSSA (Enany et al., 2014). These were Asp23 (alkaline 
shock protein 23), AhpC (alkyl hydroperoxide reductase subunit C), a 
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general stress protein, LdhD (D-lactate dehydrogenase), LdhA (L-lactate 
dehydrogenase), PdhB (pyruvate dehydrogenase E1 component β subunit), 
SodA (superoxide dismutase), LipA (triacylglycerol lipase precursor), TpiA 
(triosephosphate isomerase) and a universal stress protein family protein 
(Enany et al., 2014). Whereas, proteomic response prior to oxacillin 
treatment in MRSA showed 72 differentially expressed proteins involved in 
diverse functional categories, such as oxidation-reduction homeostasis and 
cell wall biosynthesis, indicating a diverse response of the bacteria to 
oxacillin (Liu et al., 2016c).  
Despite several studies, there is no mechanistic understanding of the 
processes underpinning the ability of S. aureus to attain high-level β-lactam 
resistance. My work has identified mutations in rpoB or rpoC as being solely 
responsible for resistance in the presence of mecA. It is now important to 
explain how this effect is mediated.   
5.1.1 Aims 
The overall aim of this chapter was to establish an RNA-seq approach to 
understand the molecular basis of methicillin resistance in a well-defined 
strain background. The specific aims of this chapter were to: 
i. Examine transcriptomic responses of experimentally evolved strains 
expressing low-level and high-level resistance 
ii. Systematic identification and comparative analysis of differentially 
expressed genes associated with high-level resistance 
iii. Determine putative regulatory mechanism(s) responsible for increased 






5.2.1 Transcriptomics project workflow and data analysis 
The popularity of deep sequencing of cDNA molecules (RNA-Seq) has 
become the tool of choice for global gene expression studies, replacing 
microarrays to measure simultaneous expression of genes (Wang et al., 
2008). Transcriptome profiling using RNA-Seq is a high-throughput 
sequencing method to map and quantify the complete set of transcripts in 
order to understand the importance of functional elements of the genome 
involved in cellular physiology under various conditions (Wang et al., 2009).  
My previous work (Chapter 4) determined that development of high-level 
resistance is conferred by the acquisition of nonsynonymous mutations in 
either rpoB or rpoC. In order to better understand the impact of these 
mutations on global gene expression, RNA-Seq and preliminary analysis was 
performed by the Glasgow Polyomics facility at the University of Glasgow 
(Figure 5.1) for comparative transcriptome profiling of five representative 
strains listed in Table 4.1. Total RNA was isolated from WT control 
(SH1000), untrained (SJF4996; SH1000 lysA::pmecA), trained-rpoB 
(SJF5003; SH1000 lysA::pmecA rpoB-H929Q), trained-mecA-cured-rpoB 
(SJF5010; SH1000 lysA::kanA rpoB-H929Q) and trained-rpoC (SJF5034; 
SH1000 lysA::pmecA rpoC-G740R) strains. These five representative strains 
used for transcriptome analysis will be referred to as WT, untrained, trained-
rpoB, trained-mecA-cured-rpoB and trained-rpoC. The integrity of total RNA 
was measured prior to the preparation of cDNA library followed by rRNA 
(ribosomal RNA) depletion. All samples were supplied with three biological 
replicates to control sample variation. cDNA libraries were sequenced with a 
75-basepair single-end read using an Illumina NextSeq™ 500 platform.  
For differential gene expression analysis, reads were aligned to the 
NCTC8325 genome and expression values were determined as normalised 
counts using DESeq2 package (Love et al., 2014) for each gene. The mecA 
DNA sequence was added to the reference genome prior to alignment. 
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Differential expression of each gene was tested for variance and estimated 
differential expression was corrected for multiple comparisons (Padj).  
5.2.1.1 Principal Component analysis 
DESeq2 is a method which enables a quantitative analysis of comparative 
transcriptomics data by using a number of computational packages (Love et 
al., 2014). In order to detect a possible variation in large data sets principal 
component analysis (PCA) was used, a statistical method which uses gene 
expression values to define unrelated variables and assign as a principal 
component(s), allowing the identification of outliers (Stacklies et al., 2007).  
PCA analysis of 15 samples (5 representative strains, each with three 
biological replicates) identified two outliers clustered with a group of different 
strains. The samples with swapped groups were one of the replicates of WT 
control (SH1000) and one of the replicates of trained-mecA-cured-rpoB 
(SJF5010; SH1000 lysA::kanA rpoB-H929Q) (Figure 5.2). For comparative 




Figure 5.1 RNA-Seq pipeline for transcriptome profiling 
Stepwise process illustrating RNA-Seq workflow of five representative strains, WT, 
untrained, trained-rpoB, trained-mecA-cured-rpoB and trained-rpoC. Steps listed on the 
left side were performed in-house. Steps listed on the right side were carried out by 






Figure 5.2 Principal component analysis to identify sample variation  
2D PCA score plot displaying three biological replicates of each strain clustered together. 
The samples are WT, untrained, trained-rpoB, trained-mecA-cured-rpoB and trained-
rpoC. The replicates which are not clustered within the corresponding group are marked 





5.2.2 Comparative pairwise analysis of expressed genes 
The goal of transcriptomics analysis was to identify differentially expressed 
genes among five strains in an accurate and unbiased manner. Primary data 
analysis using the DESeq2 platform generated raw files for each sample 
containing expression values (normalised counts), p value, padj (adjusted p 
value) and log2foldchange (log2fc) for each gene. The data was then 
compared in a pairwise manner between the five samples, resulting in a total 
of ten pairwise comparisons. In order to carry out secondary analysis to 
identify statistically significant differentially expressed genes (DEGs), all 
genes from each pairwise comparisons were annotated using the NCTC8325 
genome which produced raw gene names. Next, raw gene names were used 
to retrieve UniProt protein accession, gene ids (locus tags) and their 
description using the UniProtKB database. Subsequently, from each pairwise 
comparison, genes with an adjusted P value <0.05 and log2fc ≥±1 were 
identified as being statistically significant DEGs. Therefore, the non-
significant gene sets were removed retaining only important gene sets for 
each pairwise comparison. Important gene sets were used to retrieve 
common genes with differential expression between pairwise and group wise 
comparisons. 
5.2.2.1 Identification of DEGs in untrained compared to SH1000 
In order to determine the impact of the acquisition of chromosomal mecA and 
concomitant transcriptional changes in MRSA, global gene expression 
profiles from untrained exhibiting low-level oxacillin resistance (MIC = 2 
µg/ml) and WT were compared. Pairwise comparison of RNA-Seq data 
identified 193 DEGs with a significant threshold of padj <0.05 and log2fc ≥±1 
(2-fold change) (Figure 5.3 A). The variability in all samples of WT and 
untrained (columns) for 193 DEGs is shown in a heatmap created based on 
log2 transformed normalised counts which identified changes in expression 
profiles of both strains (Figure 5.3 A). The full list of 193 DEGs with 
differential expression is shown in Appendix 4 Table 1. This data suggests 
that acquisition of mecA on its own influenced profound transcriptional 
changes whilst exhibiting low-level resistance. 
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5.2.2.2 Identification of DEGs in trained-rpoB (H929Q) mutant 
compared to SH1000 
In order to assess the transcriptional response due to the acquisition of a 
nonsynonymous mutation in rpoB (H929Q) of trained-rpoB mutant compared 
to WT, differentially expressed genes from both strains were identified. 
Based on a pairwise comparison using both strains, there were 9 DEGs 
identified with significant differential expression (Figure 5.4 A). Three and two 
biological replicates of trained-rpoB mutant and WT were used for 
transcriptome comparison, respectively. The full list of 9 DEGs with 
expression values are listed in Appendix 4 Table 2. The expression of mecA 
between strains was demonstrated by boxplot (Figure 5.4 B). Surprisingly, 
this observation revealed that even though the trained-rpoB mutant exhibits 
high-level oxacillin resistance (MIC ≥256 µg/ml), it requires minimal 
transcriptional alterations to be able to produce such a high-level resistance. 
This observation is further supported by PCA analysis as both these strains 
cluster close to each other (Figure 5.2). 
5.2.2.3 Identification of DEGs in trained-mecA-cured-rpoB (H929Q) 
compared to SH1000 
In order to analyse the impact of rpoB mutation on gene expression, trained-
mecA-cured-rpoB was used for comparative analysis against WT. Trained-
mecA-cured-rpoB was derived from trained-rpoB by removal of mecA 
(section 4.2.1.3), resulting into restored susceptibility to oxacillin. Therefore, 
this background allowed to investigate transcriptional changes implemented 
by rpoB mutation alone. Pairwise comparison of RNA-Seq data identified 122 
DEGs in trained-mecA-cured-rpoB (Figure 5.5). Two biological replicates 
from both strains were used for data analysis. The full list of 122 DEGs with 
differential expression are shown in Appendix 4 Table 3. This observation 
indicates that mutation in rpoB induces a substantial transcriptional change 




5.2.2.4 Identification of DEGs in trained-rpoC (G740R) compared to 
SH1000 
In order to examine the transcriptional changes acquired by trained-rpoC 
strain compared to WT, RNA-Seq data was compared from all biological 
replicates of both strains. There were 120 DEGs identified between two 
strains (Figure 5.6 A). The details of DEGs are listed in Appendix 4 Table 4. 
The expression of mecA was significantly higher compared to WT due to lack 
of mecA gene (Figure 5.6 B). Unlike transcriptional responses observed due 
acquisition of rpoB mutation (in the presence of a chromosomal copy of 
mecA), rpoC mutant shown to have considerable transcriptional changes 
compared to WT. However, there were 73 genes found to be reverted back 
to WT level compared to the original 193 DEGs identified in untrained strain 
(section 5.2.2.1). Taken together, this data suggests that rpoC mutations 
caused significant changes in transcriptional profile while exhibiting high-
level oxacillin resistance (MIC ≥256 µg/ml) similar to that of rpoB mutant 
(SJF5003). 
5.2.2.5 Identification of DEGs in trained-rpoB (H929Q) compared to 
untrained 
In the presence of mecA, the acquisition of the rpoB mutation caused a 
dramatic increase in the resistance phenotype compared to its parental 
strain, untrained. This observation indicates obvious transcriptional changes 
have occurred for concomitant increased resistance. In order to examine the 
transcriptional response in trained-rpoB. This was compared to untrained. 
Pairwise comparative analysis of transcriptional profiles from untrained and 
trained conditions identified 172 DEGs with significant differential expression 
(Figure 5.7 A), potentially associated with high-level oxacillin resistance. 
Furthermore, the acquisition of the rpoB mutation led to increased mecA 
expression (Figure 5.7 B), suggesting some increase in the expression of 
mecA is required but not sufficient for developing high-level resistance. 
Three biological replicates of both conditions were used for comparison. The 




Figure 5.3 The diversity of expression profiles in untrained compared to WT 
A) Heatmap representation of 193 (out of 2895) statistically significant DEGs (padj <0.05, 
log2fc ≥±1) in untrained relative to WT across all biological replicates. The rows (genes) 
and columns (replicates) of the heatmap were linked using hierarchical clustering. 
Heatmap was generated using R software (R Development core team, 2012), pheatmap 
package.  
B) Boxplot comparing the mecA gene expression data using normalised counts from five 







Figure 5.4 The diversity of expression profiles in trained-rpoB mutant compared to 
SH1000 
A) Heatmap representation of 9 (out of 2895) statistically significant DEGs (padj <0.05, 
log2fc ≥±1) in trained-rpoB relative to WT across all biological replicates. The rows 
(genes) and columns (replicates) of the heatmap were linked using hierarchical clustering. 
Heatmap was generated using R software (R Development core team, 2012), pheatmap 
package.  
B) Boxplot comparing the mecA gene expression data using normalised counts from five 






Figure 5.5 The diversity in expression profiles of mecA-cured rpoB mutant 
compared to SH1000 
Heatmap representation of 122 (out of 2895) statistically significant DEGs (padj <0.05, 
log2fc ≥±1) in trained-mecA-cured-rpoB relative to WT across all biological replicates. The 
rows (genes) and columns (replicates) of the heatmap were linked using hierarchical 







Figure 5.6 The diversity of expression profiles in rpoC mutant compared to SH1000 
A) Heatmap representation of 120 (out of 2895) statistically significant DEGs (padj <0.05, 
log2fc ≥±1) in trained-rpoC relative to WT across all biological replicates. The rows 
(genes) and columns (replicates) of the heatmap were linked using hierarchical clustering. 
Heatmap was generated using R software (R Development core team, 2012), pheatmap 
package.  
B) Boxplot comparing the mecA gene expression data using normalised counts from five 








Figure 5.7 The diversity of expression profiles in trained-rpoB mutant compared to 
untrained  
A) Heatmap representation of 172 (out of 2895) statistically significant DEGs (padj <0.05, 
log2fc ≥±1) in trained-rpoB relative to untrained across all biological replicates. The rows 
(genes) and columns (replicates) of the heatmap were linked using hierarchical clustering. 
Heatmap was generated using R software (R Development core team, 2012), pheatmap 
package.  
B) Boxplot comparing the mecA gene expression data using normalised counts from six 
samples (Untrained-1, 2, 3 and trained-rpoB-1, 2, 3). Boxplots were created using 




5.2.2.6 Identification of DEGs in trained-mecA-cured-rpoB (H929Q) 
compared to untrained 
In order to determine the transcriptional response in the presence of rpoB 
mutation alone, transcriptional profiles of trained-mecA-cured-rpoB and 
untrained was compared. Pairwise comparison identified 57 DEGs with 
differential expression (Figure 5.8 A). Three biological replicates of both 
strains were used for the data analysis. The full list of 57 DEGs with 
differential expression are listed in Appendix 4 Table 6. This observation 
identified the transcriptional changes caused by the rpoB mutation 
independent of mecA. There was an obvious significant increase in mecA 
expression in untrained compared to mecA-cured-rpoB strain (Figure 5.8 B).  
5.2.2.7 Identification of DEGs in trained-rpoC (G740R) compared to 
untrained 
In order to determine the transcriptional changes acquired due to the rpoC 
mutation, RNA-Seq data was compared between untrained and trained-rpoC 
strains. There were 291 DEGs identified with differential expression (Figure 
5.9 A). The details of DEGs are listed in Appendix 4 Table 7. A significant 
increase in the expression of mecA was also noted in trained-rpoC compared 
to the untrained strain (Figure 5.9 B). This data further supports the 
hypothesis that some increase in mecA expression is associated with the 
development of high-level resistance but is not sufficient as the rpoC 
mutation influenced substantial transcriptional changes. It is also important to 
note that acquisition of rpoC mutation induces increased transcriptional 
changes compared to the rpoB mutation (Figure 5.7 A). 
5.2.2.8 Identification of DEGs in trained-rpoB (H929Q) compared to 
trained-mecA-cured-rpoB (H929Q) 
In order to determine the transcriptional changes that occurred between 
trained-rpoB and trained-mecA-cured-rpoB, pairwise comparison was carried 
out. Subsequently, the data analysis identified 170 DEGs with differential 
expression between two strains (Figure 5.10 A). The full list of DEGs are 
listed in Appendix 4 Table 8. This observation suggested that removal of 
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mecA led to considerable transcriptional changes and was unable to revert 
back to WT level in the absence of mecA. There was an obvious significantly 
increased mecA expression in trained-rpoB compared to mecA-cured-rpoB 
strain (Figure 5.10 B). 
5.2.2.9 Identification of DEGs in trained-rpoB (H929Q) compared to 
trained-rpoC (G740R) 
To assess the transcriptional changes between trained-rpoB and trained-
rpoC and subsequently investigate mecA dependent common DEGs 
(described in detail later in this chapter), pairwise comparison was carried 
out. There were 111 DEGs identified between trained-rpoB and trained-rpoC 
strains (Figure 5.11 A). Three biological replicates of each strain were 
included prior to data analysis. The detailed list of 111 DEGs are shown in 
Appendix 4 Table 9. The expression of mecA was noted to have less than 
0.5-fold decrease for trained-rpoC compared to trained-rpoB but both strains 
have significant increase over untrained, resulting in high-level oxacillin 
resistance in both cases (Figure 5.11 B). 
5.2.2.10   Identification of DEGs in trained-rpoC (G740R) compared 
to trained-mecA-cured-rpoB (H929Q) 
Transcriptional profiles of trained-rpoC and trained-mecA-cured-rpoB were 
compared for pairwise data analysis. There were 251 DEGs identified with 
significant differential expression (Figure 5.12 A). The full list of DEGs are 
listed in Appendix 4 Table 10. Significantly higher expression of mecA was 
reported for trained-rpoC compared to trained-mecA-cured-rpoB as expected 




Figure 5.8 The diversity of expression profiles in mecA-cured-rpoB mutant 
compared to untrained 
A) Heatmap representation of 57 (out of 2895) statistically significant DEGs (padj <0.05, 
log2fc ≥±1) in trained-mecA-cured-rpoB relative to untrained across all biological 
replicates. The rows (genes) and columns (replicates) of the heatmap were linked using 
hierarchical clustering. Heatmap was generated using R software (R Development core 
team, 2012), pheatmap package.  
B) Boxplot comparing the mecA gene expression data using normalised counts from six 
samples (Untrained-1, 2, 3 and trained-mecA-cured-rpoB-2, 3). Boxplots were created 






Figure 5.9 The diversity of expression profiles in trained-rpoC mutant compared to 
untrained  
A) Heatmap representation of 291 (out of 2895) statistically significant DEGs (padj <0.05, 
log2fc ≥±1) in trained-rpoC relative to untrained across all biological replicates. The rows 
(genes) and columns (replicates) of the heatmap were linked using hierarchical clustering. 
Heatmap was generated using R software (R Development core team, 2012), pheatmap 
package.  
B) Boxplot comparing the mecA gene expression data using normalised counts from six 
samples (Untrained-1, 2, 3 and trained-rpoC-1, 2, 3). Boxplots were created using 





Figure 5.10 The diversity of expression profiles in trained-rpoB mutant compared to 
mecA-cured-rpoB mutant 
A) Heatmap representation of 170 (out of 2895) statistically significant DEGs (padj <0.05, 
log2fc ≥±1) in trained-mecA-cured-rpoB relative to trained-rpoB across all biological 
replicates. The rows (genes) and columns (replicates) of the heatmap were linked using 
hierarchical clustering. Heatmap was generated using R software (R Development core 
team, 2012), pheatmap package.  
B) Boxplot comparing the mecA gene expression data using normalised counts from five 
samples (trained-rpoB-1, 2, 3 and trained-mecA-cured-rpoB-2, 3). Boxplots were created 





Figure 5.11 The diversity of expression profiles in trained-rpoC mutant compared to 
trained-rpoB mutant 
A) Heatmap representation of 111 (out of 2895) statistically significant DEGs (padj <0.05, 
log2fc ≥±1) in trained-rpoC relative to trained-rpoB across all biological replicates. The 
rows (genes) and columns (replicates) of the heatmap were linked using hierarchical 
clustering. Heatmap was generated using R software (R Development core team, 2012), 
pheatmap package.  
B) Boxplot comparing the mecA gene expression data using normalised counts from six 
samples (trained-rpoB-1, 2, 3 and trained-rpoC-1, 2, 3). Boxplots were created using 





Figure 5.12 The diversity of expression profiles in trained-rpoC mutant compared to 
mecA-cured-rpoB mutant 
A) Heatmap representation of 251 (out of 2895) statistically significant DEGs (padj <0.05, 
log2fc ≥±1) in trained-rpoC relative to trained-mecA-cured-rpoB across all biological 
replicates. The rows (genes) and columns (replicates) of the heatmap were linked using 
hierarchical clustering. Heatmap was generated using R software (R Development core 
team, 2012), pheatmap package.  
B) Boxplot comparing the mecA gene expression data using normalised counts from five 
samples (trained-rpoC-1, 2, 3 and trained-mecA-cured-rpoB-2, 3). Boxplots were created 




5.2.3 Identification of unique and shared DEGs among untrained and 
trained strains relative to WT   
To identify the expression level distribution of shared gene content among 
untrained and trained strains compared to WT, DEGs obtained from pairwise 
comparisons were analysed for common gene pools between strains. This 
approach was used to distinguish between unique and overlapping gene 
pools by comparing two pairwise comparisons relative to WT. There were 
only 3 common DEGs identified between untrained and trained-rpoB 
compared to WT (Figure 5.13 A) even though, the pairwise comparison of 
untrained against WT identified a substantial transcriptional change. 
Whereas, untrained and trained-rpoC shared 29 common DEGs when 
compared to WT (Figure 5.13 C). It is important to note that trained-rpoB 
showed a similar transcriptional profile as WT while trained-rpoC retained 
higher differential gene expression. In addition, trained-rpoB and trained-
rpoC demonstrated 3 overlapping DEGs compared to WT (Figure 5.13 B). 
Moreover, 90 common DEGs were identified between untrained and trained-
mecA-cured-rpoB compared to WT (Figure 5.13 D). This observation 
suggests that acquisition of the rpoB mutation led to minimal transcriptional 
change by shifting gene expression to the WT level in the presence of mecA 
but removal of mecA induced a considerable transcriptional change. The 
unique DEGs identified by the pairwise comparisons were not considered for 
further analysis. 
In order to further investigate the shared gene content expressed by both 
groups, untrained and trained (rpoB and rpoC) strains compared to WT, the 
data from three pairwise comparisons were merged and visualised using a 
three-set proportional Venn diagram (Figure 5.13 E). This approach detected 
3 common genes with differential gene expression among both groups of 
strains. These genes included lysA encoding the terminal enzyme of the 
lysine biosynthesis pathway, mecA encoding PBP2A and nirR 
(SAOUHSC_02685) encoding nitrite reductase transcriptional regulator. The 
mecA gene was introduced at the 3’ of the lysA gene via pGM072 vector 
(McVicker et al., 2014). Therefore, lysA was found to be downregulated in 
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untrained and trained-rpoB and rpoC strains compared to WT (Figure 5.13 
E). It is obvious to have found mecA as one of the common DEGs because 
of its elevated expression and production of PBP2A in trained-rpoB and rpoC 
strains compared to untrained as well as WT. In addition, upregulation of 
nirR was observed in untrained whereas, trained-rpoB and rpoC showed 
downregulation of nirR, suggesting that the presence of mecA alone induces 
the expression of nirR which is repressed by the acquisition of either rpo 
mutations (Figure 5.13 D, bar plot). Nitrite reductase regulator (nirR) is 
positively and negatively regulated by nreC (response regulator) and rex 
(redox-sensing transcriptional repressor), respectively during nitrogen and 
anaerobic metabolism (Schlag et al., 2008; Somerville and Proctor, 2009). 
In an effort to determine the common DEGs amongst untrained, trained-
rpoB-rpoC and trained-mecA-cured-rpoB strains compared to WT, a four-set 
Venn diagram was created by introducing the data obtained from pairwise 
comparisons of trained-mecA-cured-rpoB relative to WT (Figure 5.14). Only 
one gene, lysA was found to be common between all four strains compared 
to WT exhibiting reduced expression. 
An interesting observation provided by the comparative analysis for the 
identification of DEGs is that the presence of mecA alone induces a 
significant amount of stress to the cell which is compensated by the 
acquisition of rpoB and partially compensated by rpoC mutations to lead to 
WT level of gene expression, accompanied by concomitant high-level 
oxacillin resistance.  
   




Figure 5.13 Detection of shared and unique DEGs among strains 
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A) Two-set proportional Venn diagram illustrating the total number of DEGs (listed in brackets) altered in untrained and trained-rpoB compared to 
WT. The identified DEGs using a significance threshold (padj <0.05, log2fc ≥±1) from pairwise comparisons of untrained (grey) and trained-rpoB 
(red) against WT (white background) determined 190 and 6 unique DEGs for untrained and trained-rpoB, respectively and 3 overlapping DEGs 
between them.  
B) Two-set proportional Venn diagram illustrating the total number of DEGs (listed in brackets) altered in trained-rpoB and trained-rpoC compared to 
WT. The identified DEGs using a significance threshold (padj <0.05, log2fc ≥±1) from pairwise comparisons of trained-rpoB (red) and trained-rpoC 
(blue) against WT (white background) determined 6 and 117 unique DEGs for trained-rpoB and trained-rpoC, respectively and 3 overlapping DEGs 
between them.  
C) Two-set proportional Venn diagram illustrating the total number of DEGs (listed in brackets) altered in untrained and trained-rpoC compared to 
WT. The identified DEGs using a significance threshold (padj <0.05, log2fc ≥±1) from pairwise comparisons of untrained (grey) and trained-rpoC 
(blue) against WT (white background) determined 164 and 91 unique DEGs for untrained and trained-rpoC, respectively and 29 overlapping DEGs 
between them.  
D) Two-set proportional Venn diagram illustrating the total number of DEGs (listed in brackets) altered in untrained and trained-mecA-cured-rpoB 
compared to WT. The identified DEGs using a significance threshold (padj <0.05, log2fc ≥±1) from pairwise comparisons of untrained (grey) and 
trained-mecA-cured-rpoB (green) against WT (white background) determined 103 and 32 unique DEGs for untrained and trained-mecA-cured-rpoB, 
respectively and 90 overlapping DEGs between them.  
E) Three-set proportional Venn diagram facilitate visualising the shared DEGs among untrained (grey), trained-rpoB (red) and trained-rpoC (blue) 
compared to WT (white background). Two-set Venn diagrams (A, B, C) were merged together to identify overlapping DEGs among the strains. 3 
common DEGs are marked by a dotted circle. Bar plot indicates log2FoldChange of expression levels of three common DEGs (lysA, mecA, nirR) 




Figure 5.14 Four-set Venn diagram illustrating unique and common DEGs between 
untrained and trained strains 
The lysA gene (marked by a dotted circle) was shared among four strains based on 
pairwise comparison of untrained (yellow), trained-rpoB (red), trained-mecA-cured-rpoB 
(green) and trained-rpoC (blue) compared to control (WT; white background). lysA was 





5.2.4 Identification of DEGs associated with high-level resistance 
To determine the transcriptional response promoted by mecA alone and 
following acquisition of rpoB or rpoC mutations, comparative analysis of 
untrained versus trained transcriptomes was performed by combining the 
data obtained from pairwise analysis. This approach enabled the 
identification and characterisation of DEGs associated with high-level 
resistance developed by trained-rpoB or rpoC strains. The data obtained 
from two pairwise comparisons of trained- rpoB or rpoC identified 121 
common DEGs between these two strains compared to untrained (Figure 
5.15 A), suggesting that the common gene pool may contain a gene or 
number of genes associated with high-level oxacillin resistance (Table 5.1). 
The transcriptomic profile of trained-rpoC showed an extensive 
transcriptional change compared to untrained. However, there were only 35 
common DEGs identified between trained-rpoC and trained-mecA-cured-
rpoB relative to untrained (Figure 5.15 B). Additionally, two pairwise 
comparisons of trained-rpoB and trained-mecA-cured-rpoB against untrained 
were combined to determine the transcriptional change introduced by rpoB 
(H929Q) mutation. There were 28 common DEGs identified, suggesting that 
the permanent differential expression of these genes is due to the presence 
of rpoB mutation alone regardless of mecA presence (Figure 5.15 C). The 
identified unique gene sets from combined pairwise comparisons were not 
considered for further analysis. 
By combining the data obtained from all trained strains and comparing 
against untrained enabled the identification of overlapping DEGs between 
untrained and trained strains. Three-set proportional Venn diagram showed 
26 DEGs shared by all three trained strains compared to untrained (Figure 
5.16 A). These 26 DEGs were part of 121 DEGs originally identified following 
acquisition of rpoB or rpoC mutations in the presence of mecA (Figure 5.15 
A). Notably, out of 26 overlapping DEGs within all three trained strains, 22 
genes were upregulated in untrained whereas, the same 22 genes were 
downregulated in all three trained strains (Figure 5.16 A). This observation 
suggests that acquisition of the mecA induced severe alterations in the gene 
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expression whereas, rpo mutations restored expression levels for most of 
these genes to WT levels. The rest of the 95 (Figure 5.17) genes showed a 
similar distribution of differential expression for 56 genes (out of 83 genes) 
accompanying reduced expression in untrained while trained- rpoB or rpoC 
showed increased expression in 66 genes out of 95 (Figure 5.16 A).  
The database of Clusters of Orthologous Groups (COGs) was used for 
functional categorisation of 121 genes (Figure 5.16 B and C and Table 5.1) 
(Tatusov et al., 2000). These set of common genes were shared between 
trained-rpoB and rpoC which also contains 26 DEGs shared by all three 
trained strains (rpoB, rpoC and mecA-cured-rpoB) (Figure 5.16). All DEGs 
were classified into broad functional categories and then COG categories 
were retrieved manually for each gene by searching UniProt accession NCBI 
database (Table 5.1). Functional categorisation detected that 52 genes 
affected were involved in metabolism, 19 genes associated with cellular 
processes and signalling and 12 genes related to information storage and 
processes. The term ‘multi class’ was applied to 14 genes as they matched 
to more than one COG categories of same or different broad functional 
groups (Figure 5.18 A). 24 genes were assigned to poorly characterised 
category as their function was either based on prediction (R) or unknown to 
categories (S).  
From 95 key genes (Figure 5.16 A and Figure 5.17), specifically associated 
with high-level resistance in response to the acquisition of rpoB and rpoC, 16 
genes assigned to the category “Cellular processes and signalling” were 
upregulated compared to untrained. 11 genes assigned to “Information 
storage and processing” were also upregulated compared to untrained. 
Moreover, 21 genes related to the category “Metabolism”, were considerably 
upregulated in trained- rpoB and rpoC strains compared to untrained (Table 
5.1). The differential expression of identified genes was found to be 
controlled by different transcriptional regulators without affecting their own 
expression (Figure 5.18 C). Six genes (yusE, yusF, proP, Saouhsc_00356, 
yfcH and yhbs) were found to be controlled by sigB, a general stress 
response alternative sigma factor (Bischoff et al., 2004). Ferric uptake 
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repressor (fur) controlled genes (sirB, sirA, ocd2, sbnA and sbnC) were also 
identified with higher expression in trained-rpoB and rpoC compared to 
untrained (Horsburgh et al., 2001; Mäder et al., 2016). These observations 
indicate that the presence of mecA may induce oxidative stress resulting into 
substantial transcriptional changes. In addition, four genes (aur, hisZ, yrbD 
and sodM) were identified to be negatively regulated by CodY, which 
regulates the expression of metabolic and virulence genes associated with 
nucleotide transport, energy production and defence mechanisms (Pohl et 
al., 2009). Three genes (fib, lukG and saeP) were found to be controlled by 
the SaeRS two-component system (TCS). SaeRS regulates the production 
of virulence factors including surface proteins, leukocidins and hemolysins 
(Liu et al., 2016b). Moreover, NreBC TCS which regulates nitrate/nitrite 
reduction in response to oxygen (Schlag et al., 2008) showed reduced 
expression in trained-rpoB and rpoC strains compared to untrained (Figure 
5.19 A). NreBC is dually regulated by NreC and Rex - a redox sensing 
transcriptional repressor (Pagels et al., 2010). This suggests that mecA 
alone induces partial anaerobiosis even in the presence of oxygen. This 
phenomenon is then reversed back to aerobic respiration upon acquisition of 
rpoB or rpoC mutations. 
Interestingly, comparison of all three trained strains including mecA-cured-
rpoB against untrained identified an overlapping pool of 26 genes associated 
with anaerobic fermentative metabolism (22 genes), involved in nitrite and 
nitrate reduction, found to be down regulated (Figure 5.19 B). It is known that 
the expression of these genes is regulated dually by Rex and NreC (Pagels 
et al., 2010; Schlag et al., 2008). Based on these observations, it appears 
that the untrained strain initiated anaerobic growth to adapt to the presence 
of non-native gene, mecA; as reflected by elevated expression of 
fermentation enzymes such as, lactate dehydrogenase (ldh1), alcohol 
dehydrogenases (adhE and adh) and alanine dehydrogenase (ald1) (Figure 
5.19 B). The remaining four DEGs exhibited reduced expression in the 
untrained strain compared to WT. These genes are spa encoding IgG 
binding protein A, sbi encoding IgG binding protein Sbi, ecb encoding 
fibrinogen-binding protein and icaB encoding polysaccharide intercellular 
208 
 
adhesin (PIA) biosynthesis deacetylase (Figure 5.19 B). Of these four genes 
sbi, spa and ecb exhibited increased expression in the trained strains 
compared to the untrained strain. icaB was only found to be upregulated in 
trained-rpoB (Figure 5.19). Overexpression of icaB has been shown to lead 
to synthesis of increased levels of PIA, producing a heavy biofilm (Cerca et 
al., 2007). The increased expression of spa and SaeRS-dependent genes 
(sbi and ecb) in the trained strains compared to the untrained strain reflects 
the importance of host evasion immune response in S. aureus (Mäder et al., 






Figure 5.15 Identification of overlapping genes in the trained strains compared to 
untrained 
A) Two-set proportional Venn diagram displaying the total number of DEGs (listed in 
brackets) altered in trained-rpoB and trained-rpoC compared to untrained. The identified 
DEGs using significant threshold (padj <0.05, log2fc ≥±1) from pairwise comparisons of 
trained-rpoB (red) and trained-rpoC (blue) against untrained (white background) 
determined 51 and 170 unique DEGs for trained-rpoB and trained-rpoC, respectively and 
121 shared genes between them.  
B) Two-set proportional Venn diagram displaying the total number of DEGs (listed in 
brackets) altered in trained-rpoC and trained-mecA-cured-rpoB compared to untrained. 
The identified DEGs using significant threshold (padj <0.05, log2fc ≥±1) from pairwise 
comparisons of trained-rpoC (blue) and trained-mecA-cured-rpoB (green) against 
untrained (white background) determined 256 and 22 unique DEGs for trained-rpoC and 
trained-mecA-cured-rpoB, respectively and 35 shared genes between them.  
C) Two-set proportional Venn diagram displaying the total number of DEGs (listed in 
brackets) altered in trained-rpoB and trained-mecA-cured-rpoB compared to untrained. 
The identified DEGs using significant threshold (padj <0.05, log2fc ≥±1) from pairwise 
comparisons of trained-rpoB (red) and trained-mecA-cured-rpoB (green) against untrained 
(white background) determined 114 and 29 unique DEGs for trained-rpoB and trained-




Figure 5.16 Identification of shared gene pool in the trained strains compared to 
untrained 
A) Three-set proportional Venn diagram constructed by merging Figure 5.15 A, B and C 
facilitated visualising the shared DEGs among all three trained strains (rpoB, rpoC and 
mecA-cured-rpoB) compared to untrained (white background). 26 common DEGs are 
marked by a dotted circle.  
B) Chord plot illustrating 26 common genes (intersecting genes from Figure 5.16 A) that 
were differentially expressed in untrained (SJF4996) compared to WT. The 
log2FoldChange of individual genes is shown on the left and their corresponding 
functional categories on the right side of chord diagram. Chord connects gene names 
(left) with COG classification based functional categories (right, key below).  
C) Chord plot displaying 24 common genes (intersecting genes from Figure 5.16 A) out of 
26 genes that were differentially expressed in the three trained strains compared to the 
untrained (SJF4996). mecA was not included as SJF5010 (mecA cured) showed an 
obvious reduced mecA expression. icaB was not included because it was upregulated 
only in trained-rpoB (SJF5003). Each segment on the left represents the average 
log2FoldChange of individual genes from the three trained strains which connects to their 
functional categories on the right. Chord diagrams were generated using GOplot R 




Figure 5.17 Identification of shared genes between trained-rpoB and rpoC 
compared to the untrained 
Chord diagram displaying 95 common genes between trained-rpoB and trained-rpoC 
(intersecting genes from Figure 5.16 A) out of 121 common genes (differentially 
expressed in the three trained strains) compared to the untrained strain (SJF4996). Each 
segment on the left represents the average log2FoldChange of individual genes from the 
three trained strains which connects to their functional categories on the right. Numbers 
on the left refer to NCTC8325 locus tag. Chord diagram was generated using GOplot R 





















Cellular processes and signalling 
VW Q2G012 emp SAOUHSC_00816 Extracellular matrix protein-binding protein emp -1.77 1.88 - 1.41 - 
V Q2G140 mepA SAOUHSC_00315 
Multidrug export protein MepA (Staphylococcal 
virulence regulator protein A) 
1.14 -1.06 - -1.10 MepR 
T Q2FVM6 nreB SAOUHSC_02676 
Oxygen sensor histidine kinase NreB (Nitrogen 
regulation protein B) 
1.12 -1.14 - -1.29 Rex, NreC 
O Q2FZZ3 yusE SAOUHSC_00841 Uncharacterized protein - 1.33 - 1.82 SigB 
VW Q2FZB8 fib SAOUHSC_01114 Fibrinogen-binding protein -1.60 1.85 - 1.89 SaeR 
V Q2FYW3 yvfR SAOUHSC_01311 ABC transporter, ATP-binding protein, putative - 1.25 - 2.22 - 
T Q2FXL6 ydaA/uspA1 SAOUHSC_01819 Putative universal stress protein -1.50 1.33 - 1.23 - 
O Q2FXE9 spdA SAOUHSC_01900 Uncharacterized protein membrane spanning protein -1.25 1.41 - 2.12 - 
V Q2FWP0 lukG SAOUHSC_02241 Uncharacterized leukocidin-like protein 1 1.20 -1.17 - -1.36 SaeR 
M Q2FW95 fmtB SAOUHSC_02404 Extracellular matrix-binding protein -1.28 1.19 - 3.04 - 
M Q2FVL5 fmhA/femA SAOUHSC_02696 methicillin resistance determinant protein -1.15 1.19 - 2.19 - 
M Q2FVH5  SAOUHSC_02737 Epimerase/dehydratase, putative -1.35 1.22 - 1.20 - 
V Q2FVB4 ydbJ SAOUHSC_02820 ABC-type multidrug transport system -2.65 2.48 - 2.18 - 
M Q2FVB3  SAOUHSC_02821 Membrane spanning protein, putative -2.09 1.97 - 1.60 - 
O Q2FV35  SAOUHSC_02904 
Uncharacterized protein monooxygenase/thioredoxin 
reductase 
- -1.00 - -1.05 Zur 
V Q2FUY3 estA/xynC SAOUHSC_02962 Tributyrin esterase, putative -1.69 1.22 - 2.23 - 
O Q2FUX4 aur SAOUHSC_02971 Aureolysin, putative -1.75 1.52 - 3.18 CodY 
VM Q2G2B2 sasG SAOUHSC_02798 Surface protein G -1.54 1.34 - 1.58 - 
O P72360 scdA SAOUHSC_00229 
Iron-sulfur cluster repair protein ScdA (Cell wall-related 
protein ScdA) 




mecA SACOL0033 Penicillin-binding protein 2A 11.31 1.12 -11.19 0.60 - 
O Q2G1D7 pflA SAOUHSC_00188 Pyruvate formate-lyase-activating enzyme 3.16 -3.72 -3.15 -4.10 CcpA, Rex 
V Q2FVK5 sbi SAOUHSC_02706 Immunoglobulin-binding protein sbi -1.63 1.66 1.40 1.38 SaeR 
V P02976 spa SAOUHSC_00069 
Immunoglobulin G-binding protein A (IgG-binding 
protein A) 
-2.21 1.67 1.90 1.01 CcpA 
Cellular processes and signalling, information storage and processing 
TK Q2FVM7 nreC SAOUHSC_02675 
Oxygen regulatory protein NreC (Nitrogen regulation 
protein C) 
1.31 -1.27 - -1.20 Rex, NreC 
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Information storage and processing 
J Q2FUQ2 mnmE/trmE SAOUHSC_03053 tRNA modification GTPase MnmE -1.68 1.33 - 1.96 - 
L O50581 recG SAOUHSC_01194 ATP-dependent DNA helicase RecG -1.58 1.59 - 2.30 - 
L Q2FZD7 rnhC SAOUHSC_01095 Ribonuclease HIII (RNase HIII) -1.12 1.00 - 1.18 - 
K Q2FUQ1 rnpA SAOUHSC_03054 Ribonuclease P protein component (RNase P protein) -2.10 1.67 - 2.53 - 
L Q2G057 comFA SAOUHSC_00765 Uncharacterized protein comF operon protein 1 -1.68 1.49 - 2.65 - 
J Q2FZZ4 yusF SAOUHSC_00840 5S rRNA maturation endonuclease (Ribonuclease M5) -2.17 1.92 - 2.75 SigB 
L Q2FYS2 uvrX SAOUHSC_01363 Nucleotidyltransferase -1.21 1.26 - 2.08 LexA 
L Q2G2Y4  SAOUHSC_01918 
Uncharacterized protein excalibur calcium-binding 
domain protein 
1.04 -1.08 - -1.58 - 
L Q2FWL3 mutS SAOUHSC_02276 MutS domain V protein - 1.12 - 1.27 - 
K Q2G0D1 sarX SAOUHSC_00674 
HTH-type transcriptional regulator SarX 
(Staphylococcal accessory regulator X) 
1.54 -1.63 - -3.24 - 
L Q2FZD0 uvrC SAOUHSC_01102 
UvrABC system protein C (Protein UvrC) (Excinuclease 
ABC subunit C) 
-1.47 1.29 - 2.40 - 
K Q2G1V2 nirR SAOUHSC_02685 Transcriptional regulator, Nitrite reductase 2.41 -3.45 -3.26 -3.70 Rex, NreC 
Information storage and processing or cellular processes and signalling 
JU Q2FYF4 ansA SAOUHSC_01497 L-asparaginase, putative -1.17 1.15 - 1.00 - 
TK Q2FWH6 kdpE SAOUHSC_02315 DNA-binding response regulator, putative -1.25 1.21 - 3.55 - 
Metabolism 
E Q2FZU1 argG SAOUHSC_00899 Argininosuccinate synthase 1.11 -1.28 - -1.36 ArgR, CodY 
G Q2FV87 glcB SAOUHSC_02848 
Phosphotransferase system IIC components, 
glucose/maltose/N-acetylglucosamine-specific 
- -1.11 - -1.19 - 
F Q2G0Y6 guaA SAOUHSC_00375 GMP synthase, PP-ATPase domain/subunit 1.13 -1.08 - -1.18 - 
E Q2FUT6 hisZ SAOUHSC_03015 ATP phosphoribosyltransferase regulatory subunit 1.00 -1.27 - -1.06 CodY, HisR 
I Q2G155 geh/lip2 SAOUHSC_00300 Lipase 2 (Glycerol ester hydrolase 2) -1.71 1.61 - 1.34 - 
E Q2G0V2 metN1 SAOUHSC_00423 Methionine import ATP-binding protein MetN 1 -1.21 1.06 - 1.39 CymR 
F Q2FZ75 pyrB SAOUHSC_01166 Aspartate carbamoyltransferase 1.03 -1.13 - -1.18 - 
F Q2FZ71 pyrF SAOUHSC_01171 
Orotidine 5'-phosphate decarboxylase (OMP 
decarboxylase) 
1.18 -1.34 - -1.57 - 
F Q2FZ77 pyrR SAOUHSC_01164 
Pyrimidine operon attenuation protein/uracil 
phosphoribosyltransferase 
2.03 -2.12 - -2.50 - 
G Q2G252 rlmH SAOUHSC_00027 Ribosomal RNA large subunit methyltransferase H -1.69 1.55 - 1.92 - 
E Q2G1H3 rocD/argD SAOUHSC_00150 
Acetylornithine/succinyldiaminopimelate/putrescine 
aminotransferase 
-1.32 1.05 - 1.22 ArgR 
F Q2G253 adsA SAOUHSC_00025 Uncharacterized protein -2.94 2.60 - 2.41 - 
P Q2G1N5 sirB SAOUHSC_00072 Lipoprotein, SirB, putative -1.38 1.17 - 2.18 Fur 
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P Q2G1N4 sirA SAOUHSC_00074 Periplasmic binding protein, putative SirA -1.59 1.50 - 1.99 Fur 
E Q2G1N2 ocd2 SAOUHSC_00076 Ornithine cyclodeaminase, putative -1.16 1.03 - 2.53 Fur 
G Q2G145 ulaA SAOUHSC_00310 PTS system ascorbate-specific transporter subunit IIC -1.31 1.24 - 1.55 - 
F Q2G0Y8 pbuX SAOUHSC_00373 Xanthine permease, putative 1.31 -1.26 - -1.20 - 
G Q2G0U0 treP SAOUHSC_00437 Uncharacterized protein 1.43 -1.35 - -1.15 CcpA 
H Q2G0Q7 folP SAOUHSC_00489 Dihydropteroate synthase (DHPS) -1.55 1.55 - 1.81 - 
H Q2G0Q6 folB SAOUHSC_00490 7,8-dihydroneopterin aldolase -1.04 1.11 - 1.41 - 
C Q2G0M2  SAOUHSC_00538 Haloacid dehalogenase-like hydrolase, putative -1.08 1.10 - 1.13 - 
GEPR Q2G0K4 proP SAOUHSC_00556 Proline/betaine transporter, putative 1.63 -1.37 - -1.22 SigB 
I Q2G0E5 aes SAOUHSC_00661 Acetyl esterase/lipase 1.34 -1.36 - -1.08 - 
G Q2G239 fruA SAOUHSC_00708 Fructose specific permease, putative 1.23 -1.12 - -1.22 FruR, CcpA 
E Q2FZQ1 yrbD SAOUHSC_00949 Uncharacterized protein -1.27 1.07 - 1.61 CodY 
F Q2FZ76 pyrP SAOUHSC_01165 Uracil permease, putative 1.52 -1.44 - -1.57 - 
I Q2FYZ3 pldB SAOUHSC_01279 Hydrolase, alpha/beta fold family domain protein -1.07 1.26 - 1.60 - 
Q Q2FY61  SAOUHSC_01604 
Uncharacterized protein glyoxalase/bleomycin 
resistance protein/dioxygenase 
-1.65 1.57 - 1.69 - 
C Q2FY54 bfmBB SAOUHSC_01611 
Dihydrolipoamide acetyltransferase component of 
pyruvate dehydrogenase complex 
1.09 -1.03 - -1.23 - 
Q Q2FXE2 yvgN SAOUHSC_01907 
Aldo/keto reductase, related to diketogulonate 
reductase 
-1.64 1.35 - 1.81 - 
E Q2FV98 yncA SAOUHSC_02836 L-amino acid N-acyltransferase 1.02 -1.18 - -1.16 - 
E Q2G1N3 sbnA SAOUHSC_00075 Probable siderophore biosynthesis protein SbnA -1.18 1.04 - 2.62 Fur 
P Q2G261 sodM SAOUHSC_00093 Superoxide dismutase [Mn/Fe] -1.28 1.09 - 1.10 CodY 
E Q2FZL2 sspA SAOUHSC_00988 V8-like Glu-specific endopeptidase -1.36 1.07 - 1.68 - 
E Q2FZL3 sspB SAOUHSC_00987 Staphylococcal cysteine proteinase B -1.19 1.03 - 1.53 - 
H Q2FWG0 tenA SAOUHSC_02331 Aminopyrimidine aminohydrolase (Thiaminase II) - 1.16 - 1.73 - 
E Q2FVW5 ureA SAOUHSC_02558 Urease subunit gamma 1.96 -1.88 - -1.54 - 
E Q2G2K6 ureB SAOUHSC_02559 Urease subunit beta 1.62 -1.38 - -1.27 - 
E Q2G2K5 ureC SAOUHSC_02561 Urease subunit alpha 1.72 -1.63 - -1.32 - 
F Q2G0Y9 xpt SAOUHSC_00372 Xanthine phosphoribosyltransferase (XPRTase) 1.09 -1.13 - -1.00 - 
H Q2FVM0 nasF/cobA SAOUHSC_02682 Uroporphyrin-III C-methyltransferase, putative 3.13 -3.33 -2.74 -3.49 Rex, NreC 
C Q2FVQ4 lctP SAOUHSC_02648 L-lactate permease 1.85 -2.25 -1.72 -2.64 Rex 
CP Q2FVM2 narH SAOUHSC_02680 Nitrate reductase, beta subunit 3.08 -3.49 -3.27 -3.74 Rex, NreC 
C Q2FVL8 nirB/nasD SAOUHSC_02684 
Assimilatory nitrite reductase [NAD(P)H], large subunit, 
putative 
2.88 -3.40 -3.40 -3.78 Rex, NreC 
CP Q2FVM1 narG SAOUHSC_02681 Nitrate reductase, alpha subunit 2.87 -3.73 -3.67 -4.06 Rex, NreC 
C Q2G218 ldh1 SAOUHSC_00206 L-lactate dehydrogenase 1 (L-LDH 1) 2.39 -3.45 -3.40 -4.13 Rex 
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C Q2G1D8 pflB SAOUHSC_00187 Formate acetyltransferase (Pyruvate formate-lyase) 2.87 -3.41 -3.05 -3.57 Rex, CcpA 
P Q2FVN1 narT/narK SAOUHSC_02671 Probable nitrate transporter NarT 2.39 -2.94 -3.06 -2.96 Rex, NreC 
P Q2G172  SAOUHSC_00281 Uncharacterized protein, formate-nitrite transporter 2.21 -2.66 -2.40 -2.23 Rex 
F Q2FV02 nrdD SAOUHSC_02942 
Anaerobic ribonucleoside-triphosphate reductase, 
putative 
1.51 -1.58 -1.46 -1.67 NrdR 
E Q2FYJ3 tdcB SAOUHSC_01451 L-threonine dehydratase (Threonine deaminase) 2.37 -2.72 -3.11 -2.92 CodY 
CPO Q2FVM3 narJ SAOUHSC_02679 Respiratory nitrate reductase, delta subunit, putative 2.63 -2.53 -3.03 -2.97 Rex, NreC 
E Q2FYJ4  SAOUHSC_01450 Uncharacterized protein amino acid permease 1.50 -1.76 -2.06 -2.17 CodY 
G Q2G0G1 adh SAOUHSC_00608 Alcohol dehydrogenase 1.97 -2.15 -2.34 -2.57 Rex 
C Q2FYJ2 ald1 SAOUHSC_01452 Alanine dehydrogenase 1 1.84 -2.31 -2.50 -2.52 Rex 
PQ Q2FVL9 nirD/nasE SAOUHSC_02683 
Assimilatory nitrite reductase [NAD(P)H], small subunit, 
putative 
2.07 -2.38 -2.40 -2.41 Rex, NreC 
C Q2G1K9 adhE SAOUHSC_00113 Aldehyde-alcohol dehydrogenase 1.63 -1.85 -1.78 -1.80 Rex 
Metabolism and cellular processes and signalling 
CO Q2G0B2 cydC SAOUHSC_00693 ATP-binding/permease protein 1.12 -1.10 - -1.23 - 
GM Q9RQP7 icaB SAOUHSC_03004 
Peptidoglycan/xylan/chitin deacetylase, PgdA/CDA1 
family 
-1.33 1.06 -1.08 -1.04 CodY, IcaR 
Poorly characterised 
R Q2FZC0 flr SAOUHSC_01112 FPRL1 inhibitory protein -1.35 1.86 - 1.93 - 
S Q2G249  SAOUHSC_00026 Uncharacterized protein -1.53 1.37 - 1.56 - 
S Q2G1N1 sbnC SAOUHSC_00077 Uncharacterized protein -1.02 1.00 - 2.41 Fur 
S Q2G177  SAOUHSC_00270 Uncharacterized protein putative lipoprotein - 1.32 - 1.37 - 
S Q2G176  SAOUHSC_00271 Uncharacterized protein - 1.14 - 1.27 - 
S Q2G105  SAOUHSC_00356 Uncharacterized protein -1.65 1.88 - 1.22 SigB 
S Q2G0Y5  SAOUHSC_00376 Uncharacterized protein -1.07 1.53 - 2.23 - 
S Q2G0X2  SAOUHSC_00401 Uncharacterized protein -1.74 1.94 - 1.90 - 
S Q2G0E3  SAOUHSC_00662 Uncharacterized protein 1.26 -1.13 - -1.25 - 
S Q2G2G0 SaeP SAOUHSC_00717 Uncharacterized protein putative lipoprotein -1.16 1.41 - 1.46 SaeR 
R Q2G035 yfcH SAOUHSC_00792 Epimerase family protein -2.45 2.12 - 2.62 SigB 
R Q2G016 yjhQ/Yhbs SAOUHSC_00811 Predicted N-acetyltransferase -1.96 1.80 - 2.22 SigB 
S Q2FZZ6  SAOUHSC_00838 Uncharacterized protein -3.62 3.18 - 4.14 - 
S Q2FZT3  SAOUHSC_00907 UPF0344 membrane protein - 1.00 - 1.22 - 
R Q2G1U4 trfB SAOUHSC_00936 Uncharacterized protein, transcription factor - 1.01 - 2.36 - 
S Q2G200  SAOUHSC_00941 UPF0738 protein -1.54 1.51 - 1.37 - 
S Q2FZB9  SAOUHSC_01113 Uncharacterized protein membrane protein - 1.35 - 1.34 - 
S Q2FZ03  SAOUHSC_01268 Uncharacterized protein -1.08 1.32 - 1.80 - 
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S Q2FXQ3 ymaB SAOUHSC_01782 Uncharacterized protein -1.38 1.10 - 2.10 - 
S Q2G2Y3  SAOUHSC_01919 Uncharacterized protein membrane protein 1.13 -1.13 - -1.53 - 
R Q2FV53  SAOUHSC_02886 Uncharacterized protein - 1.13 - 1.97 - 
S Q2G1H7  SAOUHSC_00146 Uncharacterized protein integral membrane protein -1.42 -2.01 -1.42 -2.53 - 
R Q2FV03 nrdG SAOUHSC_02941 
Anaerobic ribonucleoside-triphosphate reductase-
activating protein 
1.62 -1.61 -1.60 -1.75 NrdR 
R Q2FZC2 ecb SAOUHSC_01110 Fibrinogen-binding protein-related -1.16 1.33 1.17 1.29 SaeR 
Table 5.1 Functional classification and differential gene expression of shared gene content of untrained, trained-rpoB and rpoC 
*, compared against WT; †, compared against untrained; 26 DEGs shared by all three trained strains are highlighted in blue, related to Figure 5.16 A.  
Clusters of orthologues groups of proteins (COGs) were retrieved from NCBI for 121 common DEGs associated with high-level resistance as follows: 
CELLULAR PROCESSES AND SIGNALING 
[M] Cell wall/membrane/envelope biogenesis; [O] Post-translational modification, protein turnover, and chaperones; [T] Signal transduction mechanisms; 
[V] Defence mechanisms 
INFORMATION STORAGE AND PROCESSING 
[J] Translation, ribosomal structure and biogenesis; [K] Transcription; [L] Replication, recombination and repair 
METABOLISM 
[C] Energy production and conversion; [E] Amino acid transport and metabolism; [F] Nucleotide transport and metabolism; [G] Carbohydrate transport and 
metabolism; [H] Coenzyme transport and metabolism; [I] Lipid transport and metabolism; [P] Inorganic ion transport and metabolism; [Q] Secondary 
metabolites biosynthesis, transport, and catabolism 
POORLY CHARACTERIZED 




Figure 5.18 Functional classification and regulation of the differentially expressed 
genes 
A) The 121 overlapping DEGs from Table 5.1 were classified into broad functional 
categories using Clusters of Orthologous Groups (COGs) classification. Different colours 
illustrate different COG functions. This demonstrates transcriptional changes due to 
significant metabolic stress. C, Energy production and conversion; E, amino acid transport and 
metabolism; F, nucleotide transport and metabolism; G, carbohydrate transport and metabolism; 
H, coenzyme transport and metabolism; I, lipid transport and metabolism; P, inorganic ion transport 
and metabolism; Q, secondary metabolites biosynthesis, transport, and catabolism; M, cell 
wall/membrane/envelope biogenesis; O, post-translational modification, protein turnover, and 
chaperones; T, signal transduction mechanisms; V, defence mechanisms; J, translation, ribosomal 
structure and biogenesis; K, transcription; L, replication, recombination and repair; R and S are 
function prediction only or function unknown categories. Total number of genes associated with 
each category are listed outside the bar.  
B) The transcriptional regulators were predicted for 24 genes out of 26 common DEGs 
identified in three trained strains (rpoB, rpoC and mecA-cured-rpoB) compared to 
untrained, related to Figure 5.16. A total of 16 out of 24 genes were directly or indirectly 
controlled by Rex.  
C) Subsequently, transcriptional regulators were predicted for 95 (Figure 5.17) DEGs 







Figure 5.19 Gene expression profiles of nitrite and nitrate reductase genes 
A) Chromosomal region of the genes involved in nitrite and nitrate reduction in S. aureus. A 
membrane bound nitrate reductase system (narGHJI) reduces nitrate to nitrite. 
Subsequently, nitrite is reduced to ammonia by NADH-dependent nitrite reductase system 
(nirBD) (Schlag et al., 2008). NreABC has been identified as an oxygen sensing system 
which regulates the expression of nitrate and nitrite reductase system as well as narK 
(Fedtke et al., 2002).  
B) Transcriptional profiles of the common gene pool involved in nitrate and nitrite reduction 
showed upregulation in untrained compared to three trained strains. The expression of 
nreBC genes were not found to be significant in trained-mecA-cured-rpoB strain compared 





5.2.5 Influence of the absence of staphylococcal respiratory regulatory 
(SrrAB) system on antibiotic resistance 
Higher expression of genes related to anaerobic metabolism was observed 
in the untrained strain compared to WT. A number of transcripts encoding 
pyruvate metabolism enzymes (Ldh1, PflB, LctP, Adh, AdhE) associated with 
anaerobic respiration were highly expressed in the untrained strain which 
exhibits low-level oxacillin resistance (MIC = 2 µg/ml). On the contrary, 
trained-rpoB and rpoC strains showed reduced expression of genes related 
to anaerobic respiration while accompanying high-level oxacillin resistance 
(MIC = ≥256 µg/ml). Therefore, it was predicted that inactivation of anaerobic 
metabolism may lead to increased resistance in the untrained strain 
aerobically and anaerobically because acquisition of the rpoB and rpoC 
mutations reduces the expression of alternative respiratory system.  
In order to test this hypothesis, the oxygen-dependent regulator SrrAB was 
disrupted, leading to impaired anaerobic respiration. SrrAB is a two-
component regulatory system (TCS), mediating the aerobic-anaerobic switch 
in S. aureus which shares a considerable homology with the ResDE two-
component regulatory system of B. subtilis required for anaerobic respiration 
(Somerville and Proctor, 2009; Throup et al., 2001). ResDE positively 
regulates anaerobic metabolism by controlling the anaerobic regulator Fnr, 
flavohemoglobin gene hmp and the nitrate reductase system nasDEF 
(Throup et al., 2001). Similar to a B. subtilis resDE mutant, an inactivation of 
srrAB in S. aureus have shown to have severe growth defect anaerobically 
(Throup et al., 2001).  
To construct an srrAB lacking strain, a phage lysate from of JMB4556, 
SH1000 srrAB::tet (Mashruwala and Boyd, 2017) was transduced into a 
clean SH1000 (SJF682) background and selected using tetracycline (5 
µg/ml) resulting into SH1000 srrAB::tet (SJF5054). The replacement of srrAB 
by tet was confirmed by DNA sequencing and PCR using primers resulting in 
a band of 2.5 kb compared to 3.2 kb in WT (Figure 5.20 A). The growth of 
SH1000 srrAB::tet (SJF5054) was examined anaerobically using BHI agar 
plate supplied with 2 mM sodium nitrate as an alternative terminal electron 
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acceptor. For anaerobic growth, plates were incubated at 37ºC in an 
anaerobic jar (Oxoid) containing a GasPak EZ (BD) to produce an anaerobic 
environment.  
In the absence of nitrate, strain lacking srrAB (SJF5054) produced small 
colonies compared to WT (Figure 5.20 B), suggesting a marked reduction in 
growth. However, in the presence of nitrate both (WT and SJG5054) strains 





Figure 5.20 Construction and growth of SH1000 srrAB::tet 
A) Phage lysate of JMB4556, SH1000 srrAB::tet (Mashruwala and Boyd, 2017) 
(SJF5051) was transduced into SH1000 (SJF682) resulting in SH1000 srrAB::tet named 
SJF5054. The transductant (lane 1) was verified by using primers srrAB_5'_up (forward) 
and srrAB_3'_down (reverse) binding upstream and downstream of srrAB, respectively, 
resulting in a band of ~2.5 kb (transductant, lane 1) and 3.2 kb for the positive control 
using SH1000 genomic DNA (lane 2). SH1000 genomic DNA was used as a template for 
the positive control. DNA fragments were used as size markers for agarose gel 
electrophoresis. 
B) Subsequently, SH1000 (top half) and SH1000 srrAB::tet (SJF5054) (bottom half) were 






5.2.5.1 Effect of aerobic and anaerobic growth conditions on antibiotic 
resistance 
In order to examine oxacillin resistance, untrained, trained-rpoB and rpoC 
strains were transduced with a phage lysate from SJF5054 (SH1000 
srrAB::tet). The resultant strains were named as untrained lysA::pmecA 
srrAB::tet (SJF5055); trained-rpoB lysA::pmecA rpoB (H929Q) srrAB::tet 
(SJF5056) and trained-rpoC lysA::pmecA rpoB (G740R) srrAB::tet 
(SJF5057). In addition to strains lacking SrrAB in SH1000, clinical MRSA 
COL and genetically complemented rpoB+ (SJF5044) and rpoC+ (SJF5045) 
were also tested for oxacillin resistance. A total of twelve strains were tested 
including five representative strains used for transcriptome analysis (Figure 
5.21).  
To test oxacillin sensitivity aerobically using Etest strips, strains were 
incubated for 24 hours at 37ºC on a BHI agar plate. For anaerobic growth 
conditions, agar plates were supplied with 2 mM NaNO3 and incubated for 24 
hours at 37ºC in an anaerobic jar as described above (section 5.2.5). In the 
absence of nitrate, poor or no growth was observed for all strains after 48 
hours incubation at 37ºC anaerobically. Reduced oxacillin MICs were noted 
for trained-rpoC (Figure 5.21 E) from ≥256 aerobically to 32 µg/ml 
anaerobically and untrained srrAB::tet (Figure 5.21 J) from 4 aerobically to 
0.5 µg/ml anaerobically. Similarly, untrained (Figure 5.21 B) showed reduced 
oxacillin MIC from being 1 aerobically to 0.25 µg/ml anaerobically. All other 
strains showed no alterations to oxacillin resistance under aerobic or 
anaerobic conditions.  
To evaluate the performance of the agar plate method for antibiotic 
susceptibility testing, MICs were tested using broth microdilution method on 
96-well plate as a reference method using oxacillin concentrations starting 
from 256 to 0.03 µg/ml. To determine the MIC under anaerobic growth 
conditions, BHI broth was supplied with 2 mM NaNO3 and plates were 
incubated for 24 hours at 37ºC. Growth was assessed using plate reader. 
MICs obtained by broth microdilution and agar plate method under aerobic 
and anaerobic conditions were plotted using a bar plot for all test strains 
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(Figure 5.22). Oxacillin MICs obtained by broth microdilution method under 
both conditions showed overall reduction in MIC values of all highly resistant 
strains (Figure 5.22 A). Trained-rpoC showed no alteration in oxacillin MIC 
(128 µg/ml) under anaerobic growth compared to the agar plate method 
(Figure 5.22 A). Consistent with MICs determined by using the agar plate 
method, broth dilution method for untrained srrAB::tet showed reduced 
resistance from 4 aerobically to 1 µg/ml anaerobically.  
To reproduce similar resistance profiles as oxacillin for all strains using 
another β-lactam antibiotic, methicillin susceptibility was determined using 
broth dilution method as methicillin Etest strips are not available 
commercially. Trained strains (Figure 5.22 B; trained-rpoB, rpoC, and 
trained-rpoB srrAB::tet) expressing high-level oxacillin resistance (MIC = >32 
µg/ml) showed reduced methicillin resistance under anaerobic conditions. 
Interestingly, methicillin MIC for untrained strain displayed similar resistance 
characteristics to that of oxacillin resistance profile with methicillin MIC from 
8 under aerobic to 4 µg/ml under anaerobic conditions (Figure 5.22 B). 
Overall, based on these observations, it is possible to speculate that the 
functionality of mecA may depend on aerobic over anaerobic growth 
conditions. However, this rationale required to be tested.   
To assess if the development of oxacillin resistance affected antibiotic 
susceptibility to other class of antibiotics. Tetracycline and chloramphenicol 
MICs were determined using agar plate and broth dilution methods under 
aerobic and anaerobic conditions. MICs were determined for untrained, 
trained-rpoB and rpoC, COL, trained-rpoB+ and trained-rpoC+ strains and 
compared against SH1000 (Figure 5.23). These strains except COL, were 
found to be sensitive to tetracycline with MIC values ≤1 µg/ml under all 
conditions (Figure 5.23 A). With the agar plate approach, chloramphenicol 
MICs showed similar values under aerobic and anaerobic conditions. 
However, all strains except COL displayed 0.06 µg/ml MIC aerobically and 




Figure 5.21 Oxacillin MIC of strains under aerobic and anaerobic growth conditions 
Oxacillin sensitivity for strains in the absence and presence of SrrAB was determined using the Etest method under aerobic and anaerobic growth 
conditions. A BHI agar plate containing 2 mM sodium nitrate was used for anaerobic incubation at 37ºC for 24 hours. Strains used are A) SH1000 (WT); B) 
untrained (SJF4996, SH1000 lysA::pmecA); C) trained-rpoB (SJF5003, SH1000 lysA::pmecA rpoB-H929Q); D) trained-mecA-cured-rpoB (SJF5010; 
SH1000 lysA::Kan rpoB-H929Q); E) trained-rpoC (SJF5034; SH1000 lysA::pmecA rpoC-G740R); F) COL (SJF315, clinical MRSA isolate); G) rpoB 
(H929Q) complemented strain, rpoB+ (SJF5044); H) rpoC (G740R) complemented strain, rpoC+ (SJF5045); I) SH1000 srrAB::tet (SJF5054); J) untrained 







Figure 5.22 β-lactam resistance under aerobic and anaerobic growth 
A) Oxacillin MIC was determined using the Etest and microdilution method under aerobic 
and anaerobic growth conditions for strains with or without the deletion of srrAB. 2 mM 
sodium nitrate was supplied to growth media prior to anaerobic incubation. The highest 
concentration of oxacillin (2048 µg/ml) was serially diluted to 0.03 µg/ml using 96-well 
plate.  
B) Methicillin sensitivity was determined using the microdilution method under aerobic and 
anaerobic growth conditions for all representative strains including srrAB mutants. 2 mM 
sodium nitrate was added to growth media prior to anaerobic incubation. The highest 
concentration of methicillin (2048 µg/ml) was serially diluted to 0.03 µg/ml using a 96-well 





Figure 5.23 Tetracycline and chloramphenicol sensitivity test under aerobic and 
anaerobic growth conditions 
A) Tetracycline sensitivity was determined using the Etest and microdilution method 
under aerobic and anaerobic growth conditions. 2 mM sodium nitrate was supplied to 
growth media prior to anaerobic incubation. The highest concentration of tetracycline 
(2048 µg/ml) was serially diluted to 0.03 µg/ml using a 96-well plate.  
B) Chloramphenicol MIC was determined using the Etest and microdilution method 
under aerobic and anaerobic growth conditions. 2 mM sodium nitrate was added to 
growth media prior to anaerobic incubation. The highest concentration of methicillin 
(64 µg/ml) was serially diluted to 0.03 µg/ml using a 96-well plate. 
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5.2.6 Resistance to oxidative stress following a mecA induced 
transcriptional response 
S. aureus is capable of resisting a wide range of stresses such as, oxidative, 
acid tolerance, osmotic with its ability to respond using an intrinsic repertoire 
of the regulatory mechanisms (Clements and Foster, 1999; Gaupp et al., 
2012). A set of genes (metN1, sirA, sirB, ocd2, sbnA, sbnC, sodM and 
SAOUHSC_02904) regulated by stress regulators such as Fur, Zur, CodY 
and CymR were found to be upregulated in trained-rpoB and rpoC strains 
compared to the untrained strain (Table 5.1). In order to test whether the 
acquired differential expression alters the sensitivity of these strains to 
various oxidative stress stimuli, disk diffusion assays were performed for 
representative strains using three oxidative stress inducing compounds, 1 M 
diamide, 2 M paraquat (methyl viologen) and 200 mM potassium tellurite 
(K2TeO3). 
Diamide is a specific thiol oxidant which causes disulphide stress resulting in 
damage to proteins (Pöther et al., 2009). S. aureus is resistant to tellurite 
(TeO32-) toxicity because of its reductive detoxification by in part cysteine 
synthetase and cysteine containing molecules which reduces tellurite to 
black crystals of tellurium (Chasteen et al., 2009; Lithgow et al., 2004). 
Paraquat (methyl viologen) induces oxidative stress by reducing oxygen to 
superoxide anions causing superoxide stress conditions which causes DNA 
damage (Lin and Everse, 1987). Both untrained and trained strains showed 
no effect on sensitivity to diamide similar to SH1000 (Figure 5.24). All 
representative strains showed no detectable growth inhibition around the 
disk with either paraquat/tellurite indicating the level of paraquat/tellurite was 
not sufficient. Interestingly, there is the potential of some susceptibility to 
paraquat in the untrained compared to WT. These observations suggest that 
the resistance to oxidative stress was maintained in all strains, independent 
of transcriptional changes in stress associated genes. Moreover, it is 
important to note that differential expression of stress related genes involved 
were not found to be significant in trained-mecA-cured-rpoB strain, meaning 




Figure 5.24 Stress resistance phenotypes of untrained and trained strains 
Disk diffusion assays were performed with 1 M diamide, 2 M paraquat (methyl viologen) 
and 200 mM potassium tellurite (K2TeO3) for WT, untrained and the three trained strains. 





5.2.7 Enzymatic determination of lactate from S. aureus culture 
supernatants 
S. aureus is a facultative anaerobe with an ability to catabolise 
carbohydrates using tricarboxylic acid cycle (TCA) under aerobic conditions, 
however this depends on the oxygen and nutrient availability (Strasters and 
Winkler, 1963). Depending on the availability of oxygen, one of the most key 
growth-limiting factor varies from site to site in the host (Coleman et al., 
1983). The physiological response of S. aureus to oxygen deprivation 
resulted in a switch from energy favourable respiratory state (aerobic) to 
anaerobic fermentative conditions (Fuchs et al., 2007), leading to the 
upregulation of fermentation genes encoding proteins such as, LDH, ADH 
accompanied by downregulation of TCA enzymes (Throup et al., 2001).  
As mentioned above in section 5.2.5, genes associated with anaerobic 
fermentative growth showed increased transcripts in untrained compared to 
trained-rpoB, rpoC and mecA-cured strains. However, comparative analysis 
of the trained strains against WT showed no change in these set of genes. 
Considering these metabolic transcriptional changes induced by the 
acquisition of mecA, extracellular amount of lactate, a major end-product of 
fermentation was quantified using a colorimetric based lactate assay 
(Abcam). To examine the extracellular lactate, strains were grown under 
aerobic conditions until OD600 reached 1. Supernatant was collected and 
samples were processed in accordance with manufacturer’s instructions.  
The levels of secreted lactate showed significant reduction in the untrained 
strain compared to WT. Whereas, the three trained strains showed moderate 
reduction in the levels of lactate compared to WT (Figure 5.25). The 
concentration of extracellular lactate was measured using a standard curve 
of known lactate standards. These observations are in line with the recent 
study (Ferreira et al., 2013) demonstrated that S. aureus uses lactate as a 
carbon source to sustain growth during glucose limiting conditions 
aerobically. Therefore, in the presence of mecA, untrained strain likely uses 




Figure 5.25 Quantification of extracellular lactate from S. aureus supernatant 
Lactate measured in SH1000, untrained, trained-rpoB, trained-mecA-cured-rpoB and 
trained-rpoC supernatants showing quantity in µmol per ml of tested supernatant. 
Samples were deproteinised prior to processing. Results are the average of three 




5.2.8 Quantification of rate of cellular respiration 
If the acquisition of mecA (untrained strain) disrupts the respiratory chain by 
inducing the expression of anaerobic fermentative genes, presumably it 
would lower the rate of oxygen consumption in untrained and it may be 
restored back to WT level of respiration rate in the trained strains following 
acquisition of rpoB or rpoC mutations. In order to investigate this hypothesis, 
a Clark-type oxygen electrode was used to measure rate of respiration at 
which oxygen is consumed. Oxygen electrode was calibrated using PBS 
prior to testing samples. Oxygen respiration rates (OCR) were measured at 
37ºC and respiration was initiated by supplying glucose.  
OCR measurements for untrained showed deceleration of cellular 
respiration, however not significant compared to WT. Whereas, trained-rpoB 
and rpoC strains showed significant acceleration of cellular respiration 
compared to untrained but similar to WT (Figure 5.26). These observations 
showed that the respiration rate affected by mecA-associated metabolic 
changes normalises to WT levels in trained-rpoB and rpoC strains. However, 
trained-mecA-cured-rpoB showed similar OCR to the untrained strain, 
suggesting mecA dependent cellular respiration in the presence of rpoB 





Figure 5.26 Determination rate of oxygen consumption in S. aureus  
Cellular respiration was measured for SH1000, untrained, trained-rpoB, trained-mecA-
cured-rpoB and trained-rpoC strains using Clark-type oxygen electrode. Data shown here 
reflect mean ±SEM of the three biological replicates. The results were compared against 
WT and untrained are shown in red and blue asterisks (above bar plot), respectively. 







The mechanisms of β-lactam resistance in S. aureus are poorly understood. 
Due to the pathogenic importance of this organism it is important to study 
gene expression and regulation and their contribution to the development of 
the high-level resistance. Previous studies have used the microarray analysis 
approach to investigate differential gene expression and identify virulence 
factors (Dunman et al., 2001; Korem et al., 2005). Here, transcriptional 
responses of S. aureus due to acquisition of mecA was successfully 
investigated using RNA-Seq, providing the distribution of differential gene 
expression required to confer oxacillin resistance. This data identified two 
important transcriptional responses induced by mecA and mutations in rpoB 
and rpoC.  
First, the primary comparative transcriptome analysis of the strains 
(untrained and trained-rpoC, mecA-cured-rpoB) determined significant 
differences in the expression patterns due to the presence of mecA and 
subsequent acquisition of rpoC mutation compared to WT, whilst, the 
acquisition of rpoB mutation showed restored gene expression to WT levels, 
suggesting that at the transcription level, S. aureus has a complex regulatory 
network specific to the acquired mutations. In addition, over one hundred 
genes were differentially expressed in untrained, trained-rpoC and mecA-
cured-rpoB strains, whereas only nine genes were shown to have differential 
expression in trained-rpoB (Figure 5.13). Surprisingly, only lysA, mecA and 
nirR were detected to be shared among untrained and trained-rpoB and rpoC 
strains. In the untrained strain, the reduced expression of mecA was 
accompanied by increased nirR transcripts and low-level oxacillin resistance 
(MIC = 2 µg/ml). Moreover, a substantial reduction in nirR transcription was 
observed upon acquisition of rpoB or rpoC mutations together with increased 
mecA expression and high-level oxacillin resistance (MIC = ≥256 µg/ml). 
This indicates that WT level nirR expression may be necessary together with 
increased mecA expression in order for the strain to develop high-level 
resistance which can be achieved by alterations in rpo. 
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Surprisingly, nirR was also identified to be the only transcriptional regulator 
found to be common among trained strains compared to the untrained strain 
along with other set of 121 DEGs. However, this group included a subset of 
26 common genes with differential expression by comparative analysis of the 
trained strains against the untrained strain (Figure 5.15 and Figure 5.16). 
The remaining 95 genes were exclusively shared by rpoB and rpoC mutants 
only (Figure 5.16 A and Figure 5.17), suggesting their connection with 
increased resistance. Systematic analysis of 121 genes to determine 
functional categories based on COG designations revealed that the majority 
of genes were related to metabolism, suggesting a mecA-derived 
transcriptional perturbation of S. aureus. Upregulation of anaerobic 
nitrate/nitrite respiration related genes (nirR, nirB, nirD, nasF, narG, narH, 
narJ, narT) and fermentation-related genes (adhE, adh, ldh1, ald1, lctP) were 
identified in the untrained strain under aerobic growth conditions. However, 
these genes showed WT level expression in trained strains. Nitrate/nitrite 
respiration related genes are regulated dually by the NreBC TCS and Rex 
(repressor of anaerobic genes) (Pagels et al., 2010; Schlag et al., 2008). It is 
unclear whether NreBC specifically detects the presence of nitrate, where 
under oxygen deprived conditions it upregulates the nitrate and nitrite 
reductase systems (Kamps et al., 2004; Schlag et al., 2008). The redox 
sensing transcriptional regulator Rex plays an important role in the 
maintenance of the NADH/NAD+ ratio independent of oxygen availability 
(Pagels et al., 2010). Considering this, it is plausible to speculate that the 
untrained strain may favour mixed metabolism of anaerobic-nitrate 
fermentative respiration to generate energy to sustain growth rate similar to 
the WT while producing low-level resistance.  
Second, the expression of oxidative stress response regulators, Fur, Zur, 
SigB and CymR regulated genes (yusE; SAOUHSC_02904, encoding 
putative thioredoxin reductase; yusF; metN1; sirB; sirA; ocd2; prop; sbnA; 
sbnC; SAOUHSC_00356, uncharacterised protein; yfcH; yhbS) were induced 
in trained strains. This induction was unable to alter the oxidative stress 
response in S. aureus upon exposure to exogenous oxidants (Figure 5.24). 
Additionally, oxacillin resistance remained largely unchanged under aerobic 
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and anaerobic growth conditions for trained strains. Whereas, the untrained 
strain lacking srrAB showed a reduction in oxacillin and methicillin MIC under 
anaerobic conditions, suggests that the expression of mecA may be 
dependent on the presence of oxygen. However, this could be tested by real-
time qPCR. Meanwhile, the levels of extracellular lactate showed a reduction 
in untrained strain compared to trained strains (Figure 5.25).  
It was shown previously that S. aureus may switch to mixed-acid (acetate, 
formate, and lactate) and butanediol fermentation under fermentative growth 
conditions, enabling pyruvate reduction to lactate or acetoin (Fuchs et al., 
2007). Furthermore, under aerobic conditions pyruvate is metabolised to 
acetyl-CoA by PDH (pyruvate dehydrogenase complex), producing NADH. 
Similar to E. coli (Hansen and Henning, 1966), reduced expression of PDH 
complex was reported in S. aureus with simultaneous increase in the 
expression of pyruvate formate lyase (PflB) under anaerobic conditions 
(Fuchs et al., 2007). Therefore, increased expression of PflA and PflB along 
with SAOUHSC_00281 (encoding nitrate/formate transporter) in the 
untrained strain may have resulted in increased extracellular formate levels. 
Furthermore, formate oxidation and nitrate reduction reactions occur 
simultaneously under anaerobic condition in E. coli (Figure 5.27) (Sawers, 
2005).  
Transcriptomics data combined with oxygen consumption rate results (Figure 
5.26), suggests that mecA might be interacting with respiratory genes 
resulting into disruption of respiration, therefore leading to a partial inhibition 
of oxygen consumption in the untrained strain. Subsequently, rpoB and rpoC 





Figure 5.27 Scheme of pyruvate metabolism in E. coli 
Key pathways of pyruvate and formate metabolism. Formate metabolism reactions are 





6 Chapter 6 
General Discussion 
Antimicrobial resistance (AMR) is a global threat to the control of an 
increasing range of difficult-to-treat infections caused by bacteria, fungi, 
viruses and parasites. AMR emerges when the pathogens causing infection 
such as bacteria, survive upon exposure to antibiotics that would normally 
inhibit their growth or kill them. Therefore, the reduced efficacy of medicines 
renders the treatment of patients costly, difficult or even impossible. The 
magnitude of the impact of AMR on not only human health but also the 
economy has been assessed and the findings are particularly shocking 
(O’Neill, 2016). Currently, 700,000 people die due to infections that are 
resistant to antibiotics every year (O’Neill, 2016). The review on AMR by Jim 
O’Neill (2016) estimated that AMR could claim 10 million lives a year (1 
person every 3 seconds) by 2050 costing up to 100 trillion USD to the 
economy if proactive solutions are not found to tackle AMR. The deaths 
attributable to AMR would be higher than that predicted for cancer.  
The development of resistance to antibiotics is a natural process and has 
been noted since the introduction of the first antibiotic. This has resulted in 
the emergence of ‘superbugs’. One such ‘superbug’ is methicillin-resistant 
Staphylococcus aureus (MRSA). Infections caused by MRSA are difficult or 
even impossible to treat, in some cases, due to its resistance to virtually all 
β-lactam antibiotics. The development of methicillin resistance in S. aureus is 
predominantly due to the acquisition of the mecA gene encoding a penicillin 
insensitive PBP (Hartman and Tomasz, 1984). The majority of MRSA 
isolates display a low-level resistance, barely above that exhibited by 
susceptible strains. However, these MRSA isolates are capable of 
developing high-level resistance upon exposure (during treatment) to β-
lactam antibiotics. This characteristic of conversion of resistance level have 
shown to be induced by chromosomal mutations in the presence of antibiotic 
(Finan et al., 2002; Ryffel et al., 1994). This means that the acquisition and 
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expression of mecA is a prerequisite, but not sufficient, to develop high-level 
resistance. This conversion has formed the basis for my project. 
To better understand the basis for the transition from low-level to high-level 
resistance, several studies by other researchers (Kim et al., 2013; Mwangi et 
al., 2013; Pozzi et al., 2012) and myself have employed a model system to 
introduce multicopy plasmid-borne mecA into an MSSA strain which 
produced derivatives with low-level resistance, capable of developing high-
level homogeneous resistance upon exposure to elevated levels of 
antibiotics. Similar to previous studies by others (Banerjee et al., 2010; 
Griffiths and O’Neill, 2012; Pozzi et al., 2012), genome sequencing of highly 
resistant isolates identified mutations in the gdpP gene (Table 3.2) implicated 
in the development of high-level resistance. GdpP (c-di-AMP 
phosphodiesterase) regulates intracellular levels of c-di-AMP, assisting 
biofilm formation, cell wall architecture and more importantly 
resistance/tolerance to β-lactams (Corrigan et al., 2011; Griffiths and O’Neill, 
2012). Elevated resistance due to deletion or disruption of gdpP indicates 
that misfolding or destabilisation of GdpP might lead to increased resistance 
and concomitant increased intracellular c-di-AMP levels which can contribute 
to the co-regulation of antibiotic resistance through its interaction with yet 
unknown c-di-AMP target proteins (Corrigan et al., 2013).  
However, naturally occurring MRSA isolates carry a single copy of mecA, 
making it more interesting and relevant system to study compared to the 
multicopy plasmid-borne mecA approach. Therefore, the molecular basis of 
MecA activity was investigated by introducing a single copy mecA integrated 
into the chromosome of an MSSA strain. Derivatives exhibited low-level 
resistance but were capable of developing high-level resistance following 
antibiotic treatment. This approach allowed the systematic tracking of the 
evolutionary progression of resistance, setting this system apart from others 
studies. Interestingly, genome sequencing revealed amino acid substitutions 
in either rpoB or rpoC (Table 4.2) that were responsible for conferring high-
level resistance. Such mutations have been identified before in highly 
resistant clinical isolates (Aiba et al., 2013; Dordel et al., 2014; Hiramatsu et 
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al., 2013; Mwangi et al., 2007) but have not really been highlighted as 
important genetic determinant(s) for developing high-level β-lactam 
resistance. 
The selection of spontaneous rpoB and rpoC mutants allowed the 
examination of the role of the mutations promoting low-level to high-level 
conversion of β-lactam resistance. Specifically, the impact of rpoB (H929Q) 
(SJF5003) and rpoC (G740R) (SJF5034) mutations were further studied in 
the context of high-level resistance. The RNAP core enzyme consists of two 
α, a β and a β’ subunits, whose activity is sufficient to carry out transcription 
(Delumeau et al., 2011). The effects of rpoB and rpoC mutations on the 
activity of RNAP and its interaction with other proteins were examined by 
employing an in vitro transcription assay in collaboration with Prof Nikolay 
Zenkin and Caitlin Griffiths (Newcastle University). Purified RNAPs from both 
trained-rpoB (H929Q) and trained-rpoC (G740R) showed prolonged pausing 
of RNAP elongation complexes at different sites of the template compared to 
the WT. RNAP pausing is a sequence-dependent process which is 
associated with coupling of transcription with translation (Landick et al., 
1985), nascent RNA transcript folding (Pan et al., 1999), recruitment of 
regulatory factors to the complex (Artsimovitch and Landick, 2000) and a 
prerequisite for transcription termination (Farnham and Platt, 1981). 
However, differences in pausing due to the acquisition of rpoB and rpoC 
mutations might affect the global pattern of transcription in the cell through 
changes in transcriptional activity. Furthermore, the presence of oxacillin 
showed no effect on the transcription of the rpoB and rpoC mutants as well 
as WT suggesting oxacillin independent RNAP activity. 
In S. aureus, the proteins that interact with RNAP resulting in regulation of its 
activity, have not been fully described. The RNAP interacting protein YsxC 
specifically binds to the β’ subunit, and has been previously reported to have 
a role in ribosomal stability and growth (Cooper et al., 2009). Extensive 
studies in B. subtilis revealed that a unique thiol/oxidative stress global 
transcriptional regulator, Spx is an RNAP-binding protein which positively 
regulates transcription in response to oxidative stress (Nakano et al., 2003a; 
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Zuber, 2004). Spx contains an N-terminal Cys-X-X-Cys (CXXC) motif which 
regulates its activity during thiol-oxidising conditions (Nakano et al., 2005; 
Pamp et al., 2006). Spx positively regulates the transcription of trxA, 
encoding thioredoxin and trxB, thioredoxin reductase (Pamp et al., 2006; 
Villanueva et al., 2016). The activation of trxA and trxB results from a direct 
interaction of Spx with α subunit of RNAP under oxidised conditions (Nakano 
et al., 2005; Pamp et al., 2006). Spx specifically interacts with the α-CTD (C-
terminal domain) of RNAP subunit α with no evidence of a direct Spx-DNA 
interaction (Nakano et al., 2003b). Even though oxidised Spx is thought to be 
the active form of Spx, recent studies on the identification of Spx regulated 
genes demonstrates new promoters activated by reduced Spx (Rochat et al., 
2012; Rojas-Tapias and Helmann., 2018). Also, disruption of S. aureus spx 
led to pleiotropic effects (Jousselin et al., 2013; Pamp et al., 2006) which 
suggests its role in cellular physiology as a global regulator. Moreover, Spx 
also serves as a negative regulator which represses the energy consuming 
functions of the cells in order to recover from stress (Nakano et al., 2003a). 
Furthermore, Spx controls the trfA gene, encoding an adaptor protein 
implicated in genetic competence and proteolysis (Jousselin et al., 2013). 
Disruption of trfA led to loss of resistance to glycopeptides and oxacillin in 
MSSA and MRSA strains providing a link between cell wall antibiotic stress 
and response mediated by Spx (Jousselin et al., 2013).  
Together, it might be possible that the gene(s) identified in my study (Figure 
5.17 and Table 5.1) are potentially under the direct or indirect control of Spx. 
Figure 6.1 depicts a model summarising the transcriptional response due to 
the expression of mecA could be linked to Spx. Potentially, Spx controls the 
activity of RNAP and/or its specificity for a specific promoter selection during 
mecA induced stress (untrained SJF4996 strain) which can be reversed 
upon the acquisition of rpoB and rpoC mutations (trained strains, SJF5003 
and SJF5034) without detectable alteration in the expression of Spx. Of 
particular significance in the work demonstrated herein was the identification 
of the set of overlapping genes from the three trained strains, implicated in 
anaerobic respiration that were upregulated in the presence of mecA alone 
and adjusted back to WT level in trained strains (Figure 5.16 and Table 5.1 
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highlighted in blue). The majority of these genes are regulated by Rex, a 
redox dependent transcriptional repressor implicated in monitoring 
metabolism and sensing O2 by responding to the NADH/NAD+ ratio 
(Somerville and Proctor, 2009). Upregulation of anaerobic-associated genes 
suggests that Rex activity has been compromised in response to mecA-
induced metabolic stress in the untrained strain and that the rpoB and rpoC 
mutations has restored the production of Rex repressing anaerobic genes to 
WT levels. However, rex is not controlled at the transcriptional level. This 
suggests that PBP2A might be interacting with component(s) of the 
respiratory chain resulting in perturbation of respiration causing a 
deceleration of the respiration rate (Figure 5.26) and concomitant redox 
imbalance accompanied by low-level resistance. Subsequently, mutations in 
rpoB and rpoC potentially reduces the redox-related stress, suggesting that 
high-level resistance would only occur when there is optimal redox balance 






Figure 6.1 Model of proposed Spx-dependent transcriptional regulation 
This model summarises the mecA-dependent cell wall stress and concomitant impact on global transcription might have induced Spx regulated 
mechanisms to recover from the stress in the untrained strain. This is probably due to a possible interaction of PBP2A with respiratory system. The 
mutation in rpoB and rpoC of the trained strains stabilises transcription to the WT level accompanied by increased PBP2A production leading to finely 
adjusted adaptation for the development of high-level β-lactam resistance. The dashed arrows indicate the proposed pathways and protein-protein 




6.1 Future perspectives 
This work provides important information on the mecA-induced 
transcriptional response, specifically, upregulation of anaerobic metabolism 
which could be crucial for growth. Future work could be carried out to identify 
a possible direct or indirect interaction of mecA with anaerobic fermentative-
related proteins. This could be done using the bacterial two-hybrid method. 
Understanding this will identify whether the wider PG synthesis machinery is 
actually interacting with the respiratory chain. Coupled with this, it would be 
particularly interesting to examine if the untrained strain has two populations 
or the whole population is carrying out mixed metabolism as the untrained 
strain showed upregulation of genes associated with anaerobic respiration. 
This could be performed by the localisation studies using fluorescent-labelled 
anaerobic gene, such as ldh.  
The molecular localisation and role of PBP2A in cell division has not been 
studied yet. Prior studies have demonstrated that the cooperative function of 
PBP2 and PBP2A is required for continual cell wall biosynthesis in the 
presence of β-lactams (Pinho et al., 2001a). In the presence of oxacillin 
PBP2 is still required for its transglycosylation activity, suggesting its 
interaction with PBP2A (Pinho and Errington, 2005). However, the 
stoichiometry is unknown. From PBP2A localisation studies, preliminary data 
showed a strong PBP2A-SNAP signal to the septum in the presence of rpoB 
mutation and in the presence of oxacillin. However, septal localisation was 
also observed in the absence of oxacillin suggesting the importance of rpoB 
mutation for the recruitment of PBP2A to the septum. For co-localisation 
studies, utilisation of SNAP and CLIP labelled proteins combined with single 
molecule imaging using super-resolution microscopy approaches would shed 
more light on the mechanistic insight of S. aureus cell division.    
To identify the link between the rpoBC mutations and high-level resistance, it 
would be interesting to study the activity of RNAP and its ability to interact 
with other proteins. This could include in vitro transcription assays using 
purified RNAP from the representative strains. Another hypothesis generated 
from this work would suggest that if the anaerobic respiration is inhibited 
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permanently by overexpressing Rex in the untrained strain would lead to 
increased oxacillin resistance without having rpoBC mutations, indicating the 
importance of aerobic respiration for the development of high-level 
resistance. 
Another avenue for future work would include investigation of RNAP binding 
proteins in S. aureus and RNAP activity in the presence and absence of 
rpoBC mutations. Spx was characterised as a novel transcriptional regulator 
impacting thiol/oxidative stress tolerance (Pamp et al., 2006; Zuber, 2004). 
Identification of an rpoB mutation in spx mutant strain was found to be 
sufficient to compensate for the loss of an otherwise essential gene 
(Villanueva et al., 2016). It would be particularly interesting to examine 
whether the rpoB and rpoC mutations identified in this study would be 
sufficient to bypass the requirement for spx without altering resistance. This 
could be done by transducing the spx mutation into the rpoBC mutants. It 
would be important to determine the activity of Spx in the presence and 
absence of oxacillin. Finally, in vitro transcription assays using purified RNAP 
and Spx on specific promoters such as, rex or nreBC, would reveal whether 
such promoters are controlled by Spx.    
Based on the comments from James O’Gara (external examiner) and Mike 
Brockhurst (internal examiner), it would be interesting to examine the 
amounts of PBP2A in other strains exhibiting low or intermediate level 
resistance to see if there is a correlation between the amounts of PBP2A 
being produced and concomitant resistance. It is also plausible to speculate 
that the expression of mecA requires certain codon(s) to be present in the 
cell for which the cell might have limited numbers of the rare corresponding 
tRNA(s) leading to codon bias. Therefore, it is tempting to speculate that this 
could then be solved by the acquisition of compensatory rpoB and rpoC 
mutations allowing efficient codon usage for mecA, resulting in concomitant 
increase in the production of PBP2A and oxacillin resistance.   
Overall my work has revealed a novel effect of acquisition of mecA on 
cellular physiology by way of altering metabolism. This alludes to an 
interaction between cell wall synthesis and respiration. This observation 
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paves the way to begin to elucidate how such an important pathogen S. 
aureus is able to develop high-level drug resistance and give possible 
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8 Appendix 1 
No. Strain Gradient plate 
Oxacillin 
MIC 
Parental strain SH1000 
1 SH1000 pmecA (SJF4981)  0.25 µg/ml 
Parental strain SH1000 pmecA (SJF4981) 
2 SH1000 pmecA -TI1 (SJF4984) 0.5 µg/ml methicillin 2 µg/ml 
3 SH1000 pmecA -TI2 (SJF4989) 0.5 µg/ml methicillin 2 µg/ml 
4 SH1000 pmecA -TI3 (SJF4992) 0.5 µg/ml methicillin 4 µg/ml 
5 SH1000 pmecA -TI4 0.5 µg/ml methicillin 1 µg/ml 
6 SH1000 pmecA -TI5 0-20 µg/ml methicillin 2 µg/ml 
7 SH1000 pmecA -TI6 0.5 µg/ml methicillin 2 µg/ml 
8 SH1000 pmecA -TI7 0.5 µg/ml methicillin 2 µg/ml 
9 SH1000 pmecA -TI8 0.5 µg/ml methicillin 2 µg/ml 
10 SH1000 pmecA -TI9 0-20 µg/ml methicillin 1 µg/ml 
11 SH1000 pmecA -TI10 0.5 µg/ml methicillin 1 µg/ml 
12 SH1000 pmecA -TI11 0.5 µg/ml methicillin 4 µg/ml 
13 SH1000 pmecA -TI12 0.5 µg/ml methicillin 2 µg/ml 
14 SH1000 pmecA -TI13 0-20 µg/ml methicillin 4 µg/ml 
Parental strain SH1000 pmecA -TI1 (SJF4984) 
15 SH1000 pmecA -TIR1 (SJF4986) 0-20 µg/ml methicillin ≥256 µg/ml 
16 SH1000 pmecA -TIR2 (SJF4987) 0-20 µg/ml methicillin ≥256 µg/ml 
17 SH1000 pmecA -TIR3 (SJF4988) 0-20 µg/ml methicillin ≥256 µg/ml 
Parental strain SH1000 pmecA (SJF4981) 
18 SH1000 pmecA -TR1 (SJF4985) 0.5 µg/ml methicillin ≥256 µg/ml 
19 SH1000 pmecA -TR2 (SJF4990) 0.5 µg/ml methicillin ≥256 µg/ml 
20 SH1000 pmecA -TR3 (SJF4991) 0.5 µg/ml methicillin ≥256 µg/ml 
21 SH1000 pmecA -TR4 0-20 µg/ml methicillin ≥256 µg/ml 
22 SH1000 pmecA -TR5 0.5 µg/ml methicillin ≥256 µg/ml 
23 SH1000 pmecA -TR6 0.5 µg/ml methicillin ≥256 µg/ml 
24 SH1000 pmecA -TR7 0.5 µg/ml methicillin ≥256 µg/ml 
25 SH1000 pmecA -TR8 0.5 µg/ml methicillin ≥256 µg/ml 
26 SH1000 pmecA -TR9 0.5 µg/ml methicillin ≥256 µg/ml 
27 SH1000 pmecA -TR10 0.5 µg/ml methicillin ≥256 µg/ml 
28 SH1000 pmecA -TR11 0.5 µg/ml methicillin ≥256 µg/ml 
29 SH1000 pmecA -TR12 0.5 µg/ml methicillin ≥256 µg/ml 
30 SH1000 pmecA -TR13 0.5 µg/ml methicillin ≥256 µg/ml 
31 SH1000 pmecA -TR14 0.5 µg/ml methicillin ≥256 µg/ml 
32 SH1000 pmecA -TR15 0.5 µg/ml methicillin ≥256 µg/ml 
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33 SH1000 pmecA -TR16 0.5 µg/ml methicillin ≥256 µg/ml 
34 SH1000 pmecA -TR17 0-20 µg/ml methicillin ≥256 µg/ml 
35 SH1000 pmecA -TR18 0-20 µg/ml methicillin ≥256 µg/ml 
36 SH1000 pmecA -TR19 0.5 µg/ml methicillin ≥256 µg/ml 
37 SH1000 pmecA -TR20 0.5 µg/ml methicillin ≥256 µg/ml 
38 SH1000 pmecA -TR21 0.5 µg/ml methicillin 64 µg/ml 
39 SH1000 pmecA -TR22 0.5 µg/ml methicillin ≥256 µg/ml 
40 SH1000 pmecA -TR23 0-20 µg/ml methicillin ≥256 µg/ml 
41 SH1000 pmecA -TR24 0-20 µg/ml methicillin 128 µg/ml 
42 SH1000 pmecA -TR25 0-20 µg/ml methicillin ≥256 µg/ml 
Appendix 1 Table 1 List of isolates methicillin resistant selected from two screenings. 




























































Parent – SJF4981  
(SH1000 pmecA) 
Parent - SJF4984  
(SH1000 pmecA TI1) 
Parent – SJF4981  
(SH1000 pmecA) 
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22181     A A A A A A A A A A 














 A A A A A A    
376633 Stop_Gained High E212* 
SAOUHSC_
00370 
         A 
392716     A A A A A A A A A A 
405366     G G G G G G G G G G 
412759     AT AT AT AT AT AT AT AT AT AT 
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412765     G G G G G G G G G G 
590401 Frame_Shift High R189 
SAOUHSC_
00591 
G G G G G G G G G . 
649126 Synonymous Low G202 
SAOUHSC_
00661 
T T T T T T T T T T 




G G G G G G G G G G 











T T T T T T T T T T 
841103 Synonymous Low G39 
SAOUHSC_
00877 
T T T T T T T T T T 
841139 Synonymous Low G51 
SAOUHSC_
00877 
T T T T T T T T T T 







T T T T T T T T T T 
947897     C C C C C C C C C C 


















A A A A A A A A A A 




T T T T T T T T T T 

















A A A A A A A A A A 
















G G G G G G G G G G 




Moderate D590N sucA T T T T T T T T T T 
1562913     T T T T T T T T T T 
1632624       TA TA  TA TA TA   
1636250     T T T T T T T T T . 


































G G G G G G G G G G 
1967012 Synonymous Low D13 
SAOUHSC_
02090 
























T T T T T T T T T T 





    . 
2134726     TA TA TA TA TA . . TA TA TA 
2134749 Synonymous Low Y3 
SAOUHSC_
A02189 








C C C C C C C C C C 











A A A A A A A A A A 
2244467     G G G G G G G G G G 
2244495     A A A A A A A A A A 
2244931      CT CT CT CT CT CT CT CT CT 
2272936     T T T T T T T T T T 
2296653 Frame_Shift High A10 
SAOUHSC_
02473 
G G  G G G G G G G 
2318272     A A A A A A A A A A 
2318274     T T T T T T T T T T 
2318290     A A A A A A A A A A 
2349916     T T T T T T T T T T 
2349971     A A  A A A  A A A 
2349979     T T T T T T T T T T 
2349985     A A A A A A A A A A 
2349989     A A A A A A A A A A 
2349994     T T T T T T T T T T 
2350000     AT AT AT AT AT AT AT AT AT AT 
277 
 
2350007     A A A A A A A A A A 
2350015     A A A A A A A A A A 
2350100     C C C C C C C C C C 
2383630 Synonymous Low G68 
SAOUHSC_
02591 
T T T T T T T T T T 
2383660 Synonymous Low G78 
SAOUHSC_
02591 
T T T T T T T T T T 
2420618     AT AT AT AT AT AT AT AT AT AT 
2446160 Frame_Shift High N7 
SAOUHSC_
02661 
C   C   C    
2446246 Synonymous Low E42 
SAOUHSC_
02662 
T T T T T T T T T T 
2446393     A A A A A A A A A A 
2446399     C C C C C C C C C C 







T T T T T T T T T T 
2446641 Synonymous Low I29 
SAOUHSC_
02663 







   A       
2592011     A A A A A A A A A A 











































C C C C C C C C C C 





C  C  C C C C  C 
Appendix 1 Table 2 Identification of mutations in SH1000 pmecA (SJF4981) derived resistant strains 













































































Parent - SJF4996 (SH1000 
lysA::pmecA) 
Parent - SJF4996 (SH1000 
lysA::pmecA) 
Parent - SJF4998 (SH1000 
lysA::pmecA TI1) 
22181     A A A A A A A A A A A A 
47648     . . . . . . . G . . . G 



















Moderate S169A SAOUHSC_00270     G        
392716     A A A A A A A A A A A A 
405366     G G G G G G G G . G G G 
412759     AT AT AT AT AT AT AT AT AT AT AT  

















































































G G G G G G G G G G G G 


















Low G51 SAOUHSC_00877 T T T T T T T T T T T T 





Moderate E53K SAOUHSC_00961 T T T T T T T T T T T T 























T T T T T T T T T T T T 
1041999 Intragenic Modifier  
rpmF 
SAOUHSC_01078 































G G G G G G G G G G G G 





Moderate D590N sucA T T T T T T T T T T T T 
1562913 Intragenic Modifier  SAOUHSC_01649 T T T T T T T T T T T T 
1632624 Intragenic Modifier  SAOUHSC_01726 TA TA  TA  TA TA TA TA  TA TA 

































G G G G G G G G G G G G 






















Moderate L602F SAOUHSC_02274 T T T T T T T T T T T T 




































Moderate S244Y SAOUHSC_02401 A A A A A A A A A A A A 
2244467     G G G G G G G G G G G G 
2244495     A A A A A A A A A A A A 
2244931 Intragenic Modifier  SAOUHSC_02417 A A A A A A A A A A A A 






High A10 SAOUHSC_02473 T T T T T T T T T T T T 
2318272     A A A A A A A A A A A A 
2318274     T T T T T T T T T T T T 
2318290     A A A A A A A A A A A A 
2349916 Intragenic Modifier  SAOUHSC_02555 T T T T T T T T T T T T 
2349971 Intragenic Modifier  SAOUHSC_02555 C C C C C C C C C C C C 
2349979 Intragenic Modifier  SAOUHSC_02555 A A A A A A A A A A A A 
2349985 Intragenic Modifier  SAOUHSC_02555 T T T T T T T T T T T T 
2349989 Intragenic Modifier  SAOUHSC_02555 C C C C C C C C C C C C 
2349994 Intragenic Modifier  SAOUHSC_02555 C C C C C C C C C C C C 
2350000 Intragenic Modifier  SAOUHSC_02555 C C C C C C C C C C C C 
2350007 Intragenic Modifier  SAOUHSC_02555 G G G G G G G G G G G G 
2350015 Intragenic Modifier  SAOUHSC_02555 C C C C C C C C C C C C 








Low G78 SAOUHSC_02591 T T T T T T T T T T T T 








Low E42 SAOUHSC_02662 T T T T T T T T T T T T 
2446393     A A A A A A A A A A A A 
2446399     T T T T T T T T T T T T 











Low I29 SAOUHSC_02663 A A A A A A A A A A A A 






























hisF hisI hisIE 
SAOUHSC_03008 
A A A A A A A A A A A A 
Appendix 1 Table 3 Identification of mutations in SH1000 lysA::pmecA (SJF4996) derived resistant strains 
TI, Trained-intermediate resistance; TR, Trained-high-level resistance; TIR, Trained-intermediate to trained-high-level resistance.
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9 Appendix 2 
Alignment of rpoB and rpoC amino acid sequences using Clustal Omega. The amino acid sequence of rpoB and rpoC from clinical 
MRSA isolates, COL, Mu50, Mu3, MW2, USA300, JH9, MRSA252 was aligned with NCTC8325 (MSSA) strain. Identified amino 
acid substitutions from strains listed in Table 4.3 and Table 4.4 are highlighted in green and yellow, respectively. Asterisks indicate 
fully conserved residues, colons indicate conservative substitutions with strongly similar properties, periods indicate semi 
conservative substitutions with weakly similar properties and gaps indicate not conserved residues.  
rpoB alignment results 
JH9          MAGQVVQYGRHRKRRNYARISEVLELPNLIEIQTKSYEWFLREGLIEMFRDISPIEDFTG 60 
COL          MAGQVVQYGRHRKRRNYARISEVLELPNLIEIQTKSYEWFLREGLIEMFRDISPIEDFTG 60 
Mu50         MAGQVVQYGRHRKRRNYARISEVLELPNLIEIQTKSYEWFLREGLIEMFRDISPIEDFTG 60 
8325         MAGQVVQYGRHRKRRNYARISEVLELPNLIEIQTKSYEWFLREGLIEMFRDISPIEDFTG 60 
USA300       MAGQVVQYGRHRKRRNYARISEVLELPNLIEIQTKSYEWFLREGLIEMFRDISPIEDFTG 60 
Mu3          MAGQVVQYGRHRKRRNYARISEVLELPNLIEIQTKSYEWFLREGLIEMFRDISPIEDFTG 60 
MW2          MAGQVVQYGRHRKRRNYARISEVLELPNLIEIQTKSYEWFLREGLIEMFRDISPIEDFTG 60 
MRSA252      MAGQVVQYGRHRKRRNYARISEVLELPNLIEIQTKSYEWFLREGLIEMFRDISPIEDFTG 60 
             ************************************************************ 
 
 
JH9          NLSLEFVDYRLGEPKYDLEESKNRDATYAAPLRVKVRLIIKETGEVKEQEVFMGDFPLMT 120 
COL          NLSLEFVDYRLGEPKYDLEESKNRDATYAAPLRVKVRLIIKETGEVKEQEVFMGDFPLMT 120 
Mu50         NLSLEFVDYRLGEPKYDLEESKNRDATYAAPLRVKVRLIIKETGEVKEQEVFMGDFPLMT 120 
8325         NLSLEFVDYRLGEPKYDLEESKNRDATYAAPLRVKVRLIIKETGEVKEQEVFMGDFPLMT 120 
USA300       NLSLEFVDYRLGEPKYDLEESKNRDATYAAPLRVKVRLIIKETGEVKEQEVFMGDFPLMT 120 
Mu3          NLSLEFVDYRLGEPKYDLEESKNRDATYAAPLRVKVRLIIKETGEVKEQEVFMGDFPLMT 120 
MW2          NLSLEFVDYRLGEPKYDLEESKNRDATYAAPLRVKVRLIIKETGEVKEQEVFMGDFPLMT 120 
MRSA252      NLSLEFVDYRLGEPKYDLEESKNRDATYAAPLRVKVRLIIKETGEVKEQEVFMGDFPLMT 120 




JH9          DTGTFVINGAERVIVSQLVRSPSVYFNEKIDKNGRENYDATIIPNRGAWLEYETDAKDVV 180 
COL          DTGTFVINGAERVIVSQLVRSPSVYFNEKIDKNGRENYDATIIPNRGAWLEYETDAKDVV 180 
Mu50         DTGTFVINGAERVIVSQLVRSPSVYFNEKIDKNGRENYDATIIPNRGAWLEYETDAKDVV 180 
8325         DTGTFVINGAERVIVSQLVRSPSVYFNEKIDKNGRENYDATIIPNRGAWLEYETDAKDVV 180 
USA300       DTGTFVINGAERVIVSQLVRSPSVYFNEKIDKNGRENYDATIIPNRGAWLEYETDAKDVV 180 
Mu3          DTGTFVINGAERVIVSQLVRSPSVYFNEKIDKNGRENYDATIIPNRGAWLEYETDAKDVV 180 
MW2          DTGTFVINGAERVIVSQLVRSPSVYFNEKIDKNGRENYDATIIPNRGAWLEYETDAKDVV 180 
MRSA252      DTGTFVINGAERVIVSQLVRSPSVYFNEKIDKNGRENYDATIIPNRGAWLEYETDAKDVV 180 
             ************************************************************ 
 
JH9          YVRIDRTRKLPLTVLLRALGFSSDQEIVDLLGDNEYLRNTLEKDGTENTEQALLEIYERL 240 
COL          YVRIDRTRKLPLTVLLRALGFSSDQEIVDLLGDNEYLRNTLEKDGTENTEQALLEIYERL 240 
Mu50         YVRIDRTRKLPLTVLLRALGFSSDQEIVDLLGDNEYLRNTLEKDGTENTEQALLEIYERL 240 
8325         YVRIDRTRKLPLTVLLRALGFSSDQEIVDLLGDNEYLRNTLEKDGTENTEQALLEIYERL 240 
USA300       YVRIDRTRKLPLTVLLRALGFSSDQEIVDLLGDNEYLRNTLEKDGTENTEQALLEIYERL 240 
Mu3          YVRIDRTRKLPLTVLLRALGFSSDQEIVDLLGDNEYLRNTLEKDGTENTEQALLEIYERL 240 
MW2          YVRIDRTRKLPLTVLLRALGFSSDQEIVDLLGDNEYLRNTLEKDGTENTEQALLEIYERL 240 
MRSA252      YVRIDRTRKLPLTVLLRALGFSSDQEIVDLLGDNEYLRNTLEKDGTENTEQALLEIYERL 240 
             ************************************************************ 
 
JH9          RPGEPPTVENAKSLLYSRFFDPKRYDLASVGRYKTNKKLHLKHRLFNQKLAEPIVNTETG 300 
COL          RPGEPPTVENAKSLLYSRFFDPKRYDLASVGRYKTNKKLHLKHRLFNQKLAEPIVNTETG 300 
Mu50         RPGEPPTVENAKSLLYSRFFDPKRYDLASVGRYKTNKKLHLKHRLFNQKLAEPIVNTETG 300 
8325         RPGEPPTVENAKSLLYSRFFDPKRYDLASVGRYKTNKKLHLKHRLFNQKLAEPIVNTETG 300 
USA300       RPGEPPTVENAKSLLYSRFFDPKRYDLASVGRYKTNKKLHLKHRLFNQKLAEPIVNTETG 300 
Mu3          RPGEPPTVENAKSLLYSRFFDPKRYDLASVGRYKTNKKLHLKHRLFNQKLAEPIVNTETG 300 
MW2          RPGEPPTVENAKSLLYSRFFDPKRYDLASVGRYKTNKKLHLKHRLFNQKLAEPIVNTETG 300 
MRSA252      RPGEPPTVENAKSLLYSRFFDPKRYDLASVGRYKTNKKLHLKHRLFNQKLAEPIVNTETG 300 
             ************************************************************ 
 
JH9          EIVVEEGTVLDRRKIDEIMDVLESNANSEVFELHGSVIDEPVEIQSIKVYVPNDDEGRTT 360 
COL          EIVVEEGTVLDRRKIDEIMDVLESNANSEVFELHGSVIDEPVEIQSIKVYVPNDDEGRTT 360 
Mu50         EIVVEEGTVLDRRKIDEIMDVLESNANSEVFELHGSVIDEPVEIQSIKVYVPNDDEGRTT 360 
8325         EIVVEEGTVLDRRKIDEIMDVLESNANSEVFELHGSVIDEPVEIQSIKVYVPNDDEGRTT 360 
USA300       EIVVEEGTVLDRRKIDEIMDVLESNANSEVFELHGSVIDEPVEIQSIKVYVPNDDEGRTT 360 
Mu3          EIVVEEGTVLDRRKIDEIMDVLESNANSEVFELHGSVIDEPVEIQSIKVYVPNDDEGRTT 360 
MW2          EIVVEEGTVLDRRKIDEIMDVLESNANSEVFELHGSVIDEPVEIQSIKVYVPNDDEGRTT 360 
MRSA252      EIVVEEGTVLDRRKIDEIMDVLESNANSEVFELHGSVIDEPVEIQSIKVYVPNDDEGRTT 360 




JH9          TVIGNAFPDSEVKCITPADIIASMSYFFNLLSGIGYTDDIDHLGNRRLRSVGELLQNQFR 420 
COL          TVIGNAFPDSEVKCITPADIIASMSYFFNLLSGIGYTDDIDHLGNRRLRSVGELLQNQFR 420 
Mu50         TVIGNAFPDSEVKCITPADIIASMSYFFNLLSGIGYTDDIDHLGNRRLRSVGELLQNQFR 420 
8325         TVIGNAFPDSEVKCITPADIIASMSYFFNLLSGIGYTDDIDHLGNRRLRSVGELLQNQFR 420 
USA300       TVIGNAFPDSEVKCITPADIIASMSYFFNLLSGIGYTDDIDHLGNRRLRSVGELLQNQFR 420 
Mu3          TVIGNAFPDSEVKCITPADIIASMSYFFNLLSGIGYTDDIDHLGNRRLRSVGELLQNQFR 420 
MW2          TVIGNAFPDSEVKCITPADIIASMSYFFNLLSGIGYTDDIDHLGNRRLRSVGELLQNQFR 420 
MRSA252      TVIGNAFPDSEVKCITPADIIASMSYFFNLLSGIGYTDDIDHLGNRRLRSVGELLQNQFR 420 
             ************************************************************ 
 
JH9          IGLSRMERVVRERMSIQDTESITPQQLINIRPVIASIKEFFGSSQLSQFMYQSNPLSDLT 480 
COL          IGLSRMERVVRERMSIQDTESITPQQLINIRPVIASIKEFFGSSQLSQFMDQANPLAELT 480 
Mu50         IGLSRMERVVRERMSIQDTESITPQQLINIRPVIASIKEFFGSSQLSQFMDQANPLAELT 480 
8325         IGLSRMERVVRERMSIQDTESITPQQLINIRPVIASIKEFFGSSQLSQFMDQANPLAELT 480 
USA300       IGLSRMERVVRERMSIQDTESITPQQLINIRPVIASIKEFFGSSQLSQFMDQANPLAELT 480 
Mu3          IGLSRMERVVRERMSIQDTESITPQQLINIRPVIASIKEFFGSSQLSQFMDQANPLAELT 480 
MW2          IGLSRMERVVRERMSIQDTESITPQQLINIRPVIASIKEFFGSSQLSQFMDQANPLAELT 480 
MRSA252      IGLSRMERVVRERMSIQDTESITPQQLINIRPVIASIKEFFGSSQLSQFMDQANPLAELT 480 
             ************************************************** *:***::** 
 
JH9          HKRRLSALGPGGLTRERAQMEVRDVHYSHYGRMCPIETPEGPNIGLINSLSSYARVNEFG 540 
COL          HKRRLSALGPGGLTRERAQMEVRDVHYSHYGRMCPIETPEGPNIGLINSLSSYARVNEFG 540 
Mu50         YKRRLSALGPGGLTRERAQMEVRDVHYSHYGRMCPIETPEGPNIGLINSLSSYARVNEFG 540 
8325         HKRRLSALGPGGLTRERAQMEVRDVHYSHYGRMCPIETPEGPNIGLINSLSSYARVNEFG 540 
USA300       HKRRLSALGPGGLTRERAQMEVRDVHYSHYGRMCPIETPEGPNIGLINSLSSYARVNEFG 540 
Mu3          HKRRLSALGPGGLTRERAQMEVRDVHYSHYGRMCPIETPEGPNIGLINSLSSYARVNEFG 540 
MW2          HKRRLSALGPGGLTRERAQMEVRDVHYSHYGRMCPIETPEGPNIGLINSLSSYARVNEFG 540 
MRSA252      HKRRLSALGPGGLTRERAQMEVRDVHYSHYGRMCPIETPEGPNIGLINSLSSYARVNEFG 540 
             :*********************************************************** 
 
JH9          FIETPYRKVDLDTHAITDQIDYLTADEEDSYVVAQANSKLDENGRFMDDEVVCRFRGNNT 600 
COL          FIETPYRKVDLDTHAITDQIDYLTADEEDSYVVAQANSKLDENGRFMDDEVVCRFRGNNT 600 
Mu50         FIETPYRKVDLDTHAITDQIDYLTADEEDSYVVAQANSKLDENGRFMDDEVVCRFRGNNT 600 
8325         FIETPYRKVDLDTHAITDQIDYLTADEEDSYVVAQANSKLDENGRFMDDEVVCRFRGNNT 600 
USA300       FIETPYRKVDLDTHAITDQIDYLTADEEDSYVVAQANSKLDENGRFMDDEVVCRFRGNNT 600 
Mu3          FIETPYRKVDLDTHAITDQIDYLTADEEDSYVVAQANSKLDENGRFMDDEVVCRFRGNNT 600 
MW2          FIETPYRKVDLDTHAITDQIDYLTADEEDSYVVAQANSKLDENGRFMDDEVVCRFRGNNT 600 
MRSA252      FIETPYRKVDLDTHAITDQIDYLTADEEDSYVVAQANSKLDENGRFMDDEVVCRFRGNNT 600 




JH9          VMAKEKMDYMDVSPKQVVSAATACIPFLENDDSNRALMGANMQRQAVPLMNPEAPFVGTG 660 
COL          VMAKEKMDYMDVSPKQVVSAATACIPFLENDDSNRALMGANMQRQAVPLMNPEAPFVGTG 660 
Mu50         VMAKEKMDYMDVSPKQVVSAATACIPFLENDDSNRALMGANMQRQAVPLMNPEAPFVGTG 660 
8325         VMAKEKMDYMDVSPKQVVSAATACIPFLENDDSNRALMGANMQRQAVPLMNPEAPFVGTG 660 
USA300       VMAKEKMDYMDVSPKQVVSAATACIPFLENDDSNRALMGANMQRQAVPLMNPEAPFVGTG 660 
Mu3          VMAKEKMDYMDVSPKQVVSAATACIPFLENDDSNRALMGANMQRQAVPLMNPEAPFVGTG 660 
MW2          VMAKEKMDYMDVSPKQVVSAATACIPFLENDDSNRALMGANMQRQAVPLMNPEAPFVGTG 660 
MRSA252      VMAKEKMDYMDVSPKQVVSAATACIPFLENDDSNRALMGANMQRQAVPLMNPEAPFVGTG 660 
             ************************************************************ 
 
JH9          MEHVAARDSGAAITAKHRGRVEHVESNEILVRRLVEENGVEHEGELDRYPLAKFKRSNSG 720 
COL          MEHVAARDSGAAITAKHRGRVEHVESNEILVRRLVEENGVEHEGELDRYPLAKFKRSNSG 720 
Mu50         MEHVAARDSGAAITAKHRGRVEHVESNEILVRRLVEENGVEHEGELDRYPLAKFKRSNSG 720 
8325         MEHVAARDSGAAITAKHRGRVEHVESNEILVRRLVEENGVEHEGELDRYPLAKFKRSNSG 720 
USA300       MEHVAARDSGAAITAKHRGRVEHVESNEILVRRLVEENGVEHEGELDRYPLAKFKRSNSG 720 
Mu3          MEHVAARDSGAAITAKHRGRVEHVESNEILVRRLVEENGVEHEGELDRYPLAKFKRSNSG 720 
MW2          MEHVAARDSGAAITAKHRGRVEHVESNEILVRRLVEENGVEHEGELDRYPLAKFKRSNSG 720 
MRSA252      MEHVAARDSGAAITAKHRGRVEHVESNEILVRRLVEENGVEHEGELDRYPLAKFKRSNSG 720 
             ************************************************************ 
 
JH9          TCYNQRPIVAVGDVVEYNEILADGPSMELGEMALGRNVVVGFMTWDGYNYEDAVIMSERL 780 
COL          TCYNQRPIVAVGDVVEYNEILADGPSMELGEMALGRNVVVGFMTWDGYNYEDAVIMSERL 780 
Mu50         TCYNQRPIVAVGDVVEYNEILADGPSMELGEMALGRNVVVGFMTWDGYNYEDAVIMSERL 780 
8325         TCYNQRPIVAVGDVVEYNEILADGPSMELGEMALGRNVVVGFMTWDGYNYEDAVIMSERL 780 
USA300       TCYNQRPIVAVGDVVEYNEILADGPSMELGEMALGRNVVVGFMTWDGYNYEDAVIMSERL 780 
Mu3          TCYNQRPIVAVGDVVEYNEILADGPSMELGEMALGRNVVVGFMTWDGYNYEDAVIMSERL 780 
MW2          TCYNQRPIVAVGDVVEYNEILADGPSMELGEMALGRNVVVGFMTWDGYNYEDAVIMSERL 780 
MRSA252      TCYNQRPIVAVGDVVEFNEILADGPSMELGEMALGRNVVVGFMTWDGYNYEDAVIMSERL 780 
             ****************:******************************************* 
 
JH9          VKDDVYTSIHIEEYESEARDTKLGPEEITRDIPNVSESALKNLDDRGIVYIGAEVKDGDI 840 
COL          VKDDVYTSIHIEEYESEVRDTKLGPEEITRDIPNVSESALKNLDDRGIVYIGAEVKDGDI 840 
Mu50         VKDDVYTSIHIEEYESEARDTKLGPEEITRDIPNVSESALKNLDDRGIVYIGAEVKDGDI 840 
8325         VKDDVYTSIHIEEYESEARDTKLGPEEITRDIPNVSESALKNLDDRGIVYIGAEVKDGDI 840 
USA300       VKDDVYTSIHIEEYESEARDTKLGPEEITRDIPNVSESALKNLDDRGIVYIGAEVKDGDI 840 
Mu3          VKDDVYTSIHIEEYESEARDTKLGPEEITRDIPNVSESALKNLDDRGIVYIGAEVKDGDI 840 
MW2          VKDDVYTSIHIEEYESEARDTKLGPEEITRDIPNVSESALKNLDDRGIVYIGAEVKDGDI 840 
MRSA252      VKDDVYTSIHIEEYESEARDTKLGPEEITRDIPNVSESALKNLDDRGIVYIGAEVKDGDI 840 




JH9          LVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSLRVPHGAGGIVLDVKVFNREEGDDT 900 
COL          LVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTLLRVPHGAGGIVLDVKVFNREEGDDT 900 
Mu50         LVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSLRVPHGAGGIVLDVKVFNREEGDDT 900 
8325         LVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSLRVPHGAGGIVLDVKVFNREEGDDT 900 
USA300       LVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSLRVPHGAGGIVLDVKVFNREEGDDT 900 
Mu3          LVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSLRVPHGAGGIVLDVKVFNREEGDDT 900 
MW2          LVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSLRVPHGAGGIVLDVKVFNREEGDDT 900 
MRSA252      LVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSLRVPHGAGGIVLDVKVFNREEGDDT 900 
             ********************************** ************************* 
 
JH9          LSPGVNQLVRVYIVQKRKIHVGDKMCGRHGNKGVISKIVPEEDMPYLPDGRPIDIMLNPL 960 
COL          LSPGVNQLVRVYIVQKRKIHVGDKMCGRHGNKGVISKIVPEEDMPYLPDGRPIDIMLNPL 960 
Mu50         LSPGVNQLVRVYIVQKRKIHVGDKMCGRHGNKGVISKIVPEEDMPYLPDGRPIDIMLNPL 960 
8325         LSPGVNQLVRVYIVQKRKIHVGDKMCGRHGNKGVISKIVPEEDMPYLPDGRPIDIMLNPL 960 
USA300       LSPGVNQLVRVYIVQKRKIHVGDKMCGRHGNKGVISKIVPEEDMPYLPDGRPIDIMLNPL 960 
Mu3          LSPGVNQLVRVYIVQKRKIHVGDKMCGRHGNKGVISKIVPEEDMPYLPDGRPIDIMLNPL 960 
MW2          LSPGVNQLVRVYIVQKRKIHVGDKMCGRHGNKGVISKIVPEEDMPYLPDGRPIDIMLNPL 960 
MRSA252      LSPGVNQLVRVYIVQKRKIHVGDKMCGRHGNKGVISKIVPEEDMPYLPDGRPIDIMLNPL 960 
             ************************************************************ 
 
JH9          GVPSRMNIGQVLELHLGMAAKNLGIHVASPVFDGANDDDVWSTIEEAGMARDGKTVLYDG 1020 
COL          GVPSRMNIGQVLELHLGMAAKNLGIHVASPVFDGANDDDVWSTIEEAGMARDGKTVLYDG 1020 
Mu50         GVPSRMNIGQVLELHLGMAAKNLGIHVASPVFDGANDDDVWSTIEEAGMARDGKTVLYDG 1020 
8325         GVPSRMNIGQVLELHLGMAAKNLGIHVASPVFDGANDDDVWSTIEEAGMARDGKTVLYDG 1020 
USA300       GVPSRMNIGQVLELHLGMAAKNLGIHVASPVFDGANDDDVWSTIEEAGMARDGKTVLYDG 1020 
Mu3          GVPSRMNIGQVLELHLGMAAKNLGIHVASPVFDGANDDDVWSTIEEAGMARDGKTVLYDG 1020 
MW2          GVPSRMNIGQVLELHLGMAAKNLGIHVASPVFDGANDDDVWSTIEEAGMARDGKTVLYDG 1020 
MRSA252      GVPSRMNIGQVLELHLGMAAKNLGIHVASPVFDGANDDDVWSTIEEAGMARDGKTVLYDG 1020 
             ************************************************************ 
 
JH9          RTGEPFDNRISVGVMYMLKLAHMVDDKLHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEV 1080 
COL          RTGEPFDNRISVGVMYMLKLAHMVDDKLHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEV 1080 
Mu50         RTGEPFDNRISVGVMYMLKLAHMVDDKLHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEV 1080 
8325         RTGEPFDNRISVGVMYMLKLAHMVDDKLHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEV 1080 
USA300       RTGEPFDNRISVGVMYMLKLAHMVDDKLHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEV 1080 
Mu3          RTGEPFDNRISVGVMYMLKLAHMVDDKLHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEV 1080 
MW2          RTGEPFDNRISVGVMYMLKLAHMVDDKLHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEV 1080 
MRSA252      RTGEPFDNRISVGVMYMLKLAHMVDDKLHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEV 1080 




JH9          WALEAYGAAYTLQEILTYKSDDTVGRVKTYEAIVKGENISRPSVPESFRVLMKELQSLGL 1140 
COL          WALEAYGAAYTLQEILTYKSDDTVGRVKTYEAIVKGENISRPSVPESFRVLMKELQSLGL 1140 
Mu50         WALEAYGAAYTLQEILTYKSDDTVGRVKTYEAIVKGENISRPSVPESFRVLMKELQSLGL 1140 
8325         WALEAYGAAYTLQEILTYKSDDTVGRVKTYEAIVKGENISRPSVPESFRVLMKELQSLGL 1140 
USA300       WALEAYGAAYTLQEILTYKSDDTVGRVKTYEAIVKGENISRPSVPESFRVLMKELQSLGL 1140 
Mu3          WALEAYGAAYTLQEILTYKSDDTVGRVKTYEAIVKGENISRPSVPESFRVLMKELQSLGL 1140 
MW2          WALEAYGAAYTLQEILTYKSDDTVGRVKTYEAIVKGENISRPSVPESFRVLMKELQSLGL 1140 
MRSA252      WALEAYGAAYTLQEILTYKSDDTVGRVKTYEAIVKGENISRPSVPESFRVLMKELQSLGL 1140 
             ************************************************************ 
 
JH9          DVKVMDEQDNEIEMTDVDDDDVVERKVDLQQNDAPETQKEVTD 1183 
COL          DVKVMDEQDNEIEMTDVDDDDVVERKVDLQQNDAPETQKEVTD 1183 
Mu50         DVKVMDEQDNEIEMTDVDDDDVVERKVDLQQNDAPETQKEVTD 1183 
8325         DVKVMDEQDNEIEMTDVDDDDVVERKVDLQQNDAPETQKEVTD 1183 
USA300       DVKVMDEQDNEIEMTDVDDDDVVERKVDLQQNDAPETQKEVTD 1183 
Mu3          DVKVMDEQDNEIEMTDVDDDDVVERKVDLQQNDAPETQKEVTD 1183 
MW2          DVKVMDEQDNEIEMTDVDDDDVVERKVDLQQNDAPETQKEVTD 1183 
MRSA252      DVKVMDEQDNEIEMTDVDDDDVVERKVDLQQNDAPETQKEVTD 1183 
             ******************************************* 
rpoC alignment results 
JH9          MIDVNNFHYMKIGLASPEKIRSWSFGEVKKPETINYRTLKPEKDGLFCERIFGPTKDWEC 60 
USA300       MIDVNNFHYMKIGLASPEKIRSWSFGEVKKPETINYRTLKPEKDGLFCERIFGPTKDWEC 60 
8325         MIDVNNFHYMKIGLASPEKIRSWSFGEVKKPETINYRTLKPEKDGLFCERIFGPTKDWEC 60 
COL          MIDVNNFHYMKIGLASPEKIRSWSFGEVKKPETINYRTLKPEKDGLFCERIFGPTKDWEC 60 
Mu50         MIDVNNFHYMKIGLASPEKIRSWSFGEVKKPETINYRTLKPEKDGLFCERIFGPTKDWEC 60 
Mu3          MIDVNNFHYMKIGLASPEKIRSWSFGEVKKPETINYRTLKPEKDGLFCERIFGPTKDWEC 60 
MW2          MIDVNNFHYMKIGLASPEKIRSWSFGEVKKPETINYRTLKPEKDGLFCERIFGPTKDWEC 60 
MRSA252      MIDVNNFHYMKIGLASPEKIRSWSFGEVKKPETINYRTLKPEKDGLFCERIFGPTKDWEC 60 
             ************************************************************ 
 
JH9          SCGKYKRVRYKGMVCDRCGVEVTKSKVRRERMGHIELAAPVSHIWYFKGIPSRMGLLLDM 120 
USA300       SCGKYKRVRYKGMVCDRCGVEVTKSKVRRERMGHIELAAPVSHIWYFKGIPSRMGLLLDM 120 
8325         SCGKYKRVRYKGMVCDRCGVEVTKSKVRRERMGHIELAAPVSHIWYFKGIPSRMGLLLDM 120 
COL          SCGKYKRVRYKGMVCDRCGVEVTKSKVRRERMGHIELAAPVSHIWYFKGIPSRMGLLLDM 120 
Mu50         SCGKYKRVRYKGMVCDRCGVEVTKSKVRRERMGHIELAAPVSHIWYFKGIPSRMGLLLDM 120 
Mu3          SCGKYKRVRYKGMVCDRCGVEVTKSKVRRERMGHIELAAPVSHIWYFKGIPSRMGLLLDM 120 
MW2          SCGKYKRVRYKGMVCDRCGVEVTKSKVRRERMGHIELAAPVSHIWYFKGIPSRMGLLLDM 120 
MRSA252      SCGKYKRVRYKGMVCDRCGVEVTKSKVRRERMGHIELAAPVSHIWYFKGIPSRMGLLLDM 120 
             ************************************************************ 
291 
 
JH9          SPRALEEVIYFASYVVVDPGPTGLEKKTLLSEAEFRDYYDKYPGQFVAKMGAEGIKDLLE 180 
USA300       SPRALEEVIYFASYVVVDPGPTGLEKKTLLSEAEFRDYYDKYPGQFVAKMGAEGIKDLLE 180 
8325         SPRALEEVIYFASYVVVDPGPTGLEKKTLLSEAEFRDYYDKYPGQFVAKMGAEGIKDLLE 180 
COL          SPRALEEVIYFASYVVVDPGPTGLEKKTLLSEAEFRDYYDKYPGQFVAKMGAEGIKDLLE 180 
Mu50         SPRALEEVIYFASYVVVDPGPTGLEKKTLLSEAEFRDYYDKYPGQFVAKMGAEGIKDLLE 180 
Mu3          SPRALEEVIYFASYVVVDPGPTGLEKKTLLSEAEFRDYYDKYPGQFVAKMGAEGIKDLLE 180 
MW2          SPRALEEVIYFASYVVVDPGPTGLEKKTLLSEAEFRDYYDKYPGQFVAKMGAEGIKDLLE 180 
MRSA252      SPRALEEVIYFASYVVVDPGPTGLEKKTLLSEAEFRDYYDKYPGQFVAKMGAEGIKDLLE 180 
             ************************************************************ 
 
JH9          EIDLDEELKLLRDELESATGQRLTRAIKRLEVVESFRNSGNKPSWMILDVLPIIPPEIRP 240 
USA300       EIDLDEELKLLRDELESATGQRLTRAIKRLEVVESFRNSGNKPSWMILDVLPIIPPEIRP 240 
8325         EIDLDEELKLLRDELESATGQRLTRAIKRLEVVESFRNSGNKPSWMILDVLPIIPPEIRP 240 
COL          EIDLDEELKLLRDELESATGQRLTRAIKRLEVVESFRNSGNKPSWMILDVLPIIPPEIRP 240 
Mu50         EIDLDEELKLLRDELESATGQRLTRAIKRLEVVESFRNSGNKPSWMILDVLPIIPPEIRP 240 
Mu3          EIDLDEELKLLRDELESATGQRLTRAIKRLEVVESFRNSGNKPSWMILDVLPIIPPEIRP 240 
MW2          EIDLDEELKLLRDELESATGQRLTRAIKRLEVVESFRNSGNKPSWMILDVLPIIPPEIRP 240 
MRSA252      EIDLDEELKLLRDELESATGQRLTRAIKRLEVVESFRNSGNKPSWMILDVLPIIPPEIRP 240 
             ************************************************************ 
 
JH9          MVQLDGGRFATSDLNDLYRRVINRNNRLKRLLDLGAPGIIVQNEKRMLQEAVDALIDNGR 300 
USA300       MVQLDGGRFATSDLNDLYRRVINRNNRLKRLLDLGAPGIIVQNEKRMLQEAVDALIDNGR 300 
8325         MVQLDGGRFATSDLNDLYRRVINRNNRLKRLLDLGAPGIIVQNEKRMLQEAVDALIDNGR 300 
COL          MVQLDGGRFATSDLNDLYRRVINRNNRLKRLLDLGAPGIIVQNEKRMLQEAVDALIDNGR 300 
Mu50         MVQLDGGRFATSDLNDLYRRVINRNNRLKRLLDLGAPGIIVQNEKRMLQEAVDALIDNGR 300 
Mu3          MVQLDGGRFATSDLNDLYRRVINRNNRLKRLLDLGAPGIIVQNEKRMLQEAVDALIDNGR 300 
MW2          MVQLDGGRFATSDLNDLYRRVINRNNRLKRLLDLGAPGIIVQNEKRMLQEAVDALIDNGR 300 
MRSA252      MVQLDGGRFATSDLNDLYRRVINRNNRLKRLLDLGAPGIIVQNEKRMLQEAVDALIDNGR 300 
             ************************************************************ 
 
JH9          RGRPVTGPGNRPLKSLSHMLKGKQGRFRQNLLGKRVDYSGRSVIAVGPSLKMYQCGLPKE 360 
USA300       RGRPVTGPGNRPLKSLSHMLKGKQGRFRQNLLGKRVDYSGRSVIAVGPSLKMYQCGLPKE 360 
8325         RGRPVTGPGNRPLKSLSHMLKGKQGRFRQNLLGKRVDYSGRSVIAVGPSLKMYQCGLPKE 360 
COL          RGRPVTGPGNRPLKSLSHMLKGKQGRFRQNLLGKRVDYSGRSVIAVGPSLKMYQCGLPKE 360 
Mu50         RGRPVTGPGNRPLKSLSHMLKGKQGRFRQNLLGKRVDYSGRSVIAVGPSLKMYQCGLPKE 360 
Mu3          RGRPVTGPGNRPLKSLSHMLKGKQGRFRQNLLGKRVDYSGRSVIAVGPSLKMYQCGLPKE 360 
MW2          RGRPVTGPGNRPLKSLSHMLKGKQGRFRQNLLGKRVDYSGRSVIAVGPSLKMYQCGLPKE 360 
MRSA252      RGRPVTGPGNRPLKSLSHMLKGKQGRFRQNLLGKRVDYSGRSVIAVGPSLKMYQCGLPKE 360 




JH9          MALELFKPFVMKELVQREIATNIKNAKSKIERMDDEVWDVLEEVIREHPVLLNRAPTLHR 420 
USA300       MALELFKPFVMKELVQREIATNIKNAKSKIERMDDEVWDVLEEVIREHPVLLNRAPTLHR 420 
8325         MALELFKPFVMKELVQREIATNIKNAKSKIERMDDEVWDVLEEVIREHPVLLNRAPTLHR 420 
COL          MALELFKPFVMKELVQREIATNIKNAKSKIERMDDEVWDVLEEVIREHPVLLNRAPTLHR 420 
Mu50         MALELFKPFVMKELVQREIATNIKNAKSKIERMDDEVWDVLEEVIREHPVLLNRAPTLHR 420 
Mu3          MALELFKPFVMKELVQREIATNIKNAKSKIERMDDEVWDVLEEVIREHPVLLNRAPTLHR 420 
MW2          MALELFKPFVMKELVQREIATNIKNAKSKIERMDDEVWDVLEEVIREHPVLLNRAPTLHR 420 
MRSA252      MALELFKPFVMKELVQREIATNIKNAKSKIERMDDEVWDVLEEVIREHPVLLNRAPTLHR 420 
             ************************************************************ 
 
JH9          LGIQAFEPTLVEGRAIRLHPLVTTAYNADFDGDQMAVHVPLSKEAQAEARMLMLAAQNIL 480 
USA300       LGIQAFEPTLVEGRAIRLHPLVTTAYNADFDGDQMAVHVPLSKEAQAEARMLMLAAQNIL 480 
8325         LGIQAFEPTLVEGRAIRLHPLVTTAYNADFDGDQMAVHVPLSKEAQAEARMLMLAAQNIL 480 
COL          LGIQAFEPTLVEGRAIRLHPLVTTAYNADFDGDQMAVHVPLSKEAQAEARMLMLAAQNIL 480 
Mu50         LGIQAFEPTLVEGRAIRLHPLVTTAYNADFDGDQMAVHVPLSKEAQAEARMLMLAAQNIL 480 
Mu3          LGIQAFEPTLVEGRAIRLHPLVTTAYNADFDGDQMAVHVPLSKEAQAEARMLMLAAQNIL 480 
MW2          LGIQAFEPTLVEGRAIRLHPLVTTAYNADFDGDQMAVHVPLSKEAQAEARMLMLAAQNIL 480 
MRSA252      LGIQAFEPTLVEGRAIRLHPLVTTAYNADFDGDQMAVHVPLSKEAQAEARMLMLAAQNIL 480 
             ************************************************************ 
 
JH9          NPKDGKPVVTPSQDMVLGNYYLTLERKDAVNTGAIFNNTNEVLKAYANGFVHLHTRIGVH 540 
USA300       NPKDGKPVVTPSQDMVLGNYYLTLERKDAVNTGAIFNNTNEVLKAYANGFVHLHTRIGVH 540 
8325         NPKDGKPVVTPSQDMVLGNYYLTLERKDAVNTGAIFNNTNEVLKAYANGFVHLHTRIGVH 540 
COL          NPKDGKPVVTPSQDMVLGNYYLTLERKDAVNTGAIFNNTNEVLKAYANGFVHLHTRIGVH 540 
Mu50         NPKDGKPVVTPSQDMVLGNYYLTLERKDAVNTGAIFNNTNEVLKAYANGFVHLHTRIGVH 540 
Mu3          NPKDGKPVVTPSQDMVLGNYYLTLERKDAVNTGAIFNNTNEVLKAYANGFVHLHTRIGVH 540 
MW2          NPKDGKPVVTPSQDMVLGNYYLTLERKDAVNTGAIFNNTNEVLKAYANGFVHLHTRIGVH 540 
MRSA252      NPKDGKPVVTPSQDMVLGNYYLTLERKDAVNTGAIFNNTNEVLKAYANGFVHLHTRIGVH 540 
             ************************************************************ 
 
JH9          ASSFNNPTFTEEQNKKILATSVGKIIFNEIIPDSFAYINEPTQENLERKTPNRYFIDPTT 600 
USA300       ASSFNNPTFTEEQNKKILATSVGKIIFNEIIPDSFAYINEPTQENLERKTPNRYFIDPTT 600 
8325         ASSFNNPTFTEEQNKKILATSVGKIIFNEIIPDSFAYINEPTQENLERKTPNRYFIDPTT 600 
COL          ASSFNNPTFTEEQNKKILATSVGKIIFNEIIPDSFAYINEPTQENLERKTPNRYFIDPTT 600 
Mu50         ASSFNNPTFTEEQNKKILATSVGKIIFNEIIPDSFAYINEPTQENLERKTPNRYFIDPTT 600 
Mu3          ASSFNNPTFTEEQNKKILATSVGKIIFNEIIPDSFAYINEPTQENLERKTPNRYFIDPTT 600 
MW2          ASSFNNPTFTEEQNKKILATSVGKIIFNEIIPDSFAYINEPTQENLERKTPNRYFIDPTT 600 
MRSA252      ASSFNNPTFTEEQNKKILATSVGKIIFNEIIPDSFAYINEPTQENLERKTPNRYFIDPTT 600 




JH9          LGEGGLKEYFENEELIEPFNKKFLGNIIAEVFNRFSITDTSMMLDRMKDLGFKFSSKAGI 660 
USA300       LGEGGLKEYFENEELIEPFNKKFLGNIIAEVFNRFSITDTSMMLDRMKDLGFKFSSKAGI 660 
8325         LGEGGLKEYFENEELIEPFNKKFLGNIIAEVFNRFSITDTSMMLDRMKDLGFKFSSKAGI 660 
COL          LGEGGLKEYFENEELIEPFNKKFLGNIIAEVFNRFSITDTSMMLDRMKDLGFKFSSKAGI 660 
Mu50         LGEGGLKEYFENEELIEPFNKKFLGNIIAEVFNRFSITDTSMMLDRMKDLGFKFSSKAGI 660 
Mu3          LGEGGLKEYFENEELIEPFNKKFLGNIIAEVFNRFSITDTSMMLDRMKDLGFKFSSKAGI 660 
MW2          LGEGGLKEYFENEELIEPFNKKFLGNIIAEVFNRFSITDTSMMLDRMKDLGFKFSSKAGI 660 
MRSA252      LGEGGLKEYFENEELIEPFNKKFLGNIIAEVFNRFSITDTSMMLDRMKDLGFKFSSKAGI 660 
             ************************************************************ 
 
JH9          TVGVADIVVLPDKQQILDEHEKLVDRITKQFNRGLITEEERYNAVVEIWTDAKDQIQGEL 720 
USA300       TVGVADIVVLPDKQQILDEHEKLVDRITKQFNRGLITEEERYNAVVEIWTDAKDQIQGEL 720 
8325         TVGVADIVVLPDKQQILDEHEKLVDRITKQFNRGLITEEERYNAVVEIWTDAKDQIQGEL 720 
COL          TVGVADIVVLPDKQQILDEHEKLVDRITKQFNRGLITEEERYNAVVEIWTDAKDQIQGEL 720 
Mu50         TVGVADIVVLPDKQQILDEHEKLVDRITKQFNRGLITEEERYNAVVEIWTDAKDQIQGEL 720 
Mu3          TVGVADIVVLPDKQQILDEHEKLVDRITKQFNRGLITEEERYNAVVEIWTDAKDQIQGEL 720 
MW2          TVGVADIVVLPDKQQILDEHEKLVDRITKQFNRGLITEEERYNAVVEIWTDAKDQIQGEL 720 
MRSA252      TVGVADIVVLPDKQQILDEHEKLVDRITKQFNRGLITEEERYNAVVEIWTDAKDQIQGEL 720 
             ************************************************************ 
 
JH9          MQSLDKTNPIFMMSDSGARGNASNFTQLAGMRGLMAAPSGKIIELPITSSFREGLTVLEY 780 
USA300       MQSLDKTNPIFMMSDSGARGNASNFTQLAGMRGLMAAPSGKIIELPITSSFREGLTVLEY 780 
8325         MQSLDKTNPIFMMSDSGARGNASNFTQLAGMRGLMAAPSGKIIELPITSSFREGLTVLEY 780 
COL          MQSLDKTNPIFMMSDSGARGNASNFTQLAGMRGLMAAPSGKIIELPITSSFREGLTVLEY 780 
Mu50         MQSLDKTNPIFMMSDSGARGNASNFTQLAGMRGLMAAPSGKIIELPITSSFREGLTVLEY 780 
Mu3          MQSLDKTNPIFMMSDSGARGNASNFTQLAGMRGLMAAPSGKIIELPITSSFREGLTVLEY 780 
MW2          MQSLDKTNPIFMMSDSGARGNASNFTQLAGMRGLMAAPSGKIIELPITSSFREGLTVLEY 780 
MRSA252      MQSLDKTNPIFMMSDSGARGNASNFTQLAGMRGLMAAPSGKIIELPITSSFREGLTVLEY 780 
             ************************************************************ 
 
JH9          FISTHGARKGLADTALKTADSGYLTRRLVDVAQDVIVREEDCGTDRGLLVSDIKEGTEMI 840 
USA300       FISTHGARKGLADTALKTADSGYLTRRLVDVAQDVIVREEDCGTDRGLLVSDIKEGTEMI 840 
8325         FISTHGARKGLADTALKTADSGYLTRRLVDVAQDVIVREEDCGTDRGLLVSDIKEGTEMI 840 
COL          FISTHGARKGLADTALKTADSGYLTRRLVDVAQDVIVREEDCGTDRGLLVSDIKEGTEMI 840 
Mu50         FISTHGARKGLADTALKTADSGYLTRRLVDVAQDVIVREEDCGTDRGLLVSDIKEGTEMI 840 
Mu3          FISTHGARKGLADTALKTADSGYLTRRLVDVAQDVIVREEDCGTDRGLLVSDIKEGTEMI 840 
MW2          FISTHGARKGLADTALKTADSGYLTRRLVDVAQDVIVREEDCGTDRGLLVSDIKEGTEMI 840 
MRSA252      FISTHGARKGLADTALKTADSGYLTRRLVDVAQDVIVREEDCGTDRGLLVSDIKEGTEMI 840 




JH9          EPFIERIEGRYSKKTIRHPETDEIIIRPDELITPEIAKKITDAGIEQMYIRSAFTCNARH 900 
USA300       EPFIERIEGRYSKETIHHPETDEIIIRPDELITPEIAKKITDAGIEQMYIRSAFTCNARH 900 
8325         EPFIERIEGRYSKETIRHPETDEIIIRPDELITPEIAKKITDAGIEQMYIRSAFTCNARH 900 
COL          EPFIERIEGRYSKETIRHPETDEIIIRPDELITPEIAKKITDAGIEQMYIRSAFTCNARH 900 
Mu50         EPFIERIEGRYSKETIRHPETDEIIIRPDELITPEIAKKITDAGIEQMYIRSAFTCNARH 900 
Mu3          EPFIERIEGRYSKETIRHPETDEIIIRPDELITPEIAKKITDAGIEQMYIRSAFTCNARH 900 
MW2          EPFIERIEGRYSKETIRHPETDEIIIRPDELITPEIAKKITDAGIEQMYIRSAFTCNARH 900 
MRSA252      EPFIERIEGRYSKETIRHPETDEVIIRPDELITPEIAKKITDAGIEQMYIRSAFTCNARH 900 
             *************:**:******:************************************ 
 
JH9          GVCEKCYGKNLATGEKVEVGEAVGTIAAQSIGEPGTQLTMRTFHTGGVAGSDITQGLPRI 960 
USA300       GVCEKCYGKNLATGEKVEVGEAVGTIAAQSIGEPGTQLTMRTFHTGGVAGSDITQGLPRI 960 
8325         GVCEKCYGKNLATGEKVEVGEAVGTIAAQSIGEPGTQLTMRTFHTGGVAGSDITQGLPRI 960 
COL          GVCEKCYGKNLATGEKVEVGEAVGTIAAQSIGEPGTQLTMRTFHTGGVAGSDITQGLPRI 960 
Mu50         GVCEKCYGKNLATGEKVEVGEAVGTIAAQSIGEPGTQLTMRTFHTGGVAGSDITQGLPRI 960 
Mu3          GVCEKCYGKNLATGEKVEVGEAVGTIAAQSIGEPGTQLTMRTFHTGGVAGSDITQGLPRI 960 
MW2          GVCEKCYGKNLATGEKVEVGEAVGTIAAQSIGEPGTQLTMRTFHTGGVAGSDITQGLPRI 960 
MRSA252      GVCEKCYGKNLATGEKVEVGEAVGTIAAQSIGEPGTQLTMRTFHTGGVAGSDITQGLPRI 960 
             ************************************************************ 
 
JH9          QEIFEARNPKGQAVITEIEGVVEDIKLAKDRQQEIVVKGANETRSYLASGTSRIIVEIGQ 1020 
USA300       QEIFEARNPKGQAVITEIEGVVEDIKLAKDRQQEIVVKGANETRSYLASGTSRIIVEIGQ 1020 
8325         QEIFEARNPKGQAVITEIEGVVEDIKLAKDRQQEIVVKGANETRSYLASGTSRIIVEIGQ 1020 
COL          QEIFEARNPKGQAVITEIEGVVEDIKLAKDRQQEIVVKGANETRSYLASGTSRIIVEIGQ 1020 
Mu50         QEIFEARNPKGQAVITEIEGVVEDIKLAKDRQQEIVVKGANETRSYLASGTSRIIVEIGQ 1020 
Mu3          QEIFEARNPKGQAVITEIEGVVEDIKLAKDRQQEIVVKGANETRSYLASGTSRIIVEIGQ 1020 
MW2          QEIFEARNPKGQAVITEIEGVVEDIKLAKDRQQEIVVKGANETRSYLASGTSRIIVEIGQ 1020 
MRSA252      QEIFEARNPKGQAVITEIEGVVEDIKLAKDRQQEIVVKGANETRSYLASGTSRIIVEIGQ 1020 
             ************************************************************ 
 
JH9          PVQRGEVLTEGSIEPKNYLSVAGLNATESYLLKEVQKVYRMQGVEIDDKHVEVMVRQMLR 1080 
USA300       PVQRGEVLTEGSIEPKNYLSVAGLNATESYLLKEVQKVYRMQGVEIDDKHVEVMVRQMLR 1080 
8325         PVQRGEVLTEGSIEPKNYLSVAGLNATESYLLKEVQKVYRMQGVEIDDKHVEVMVRQMLR 1080 
COL          PVQRGEVLTEGSIEPKNYLSVAGLNATESYLLKEVQKVYRMQGVEIDDKHVEVMVRQMLR 1080 
Mu50         PVQRGEVLTEGSIEPKNYLSVAGLNATESYLLKEVQKVYRMQGVEIDDKHVEVMVRQMLR 1080 
Mu3          PVQRGEVLTEGSIEPKNYLSVAGLNATESYLLKEVQKVYRMQGVEIDDKHVEVMVRQMLR 1080 
MW2          PVQRGEVLTEGSIEPKNYLSVAGLNATESYLLKEVQKVYRMQGVEIDDKHVEVMVRQMLR 1080 
MRSA252      PVQRGEVLTEGSIEPKNYLSVAGLNATESYLLKEVQKVYRMQGVEIDDKHVEVMVRQMLR 1080 




JH9          KVRIIEAGDTKLLPGSLVDIHNFTDANREAFKHRKRPATAKPVLLGITKASLETESFLSA 1140 
USA300       KVRIIEAGDTKLLPGSLVDIHNFTDANREAFKHRKRPATAKPVLLGITKASLETESFLSA 1140 
8325         KVRIIEAGDTKLLPGSLVDIHNFTDANREAFKHRKRPATAKPVLLGITKASLETESFLSA 1140 
COL          KVRIIEAGDTKLLPGSLVDIHNFTDANREAFKHRKRPATAKPVLLGITKASLETESFLSA 1140 
Mu50         KVRIIEAGDTKLLPGSLVDIHNFTDANREAFKHRKRPATAKPVLLGITKASLETESFLSA 1140 
Mu3          KVRIIEAGDTKLLPGSLVDIHNFTDANREAFKHRKRPATAKPVLLGITKASLETESFLSA 1140 
MW2          KVRIIEAGDTKLLPGSLVDIHNFTDANREAFKHRKRPATAKPVLLGITKASLETESFLSA 1140 
MRSA252      KVRIIEAGDTKLLPGSLVDIHNFTDANREAFKHRKRPATAKPVLLGITKASLETESFLSA 1140 
             ************************************************************ 
 
JH9          ASFQETTRVLTDAAIKGKRDDLLGLKENVIIGKLIPAGTGMRRYSDVKYEKTAKPVAEVE 1200 
USA300       ASFQETTRVLTDAAIKGKRDDLLGLKENVIIGKLIPAGTGMRRYSDVKYEKTAKPVAEVE 1200 
8325         ASFQETTRVLTDAAIKGKRDDLLGLKENVIIGKLIPAGTGMRRYSDVKYEKTAKPVAEVE 1200 
COL          ASFQETTRVLTDAAIKGKRDDLLGLKENVIIGKLIPAGTGMRRYSDVKYEKTAKPVAEVE 1200 
Mu50         ASFQETTRVLTDAAIKGKRDDLLGLKENVIIGKLIPAGTGMRRYSDVKYEKTAKPVAEVE 1200 
Mu3          ASFQETTRVLTDAAIKGKRDDLLGLKENVIIGKLIPAGTGMRRYSDVKYEKTAKPVAEVE 1200 
MW2          ASFQETTRVLTDAAIKGKRDDLLGLKENVIIGKLIPAGTGMRRYSDVKYEKTAKPVAEVE 1200 
MRSA252      ASFQETTRVLTDAAIKGKRDDLLGLKENVIIGKLIPAGTGMRRYSDVKYEKTAKPVAEVE 1200 
             ************************************************************ 
 
JH9          SQTEVTE 1207 
USA300       SQTEVTE 1207 
8325         SQTEVTE 1207 
COL          SQTEVTE 1207 
Mu50         SQTEVTE 1207 
Mu3          SQTEVTE 1207 
MW2          SQTEVTE 1207 
MRSA252      SQTEVTE 1207 
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Alignment of rpoB and rpoC amino acid sequences using Clustal Omega tool. The amino acid sequence of rpoB and rpoC from 
Bacillus subtilis, Escherichia coli, and Thermus aquaticus was aligned with S. aureus NCTC8325 (MSSA) strain. Identified amino 
acid substitutions from strains listed in Table 4.3 and Table 4.4 are highlighted in green and yellow, respectively. Asterisks indicate 
fully conserved residues, colons indicate conservative substitutions with strongly similar properties, periods indicate semi 
conservative substitutions with weakly similar properties and gaps indicate not conserved residues.  
rpoB alignment results 
E. coli           ---MVYSYTEKKRIRKDFGKRPQVLDVPYLLSIQLDSFQKFIEQDP----EGQYGLEAAF 53 
T. aquaticus      ------------MEIKRFGRIREVIPLPPLTEIQVESYKKALQADVPPEKRENVGIQAAF 48 
S. aureus         MAGQVVQY-GRHRKRRNYARISEVLELPNLIEIQTKSYEWFLRE----------GLIEMF 49 
B. subtilis       MTGQLVQY-GRHRQRRSYARISEVLELPNLIEIQTSSYQWFLDE----------GLREMF 49 
                                 : :.:  :*: :* * .** .*::  :            *:   * 
 
E. coli           RSVFPIQS---YSGNSELQYVSYRLGEPVFDVQECQIRGVTYSAPLRVKLRLVIYEREAP 110 
T. aquaticus      KETFPIEEGDKGKGGLVLDFLEYRIGDPPFSQDECREKDLTYQAPLYARLQLIHKDT--- 105 
S. aureus         RDISPIED---FTGNLSLEFVDYRLGEPKYDLEESKNRDATYAAPLRVKVRLIIKET--- 103 
B. subtilis       QDISPIED---FTGNLSLEFIDYSLGEPKYPVEESKERDVTYSAPLRVKVRLINKET--- 103 
                  :.  **:.    .*.  *:::.* :*:* :  :*.: :. ** *** .:::*:  :     
 
E. coli           EGTVKDIKEQEVYMGEIPLMTDNGTFVINGTERVIVSQLHRSPGVFFDSDKGKTHSSGKV 170 
T. aquaticus      ----GLIKEDEVFLGHLPLMTEDGSFIINGADRVIVSQIHRSPGVYFTPDP---ARPGRY 158 
S. aureus         ----GEVKEQEVFMGDFPLMTDTGTFVINGAERVIVSQLVRSPSVYFNEKI---DKNGRE 156 
B. subtilis       ----GEVKDQDVFMGDFPIMTDTGTFIINGAERVIVSQLVRSPSVYFSGKV---DKNGKK 156 
                        :*:::*::*.:*:**: *:*:***::******: ***.*:*  .       *:  
 
E. coli           LYNARIIPYRGSWLDFEFDPKDNLFVRIDRRRKLPATIILRALNYTTEQILDLFFEKVIF 230 
T. aquaticus      IASIIPLPKRGPWIDLEVEASGVVTMKVN-KRKFPLVLLLRVLGYDQETLVRELSAY--- 214 
S. aureus         NYDATIIPNRGAWLEYETDAKDVVYVRIDRTRKLPLTVLLRALGFSSDQEIVDLLGD--- 213 
B. subtilis       GFTATVIPNRGAWLEYETDAKDVVYVRIDRTRKLPVTVLLRALGFGSDQEILDLIGE--- 213 
                        :* ** *:: * : .. : ::::  **:* .::**.*.:  :  :  :       
297 
 
E. coli           EIRDNKLQMELVPERLRGETASFDIEANGKVYVEKGRRITARHIRQLEKDDVKLIEVPVE 290 
T. aquaticus      ------------------------------------------------------------ 214 
S. aureus         ------------------------------------------------------------ 213 
B. subtilis       ------------------------------------------------------------ 213 
                                                                               
E. coli           YIAGKVVAKDYIDESTGELICAANMELSLDLLAKLSQSGHKRIETLFTNDLDHGPYISET 350 
T. aquaticus      -----------------------------------------------------GDLVQGL 221 
S. aureus         -----------------------------------------------------NEYLRNT 220 
B. subtilis       -----------------------------------------------------NEYLRNT 220 
                                                                       .  :    
 
E. coli           LRVD-PTNDRLSALVEIYRMMRPGEPPTREAAESLFENLFFSEDRYDLSAVGRMKFNRSL 409 
T. aquaticus      LDEAVLAMRPEEAMVRLFTLLRPGDPPKKDKALAYLFGLLADPKRYDLGEAGRYKAEEKL 281 
S. aureus         LEKDG-TENTEQALLEIYERLRPGEPPTVENAKSLLYSRFFDPKRYDLASVGRYKTNKKL 279 
B. subtilis       LDKDN-TENSDKALLEIYERLRPGEPPTVENAKSLLDSRFFDPKRYDLANVGRYKINKKL 279 
                  *     :    .*::.::  :***:**. : * : : . : . .****. .** * :..* 
 
E. coli           LREEIE--------------GS-------------------------------------- 417 
T. aquaticus      GVGLSG------RTLVRFEDGE-------------------------------------- 297 
S. aureus         HLKHRLFNQKLAEPIVNTETGEIVVEEGTVLDRRKIDEIMDVLESNANSEVFELHGSVID 339 
B. subtilis       HIKNRLFNQRLAETLVDPETGEILAEKGQILDRRTLDKVLPYLENGIGFRKLYPNGGVVE 339 
                                      *.                                       
 
E. coli           ----------------------------------GILSKDDIIDVMKKLIDIRNGKG--E 441 
T. aquaticus      ------------------------------------FKDEVFLPTLRYLFALTAGVPGHE 321 
S. aureus         EPVEIQSIKVYVPNDDEGRT-TTVIGNAFPDSEVKCITPADIIASMSYFFNLLSGIG--Y 396 
B. subtilis       DEVTLQSIKIFAPTDQEGEQVINVIGNAYIEEEIKNITPADIISSISYFFNLLHGVG--D 397 
                                                      :.   ::  :  :: :  *      
 
E. coli           VDDIDHLGNRRIRSVGEMAENQFRVGLVRVERAVKERLSLGDLDTLMPQDMINAKPISAA 501 
T. aquaticus      VDDIDHLGNRRIRTVGELMADQFRVGLARLARGVRERMVMGSPDTLTPAKLVNSRPLEAA 381 
S. aureus         TDDIDHLGNRRLRSVGELLQNQFRIGLSRMERVVRERMSIQDTESITPQQLINIRPVIAS 456 
B. subtilis       TDDIDHLGNRRLRSVGELLQNQFRIGLSRMERVVRERMSIQDTNTITPQQLINIRPVIAS 457 
                  .**********:*:***:  :***:** *: * *:**: : . ::: * .::* :*: *: 
 
E. coli           VKEFFGSSQLSQFMDQNNPLSEITHKRRISALGPGGLTRERAGFEVRDVHPTHYGRVCPI 561 
T. aquaticus      LREFFSRSQLSQFKDETNPLSSLRHKRRISALGPGGLTRERAGFDVRDVHRTHYGRICPV 441 
S. aureus         IKEFFGSSQLSQFMDQANPLAELTHKRRLSALGPGGLTRERAQMEVRDVHYSHYGRMCPI 516 
B. subtilis       IKEFFGSSQLSQFMDQTNPLAELTHKRRLSALGPGGLTRERAGMEVRDVHYSHYGRMCPI 517 
                  ::***. ****** *: ***:.: ****:************* ::***** :****:**: 
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E. coli           ETPEGPNIGLINSLSVYAQTNEYGFLETPYRKVT--DGVVTDEIHYLSAIEEGNYVIAQA 619 
T. aquaticus      ETPEGANIGLITSLAAYARVDALGFIRTPYRRVK--NGVVTEEVVYMTASEEDRYTIAQA 499 
S. aureus         ETPEGPNIGLINSLSSYARVNEFGFIETPYRKVDLDTHAITDQIDYLTADEEDSYVVAQA 576 
B. subtilis       ETPEGPNIGLINSLSSYAKVNRFGFIETPYRRVDPETGKVTGRIDYLTADEEDNYVVAQA 577 
                  ***** *****.**: **:.:  **:.****:*      :* .: *::* **. *.:*** 
 
E. coli           NSNLDEEGHFVEDLVTCRSKGESSLFSRDQVDYMDVSTQQVVSVGASLIPFLEHDDANRA 679 
T. aquaticus      NTPLEGD-RIATDRVVARRRGEPVIVAPEEVEFMDVSPKQVFSLNTNLIPFLEHDDANRA 558 
S. aureus         NSKLDENGRFMDDEVVCRFRGNNTVMAKEKMDYMDVSPKQVVSAATACIPFLENDDSNRA 636 
B. subtilis       NARLDDEGAFIDDSIVARFRGENTVVSRNRVDYMDVSPKQVVSAATACIPFLENDDSNRA 637 
                  *: *: :  :  * :..* :*:  :.: :.:::**** :**.*  :  *****:**:*** 
 
E. coli           LMGANMQRQAVPTLRADKPLVGTGMERAVAVDSGVTAVAKRGGVVQYVDASRIVIKVNED 739 
T. aquaticus      LMGSNMQTQAVPLIRAQAPVVMTGLEERVVRDSLAALYAEEDGEVVKVDGTRIAVRY--- 615 
S. aureus         LMGANMQRQAVPLMNPEAPFVGTGMEHVAARDSGAAITAKHRGRVEHVESNEILVRRLVE 696 
B. subtilis       LMGANMQRQAVPLMQPEAPFVGTGMEYVSGKDSGAAVICKHPGIVERVEAKNVWVRRYEE 697 
                  ***:*** **** :. : *.* **:*     ** .:  .:. * *  *:...: ::     
 
E. coli           -EMYPGEAGIDIYNLTKYTRSNQNTCINQMPCVSLGEPVERGDVLADGPSTDLGELALGQ 798 
T. aquaticus      -----EDGRLVEHPLRRYARSNQGTAFDQRPRVRVGQRVKKGDLLADGPASEEGFLALGQ 670 
S. aureus         ENGVEHEGELDRYPLAKFKRSNSGTCYNQRPIVAVGDVVEYNEILADGPSMELGEMALGR 756 
B. subtilis       VDGQKVKGNLDKYSLLKFVRSNQGTCYNQRPIVSVGDEVVKGEILADGPSMELGELALGR 757 
                        .. :  : * :: ***..*. :* * * :*: *  .::*****: : * :***: 
E. coli           NMRVAFMPWNGYNFEDSILVSERVVQEDRFTTIHIQELACVSRDTKLGPEEITADIPNVG 858 
T. aquaticus      NVLVAIMPFDGYNFEDAIVISEELLKRDFYTSIHIERYEIEARDTKLGPERITRDIPHLS 730 
S. aureus         NVVVGFMTWDGYNYEDAVIMSERLVKDDVYTSIHIEEYESEARDTKLGPEEITRDIPNVS 816 
B. subtilis       NVMVGFMTWDGYNYEDAIIMSERLVKDDVYTSIHIEEYESEARDTKLGPEEITRDIPNVG 817 
                  *: *.:* ::***:**::::**.::: * :*:***:.    :********.** ***::. 
 
E. coli           EAALSKLDESGIVYIGAEVTGGDILVGKVTPKGETQLTPEEKLLRAIFGEKASDVKDSSL 918 
T. aquaticus      EAALRDLDEEGIVRIGAEVKPGDILVGRTSFKGEQEPSPEERLLRSIFGEKARDVKDTSL 790 
S. aureus         ESALKNLDDRGIVYIGAEVKDGDILVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSL 876 
B. subtilis       EDALRNLDDRGIIRIGAEVKDGDLLVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSL 877 
                  * ** .**: **: *****. **:***:.: **  : : **:**::****** :*:*:** 
 
E. coli           RVPNGVSGTVIDVQVFTRDGVEKDKRALEIEEMQLKQAKKDLSEELQILEAGLFSRIRAV 978 
T. aquaticus      RVPPGEGGIVVGRLRLRRGD---------------------------------------- 810 
S. aureus         RVPHGAGGIVLDVKVFNREE---------------------------------------- 896 
B. subtilis       RVPHGGGGIIHDVKVFNRED---------------------------------------- 897 
                  *** * .* : .   : *                                           
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E. coli           LVAGGVEAEKLDKLPRDRWLELGLTDEEKQNQLEQLAEQYDELKHEFEKKLEAKRRKITQ 1038 
T. aquaticus      -----------------------------------------------------------P 811 
S. aureus         -----------------------------------------------------------G 897 
B. subtilis       -----------------------------------------------------------G 898 
                                                                               
 
E. coli           GDDLAPGVLKIVKVYLAVKRRIQPGDKMAGRHGNKGVISKINPIEDMPYDENGTPVDIVL 1098 
T. aquaticus      GVELKPGVREVVRVFVAQKRKLQVGDKLANRHGNKGVVAKILPVEDMPHLPDGTPVDVIL 871 
S. aureus         DDTLSPGVNQLVRVYIVQKRKIHVGDKMCGRHGNKGVISKIVPEEDMPYLPDGRPIDIML 957 
B. subtilis       D-ELPPGVNQLVRVYIVQKRKISEGDKMAGRHGNKGVISKILPEEDMPYLPDGTPIDIML 957 
                  .  * *** ::*:*::. **::  ***:..*******::** * ****:  :* *:*::* 
 
E. coli           NPLGVPSRMNIGQILETHLGMAAKGIGDKINAMLKQQQEVAKLREFIQRAYDLGADVRQK 1158 
T. aquaticus      NPLGVPSRMNLGQILETHLGLAGYFLGQRYISPVFDGATEPEIKELLAEAFNLYFGKRQG 931 
S. aureus         NPLGVPSRMNIGQVLELHLGMAAKNLGIHVASPVFDGANDDDVWSTIEEA---------- 1007 
B. subtilis       NPLGVPSRMNIGQVLELHMGMAARYLGIHIASPVFDGAREEDVWETLEEA---------- 1007 
                  **********:**:** *:*:*.  :* :  : : :     .: . : .*           
E. coli           VDLSTFS-DEEVMRLAENLRKGMPIATPVFDGAKEAEIKELLKLGDLPTSGQIRLYDGRT 1217 
T. aquaticus      EGFGVDKREKEVLARAEKLGLVSP------------GKSPEEQLKELFDLGKVVLYDGRT 979 
S. aureus         ---------------------------------------------GMARDGKTVLYDGRT 1022 
B. subtilis       ---------------------------------------------GMSRDAKTVLYDGRT 1022 
                                                                :   .:  ****** 
 
E. coli           GEQFERPVTVGYMYMLKLNHLVDDKMHARSTGSYSLVTQQPLGGKAQFGGQRFGEMEVWA 1277 
T. aquaticus      GEPFEGPIVVGQMFIMKLYHMVEDKMHARSTGPYSLITQQPLGGKAQFGGQRFGEMEVWA 1039 
S. aureus         GEPFDNRISVGVMYMLKLAHMVDDKLHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEVWA 1082 
B. subtilis       GEPFDNRVSVGIMYMIKLAHMVDDKLHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEVWA 1082 
                  ** *:  : ** *:::** *:*:**:****** ***:*********************** 
 
E. coli           LEAYGAAYTLQEMLTVKSDDVNGRTKMYKNIVDGNHQMEPGMPESFNVLLKEIRSLGINI 1337 
T. aquaticus      LEAYGAAHTLQEMLTIKSDDIEGRNAAYQAIIKGEDVPEPSVPESFRVLVKELQALALDV 1099 
S. aureus         LEAYGAAYTLQEILTYKSDDTVGRVKTYEAIVKGENISRPSVPESFRVLMKELQSLGLDV 1142 
B. subtilis       LEAYGAAYTLQEILTVKSDDVVGRVKTYEAIVKGDNVPEPGVPESFKVLIKELQSLGMDV 1142 
                  *******:****:** ****  **   *: *:.*:.  .*.:****.**:**:::*.::: 
 
E. coli           ELEDE---------------------------------------------- 1342 
T. aquaticus      QTLDEKDNPVDIFEGLASKR------------------------------- 1119 
S. aureus         KVMDEQDNEIEMTDVDDDDVVERKVDLQQ--NDAPETQKEVT------D-- 1183 
B. subtilis       KILSGDEEEIEMRDLEDEEDAKQADGLALSGDEEPEETASADVERDVVTKE 1193 
                  :  .                                                
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rpoC alignment results 
 
T. aquaticus      ------------MKKEVRKVRIALASPEKIRSWSYGEVEKPETINYRTLKPERDGLFDER 48 
E. coli           MKDLLKFLKAQTKTEEFDAIKIALASPDMIRSWSFGEVKKPETINYRTFKPERDGLFCAR 60 
S. aureus         ----------LIDVNNFHYMKIGLASPEKIRSWSFGEVKKPETINYRTLKPEKDGLFCER 50 
B. subtilis       ----------MLDVNNFEYMNIGLASPDKIRSWSFGEVKKPETINYRTLKPEKDGLFCER 50 
                                ::.  :.*.****: *****:***:*********:***:****  * 
 
T. aquaticus      IFGPIKDYECACGKYKRQRFEGKVCERCGVEVTRSIVRRYRMGHIELATPAAHIWFVKDV 108 
E. coli           IFGPVKDYECLCGKYKRLKHRGVICEKCGVEVTQTKVRRERMGHIELASPTAHIWFLKSL 120 
S. aureus         IFGPTKDWECSCGKYKRVRYKGMVCDRCGVEVTKSKVRRERMGHIELAAPVSHIWYFKGI 110 
B. subtilis       IFGPTKDWECHCGKYKRVRYKGVVCDRCGVEVTRAKVRRERMGHIELAAPVSHIWYFKGI 110 
                  **** **:** ****** :..* :*::******:: *** ********:*.:***:.*.: 
 
T. aquaticus      PSKIGTLLDLSATELEQVLYFNKYIVLDPKGAVLDGVPVEKRQLLTDEEYRELRYGKQET 168 
E. coli           PSRIGLLLDMPLRDIERVLYFESYVVIEGGMT-----NLERQQILTEEQYLDALEE---- 171 
S. aureus         PSRMGLLLDMSPRALEEVIYFASYVVVDPGPT-----GLEKKTLLSEAEFRDYYDK---- 161 
B. subtilis       PSRMGLVLDMSPRALEEVIYFASYVVTDPANT-----PLEKKQLLSEKEYRAYLDK---- 161 
                  **::* :**:    :*.*:** .*:* :   :      :*:: :*:: ::           
 
T. aquaticus      YPLPAGVDALVKDGEEVVKGQELAPGVVSRMDGVALYRFPRRVRVDYLRKERAALRIPLS 228 
E. coli           ------------------------------------------------------------ 171 
S. aureus         ------------------------------------------------------------ 161 
B. subtilis       ------------------------------------------------------------ 161 
                                                                               
 
T. aquaticus      AWVEKEAYRPGEVLAELSEPYLFRAEESGVVELKDLAEGHLIYLRQEEEVVARYFLPAGM 288 
E. coli           ------------------------------------------------------------ 171 
S. aureus         ------------------------------------------------------------ 161 
B. subtilis       ------------------------------------------------------------ 161 
                                                                               
T. aquaticus      TPLVVEGEIVEVGQPLAEGKGLLRLPRHMTAKEVEAEEEGDSVHLTLFLEWTEPKDYKVA 348 
E. coli           ------------------------------------------------------------ 171 
S. aureus         ------------------------------------------------------------ 161 
B. subtilis       ------------------------------------------------------------ 161 
                                                                             
T. aquaticus      PHMNVIVPEGAKVQAGEKIVAAIDPEEEVIAEAEGVVHLHEPASILVVKARVYPFEDDVE 408 
E. coli           ------------------------------------------------------------ 171 
S. aureus         ------------------------------------------------------------ 161 
B. subtilis       ------------------------------------------------------------ 161 
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T. aquaticus      VTTGDRVAPGDVLADGGKVKSEIYGRVEVDLVRNVVRVVESYDIDARMGAEAIQELLKEL 468 
E. coli           ---------------------------------------FGDEFDAKMGAEAIQALLKSM 192 
S. aureus         ---------------------------------------YPGQFVAKMGAEGIKDLLEEI 182 
B. subtilis       ---------------------------------------YGNKFQASMGAEAIHKLLQDI 182 
                                                            .: * ****.*: **:.: 
T. aquaticus      DLEKLERELLEEMKHPS-RARRAKARKRLEVVRAFLDSGNRPEWMILEAVPVLPPDLRPM 527 
E. coli           DLEQECEQLREELNETNSETKRKKLTKRIKLLEAFVQSGNKPEWMILTVLPVLPPDLRPL 252 
S. aureus         DLDEELKLLRDELESATG-QRLTRAIKRLEVVESFRNSGNKPSWMILDVLPIIPPEIRPM 241 
B. subtilis       DLVKEVDMLKEELKTSQG-QRRTRAIKRLEVLEAFRNSGNKPSWMILDVLPVIPPELRPM 241 
                  ** :    * :*::      :  :  **::::.:* :***:*.**** .:*::**::**: 
 
T. aquaticus      VQVDGGRFATSDLNDLYRRLINRNNRLKKLLAQGAPEIIIRNEKRMLQEAVDAVIDNGRR 587 
E. coli           VPLDGGRFATSDLNDLYRRVINRNNRLKRLLDLAAPDIIVRNEKRMLQEAVDALLDNGRR 312 
S. aureus         VQLDGGRFATSDLNDLYRRVINRNNRLKRLLDLGAPGIIVQNEKRMLQEAVDALIDNGRR 301 
B. subtilis       VQLDGGRFATSDLNDLYRRVINRNNRLKRLLDLGAPSIIVQNEKRMLQEAVDALIDNGRR 301 
                  * :****************:********:**  .** **::************::***** 
 
T.aquaticus      GSPVTNPGSERPLRSLTDILSGKQGRFRQNLLGKRVDYSGRSVIVVGPQLKLHQCGLPKR 647 
E.coli           GRAITGSN-KRPLKSLADMIKGKQGRFRQNLLGKRVDYSGRSVITVGPYLRLHQCGLPKK 371 
S.aureus         GRPVTGPG-NRPLKSLSHMLKGKQGRFRQNLLGKRVDYSGRSVIAVGPSLKMYQCGLPKE 360 
B.subtilis       GRPVTGPG-NRPLKSLSHMLKGKQGRFRQNLLGKRVDYSGRSVIVVGPHLKMYQCGLPKE 360 
                 *  :*. . :***:**:.::.***********************.*** *:::******. 
 
T. aquaticus      MALELFKPFLLKKMEEKAFAPNVKAARRMLERQRDIKDEVWDALEEVIHGKVVLLNRAPT 707 
E. coli           MALELFKPFIYGKLELRGLATTIKAAKKMVERE---EAVVWDILDEVIREHPVLLNRAPT 428 
S. aureus         MALELFKPFVMKELVQREIATNIKNAKSKIERM---DDEVWDVLEEVIREHPVLLNRAPT 417 
B. subtilis       MALELFKPFVMKELVEKGLAHNIKSAKRKIERV---QPEVWDVLESVIKEHPVLLNRAPT 417 
                  *********:  ::  : :* .:* *:  :**    .  *** *:.**: : ******** 
 
T. aquaticus      LHRLGIQAFQPVLVEGQSIQLHPLVCEAFNADFDGDQMAVHVPLSSFAQAEARIQMLSAH 767 
E. coli           LHRLGIQAFEPVLIEGKAIQLHPLVCAAYNADFDGDQMAVHVPLTLEAQLEARALMMSTN 488 
S. aureus         LHRLGIQAFEPTLVEGRAIRLHPLVTTAYNADFDGDQMAVHVPLSKEAQAEARMLMLAAQ 477 
B. subtilis       LHRLGIQAFEPTLVEGRAIRLHPLVCTAYNADFDGDQMAVHVPLSAEAQAEARILMLAAQ 477 
                  *********:*.*:**::*:*****  *:***************:  ** ***  *:::: 
 
T. aquaticus      NLLSPASGEPLAKPSRDIILGLYYITQVRKEKKGAGMAFATPEEALAAYERGEVALNAPI 827 
E. coli           NILSPANGEPIIVPSQDVVLGLYYMTRDCVNAKGEGMVLTGPKEAERLYRSGLASLHARV 548 
S. aureus         NILNPKDGKPVVTPSQDMVLGNYYLTLERKDAVNTGAIFNNTNEVLKAYANGFVHLHTRI 537 
B. subtilis       NILNPKDGKPVVTPSQDMVLGNYYLTLERAGAVGEGMVFKNTDEALLAYQNGYVHLHTRV 537 
                  *:*.* .*:*:  **:*::** **:*       . *  :   .*.   *  * . *:: : 
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T. aquaticus      VVAGRET-----------------SVGRLKFVFANPDEALLAVAHGLLDLQDVVTVRYLG 870 
E. coli           KVRITEYEKDANGELVAKTSLKDTTVGRAILWMIVPKGLPYSIVN--------------- 593 
S. aureus         GVHASSFNNPTFTEE-QNKKILATSVGKIIFNEIIPDSFAYINEPTQENL---------- 586 
B. subtilis       AVAANSLKNVTFTEE-QRSKLLITTVGKLVFNEILPESFPYMNEPTKSNI---------- 586 
                   *   .                  :**:  :    *.                        
T. aquaticus      RRLETSPGRILFARIVGEAVGDEKVAQELIQMDVPQEKNSLKDLVYQAFLRLGMEKTARL 930 
E. coli           ---------------------------------QALGKKAISKMLNTCYRILGLKPTVIF 620 
S. aureus         --ERKTPNRYFIDP-TTLGEGGLKEYFENEELIEPFNKKFLGNIIAEVFNRFSITDTSMM 643 
B. subtilis       --EEKTPDRFFLEK-GA----DVKAVIAQQPINAPFKKGILGKIIAEIFKRFHITETSKM 639 
                                                       *  : .::   :  : :  *  : 
 
T. aquaticus      LDALKYYGFTLSTTSGITIGIDDAVIPEEKQRYLEEADRKLRQIEQAYEMGFLTDRERYD 990 
E. coli           ADQIMYTGFAYAARSGASVGIDDMVIPEKKHEIISEAEAEVAEIQEQFQSGLVTAGERYN 680 
S. aureus         LDRMKDLGFKFSSKAGITVGVADIVVLPDKQQILDEHEKLVDRITKQFNRGLITEEERYN 703 
B. subtilis       LDRMKNLGFKYSTKAGITVGVSDIVVLDDKQEILEEAQSKVDNVMKQFRRGLITEEERYE 699 
                   * :   **  :: :* ::*: * *:  .*:. :.* :  : .: : :. *::*  ***: 
 
T. aquaticus      QVIQLWTETTEKVTQAVFKNFE------------ENYPFNPLYVMAQSGARGNPQQIRQL 1038 
E. coli           KVIDIWAAANDRVSKAMMDNLQTETVINRDGQEEKQVSFNSIYMMADSGARGSAAQIRQL 740 
S. aureus         AVVEIWTDAKDQIQGELMQSLD---------------KTNPIFMMSDSGARGNASNFTQL 748 
B. subtilis       RVISIWSAAKDVIQGKLMKSLD---------------ELNPIYMMSDSGARGNASNFTQL 744 
                   *:.:*: :.: :   ::..::                 * :::*::*****.  :: ** 
 
T. aquaticus      CGMRGLMQKPSGETFEVPVRSSFREGLTVLEYFISSHGARKGGADTALRTADSGYLTRKL 1098 
E. coli           AGMRGLMAKPDGSIIETPITANFREGLNVLQYFISTHGARKGLADTALKTANSGYLTRRL 800 
S. aureus         AGMRGLMAAPSGKIIELPITSSFREGLTVLEYFISTHGARKGLADTALKTADSGYLTRRL 808 
B. subtilis       AGMRGLMANPAGRIIELPIKSSFREGLTVLEYFISTHGARKGLADTALKTADSGYLTRRL 804 
                  .******  * *  :* *: :.*****.**:****:****** *****:**:******:* 
 
T. aquaticus      VDVAHEIVVREADCGTTNYISVP-LFQMDEVTRTLRLRKRSDIESGLYGRVLAREVEALG 1157 
E. coli           VDVAQDLVVTEDDCGTHEGIMMTPVIEGGDVKEPLR--------DRVLGRVTAEDVLKPG 852 
S. aureus         VDVAQDVIVREEDCGTDRGLLVSDIKEGTEMIEPFI--------ERIEGRYSKETIRHPE 860 
B. subtilis       VDVAQDVIIRETDCGTDRGILAKPLKEGTETIERLE--------ERLIGRFARKQVKHPE 856 
                  ****::::: * **** . :    : :  :  . :         . : **   . :     
 
T. aquaticus      RR--LEEGRYLSLEDVHFLIKAAEAGEVREVPVRSPLTCQTRYGVCQKCYGYDLSMARPV 1215 
E. coli           TADILVPRNTLLHEQW---CDLLEENSVDAVKVRSVVSCDTDFGVCAHCYGRDLARGHII 909 
S. aureus         TDEIIIRPDELITPEI---AKKITDAGIEQMYIRSAFTCNARHGVCEKCYGKNLATGEKV 917 
B. subtilis       TGEVLVNENELIDEDK---ALEIVEAGIEEVWIRSAFTCNTPHGVCKRCYGRNLATGSDV 913 
                      :     *   :            :  : :** .:*:: .*** :*** :*: .  : 
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T. aquaticus      SIGEAVGVVAAESIGEPGTQLTMRTFHTGGVAVG-------------------------- 1249 
E. coli           NKGEAIGVIAAQSIGEPGTQLTMRTFHIGGAASRAAAESSIQVKNKGSIKLSNVKSVVNS 969 
S. aureus         EVGEAVGTIAAQSIGEPGTQLTMRTFHTGGVAGS-------------------------- 951 
B. subtilis       EVGEAVGIIAAQSIGEPGTQLTMRTFHTGGVAGD-------------------------- 947 
                  . ***:* :**:*************** **.*                             
 
T. aquaticus      ------------------------------------------------------------ 1249 
E. coli           SGKLVITSRNTELKLIDEFGRTKESYKVPYGAVLAKGDGEQVAGGETVANWDPHTMPVIT 1029 
S. aureus         ------------------------------------------------------------ 951 
B. subtilis       ------------------------------------------------------------ 947 
                                                                               
T. aquaticus      ------------------------------------------------------------ 1249 
E. coli           EVSGFVRFTDMIDGQTITRQTDELTGLSSLVVLDSAERTAGGKDLRPALKIVDAQGNDVL 1089 
S. aureus         ------------------------------------------------------------ 951 
B. subtilis       ------------------------------------------------------------ 947 
                                                                               
 
T. aquaticus      ------------------------------------------TDITQGLPRVIELFEARR 1267 
E. coli           IPGTDMPAQYFLPGKAIVQLEDGVQISSGDTLARIPQESGGTKDITGGLPRVADLFEARR 1149 
S. aureus         -------------------------------------------DITQGLPRIQEIFEARN 968 
B. subtilis       -------------------------------------------DITQGLPRIQELFEARN 964 
                                                             *** ****: ::****. 
 
T. aquaticus      PKAKAVISEIDGVVRIEE---GEDRLSVFVESEGFSKEYKLPKDARLLVKDGDYVEAGQP 1324 
E. coli           PKEPAILAEISGIVSFGKETKGKRRLVITPVDGSDPYEEMIPKWRQLNVFEGERVERGDV 1209 
S. aureus         PKGQAVITEIEGVVEDIKLAKDRQQEIVVK-GANETRSYLASGTSRIIVEIGQPVQRGEV 1027 
B. subtilis       PKGQATITEIDGTVVEINEVRDKQQEIVVQ-GAVETRSYTAPYNSRLKVAEGDKITRGQV 1023 
                  **  * ::**.* *   :   .. :  :   .     .       :: *  *: :  *:  
 
T. aquaticus      LTRGAIDPHQLLEAKGPEAVERYLVDEIQKVYRAQGVKLHDKHIEIVVRQMLKYVEVTDP 1384 
E. coli           ISDGPEAPHDILRLRGVHAVTRYIVNEVQDVYRLQGVKINDKHIEVIVRQMLRKATIVNA 1269 
S. aureus         LTEGSIEPKNYLSVAGLNATESYLLKEVQKVYRMQGVEIDDKHVEVMVRQMLRKVRIIEA 1087 
B. subtilis       LTEGSIDPKELLKVTDLTTVQEYLLHEVQKVYRMQGVEIGDKHVEVMVRQMLRKVRVIDA 1083 
                  :: *   *:: *   .  :.  *::.*:*.*** ***:: ***:*::*****: . : :  
 
T. aquaticus      GDSRLLEGQVLEKWDVEALNERLIAEGKVPVAWKPLLMGVTKSALSTKSWLSAASFQNTT 1444 
E. coli           GSSDFLEGEQVEYSRVKIANRELEANGKVGATYSRDLLGITKASLATESFISAASFQETT 1329 
S. aureus         GDTKLLPGSLVDIHNFTDANREAFKHRKRPATAKPVLLGITKASLETESFLSAASFQETT 1147 
B. subtilis       GDTDVLPGTLLDIHQFTEANKKVLLEGNRPATGRPVLLGITKASLETDSFLSAASFQETT 1143 
                  *.: .* *  ::   .   *..   . :  .:    *:*:**::* *.*::******:** 
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T. aquaticus      HVLTEAAIAGKKDELIGLKENVILGRLIPAGTGSDFVRFTQVVDQRTLKAIEEARKEAVE 1504 
E. coli           RVLTEAAVAGKRDELRGLKENVIVGRLIPAGTGYAYHQDRMRR--RAAGEAPAA--PQVT 1385 
S. aureus         RVLTDAAIKGKRDDLLGLKENVIIGKLIPAGTGMRRYSDVKYE--KTA--KPVA--EVES 1201 
B. subtilis       RVLTDAAIKGKRDELLGLKENVIIGKLVPAGTGMMKYRKVKPV--SNV--QPTD--DMVP 1197 
                  :***:**: **:*:* *******:*:*:*****                            
 
T. aquaticus      AKEKEAPRRPVRREQPGKGL------ 1524 
E. coli           AEDASAS----LAELLNAGLGGSDNE 1407 
S. aureus         QTEVTE-------------------- 1207 




11  Appendix 4 





log2FC pvalue padj WT-2 WT-3 Untrained-1 Untrained-2 Untrained-3 
Q2FZZ6 SAOUHSC_00838 -3.623428912 0 0 6245.149812 6866.132959 517.7732717 486.7565208 547.4800408 
Q2FYN4 lysA -4.46262018 0 0 31469.09985 34143.42962 1436.991899 1420.954613 1418.517704 
A0A0H2WXF8  mecA 11.3123129 0 0 0.85386243 2.530204996 44124.77507 47471.86576 51286.4511 
Q2G253 SAOUHSC_00025 -2.944785809 2.97E-304 1.70E-301 4806.391617 4913.658103 636.3821268 558.8339287 655.3325817 
Q2G035 SAOUHSC_00792 -2.453887271 1.89E-190 8.63E-188 5949.713411 6160.205765 1135.147569 1030.613326 1078.525409 
Q2FVH5 SAOUHSC_02737 -1.35420084 2.50E-139 9.52E-137 4078.046965 4154.596604 1588.294221 1622.209713 1597.244772 
Q2FUQ2 mnmE -1.683908937 4.91E-133 1.60E-130 7946.043772 7903.517007 2361.532719 2505.860012 2464.173767 
O50581 recG -1.578539567 1.25E-129 3.57E-127 4168.556382 4505.451697 1373.125593 1416.274262 1537.669083 
Q2FUQ1 rnpA -2.095289139 1.52E-112 3.87E-110 1090.382323 1027.263229 226.5733259 243.3782604 258.8460981 
Q2G239 SAOUHSC_00708 1.225161765 1.28E-110 2.93E-108 4320.543895 4620.997725 10186.67591 10480.24232 10832.50377 
Q2FXV8 recD2 1.290060324 4.00E-110 8.30E-108 1952.783377 2014.043177 4612.820028 4966.788653 5057.770583 
Q2G2B2 sasG -1.536353721 5.38E-104 1.03E-101 6222.095526 6339.850319 1932.716089 2181.979712 2329.614883 
Q2FXE2 SAOUHSC_01907 -1.638471128 8.04E-103 1.41E-100 1616.36158 1612.583984 528.4176561 497.9893636 509.4748598 
Q2G0K4 SAOUHSC_00556 1.626727783 8.79E-96 1.44E-93 3680.147072 3468.067648 11142.38957 12168.91302 10194.63303 
Q2FZD0 uvrC -1.47372536 3.00E-94 4.58E-92 3590.491517 3472.284657 1212.699513 1296.457272 1273.687149 
Q2FY54 SAOUHSC_01611 1.091921878 1.96E-91 2.79E-89 2787.006971 2890.337508 6001.912197 6025.484086 6195.871681 
Q2FUQ3 mnmG -1.266946107 4.75E-91 6.39E-89 11567.27434 11077.23747 4497.252426 4757.108921 4780.435478 
Q2FXM1 SAOUHSC_01814 -1.345423901 3.77E-84 4.79E-82 4034.499981 3547.347405 1539.634178 1469.630265 1426.735041 
Q2G2K5 ureC 1.724339142 1.26E-81 1.51E-79 373.1378818 430.1348494 1402.777806 1318.922957 1324.018335 
Q2FUY3 SAOUHSC_02962 -1.688404134 2.99E-81 3.42E-79 1523.290575 1591.498943 432.6181961 463.354765 535.1540362 
Q2G243 radA -1.189714674 7.99E-80 8.70E-78 5317.00135 5319.334304 2132.678454 2357.960915 2471.363937 
Q2G170 SAOUHSC_00284 -1.748696713 9.77E-73 1.02E-70 2678.566442 2596.833728 773.9988114 675.8427078 857.6844917 
Q2FYZ0 SAOUHSC_01282 -1.559871213 1.32E-72 1.25E-70 2955.21787 2584.182703 859.1538869 916.4127575 1005.596548 
Q2FW95 SAOUHSC_02404 -1.282952149 1.30E-72 1.25E-70 1876.789621 1993.801537 761.8338006 799.4039784 809.4076401 
Q2G204 SAOUHSC_00942 -1.264027314 4.40E-72 4.02E-70 2635.873321 2713.223158 1075.843142 1103.626804 1138.101098 
Q2FY14 SAOUHSC_01660 1.309698377 8.36E-72 7.35E-70 872.6474033 854.3658871 2061.969329 2223.166802 2197.110333 
Q2G0Y8 SAOUHSC_00373 1.306298154 4.83E-70 4.09E-68 2394.230253 2741.055413 6036.12629 6543.130924 6643.716518 
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Q2FXQ3 SAOUHSC_01782 -1.379629519 7.15E-70 5.84E-68 4074.631515 4086.281069 1512.262904 1585.702974 1561.293925 
Q2FY61 SAOUHSC_01604 -1.651828042 2.06E-68 1.63E-66 1425.950258 1432.93943 489.6416842 436.2087283 409.8396553 
Q2G0Q8 SAOUHSC_00488 -1.26093476 2.93E-67 2.23E-65 13972.6048 13396.59205 5291.779693 5535.919354 6169.165338 
Q9F1K0 dnaE 1.001370651 1.95E-64 1.44E-62 2456.562211 2430.6836 4682.76884 4907.816228 5154.324287 
Q2FZ77 pyrR 2.029834725 6.35E-63 4.53E-61 485.8477226 462.1841127 2085.539037 1933.9211 1997.839924 
Q2G0Q7 SAOUHSC_00489 -1.54649048 2.83E-59 1.90E-57 1351.664226 1389.925945 397.6437901 497.9893636 493.0401869 
Q2FYF4 SAOUHSC_01497 -1.169539583 6.42E-58 4.20E-56 3107.205382 3208.299935 1294.053023 1458.397422 1431.870876 
P0A084 msrA1 -1.335988811 1.81E-55 1.12E-53 1094.651635 1097.265567 409.8088009 414.6791129 465.3066763 
Q2G0B2 SAOUHSC_00693 1.116438245 9.64E-55 5.65E-53 754.8143879 783.5201472 1639.235204 1737.346351 1660.929129 
Q2FWX1 SAOUHSC_02150 -1.684985359 1.07E-53 6.12E-52 6010.337643 5147.280364 1624.02894 1725.177438 1725.640654 
Q2FUX4 SAOUHSC_02971 -1.749715633 3.17E-53 1.77E-51 810.3154459 820.6298205 275.2333691 207.8075916 219.81375 
Q2G0Y6 guaA 1.134068581 6.12E-53 3.33E-51 7126.335839 7644.592696 14582.04637 16863.30524 17561.47516 
Q2G2J9 SAOUHSC_01412 1.172508124 1.24E-51 6.45E-50 784.699573 809.6655989 1735.034664 1874.948675 1836.574696 
Q2FZD3 mutS2 1.172240604 1.41E-51 7.16E-50 1757.248881 1831.868417 3698.163279 4284.393454 4269.933452 
Q2G0E5 SAOUHSC_00661 1.338498674 3.44E-51 1.67E-49 426.0773525 432.6650544 1119.941306 1090.521821 1088.797079 
Q2G105 SAOUHSC_00356 -1.645860951 2.58E-45 1.18E-43 8865.653609 6895.652017 2881.58693 2295.24421 2160.132319 
Q2FYM1 odhA -1.056396989 5.06E-45 2.23E-43 3850.919558 4211.104516 1877.97354 1829.081234 2069.741618 
Q2FVI5 SAOUHSC_02725 1.100804124 9.54E-45 4.04E-43 1096.35936 1122.567617 2394.986499 2342.047721 2462.119433 
Q2FZE9 isdA -1.534673475 8.83E-44 3.67E-42 1774.326129 1908.617969 574.7967597 614.0620724 675.8759228 
Q2FZZ4 SAOUHSC_00840 -2.173204239 5.82E-43 2.38E-41 363.7453951 398.9289878 88.95664139 76.75775905 67.79302569 
Q2FY74 xerD -1.048061278 7.75E-43 3.11E-41 2514.624856 2205.495355 1062.917818 1148.558175 1191.513785 
Q2FVM0 SAOUHSC_02682 3.131994355 4.27E-42 1.68E-40 140.0334385 85.18356821 1368.563714 743.2397645 1520.207243 
Q2FZD7 rnhC -1.123040723 2.42E-40 9.08E-39 1540.367823 1603.306566 660.7121484 754.4726073 732.3701109 
Q2FXL6 SAOUHSC_01819 -1.496603269 1.83E-38 6.44E-37 2368.61438 2390.20032 762.5941138 780.6825738 925.4775174 
Q2G0Z4 SAOUHSC_00367 -1.183738008 2.52E-38 8.74E-37 2355.806444 2507.433151 970.9199235 1028.741185 1177.133446 
Q2FXN6 SAOUHSC_01800 -1.078018085 1.83E-37 5.96E-36 1301.286343 1247.391063 573.2761334 613.1260022 609.1100642 
Q2G261 sodM -1.281736931 4.53E-37 1.46E-35 1533.536924 1490.290743 532.9795351 621.5506343 686.1475934 
Q2FXH7 SAOUHSC_01870 1.032378582 5.31E-36 1.69E-34 1094.651635 1196.786963 2531.84287 2230.655364 2325.506215 
Q2G200 SAOUHSC_00941 -1.543379026 5.87E-36 1.84E-34 685.6515311 616.5266175 193.1195463 230.2732772 229.0582535 
Q2FVV1 SAOUHSC_02590 1.024688605 1.18E-35 3.64E-34 1408.873009 1330.044426 2880.826617 2776.384309 2769.242383 
Q2G0D7 SAOUHSC_00668 1.174335722 2.54E-35 7.65E-34 1320.925179 1260.88549 3320.287632 2908.370212 2621.330327 
Q2FZQ1 SAOUHSC_00949 -1.266113252 4.02E-35 1.19E-33 592.5805263 607.2491991 246.3414685 232.1454176 257.818931 
Q2G1S4 SAOUHSC_00018 1.123199184 4.17E-35 1.22E-33 3422.280619 3689.882286 7101.325047 8097.94358 8320.053153 
Q2G252 rlmH -1.693180269 2.27E-34 6.32E-33 526.8331192 474.8351377 130.0135528 161.9401502 155.1022254 
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Q2FZU7 SAOUHSC_00893 -1.030289243 1.97E-33 5.23E-32 2278.958825 2310.077162 1067.479697 1150.430316 1120.639258 
Q2G155 lip2 -1.711560406 3.36E-33 8.82E-32 3990.099134 4002.784304 1091.049405 1100.818593 1311.69233 
Q2G0Y9 xpt 1.087222027 4.09E-33 1.06E-31 660.0356582 641.8286674 1320.663984 1445.292439 1431.870876 
Q2G0U0 SAOUHSC_00437 1.43171561 4.62E-33 1.19E-31 461.0857121 492.5465726 1310.019599 1189.745265 1454.468551 
P72360 scdA -1.496969614 1.64E-32 4.18E-31 829.9542818 705.0837923 269.9111769 223.7207855 297.8784462 
Q2FVM2 SAOUHSC_02680 3.076035689 1.12E-31 2.76E-30 114.4175656 54.82110826 1107.776295 554.1535776 1119.612091 
Q2FZ76 SAOUHSC_01165 1.520197927 2.55E-30 6.02E-29 292.8748134 343.2644779 859.9142001 1015.636202 958.3468632 
Q2G145 SAOUHSC_00310 -1.309955138 3.93E-30 9.18E-29 574.6494153 547.3676809 211.3670624 221.8486451 232.1397546 
Q2FVB4 SAOUHSC_02820 -2.64869542 1.19E-29 2.66E-28 400.4614796 457.9671044 42.57753776 66.4609865 55.46702102 
Q2G0M2 SAOUHSC_00538 -1.07999562 1.44E-28 3.11E-27 998.1651804 1034.853844 414.37068 492.3729422 522.8280315 
Q2FY13 SAOUHSC_01661 1.368880801 3.62E-28 7.52E-27 293.7286759 361.8193145 856.1126342 915.4766873 843.3041529 
Q2G249 SAOUHSC_00026 -1.526805438 1.15E-27 2.32E-26 619.0502616 517.8486226 204.5242439 182.5336953 180.7814018 
Q2G2J3 SAOUHSC_02573 1.010098907 1.43E-27 2.87E-26 1045.981477 1093.89196 1963.888929 2384.170882 2201.219001 
Q2FVN5 SAOUHSC_02667 1.006979382 7.16E-27 1.38E-25 5818.218597 5826.218705 12558.0927 11424.73719 11510.43403 
Q2G272 ureD 1.193245969 9.31E-27 1.77E-25 247.6201046 242.8996797 598.3664681 558.8339287 555.6973773 
Q2G012 emp -1.774172394 1.04E-25 1.89E-24 339.8372471 388.8081678 114.8072893 99.22344463 82.17336448 
Q9RQP9 icaA -2.080887154 1.88E-25 3.36E-24 890.5785143 916.7776104 142.9388768 250.8668223 173.5912325 
Q2FVQ4 SAOUHSC_02648 1.853909774 2.46E-25 4.36E-24 913.6327999 718.578219 3530.894381 2070.587354 3848.794959 
Q2FVL8 SAOUHSC_02684 2.884563077 2.89E-25 5.08E-24 233.1044433 150.9688981 2032.317115 1169.15172 2443.630426 
Q2G2K7 ureF 1.295798145 4.13E-25 7.15E-24 197.2422213 178.8011531 491.9226237 457.7383436 469.4153446 
Q2G016 SAOUHSC_00811 -1.958211422 1.88E-24 3.12E-23 1045.981477 1057.625689 242.5399026 258.3553841 235.2212558 
Q2FVM7 nreC 1.30902281 3.80E-24 6.16E-23 342.3988343 298.5641896 824.1794809 703.9248147 918.287348 
Q2FVM6 nreB 1.121107656 4.99E-24 7.98E-23 624.1734362 593.7547725 1377.687472 1211.274881 1447.278382 
Q2G1D7 pflA 3.159311443 1.43E-23 2.24E-22 134.0564015 74.21934656 1361.720895 869.6092459 2208.40917 
Q2FYZ3 SAOUHSC_01279 -1.065658677 2.73E-23 4.19E-22 543.0565054 583.6339525 278.2746218 251.8028925 263.9819334 
Q2FY36 SAOUHSC_01630 -1.107241705 4.15E-23 6.25E-22 1060.497138 1037.384049 434.1388225 491.436872 512.5563609 
Q2FXQ4 SAOUHSC_01781 -1.027282007 9.86E-23 1.44E-21 3578.537443 4163.030621 1925.87327 1805.679478 1892.041717 
Q2FZ71 pyrF 1.183951733 7.24E-22 1.00E-20 263.8434908 261.4545163 627.2583687 571.938912 628.6262382 
Q2FVA4 SAOUHSC_02829 -1.130611849 1.37E-20 1.83E-19 2329.336708 2380.0795 977.7627421 1136.389262 1043.601729 
Q2FZL3 sspB -1.191183294 1.97E-20 2.56E-19 480.724548 528.8128443 206.8051834 203.1272404 238.302757 
Q2G172 SAOUHSC_00281 2.208576486 2.43E-20 3.14E-19 132.3486766 99.52139653 681.2406041 381.9166548 813.5163083 
Q2G1N4 SAOUHSC_00074 -1.592408565 2.84E-20 3.65E-19 1619.777029 1950.788052 534.5001615 620.6145641 514.610695 
Q2G2P5 SAOUHSC_00201 1.259550498 7.70E-20 9.67E-19 297.997988 253.0204996 697.9674939 586.9160357 753.9406191 
Q2FYV0 SAOUHSC_01324 -1.184197327 3.22E-19 3.84E-18 669.428145 573.5131325 263.0683583 249.930752 286.5796086 
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P02976 spa -2.206365432 3.78E-19 4.47E-18 13696.80724 17790.71473 1646.078022 2958.918004 3718.344743 
Q2FVB3 SAOUHSC_02821 -2.094121925 4.93E-19 5.76E-18 260.4280411 254.707303 55.50286172 43.99530092 51.3583528 
Q2FYL4 SAOUHSC_01425 -1.147380651 3.02E-18 3.36E-17 1583.060945 1395.829756 629.5393083 707.6690957 628.6262382 
Q2FVM1 SAOUHSC_02681 2.869014337 4.65E-18 5.08E-17 365.45312 143.3782831 3190.274079 1802.871268 3775.866098 
Q2G278 SAOUHSC_00773 -1.241914917 5.67E-18 6.17E-17 344.9604216 326.3964445 147.5007558 139.4744646 123.2600467 
Q2G185 essB -1.067337922 6.40E-18 6.94E-17 441.4468762 493.3899743 233.4161445 213.424013 206.4605782 
Q2G2H9 mnhG1 1.352513752 1.17E-17 1.25E-16 257.0125914 304.4680012 886.5251612 732.0069217 623.490403 
Q2G1D8 pflB 2.869828742 1.90E-17 2.02E-16 573.7955528 235.3090647 4923.027803 2706.179042 7712.997423 
Q2FZL2 sspA -1.359353928 1.37E-16 1.34E-15 393.6305801 410.7366111 139.8976241 153.5155181 155.1022254 
Q2G1N5 SAOUHSC_00072 -1.376663903 2.29E-16 2.20E-15 565.2569285 651.1060858 199.9623648 228.4011367 241.3842581 
Q2FVL5 SAOUHSC_02696 -1.154446686 4.61E-16 4.32E-15 488.4093098 508.5712043 231.8955181 204.9993809 214.6779147 
Q2FZ75 pyrB 1.033311278 5.38E-16 5.02E-15 337.2756598 323.0228379 658.4312089 732.0069217 679.984591 
Q2FV98 SAOUHSC_02836 1.018268577 5.45E-16 5.07E-15 274.9437024 240.3694747 567.193628 533.5600324 492.0130198 
Q2G057 SAOUHSC_00765 -1.680115575 5.86E-16 5.40E-15 151.9875125 136.6310698 45.61879045 32.76245813 42.11384929 
Q2FVN1 narT 2.394296685 9.85E-16 8.87E-15 490.9708971 251.3336963 3046.574889 1449.97279 3345.483101 
Q2G273 ureG 1.166206736 1.36E-15 1.21E-14 314.2213742 269.0451313 753.4703557 668.3541459 602.9470618 
Q2G0E3 SAOUHSC_00662 1.26244152 3.38E-15 2.90E-14 158.8184119 152.6557015 434.8991357 357.5788288 374.9159754 
Q2FW50 SAOUHSC_02467 1.059870034 4.05E-15 3.44E-14 767.6223244 851.8356821 1589.054534 1746.707054 1851.982202 
Q2FVW5 ureA 1.958186746 4.47E-15 3.78E-14 22.20042317 32.89266495 139.8976241 121.6891302 122.2328797 
Q2FVM3 SAOUHSC_02679 2.629933289 5.87E-15 4.90E-14 18.78497346 15.18122998 208.3258097 99.22344463 217.7594159 
Q2G1V2 SAOUHSC_02685 2.410897885 1.03E-14 8.47E-14 80.2630684 38.79647661 528.4176561 202.1911702 530.0182009 
Q2FV02 SAOUHSC_02942 1.514137087 1.05E-14 8.54E-14 451.6932254 320.4926329 1227.905776 831.2303663 1489.392231 
Q2FV66 SAOUHSC_02871 -1.046417235 1.34E-14 1.08E-13 352.6451835 391.3383728 174.8720301 172.2369228 179.7542348 
Q2G2C4 tarI' -1.038853068 3.51E-14 2.73E-13 413.269416 408.2064061 183.9957882 191.8943976 209.5420794 
Q2G0Q6 SAOUHSC_00490 -1.042525482 4.10E-14 3.17E-13 346.6681465 384.5911595 149.0213821 196.5747488 175.6455666 
Q2FYV4 SAOUHSC_01320 -1.095141998 4.69E-14 3.59E-13 590.8728014 707.6139973 277.5143086 314.5195981 291.7154439 
Q2G1I7 SAOUHSC_00135 -1.018005354 1.75E-13 1.28E-12 722.3676156 590.3811658 301.084017 312.6474576 335.8836273 
Q2G2K8 ureE 1.272856649 3.79E-13 2.67E-12 86.24010541 86.02696988 206.8051834 232.1454176 218.7865829 
Q2G267 SAOUHSC_01181 -1.059828857 4.54E-13 3.18E-12 495.2402093 357.6023062 188.5576672 190.0222572 217.7594159 
Q2FYJ3 tdcB 2.366717501 4.70E-13 3.26E-12 60.62423252 34.57946828 342.9012416 162.8762204 572.1320502 
Q2FZ70 pyrE 1.04914101 8.78E-13 5.94E-12 192.9729091 184.7049647 362.6693841 452.1219222 393.4049824 
Q2G1J7 SAOUHSC_00125 1.079521953 1.15E-12 7.72E-12 168.2108987 177.1143498 370.2725159 366.9395311 391.3506483 
Q2FVW6 SAOUHSC_02557 1.484636128 1.48E-12 9.78E-12 78.55534354 60.72491991 229.6145786 248.9946818 162.2923948 
Q2FYS2 SAOUHSC_01363 -1.213110887 1.80E-12 1.19E-11 345.8142841 344.1078795 144.4595031 152.5794479 128.395882 
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Q2FYV3 SAOUHSC_01321 -1.063325676 1.85E-12 1.21E-11 412.4155536 475.6785393 174.8720301 218.1043641 225.9767523 
Q2G2R8 sspP -1.067633209 2.16E-12 1.40E-11 346.6681465 322.1794362 138.3769977 157.259799 169.4825642 
Q2G1H3 rocD -1.319086594 2.40E-12 1.54E-11 251.8894168 259.767713 79.83288329 101.0955851 108.8797079 
Q2G218 ldh1 2.541663509 4.46E-12 2.79E-11 1461.81248 569.2961242 10493.84243 6274.478768 15855.35068 
Q2G140 mepA 1.142945237 5.80E-12 3.62E-11 85.38624298 91.93078154 217.4495678 201.2551 192.0802395 
Q2G2K6 ureB 1.617649821 6.31E-12 3.93E-11 33.30063476 39.63987828 120.8897947 135.7301837 126.3415479 
Q2FXD2 SAOUHSC_01931 1.300201795 2.15E-11 1.27E-10 347.5220089 339.8908712 1214.220139 818.1253831 683.0660922 
Q2G1H7 SAOUHSC_00146 1.563813363 2.65E-11 1.54E-10 237.3737555 185.5483664 694.9262412 401.5741297 978.8902043 
Q2FVK5 sbi -1.633777724 4.28E-11 2.46E-10 1840.073536 1926.329404 517.7732717 505.4779255 543.3713726 
Q2FZU1 argG 1.111985435 4.74E-11 2.71E-10 192.9729091 227.7184497 425.0150644 411.8709022 581.3765537 
Q2G0D1 sarX 1.544818749 4.94E-11 2.81E-10 160.5261368 134.1008648 560.3508094 451.185852 411.8939894 
Q2FWH6 SAOUHSC_02315 -1.250298147 1.00E-10 5.49E-10 158.8184119 137.4744715 54.74254854 39.31494976 82.17336448 
Q2G0V2 metN1 -1.211419608 1.30E-10 6.97E-10 156.2568247 177.9577514 55.50286172 75.82168882 73.95602803 
Q2FVC4 SAOUHSC_02789 1.025832791 1.44E-10 7.69E-10 116.1252905 113.8592248 239.4986499 226.5289962 262.9547663 
Q2G173 SAOUHSC_00280 1.084494347 2.54E-10 1.32E-09 528.540844 505.1975976 1532.791359 997.8508677 897.7440069 
Q2FV03 SAOUHSC_02941 1.621169787 3.56E-10 1.84E-09 42.69312149 57.35131325 202.2433043 117.008779 213.6507476 
Q2G2A0 SAOUHSC_01694 1.008833581 4.48E-10 2.30E-09 598.5575633 706.7705957 1696.258692 1251.525901 1132.965263 
Q2G1J9 SAOUHSC_00123 1.106075705 9.15E-10 4.60E-09 93.07100485 83.49676488 208.3258097 189.0861869 199.2704089 
Q2G1H4 argC -1.038352266 1.01E-09 5.08E-09 215.1733323 247.9600897 103.4025917 117.9448493 103.7438727 
Q2G0G1 adh 1.971970217 2.04E-09 9.95E-09 232.2505809 126.5102498 798.3288329 520.4550492 1676.336635 
Q2G0S6 SAOUHSC_00468 1.021460067 2.15E-09 1.04E-08 470.4781988 407.3630044 761.8338006 1130.772841 886.4451693 
Q2FXE9 SAOUHSC_01900 -1.246695151 2.65E-09 1.28E-08 128.0793645 125.6668482 58.54411442 40.25101999 48.27685163 
Q2FVA8 SAOUHSC_02825 -1.294477213 3.39E-09 1.61E-08 141.7411633 114.7026265 53.2219222 45.86744139 43.14101635 
Q2FUQ8 SAOUHSC_03046 -2.034707586 7.72E-09 3.47E-08 765.0607371 1031.480237 123.9310474 87.99060184 128.395882 
Q2G2Y3 SAOUHSC_01919 1.127033118 1.01E-08 4.47E-08 414.1232785 495.9201793 904.0123642 1127.96463 1127.829427 
Q2FWP0 SAOUHSC_02241 1.196053425 1.24E-08 5.44E-08 97.340317 97.8345932 215.9289415 191.8943976 310.2044509 
Q9RQP7 icaB -1.333223395 2.49E-08 1.05E-07 224.565819 243.7430813 62.34568029 110.4562874 73.95602803 
Q2FVL9 SAOUHSC_02683 2.069681362 2.71E-08 1.14E-07 6.830899438 4.217008327 64.62661981 21.52961534 66.76585864 
Q2FZB8 SAOUHSC_01114 -1.604627824 3.34E-08 1.40E-07 193.8267716 207.4768097 42.57753776 55.22814371 57.52135513 
Q2FYH4 SAOUHSC_01478 1.02871023 3.83E-08 1.59E-07 149.4259252 166.9935298 396.1231638 347.2820562 275.280771 
Q2G1K0 SAOUHSC_00122 1.142068011 4.14E-08 1.71E-07 108.4405286 91.93078154 248.622408 239.6339795 216.7322488 
Q2G0X2 SAOUHSC_00401 -1.738567882 4.97E-08 2.03E-07 134.9102639 88.55717488 25.85064792 18.72140465 23.62484229 
Q2FYJ4 SAOUHSC_01450 1.499322103 6.19E-08 2.50E-07 139.1795761 83.49676488 369.5122027 190.0222572 532.072535 
Q2FZC0 flr -1.348357606 9.48E-08 3.76E-07 96.48645457 104.5818065 42.57753776 34.6345986 24.65200934 
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Q2G1J8 SAOUHSC_00124 1.338694556 1.57E-07 6.10E-07 43.54698392 40.48327994 164.2276456 110.4562874 87.30919976 
Q2FXG0 SAOUHSC_01888 1.063121126 2.74E-07 1.03E-06 59.77037009 55.66450992 130.773866 140.4105349 117.0970444 
Q2FV55 ssaA 1.320590045 3.11E-07 1.16E-06 862.4010541 931.1154387 2691.508637 2892.457018 2131.371641 
Q2FYJ2 ald1 1.835121381 5.89E-07 2.16E-06 84.53238055 32.89266495 323.8934122 147.8990967 582.4037207 
Q2G1N1 SAOUHSC_00077 -1.015653253 1.75E-06 6.11E-06 188.703597 193.9823831 100.361339 87.05453161 78.06469625 
Q2G0Y5 SAOUHSC_00376 -1.068958766 1.84E-06 6.42E-06 82.82465569 104.5818065 50.94098267 35.57066883 35.95084696 
Q2FYJ5 norB 1.123175429 2.15E-06 7.48E-06 105.0250789 94.46098653 253.9446002 146.9630265 307.1229497 
Q2G2V7 SAOUHSC_02008 1.009072825 4.16E-06 1.38E-05 288.6055013 308.6850096 905.5329905 566.3224906 460.1708411 
Q2G1K9 SAOUHSC_00113 1.630297853 4.45E-06 1.47E-05 448.2777756 346.6380845 1208.897947 823.7418045 3701.91007 
Q2FZC2 SAOUHSC_01110 -1.156756762 4.62E-06 1.52E-05 138.3257136 167.8369314 60.06474076 68.33312696 55.46702102 
Q2FWN9 SAOUHSC_02243 1.052572949 5.21E-06 1.70E-05 81.11693083 71.68914157 162.7070193 131.0498325 217.7594159 
Q2G2G0 SAOUHSC_00717 -1.16330717 5.86E-06 1.90E-05 222.0042317 254.707303 86.67570186 92.670953 104.7710397 
Q2FVA0 SAOUHSC_02833 1.010239316 5.91E-06 1.91E-05 58.91650766 84.34016655 193.1195463 152.5794479 120.1785455 
Q2G0V1 SAOUHSC_00424 -1.198137331 7.56E-06 2.40E-05 70.87058167 81.80996155 29.6522138 32.76245813 23.62484229 
Q2FZ03 SAOUHSC_01268 -1.08405247 1.58E-05 4.80E-05 55.50105794 59.03811658 25.09033475 20.59354511 26.70634345 
Q2G1N2 SAOUHSC_00076 -1.159453273 1.85E-05 5.57E-05 96.48645457 95.3043882 42.57753776 32.76245813 35.95084696 
Q2G0G9 SAOUHSC_00599 1.346217571 2.39E-05 7.10E-05 22.20042317 39.63987828 130.773866 101.0955851 72.92886097 
Q2G1N3 sbnA -1.184280884 3.28E-05 9.47E-05 53.79333308 66.62873157 24.33002158 21.52961534 20.54334112 
Q2G192 SAOUHSC_00254 1.26636304 0.000105547 0.000286216 13.66179888 18.55483664 86.67570186 35.57066883 40.05951518 
Q2FXD3 SAOUHSC_01930 1.399919361 0.000144572 0.000384741 4.269312149 4.217008327 139.1373109 14.97712372 15.40750584 
Q2G2Y4 SAOUHSC_01918 1.038319091 0.000226046 0.000580608 394.4844426 428.4480461 903.252051 997.8508677 996.3520443 
Q9EYW6 sspC -1.05296954 0.000584879 0.001419355 44.40084635 52.29090326 15.96657666 25.27389627 16.4346729 
Q2FX92 SAOUHSC_01985 1.144740058 0.001124866 0.002626602 5.977037009 5.903811658 26.6109611 19.65747488 19.51617406 
Q2G0V9 SAOUHSC_00415 1.161513021 0.001186946 0.002760283 12.80793645 21.9284433 114.0469761 51.48386278 23.62484229 
Q2FVB5 SAOUHSC_02819 1.19088968 0.001304336 0.003005757 1.70772486 5.903811658 24.33002158 14.97712372 14.38033878 
Q2FVR2 SAOUHSC_02639 1.113070382 0.002896708 0.006247051 5.123174579 5.903811658 36.49503236 15.91319395 18.48900701 
Q2FVA1 SAOUHSC_02832 1.09163811 0.003439615 0.007246967 6.830899438 8.434016655 56.26317489 35.57066883 17.46183995 
Q2FVE3 SAOUHSC_02771 1.090224987 0.003498775 0.007351286 5.977037009 14.33782831 80.59319647 17.78533441 23.62484229 
Q2G2F9 SAOUHSC_00718 1.070014507 0.00388212 0.008075093 119.5407402 177.1143498 1034.025917 413.7430427 217.7594159 
Q2FUT6 hisZ 1.004580956 0.004697004 0.009621283 9.392486728 10.12081999 24.33002158 24.33782604 31.84217873 
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log2FC pvalue padj WT-2 WT-3 rpoB-1 rpoB-2 rpoB-3 
Q2FYN4 lysA -4.261094316 0 0 31469.09985 34143.42962 1572.360326 1499.619166 1868.739115 
A0A0H2WXF8  mecA 12.43006172 0 0 0.85386243 2.530204996 99804.5093 100391.5559 111770.9285 
Q9F0R1 sarR 1.225228975 0.000000424 0.000109775 93.07100485 122.2932415 362.2803184 268.5295675 200.1661981 
Q2FWA5 SAOUHSC_02393 1.022828012 3.51E-05 3.30E-03 87.94783027 122.2932415 310.2224427 209.2951041 184.5282139 
Q2FZ85 SAOUHSC_01155 1.047793407 4.47E-05 3.85E-03 134.9102639 171.2105381 521.6411623 288.2743887 254.8991429 
Q2G0M0 SAOUHSC_00540 1.038887294 1.39E-04 8.46E-03 115.271428 150.1254965 456.8344191 259.644398 198.6023997 
Q2FZM7 SAOUHSC_00973 1.25679853 4.18E-04 1.59E-02 34.15449719 46.3870916 219.9179645 86.87721303 95.39170378 
Q2G021 SAOUHSC_00806 1.026916533 7.71E-04 2.35E-02 46.96243364 95.3043882 229.4796152 133.2775427 143.8694549 
Q2G1V2 SAOUHSC_02685 -1.039598681 1.45E-03 3.24E-02 80.2630684 38.79647661 19.12330127 15.79585691 34.4035653 










Q2FZZ6 SAOUHSC_00838 -3.453504864 0 0 6245.149812 6866.132959 620.8316527 532.6217821 
Q2FYN4 lysA -4.757998525 0 0 31469.09985 34143.42962 1219.119139 1084.667391 
Q2G253 SAOUHSC_00025 -2.59074903 3.23E-198 2.41E-195 4806.391617 4913.658103 824.5962314 748.3284923 
Q2G035 SAOUHSC_00792 -2.625535169 7.00E-177 3.92E-174 5949.713411 6160.205765 993.6774776 910.875255 
Q2FVH5 SAOUHSC_02737 -1.487545138 1.69E-134 7.58E-132 4078.046965 4154.596604 1420.282468 1497.679291 
O50581 recG -1.600934521 3.93E-109 1.47E-106 4168.556382 4505.451697 1415.947051 1412.827837 
Q2FXV8 recD2 1.37202931 1.91E-105 6.12E-103 1952.783377 2014.043177 5201.632799 5135.046471 
Q2G239 SAOUHSC_00708 1.253284645 2.18E-97 6.11E-95 4320.543895 4620.997725 10656.45393 10778.17936 
Q2FY54 SAOUHSC_01611 1.170542253 1.34E-88 3.34E-86 2787.006971 2890.337508 6513.529853 6328.078371 
Q2G0Y8 SAOUHSC_00373 1.588386696 6.86E-87 1.54E-84 2394.230253 2741.055413 7976.299404 7664.233206 
Q2FUQ2 mnmE -1.467239779 6.17E-85 1.26E-82 7946.043772 7903.517007 2901.260768 2770.451112 
Q2FUQ1 rnpA -1.938137497 6.38E-79 1.19E-76 1090.382323 1027.263229 269.6629106 267.8443511 
Q2FZ64 SAOUHSC_01187 1.016089275 4.74E-74 8.17E-72 4693.681777 4939.803555 9627.226033 9933.754043 
Q2FXE2 SAOUHSC_01907 -1.496659505 6.65E-71 1.06E-68 1616.36158 1612.583984 574.0091537 554.0902224 
Q2FZD0 uvrC -1.371021843 6.03E-68 9.02E-66 3590.491517 3472.284657 1312.764137 1389.314783 
Q2FY61 SAOUHSC_01604 -1.787426108 4.97E-64 6.97E-62 1425.950258 1432.93943 398.8583243 407.9003667 
Q2G105 SAOUHSC_00356 -2.147268139 2.76E-63 3.64E-61 8865.653609 6895.652017 1800.932043 1594.798426 
312 
 
Q2FY14 SAOUHSC_01660 1.328817471 5.51E-63 6.87E-61 872.6474033 854.3658871 2244.011616 2138.665582 
Q2G0Y6 guaA 1.348305018 2.11E-62 2.49E-60 7126.335839 7644.592696 19003.86499 19022.06046 
Q2FZ77 pyrR 2.165753901 3.59E-61 4.03E-59 485.8477226 462.1841127 1960.475372 2501.584454 
Q2G2J9 SAOUHSC_01412 1.377234961 1.41E-60 1.51E-58 784.699573 809.6655989 2056.72162 2137.643275 
Q2G245 SAOUHSC_01854 -1.089395648 1.06E-58 1.08E-56 17124.21103 17155.63328 8001.44482 8008.750558 
Q2FXM1 SAOUHSC_01814 -1.214383483 1.90E-57 1.85E-55 4034.499981 3547.347405 1626.648297 1612.17764 
Q2G077 SAOUHSC_00743 1.00031206 6.19E-57 5.79E-55 4425.568974 4123.390743 8660.428138 8523.993127 
Q2FZD3 mutS2 1.334807145 2.89E-56 2.59E-54 1757.248881 1831.868417 4786.299892 4374.450299 
Q2G0E5 SAOUHSC_00661 1.487292488 2.49E-54 2.15E-52 426.0773525 432.6650544 1261.606222 1185.875753 
Q2FUX4 SAOUHSC_02971 -1.986894618 2.47E-53 2.05E-51 810.3154459 820.6298205 218.5049951 171.7475228 
Q2FZU6 rocD -1.85008255 2.06E-52 1.59E-50 993.0420059 1082.927738 254.0554109 301.5804716 
Q2G2B2 sasG -1.177474092 3.33E-52 2.49E-50 6222.095526 6339.850319 2708.768272 2797.031086 
Q2G170 SAOUHSC_00284 -1.604243615 1.88E-51 1.36E-49 2678.566442 2596.833728 908.7033129 785.1315329 
Q2G0Y7 guaB 1.006213567 1.98E-49 1.39E-47 9050.941756 9956.356661 19270.05957 19130.42497 
Q2FUY3 SAOUHSC_02962 -1.419143129 8.69E-49 5.90E-47 1523.290575 1591.498943 587.0154034 557.1571425 
Q2FXQ3 SAOUHSC_01782 -1.242883022 9.29E-48 5.95E-46 4074.631515 4086.281069 1702.084545 1706.229855 
Q9RQP9 icaA -3.27273042 2.30E-47 1.43E-45 890.5785143 916.7776104 91.04374795 52.13764086 
Q2G2N5 SAOUHSC_01354 1.019888282 5.04E-46 3.05E-44 2909.963161 3175.407271 6051.374447 6371.015251 
Q2G0Y9 xpt 1.364992936 4.46E-44 2.56E-42 660.0356582 641.8286674 1728.097044 1679.649881 
Q2G2J8 SAOUHSC_01413 1.176387549 6.48E-43 3.54E-41 496.0940717 489.172966 1156.689141 1093.868151 
Q2G204 SAOUHSC_00942 -1.057079918 9.24E-43 4.93E-41 2635.873321 2713.223158 1250.334138 1301.396408 
Q2FYZ0 SAOUHSC_01282 -1.271910327 2.83E-41 1.44E-39 2955.21787 2584.182703 1176.632057 1083.645084 
Q2FXL6 SAOUHSC_01819 -1.709113603 3.67E-41 1.83E-39 2368.61438 2390.20032 684.1287346 719.7039052 
Q2FYM1 odhA -1.095023665 3.66E-40 1.78E-38 3850.919558 4211.104516 1927.526207 1809.48283 
Q2G171 SAOUHSC_00282 1.052133641 6.11E-40 2.92E-38 819.7079326 786.8937539 1648.32538 1711.341388 
Q2G0Q7 SAOUHSC_00489 -1.372602437 2.22E-39 1.04E-37 1351.664226 1389.925945 523.7183215 514.2202618 
Q2G019 SAOUHSC_00808 -1.389032025 3.14E-39 1.44E-37 1659.908564 1529.930621 639.0404023 552.0456091 
Q2FWX1 SAOUHSC_02150 -1.548008609 1.83E-38 8.04E-37 6010.337643 5147.280364 1967.412039 1739.965975 
Q2G0B2 SAOUHSC_00693 1.008401952 3.78E-38 1.63E-36 754.8143879 783.5201472 1564.218298 1553.906159 
Q2FYF4 SAOUHSC_01497 -1.025801776 1.12E-37 4.75E-36 3107.205382 3208.299935 1520.864132 1555.950772 
Q2FVI5 SAOUHSC_02725 1.093217677 1.70E-37 7.06E-36 1096.35936 1122.567617 2224.0687 2560.878242 
Q2G1S4 SAOUHSC_00018 1.263054337 3.44E-37 1.38E-35 3422.280619 3689.882286 8843.382717 8496.390846 
P72360 scdA -1.790347684 1.44E-36 5.55E-35 829.9542818 705.0837923 226.3087449 195.2605765 
Q2G2J3 SAOUHSC_02573 1.238102216 1.23E-34 4.59E-33 1045.981477 1093.89196 2604.718275 2525.097508 
313 
 
Q2FZ76 SAOUHSC_01165 1.758507065 1.44E-34 5.31E-33 292.8748134 343.2644779 1004.082477 1253.347994 
Q2G1W4 metK 1.160609343 6.10E-34 2.21E-32 3079.881784 3262.277642 7287.835252 7080.49609 
Q2FZZ4 SAOUHSC_00840 -2.012149212 5.29E-31 1.74E-29 363.7453951 398.9289878 85.84124807 86.89606809 
Q2G2K5 ureC 1.145458229 5.52E-31 1.79E-29 373.1378818 430.1348494 917.374146 885.3175879 
Q2FZ72 carB 1.013754861 2.64E-30 8.01E-29 1684.670574 1803.192761 3460.529505 3653.724087 
Q2FXN6 SAOUHSC_01800 -1.059108242 6.34E-30 1.87E-28 1301.286343 1247.391063 600.8887365 608.2724767 
Q2FZU7 SAOUHSC_00893 -1.052385225 5.19E-29 1.45E-27 2278.958825 2310.077162 1107.265392 1079.555858 
Q2FXM0 SAOUHSC_01815 -1.054783899 1.05E-28 2.88E-27 3352.263899 2929.133984 1508.724966 1478.255464 
Q2G296 fhs -1.000987061 2.48E-26 6.11E-25 6350.17489 6090.203426 3069.474931 3077.143117 
Q2FUS7 SAOUHSC_03024 1.051543601 5.74E-26 1.35E-24 1676.985812 1541.738245 3192.600761 3568.872632 
Q2FZ74 pyrC 1.153052471 1.81E-25 4.06E-24 625.0272986 659.5401024 1409.010385 1499.723905 
Q2G200 SAOUHSC_00941 -1.410113579 2.25E-25 5.00E-24 685.6515311 616.5266175 259.2579108 212.6397902 
Q2FZQ1 SAOUHSC_00949 -1.16994686 4.98E-25 1.10E-23 592.5805263 607.2491991 250.5870777 272.9558845 
Q2FYZ3 SAOUHSC_01279 -1.219381871 4.53E-24 9.49E-23 543.0565054 583.6339525 235.8466614 236.1528439 
Q2G252 rlmH -1.495139155 5.55E-23 1.08E-21 526.8331192 474.8351377 186.4229125 151.3013892 
Q2G145 SAOUHSC_00310 -1.237418403 1.83E-22 3.39E-21 574.6494153 547.3676809 225.4416616 238.1974572 
Q2FZ71 pyrF 1.267720746 1.69E-21 2.96E-20 263.8434908 261.4545163 585.2812368 717.6592918 
Q2FY13 SAOUHSC_01661 1.282096854 2.20E-21 3.82E-20 293.7286759 361.8193145 832.3999812 812.7338133 
Q2FY36 SAOUHSC_01630 -1.133684763 3.57E-20 5.97E-19 1060.497138 1037.384049 473.4274893 461.0603142 
Q2G249 SAOUHSC_00026 -1.411756056 3.90E-20 6.47E-19 619.0502616 517.8486226 187.2899958 221.8405503 
Q2FZ75 pyrB 1.257300079 7.07E-20 1.16E-18 337.2756598 323.0228379 753.4953997 875.094521 
Q2G261 sodM -1.000307091 8.64E-20 1.39E-18 1533.536924 1490.290743 756.0966496 731.9715854 
Q9RQP7 icaB -2.414933108 4.41E-19 6.50E-18 224.565819 243.7430813 35.55041587 28.62458714 
Q2FYI3 SAOUHSC_01464 -1.007963715 5.83E-19 8.54E-18 864.9626414 798.7013772 395.3899911 418.1234335 
Q2FXQ4 SAOUHSC_01781 -1.012822938 9.35E-19 1.36E-17 3578.537443 4163.030621 2011.633288 1757.345189 
Q2G012 emp -1.626979587 1.40E-18 2.03E-17 339.8372471 388.8081678 108.3854142 109.3868151 
Q2FVB4 SAOUHSC_02820 -2.172604357 3.18E-18 4.53E-17 400.4614796 457.9671044 71.10083173 81.78453468 
Q2G1F9 SAOUHSC_00166 -1.221599648 2.28E-17 3.00E-16 433.7621143 415.7970211 185.5558292 165.6136827 
Q2G0P8 ctsR -1.063657246 1.15E-15 1.35E-14 642.1045472 700.866784 323.422076 302.6027783 
Q2G176 SAOUHSC_00271 -1.090160912 1.49E-15 1.73E-14 579.7725898 627.4908391 279.200827 271.9335778 
Q2G185 essB -1.075681991 4.05E-15 4.61E-14 441.4468762 493.3899743 228.0429115 203.43903 
Q2FVL5 SAOUHSC_02696 -1.218218612 8.16E-15 9.06E-14 488.4093098 508.5712043 178.6191626 233.0859238 
Q2G155 lip2 -1.168736258 4.40E-14 4.67E-13 3990.099134 4002.784304 1850.355792 1573.329986 
Q2G278 SAOUHSC_00773 -1.154015353 2.83E-13 2.74E-12 344.9604216 326.3964445 137.8662469 152.3236958 
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Q2G0E3 SAOUHSC_00662 1.240382106 7.95E-13 7.52E-12 158.8184119 152.6557015 435.2758235 337.3612055 
Q2G194 SAOUHSC_00251 -1.238764791 1.09E-12 1.01E-11 1034.027402 1132.688437 466.4908228 402.7888333 
Q2FZ70 pyrE 1.125289581 1.26E-12 1.16E-11 192.9729091 184.7049647 396.2570744 460.0380076 
Q2FZL2 sspA -1.270838963 1.54E-12 1.39E-11 393.6305801 410.7366111 149.13833 165.6136827 
Q2FYV4 SAOUHSC_01320 -1.120417755 2.05E-12 1.81E-11 590.8728014 707.6139973 307.8145764 266.8220444 
Q2G196 SAOUHSC_00249 -1.021205458 2.09E-12 1.84E-11 987.9188313 1009.551794 503.7754053 450.8372474 
Q2FW50 SAOUHSC_02467 1.015420532 4.62E-12 3.95E-11 767.6223244 851.8356821 1642.255796 1727.698295 
Q2G1N4 SAOUHSC_00074 -1.281170271 7.52E-12 6.27E-11 1619.777029 1950.788052 683.2616513 695.1685448 
Q2G267 SAOUHSC_01181 -1.086279549 1.60E-11 1.28E-10 495.2402093 357.6023062 201.1633288 185.0375097 
Q2G057 SAOUHSC_00765 -1.514086714 1.86E-11 1.48E-10 151.9875125 136.6310698 39.01874912 50.09302749 
Q2G177 SAOUHSC_00270 -1.415939789 5.71E-11 4.37E-10 411.5616912 516.1618193 163.011663 149.2567758 
Q2FUQ8 SAOUHSC_03046 -2.264925537 4.73E-10 3.28E-09 765.0607371 1031.480237 62.42999859 77.69530794 
Q2G140 mepA 1.110660541 5.44E-10 3.70E-09 85.38624298 91.93078154 197.6949955 204.4613367 
Q2G016 SAOUHSC_00811 -1.273216951 6.67E-10 4.49E-09 1045.981477 1057.625689 401.4595743 402.7888333 
Q2FVB3 SAOUHSC_02821 -1.503158687 1.54E-09 9.99E-09 260.4280411 254.707303 92.77791458 63.38301437 
Q2FVA8 SAOUHSC_02825 -1.450104798 2.01E-09 1.27E-08 141.7411633 114.7026265 38.15166581 43.95918739 
Q2FZC0 flr -1.625095006 4.75E-09 2.88E-08 96.48645457 104.5818065 23.41124947 26.57997377 
Q2FWH6 SAOUHSC_02315 -1.198305755 1.52E-08 8.43E-08 158.8184119 137.4744715 58.96166534 58.27148096 
Q2G1T5 SAOUHSC_02802 1.534662105 1.78E-08 9.78E-08 939.2486728 944.6098653 3677.300334 2883.927154 
Q2FVF5 SAOUHSC_02759 -1.003310648 1.92E-08 1.05E-07 1784.572478 1561.136483 839.3366477 755.4846391 
Q2G1N1 SAOUHSC_00077 -1.289360876 3.47E-08 1.85E-07 188.703597 193.9823831 73.70208167 64.40532106 
Q2FY63 SAOUHSC_01602 -1.157765709 8.14E-08 4.17E-07 119.5407402 129.0404548 53.75916546 48.04841412 
Q2G2Y3 SAOUHSC_01919 1.114819761 1.55E-07 7.60E-07 414.1232785 495.9201793 987.6078944 1132.715805 
Q2FXE9 SAOUHSC_01900 -1.195360052 1.69E-07 8.22E-07 128.0793645 125.6668482 49.42374889 50.09302749 
Q2G0F7 SAOUHSC_00612 -1.31265463 2.47E-07 1.17E-06 72.57830653 77.59295322 24.27833279 26.57997377 
Q2G0V2 metN1 -1.054838397 2.61E-07 1.23E-06 156.2568247 177.9577514 80.63874818 69.51685448 
Q2G0V1 SAOUHSC_00424 -1.285790568 8.78E-06 3.42E-05 70.87058167 81.80996155 26.01249941 24.5353604 
Q2G1N3 sbnA -1.362346531 9.45E-06 3.66E-05 53.79333308 66.62873157 15.60749965 18.4015203 
Q2G1N2 SAOUHSC_00076 -1.256020785 1.63E-05 6.09E-05 96.48645457 95.3043882 32.08208261 31.69150719 
Q2FZB9 SAOUHSC_01113 -1.264623159 3.53E-05 1.24E-04 127.225502 104.5818065 34.68333255 38.84765397 
Q2FX11 SAOUHSC_02096 -1.043052887 5.88E-05 1.99E-04 140.0334385 110.4856182 43.35416569 64.40532106 
Q2FZZ3 SAOUHSC_00841 -1.444762937 7.12E-05 2.38E-04 22.20042317 35.42286995 5.202499883 1.022306683 
Q2G2Y4 SAOUHSC_01918 1.097670361 2.43E-04 7.55E-04 394.4844426 428.4480461 978.069978 1129.648885 
Q2G056 SAOUHSC_00766 -1.120383887 5.05E-04 1.48E-03 35.00835962 37.95307495 11.27208308 13.28998688 
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Q2FYX7 SAOUHSC_01296 -1.085803355 7.20E-04 2.03E-03 40.1315342 48.9172966 19.0758329 13.28998688 
Q2G021 SAOUHSC_00806 -1.077763888 1.10E-03 2.98E-03 46.96243364 95.3043882 22.54416616 24.5353604 
Q2G0X2 SAOUHSC_00401 -1.031843312 0.001837451 0.004773541 134.9102639 88.55717488 52.02499883 31.69150719 





log2FC pvalue padj WT-2 WT-3 rpoC-1 rpoC-2 rpoC-3 
Q2FYN4 lysA -4.285372238 0 0 31469.09985 34143.42962 1587.841321 1668.537976 1584.775443 
A0A0H2WXF8 mecA 11.90874463 0 0 0.85386243 2.530204996 71586.56075 73360.77192 71785.26207 
Q2FW95 SAOUHSC_02404 1.760041899 1.38E-154 1.02E-151 1876.789621 1993.801537 6464.072182 6831.006237 6505.539375 
Q2G2J8 SAOUHSC_01413 1.645142493 4.19E-97 2.31E-94 496.0940717 489.172966 1528.172962 1588.15013 1563.06619 
Q2G2J9 SAOUHSC_01412 1.529558922 7.79E-87 3.43E-84 784.699573 809.6655989 2169.055332 2437.124211 2378.369234 
Q2FW76 SAOUHSC_02428 1.833562438 2.95E-86 1.08E-83 636.1275102 679.7817424 2538.11518 2274.38784 2344.599285 
Q2FWD4 murA 1.230935612 6.89E-78 2.17E-75 4785.898919 4642.926168 11309.36389 11145.48076 10929.40264 
Q2FXT4 ruvB 1.1311004 3.12E-73 8.58E-71 3176.368239 3393.848302 7184.512364 7482.932062 7021.73716 
Q2G025 SAOUHSC_00802 1.046832758 2.03E-68 4.97E-66 2218.334593 2330.318802 4752.474266 4690.92492 4712.113893 
Q2G082 SAOUHSC_00738 -1.66352746 5.68E-65 1.25E-62 5787.479549 6080.082606 1814.360089 1819.510272 1889.911049 
Q2FXT5 queA 1.197433409 6.42E-65 1.28E-62 2864.708452 3205.76973 6774.568641 7118.245736 7135.107702 
Q2FZF0 isdB 1.94514882 1.92E-63 3.52E-61 239.0814803 243.7430813 988.9477954 902.8927589 967.2678121 
Q2FXT3 ruvA 1.20540113 2.24E-63 3.80E-61 1649.662214 1743.311243 3944.741485 3921.358345 3951.083981 
Q2FXU7 SAOUHSC_01735 1.013125459 4.26E-63 6.69E-61 2249.07364 2116.094779 4408.828719 4377.216252 4485.37281 
Q2G2M9 SAOUHSC_02003 1.071921954 1.90E-61 2.79E-59 2061.223906 2189.470724 4384.519388 4499.758701 4589.094795 
Q2G184 essC -1.229501074 2.30E-60 3.16E-58 1676.985812 1798.132351 703.8656376 767.605896 730.8781723 
Q2FVX0 SAOUHSC_02553 1.731006702 4.65E-56 5.68E-54 467.9166115 531.3430493 1687.288585 1589.130469 1800.6619 
Q2G2J3 SAOUHSC_02573 1.441644853 1.49E-54 1.73E-52 1045.981477 1093.89196 2932.589328 2965.527248 2960.900846 
Q2FX99 SAOUHSC_01978 1.571352137 2.21E-54 2.44E-52 935.8332231 1016.299007 2987.837809 2822.397669 3053.768205 
Q2G188 esaA -1.209520203 5.15E-49 5.15E-47 1508.774913 1659.814478 664.0867319 643.1027686 730.8781723 
Q2FW77 SAOUHSC_02427 1.710986577 2.83E-48 2.71E-46 497.8017966 522.9090326 1837.564451 1581.287753 1733.122003 
Q2FXW4 SAOUHSC_01717 1.124372816 6.39E-46 5.86E-44 2439.484962 2524.301185 5331.478338 5574.210887 5462.289179 
Q2FXT1 obg 1.092834111 1.23E-44 1.08E-42 4987.410452 5284.754836 11397.76146 11108.22785 10588.08494 
Q2FZU7 SAOUHSC_00893 -1.213917779 1.44E-44 1.22E-42 2278.958825 2310.077162 1004.41737 989.1626425 938.322142 
Q2FZM6 SAOUHSC_00974 -2.211454929 2.45E-44 1.99E-42 1061.351 1059.312492 193.3696807 219.5960673 225.5350136 
Q2FXW3 SAOUHSC_01718 1.384905119 9.00E-44 7.07E-42 1200.530576 1201.847373 3013.252109 3076.305622 3478.304701 
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Q2FUX4 SAOUHSC_02971 1.426526812 1.71E-42 1.30E-40 810.3154459 820.6298205 2310.491441 2207.724748 2133.537107 
Q9RQP9 icaA -2.725296204 2.15E-40 1.48E-38 890.5785143 916.7776104 133.7013221 107.8373545 106.134124 
Q2FWH6 SAOUHSC_02315 2.296856528 1.02E-39 6.81E-38 158.8184119 137.4744715 779.0035706 720.5495959 829.7758787 
Q2FXL7 ald2 1.109656038 1.11E-34 6.60E-33 531.1024313 528.8128443 1205.521838 1104.842714 1159.032877 
Q2FXY9 SAOUHSC_01686 1.007363748 6.60E-33 3.72E-31 603.6807379 572.6697309 1228.726199 1129.351203 1222.954565 
Q2FXW5 SAOUHSC_01716 1.063366577 2.36E-32 1.30E-30 3486.320301 3689.882286 7865.17364 7511.36191 7359.436645 
Q2G0N7 SAOUHSC_00523 1.068599814 1.10E-30 5.48E-29 1361.056713 1434.626233 3027.616714 2867.49329 2995.876865 
Q2G190 SAOUHSC_00256 -1.479755104 1.46E-30 7.00E-29 601.1191506 623.2738308 216.5740423 205.8713131 215.8864568 
Q2FYV4 SAOUHSC_01320 -1.612057873 4.94E-27 2.02E-25 590.8728014 707.6139973 196.6845895 207.8319923 202.6196913 
Q2FXR0 SAOUHSC_01775 1.100767 5.47E-27 2.19E-25 759.0837001 812.1958039 1771.266275 1585.209111 1769.30409 
Q2G2L4 SAOUHSC_02814 1.035410352 6.91E-27 2.72E-25 774.4532238 745.5670723 1510.493448 1634.22609 1576.332956 
Q2FUZ6 SAOUHSC_02949 -1.386340316 1.90E-26 7.07E-25 648.9354466 593.7547725 199.9994983 234.3011611 258.0988925 
Q2G2C1 SAOUHSC_01064 -1.119304526 2.32E-26 8.35E-25 11936.14291 13358.63898 5937.001681 5687.930279 5573.247581 
Q2FY23 SAOUHSC_01650 1.026446237 1.79E-25 5.88E-24 582.3341771 519.5354259 1099.444756 1144.056297 1156.620738 
Q2G1F2 azoR -1.960077071 2.10E-25 6.78E-24 252.7432792 213.3806214 49.72363217 52.93833766 59.09740997 
Q2FYM4 SAOUHSC_01411 1.250960054 7.45E-25 2.34E-23 1369.595337 1515.592793 3498.333765 3413.542439 3637.505887 
Q2FXT2 SAOUHSC_01752 1.214281715 1.34E-24 4.09E-23 490.9708971 601.3453875 1373.477217 1265.618406 1238.63347 
Q2FVG2 SAOUHSC_02752 1.127703593 3.02E-24 8.99E-23 1064.76645 996.0573669 2405.518827 2174.393202 2297.562571 
Q2FWN0 SAOUHSC_02258 -1.28309728 6.25E-22 1.66E-20 530.2485689 446.159481 182.3199846 197.0482568 205.0318305 
Q2FWH7 SAOUHSC_02314 1.346166049 2.15E-21 5.20E-20 437.1775641 372.7835361 1075.135424 985.2412842 1114.408302 
Q9RQP7 icaB -2.375703944 5.57E-21 1.32E-19 224.565819 243.7430813 39.77890574 31.37086676 34.97601814 
Q2FV66 SAOUHSC_02871 -1.324196265 6.14E-21 1.42E-19 352.6451835 391.3383728 144.7510181 141.1689004 144.7283509 
Q2FYQ2 SAOUHSC_01383 -1.112660428 1.64E-20 3.58E-19 5951.421136 5988.995227 2703.86062 2716.520993 2699.183745 
Q2FYV3 SAOUHSC_01321 -1.422157787 5.98E-20 1.25E-18 412.4155536 475.6785393 156.9056837 144.1099192 174.8800907 
Q2FY13 SAOUHSC_01661 1.103356594 1.55E-18 2.92E-17 293.7286759 361.8193145 677.3463671 666.6309186 826.15767 
P0A0M9 SAOUHSC_00995 1.340772952 1.95E-18 3.58E-17 144.3027506 205.7900064 437.5679631 448.9955305 488.4581844 
Q2FZM5 SAOUHSC_00975 -1.302267211 3.61E-18 6.51E-17 2453.146761 2245.135234 946.9589504 869.561213 939.5282115 
Q2G2C4 tarI' -1.221737527 4.13E-18 7.39E-17 413.269416 408.2064061 184.5299238 158.815013 168.8497428 
Q2G185 essB -1.086558965 6.78E-18 1.20E-16 441.4468762 493.3899743 228.728708 221.5567465 194.1772042 
Q2FVX1 SAOUHSC_02552 1.156023668 7.35E-18 1.29E-16 222.8580942 249.646893 544.7500147 499.973189 572.8830558 
Q2G0W4 SAOUHSC_00410 -1.082157199 1.37E-17 2.33E-16 418.3925906 457.1237027 171.2702886 212.7336902 223.1228744 
Q2G0L4 sdrD -1.810148938 1.65E-17 2.76E-16 4237.719239 5524.280909 1190.052263 1185.23056 1362.858638 
Q2G1C4 tarJ' -1.096275683 1.98E-17 3.29E-16 570.3801031 619.9002241 282.8722186 285.2788196 246.0381966 
Q2G1U4 SAOUHSC_00936 1.809483812 7.04E-16 1.03E-14 64.03968223 63.25512491 245.303252 266.6523675 229.1532223 
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Q2FZI8 purM -1.200351962 2.44E-15 3.48E-14 255.3048665 234.465663 91.71247711 112.7390524 102.5159153 
Q2G2L5 SAOUHSC_02813 1.098439203 2.72E-15 3.82E-14 291.1670886 243.7430813 553.5897715 585.262733 622.3319091 
Q2FZI9 purF -1.176574689 2.76E-15 3.84E-14 312.5136493 352.5418962 153.5907749 133.3261837 139.9040726 
Q2G1M9 SAOUHSC_00079 1.301868424 4.86E-15 6.64E-14 163.0877241 198.1993914 475.1369296 422.5263617 489.664254 
Q2FXF1 SAOUHSC_01898 1.466991299 8.69E-15 1.16E-13 108.4405286 108.7988148 308.2865194 312.728328 340.1116247 
Q2FYV2 thrB -1.290344738 1.42E-14 1.86E-13 351.7913211 392.1817744 143.6460485 154.8936546 135.0797942 
Q2FZJ0 purL -1.032889139 1.62E-14 2.09E-13 362.8915327 425.0744394 174.5851974 211.7533506 176.0861603 
Q2FVL5 SAOUHSC_02696 1.038965238 1.83E-14 2.36E-13 488.4093098 508.5712043 1012.152157 1032.297584 1079.432284 
Q9ZNI1 lytN 1.458854697 1.14E-13 1.39E-12 60.62423252 75.90614989 192.2647111 219.5960673 188.1468562 
Q2G1I1 SAOUHSC_00142 1.726277886 1.17E-13 1.42E-12 73.43216896 73.3759449 270.7175529 300.964253 253.2746142 
Q2FW41 SAOUHSC_02476 1.220999533 1.94E-13 2.30E-12 146.0104755 152.6557015 327.0710027 347.0402135 408.8575914 
Q2FXX1 SAOUHSC_01709 1.02875406 6.53E-13 7.44E-12 174.1879357 187.2351697 358.0101516 399.9785512 373.8815733 
Q2FXF2 sigS 1.66334419 2.17E-12 2.39E-11 49.52402093 78.43635489 226.5187688 204.8909735 267.7474492 
Q2G1M8 SAOUHSC_00080 1.100119958 2.32E-12 2.54E-11 237.3737555 235.3090647 533.7003186 485.2680952 545.1434552 
Q2G1N1 SAOUHSC_00077 1.39368788 7.33E-12 7.61E-11 188.703597 193.9823831 558.0096499 489.1894535 548.761664 
Q2G0D1 sarX -1.697967725 2.26E-11 2.30E-10 160.5261368 134.1008648 50.82860177 39.21358345 21.70925264 
Q2FXW9 SAOUHSC_01711 1.340561916 6.25E-11 6.09E-10 99.04804186 84.34016655 274.0324617 234.3011611 237.5957095 
P60647 cidA -1.112566908 7.02E-11 6.78E-10 434.6159768 566.7659192 246.4082216 199.9892756 219.5046656 
Q2FXQ8 engB 1.169271028 1.00E-10 9.44E-10 351.7913211 393.8685778 843.0918077 787.2126877 1001.037761 
Q2FXN0 SAOUHSC_01805 1.326612794 8.82E-10 7.49E-09 51.23174579 67.47213324 160.2205925 166.6577297 164.0254644 
Q2G2Q9 SAOUHSC_00274 1.129059861 1.37E-08 1.07E-07 84.53238055 102.8950032 198.8945287 239.202859 205.0318305 
Q2FUQ8 SAOUHSC_03046 -1.992964838 1.58E-08 1.22E-07 765.0607371 1031.480237 121.5466564 106.8570149 126.6373071 
Q2G0Y5 SAOUHSC_00376 1.165070612 1.86E-08 1.42E-07 82.82465569 104.5818065 217.6790119 200.9696152 244.832127 
Q2G074 SAOUHSC_00746 1.064894988 3.14E-08 2.31E-07 440.5930138 407.3630044 1035.356519 800.9374419 943.1464203 
Q2FYH9 SAOUHSC_01468 1.293179822 4.44E-08 3.19E-07 57.2087828 57.35131325 161.3255621 141.1689004 168.8497428 
Q2FWJ9 ilvA 1.010520744 5.47E-08 3.91E-07 89.65555513 80.12315822 163.5355014 190.1858797 180.9104387 
Q2FX92 SAOUHSC_01985 1.89139491 5.78E-08 4.10E-07 5.977037009 5.903811658 28.7292097 41.17426262 56.68527079 
Q2G1N3 sbnA 1.43081482 8.48E-08 5.88E-07 53.79333308 66.62873157 193.3696807 177.4414651 168.8497428 
Q2FZJ1 purQ -1.140245969 1.13E-07 7.65E-07 110.1482534 109.6422165 36.46399692 51.95799807 49.44885324 
Q2G1N2 SAOUHSC_00076 1.366042107 1.24E-07 8.26E-07 96.48645457 95.3043882 312.7063979 237.2421799 265.3353101 
Q2FXN1 SAOUHSC_01804 1.584538155 1.25E-07 8.36E-07 13.66179888 22.77184497 69.61308504 67.64343145 69.95203629 
Q2G225 SAOUHSC_00102 1.048121708 1.45E-07 9.45E-07 72.57830653 86.87037154 181.215015 166.6577297 172.4679515 
Q2FWH9 kdpA 1.436791069 1.57E-07 1.01E-06 28.17746018 23.61524663 78.45284187 90.19124193 78.39452343 
Q2FXG6 SAOUHSC_01881 1.620023839 2.55E-07 1.56E-06 18.78497346 20.24163997 83.97768989 57.84003559 88.04308016 
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Q2FWX7 SAOUHSC_02144 1.18729952 2.72E-07 1.66E-06 46.10857121 48.9172966 89.5025379 130.385165 138.698003 
Q2G1T3 SAOUHSC_00831 -1.114486105 3.41E-07 2.07E-06 105.0250789 114.7026265 48.61866257 47.05630014 44.62457487 
Q2G073 SAOUHSC_00747 1.108721409 4.32E-07 2.61E-06 173.3340732 188.0785714 435.3580239 386.253797 436.597192 
Q2G072 SAOUHSC_00748 1.046006497 1.13E-06 6.44E-06 167.3570362 154.3425048 383.4244525 303.9052717 377.499782 
P02976 spa -1.194768359 1.27E-06 7.14E-06 13696.80724 17790.71473 5986.725313 6267.310975 6011.050843 
Q2FV53 SAOUHSC_02886 1.688275621 1.68E-06 9.23E-06 15.36952374 20.24163997 72.92799385 90.19124193 107.3401936 
Q2G1N0 SAOUHSC_00078 1.118839038 3.39E-06 1.78E-05 104.1712164 120.6064382 322.6511243 234.3011611 235.1835703 
Q2FV70 SAOUHSC_02866 -1.226084732 3.74E-06 1.96E-05 1352.518089 1486.917136 553.5897715 532.3243953 517.4038546 
Q2FYW3 SAOUHSC_01311 1.449857067 8.36E-06 4.18E-05 19.63883589 28.67565663 86.18762909 69.60411062 97.69163689 
Q2FZ79 lspA 1.017031363 1.10E-05 5.39E-05 138.3257136 169.5237348 309.3914891 321.5513843 389.560478 
Q2G218 ldh1 -1.589381221 1.53E-05 7.34E-05 1461.81248 569.2961242 140.3311397 150.9722963 136.2858638 
Q2G187 SAOUHSC_00259 -1.015547573 1.55E-05 7.41E-05 78.55534354 96.14778986 34.25405772 41.17426262 43.41850528 
Q2G180 SAOUHSC_00267 -1.312850941 4.23E-05 1.88E-04 42.69312149 44.70028827 19.88945287 9.803395862 9.64855673 
Q2FXW8 SAOUHSC_01712 1.048049425 6.51E-05 2.79E-04 81.11693083 82.65336322 198.8945287 174.5004463 189.3529258 
Q2G1V2 SAOUHSC_02685 -1.292772755 7.97E-05 3.34E-04 80.2630684 38.79647661 15.46957445 17.64611255 19.29711346 
Q2FXX0 SAOUHSC_01710 1.053973151 1.25E-04 4.97E-04 48.6701585 37.10967328 118.2317476 94.11260028 86.83701057 
Q2FXE5 crcB2 1.354620554 1.28E-04 5.12E-04 6.830899438 5.903811658 22.09939208 23.52815007 36.18208774 
Q2G2A2 SAOUHSC_01044 1.281759833 2.22E-04 8.42E-04 15.36952374 16.86803331 68.50811543 44.11528138 43.41850528 
Q2G183 SAOUHSC_00264 -1.067107739 3.03E-04 1.11E-03 60.62423252 43.85688661 17.67951366 26.46916883 18.09104387 
Q2G192 SAOUHSC_00254 1.182858768 3.16E-04 1.15E-03 13.66179888 18.55483664 51.93357138 47.05630014 54.2731316 
Q2FVM1 SAOUHSC_02681 -1.187784141 3.77E-04 1.35E-03 365.45312 143.3782831 78.45284187 96.07327945 74.77631465 
Q2FXE4 SAOUHSC_01905 1.223754636 4.44E-04 1.57E-03 17.0772486 8.434016655 36.46399692 53.91867724 36.18208774 
Q2FZS5 SAOUHSC_00915 1.141114926 4.79E-04 1.69E-03 16.22338617 16.02463164 50.82860177 55.87935641 30.15173978 
Q2FXE3 SAOUHSC_01906 1.289016844 4.90E-04 1.72E-03 5.123174579 7.590614989 28.7292097 24.50848966 27.7396006 
Q2FZZ3 SAOUHSC_00841 1.129907739 8.37E-04 2.79E-03 22.20042317 35.42286995 55.24848019 83.32886483 92.86735852 
Q2FVV5 SAOUHSC_02586 1.160649581 8.55E-04 2.84E-03 7.684761868 8.434016655 38.67393613 20.58713131 25.32746142 





log2FC pvalue padj Untrained-1 Untrained-2 Untrained-3 rpoB-1 rpoB-2 rpoB-3 
Q2FZZ6 SAOUHSC_00838 3.175099346 0 0 517.7732717 486.7565208 547.4800408 4921.062859 4877.958063 4524.068837 
Q2G253 SAOUHSC_00025 2.604026122 1.55E-281 1.77E-278 636.3821268 558.8339287 655.3325817 3716.294879 3916.385274 3821.923345 
Q2G035 SAOUHSC_00792 2.118571535 1.15E-171 8.75E-169 1135.147569 1030.613326 1078.525409 4926.374887 5062.572141 4317.647445 
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O50581 recG 1.585864987 2.03E-157 1.16E-154 1373.125593 1416.274262 1537.669083 4454.666789 4428.763382 4173.77799 
Q2FVH5 SAOUHSC_02737 1.21664534 3.52E-133 1.61E-130 1588.294221 1622.209713 1597.244772 3729.043747 3825.559096 3651.469317 
Q2FXV8 recD2 -1.209449607 8.80E-118 3.35E-115 4612.820028 4966.788653 5057.770583 2097.188705 2122.568273 2078.288104 
Q2G239 SAOUHSC_00708 -1.122298505 2.04E-114 6.65E-112 10186.67591 10480.24232 10832.50377 4879.629039 4605.479532 4943.166814 
Q2FUQ2 mnmE 1.3250476 1.39E-100 3.96E-98 2361.532719 2505.860012 2464.173767 6433.92847 6416.07963 5615.600136 
Q2FY54 SAOUHSC_01611 -1.025628383 2.37E-98 5.41E-96 6001.912197 6025.484086 6195.871681 3063.977825 2933.093181 2922.739252 
Q2G2B2 sasG 1.341430085 1.35E-96 2.80E-94 1932.716089 2181.979712 2329.614883 5418.268692 5375.527556 5635.929515 
Q2G2K5 ureC -1.630005477 2.83E-87 5.40E-85 1402.777806 1318.922957 1324.018335 437.7111178 433.3988241 417.5341788 
Q2FZD0 uvrC 1.287217894 2.62E-86 4.60E-84 1212.699513 1296.457272 1273.687149 3228.650697 3234.201703 2813.273362 
Q2G0K4 SAOUHSC_00556 -1.370495531 1.23E-84 2.00E-82 11142.38957 12168.91302 10194.63303 4086.012037 4151.348645 4625.715734 
Q2FZ77 pyrR -2.118485496 2.17E-81 3.31E-79 2085.539037 1933.9211 1997.839924 489.7689935 478.8119127 364.3650325 
Q2FXE2 SAOUHSC_01907 1.354986289 8.11E-81 1.16E-78 528.4176561 497.9893636 509.4748598 1384.31453 1330.800945 1244.783544 
Q2FUQ1 rnpA 1.674834809 2.65E-80 3.56E-78 226.5733259 243.3782604 258.8460981 799.9914363 797.6907742 760.0060334 
Q2G0Y8 SAOUHSC_00373 -1.263894043 2.85E-80 3.62E-78 6036.12629 6543.130924 6643.716518 2794.126796 2553.992615 2597.46918 
Q2FY14 SAOUHSC_01660 -1.240357737 2.13E-77 2.56E-75 2061.969329 2223.166802 2197.110333 898.7951595 865.8104071 967.9912236 
Q2FW95 SAOUHSC_02404 1.185330944 7.64E-73 8.73E-71 761.8338006 799.4039784 809.4076401 1881.520363 1848.115259 1681.083304 
Q2G2N5 SAOUHSC_01354 -1.071778313 1.07E-72 1.16E-70 5735.802586 6274.478768 6121.915653 2932.239527 2884.718369 2760.104216 
Q2FY61 SAOUHSC_01604 1.56534475 2.27E-72 2.36E-70 489.6416842 436.2087283 409.8396553 1307.821325 1433.474015 1279.18711 
Q2G105 SAOUHSC_00356 1.878564448 1.37E-71 1.36E-69 2881.58693 2295.24421 2160.132319 9017.698952 9264.27008 9437.52348 
Q2G0Q7 SAOUHSC_00489 1.552884222 1.40E-70 1.33E-68 397.6437901 497.9893636 493.0401869 1324.819815 1415.703676 1382.397806 
Q2FXM1 SAOUHSC_01814 1.120240771 3.03E-70 2.77E-68 1539.634178 1469.630265 1426.735041 3137.283813 3257.895489 3313.688858 
Q2G204 SAOUHSC_00942 1.127894283 2.08E-68 1.83E-66 1075.843142 1103.626804 1138.101098 2457.344213 2566.826749 2250.30593 
Q2FYF4 SAOUHSC_01497 1.146717372 5.52E-67 4.67E-65 1294.053023 1458.397422 1431.870876 2986.422214 3005.161778 3334.018237 
Q2G0Q8 SAOUHSC_00488 1.131366174 7.59E-67 6.20E-65 5291.779693 5535.919354 6169.165338 12864.66972 12589.29796 11986.51491 
Q2G170 SAOUHSC_00284 1.523389658 1.71E-66 1.35E-64 773.9988114 675.8427078 857.6844917 2274.610445 2341.735788 2108.000274 
Q2G2J9 SAOUHSC_01412 -1.22725667 2.00E-66 1.52E-64 1735.034664 1874.948675 1836.574696 745.8087493 764.1245782 800.6647924 
Q2G0B2 SAOUHSC_00693 -1.096595583 2.15E-62 1.58E-60 1639.235204 1737.346351 1660.929129 774.4937012 770.0480246 800.6647924 
A0A0H2WXF8  mecA 1.117748816 1.04E-61 7.43E-60 44124.77507 47471.86576 51286.4511 99804.5093 100391.5559 111770.9285 
Q2G0E5 SAOUHSC_00661 -1.35838354 2.24E-61 1.55E-59 1119.941306 1090.521821 1088.797079 443.023146 417.6029672 409.7151867 
Q2FYZ0 SAOUHSC_01282 1.29487031 3.21E-60 2.10E-58 859.1538869 916.4127575 1005.596548 2198.11724 2371.353019 2314.421665 
Q2G0Y6 guaA -1.076276495 7.30E-59 4.28E-57 14582.04637 16863.30524 17561.47516 7692.879137 7762.676432 7643.84669 
Q2G171 SAOUHSC_00282 -1.099103424 1.62E-58 9.26E-57 1542.675431 1581.958693 1568.484094 759.6200225 712.7880433 700.5816933 
Q2FWX1 SAOUHSC_02150 1.546755526 2.27E-55 1.21E-53 1624.02894 1725.177438 1725.640654 4389.860046 4820.698082 5912.721836 
Q2FVM0 SAOUHSC_02682 -3.333634781 2.19E-54 1.14E-52 1368.563714 743.2397645 1520.207243 96.67891195 91.81341832 106.3382927 
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Q2FXQ3 SAOUHSC_01782 1.102580688 2.65E-54 1.35E-52 1512.262904 1585.702974 1561.293925 3583.494176 3532.348502 2939.941035 
Q2FVI5 SAOUHSC_02725 -1.10743161 3.43E-54 1.70E-52 2394.986499 2342.047721 2462.119433 1103.839445 1085.965163 1130.62626 
Q2FZD3 mutS2 -1.05968358 9.46E-52 4.42E-50 3698.163279 4284.393454 4269.933452 1982.448898 1974.482114 1874.994309 
Q2G1S4 SAOUHSC_00018 -1.220741254 3.32E-50 1.49E-48 7101.325047 8097.94358 8320.053153 3046.979335 3187.801374 3764.062803 
Q2FUY3 SAOUHSC_02962 1.219233024 2.19E-49 9.62E-48 432.6181961 463.354765 535.1540362 1063.468031 1151.123073 1144.700445 
P0A084 msrA1 1.170810018 3.08E-49 1.30E-47 409.8088009 414.6791129 465.3066763 955.1026576 1003.036914 964.8636268 
Q2FVV1 SAOUHSC_02590 -1.093987986 1.90E-48 7.90E-47 2880.826617 2776.384309 2769.242383 1393.876181 1178.765822 1351.121837 
Q2FZT3 SAOUHSC_00907 1.003992852 1.77E-47 6.87E-46 778.5606904 770.3858012 821.7336448 1593.608439 1600.317754 1585.691601 
Q2FUX4 SAOUHSC_02971 1.520160984 1.53E-46 5.63E-45 275.2333691 207.8075916 219.81375 698.0004962 701.9283916 673.9971201 
Q2G2J8 SAOUHSC_01413 -1.056609124 8.23E-46 2.99E-44 957.2342864 992.2344463 977.8630373 462.1464472 450.1819221 487.9051079 
Q2FVM2 SAOUHSC_02680 -3.493925708 5.64E-45 2.02E-43 1107.776295 554.1535776 1119.612091 62.68193192 48.3748118 73.49852586 
Q2FVQ4 SAOUHSC_02648 -2.251737654 1.87E-43 6.27E-42 3530.894381 2070.587354 3848.794959 582.198283 584.4467058 670.8695233 
Q2G0Y9 xpt -1.128873756 5.75E-42 1.88E-40 1320.663984 1445.292439 1431.870876 652.3170543 650.5918567 591.1158037 
Q2G200 SAOUHSC_00941 1.510975019 4.61E-40 1.46E-38 193.1195463 230.2732772 229.0582535 632.1313474 684.1580526 580.1692148 
Q2FVL8 SAOUHSC_02684 -3.396471377 6.99E-39 2.13E-37 2032.317115 1169.15172 2443.630426 104.1157513 123.4051321 156.3798423 
Q2FZE9 isdA 1.303893935 3.95E-38 1.19E-36 574.7967597 614.0620724 675.8759228 1628.667824 1727.67185 1308.89928 
Q2FZD7 rnhC 1.001885656 4.01E-38 1.19E-36 660.7121484 754.4726073 732.3701109 1435.310001 1492.708478 1394.908193 
Q2FZZ4 SAOUHSC_00840 1.92108695 6.38E-38 1.87E-36 88.95664139 76.75775905 67.79302569 321.9089046 330.7257541 293.9941035 
Q2G0Z4 SAOUHSC_00367 1.062919111 2.28E-37 6.36E-36 970.9199235 1028.741185 1177.133446 2346.854027 2323.965449 2007.917175 
Q2FYZ3 SAOUHSC_01279 1.256537942 3.62E-37 9.96E-36 278.2746218 251.8028925 263.9819334 699.0629018 610.1149733 619.2641754 
Q2FXL6 SAOUHSC_01819 1.328559097 8.59E-37 2.28E-35 762.5941138 780.6825738 925.4775174 1887.894797 1930.056267 2505.205073 
Q2G155 lip2 1.607588332 1.36E-35 3.49E-34 1091.049405 1100.818593 1311.69233 3120.285323 3227.291016 4719.543639 
Q2G0U0 SAOUHSC_00437 -1.351464983 1.58E-35 4.02E-34 1310.019599 1189.745265 1454.468551 500.3930498 506.4546623 512.9258826 
Q2G1D7 pflA -3.717894792 3.70E-35 9.10E-34 1361.720895 869.6092459 2208.40917 57.3699038 72.06859717 64.11573533 
Q2G0M2 SAOUHSC_00538 1.102227527 6.35E-35 1.55E-33 414.37068 492.3729422 522.8280315 1010.34775 1005.011396 1082.148508 
Q2FWL3 SAOUHSC_02276 1.119578854 1.99E-34 4.78E-33 487.3607447 489.5647315 462.2251752 1122.962747 1098.799297 935.1514567 
Q2G0M5 SAOUHSC_00535 -1.130641337 2.73E-34 6.49E-33 772.478185 841.5271389 798.1088025 348.4690453 381.0750481 356.5460404 
Q2G019 SAOUHSC_00808 1.043586198 6.18E-34 1.43E-32 885.0045348 852.7599817 762.1579555 1867.70909 1726.684609 1609.148577 
Q2FV87 glcB -1.11251109 8.36E-34 1.91E-32 3259.462578 2711.795463 3232.494725 1291.885241 1309.081642 1618.531367 
Q2G252 rlmH 1.551027499 2.81E-33 6.31E-32 130.0135528 161.9401502 155.1022254 414.3381941 429.4498599 514.489681 
Q2G012 emp 1.878985586 3.91E-33 8.67E-32 114.8072893 99.22344463 82.17336448 365.4675353 337.6364415 472.2671236 
Q2FZ76 SAOUHSC_01165 -1.441244348 1.17E-32 2.58E-31 859.9142001 1015.636202 958.3468632 351.6562622 360.3429859 298.6854987 
Q2G172 SAOUHSC_00281 -2.663825404 2.48E-32 5.39E-31 681.2406041 381.9166548 813.5163083 70.11877131 73.05583823 104.7744943 
Q2FVM1 SAOUHSC_02681 -3.728367515 3.94E-32 8.49E-31 3190.274079 1802.871268 3775.866098 106.2405626 80.95376669 157.9436407 
321 
 
Q2G261 sodM 1.086890499 5.62E-32 1.20E-30 532.9795351 621.5506343 686.1475934 1220.704064 1368.316105 1358.940829 
Q2FZ71 pyrF -1.338754229 2.22E-31 4.53E-30 627.2583687 571.938912 628.6262382 224.1675871 247.7975053 234.5697634 
Q2G145 SAOUHSC_00310 1.23686555 6.08E-31 1.21E-29 211.3670624 221.8486451 232.1397546 553.5133311 572.5998131 459.7567362 
Q2FW52 SAOUHSC_02465 1.138142588 8.77E-31 1.69E-29 288.158693 281.7571399 295.8241121 665.0659218 598.2680806 672.4333217 
P72360 scdA 1.331586342 2.81E-30 5.22E-29 269.9111769 223.7207855 297.8784462 664.0035161 707.851838 664.6143296 
Q2FVB4 SAOUHSC_02820 2.477130486 6.65E-30 1.20E-28 42.57753776 66.4609865 55.46702102 480.2073429 392.9219407 222.059376 
Q2G1V2 SAOUHSC_02685 -3.450496566 8.04E-30 1.44E-28 528.4176561 202.1911702 530.0182009 19.12330127 15.79585691 34.4035653 
Q2FVM6 nreB -1.137894264 2.23E-29 3.93E-28 1377.687472 1211.274881 1447.278382 569.4494154 550.8805099 697.4540965 
Q2FZQ1 SAOUHSC_00949 1.071964062 9.90E-29 1.68E-27 246.3414685 232.1454176 257.818931 545.0140861 519.2887961 500.4154952 
Q2G0B8 SAOUHSC_00687 1.027354097 4.44E-28 7.35E-27 535.2604747 508.2861362 515.6378621 1122.962747 1067.207583 1022.724168 
Q2FVM7 nreC -1.265428831 8.27E-27 1.33E-25 824.1794809 703.9248147 918.287348 334.6577721 316.9043793 345.5994514 
Q2FY36 SAOUHSC_01630 1.087436381 2.14E-26 3.36E-25 434.1388225 491.436872 512.5563609 1132.524397 1019.820012 936.7152551 
Q2G1D8 pflB -3.412373749 3.16E-26 4.91E-25 4923.027803 2706.179042 7712.997423 218.8555589 192.5120061 339.3442577 
Q2G1G0 SAOUHSC_00164 1.074699135 4.26E-26 6.54E-25 306.4062092 285.5014209 300.9599474 606.6336124 618.0129018 689.6351044 
Q2G249 SAOUHSC_00026 1.365903273 6.62E-26 1.00E-24 204.5242439 182.5336953 180.7814018 446.2103629 491.6460465 581.7330132 
Q2FVN1 narT -2.943586271 7.27E-26 1.08E-24 3046.574889 1449.97279 3345.483101 229.4796152 213.2440683 264.2819334 
Q2G016 SAOUHSC_00811 1.797013337 1.57E-24 2.17E-23 242.5399026 258.3553841 235.2212558 1129.33718 1086.952404 545.7656495 
Q2G176 SAOUHSC_00271 1.13633642 5.46E-24 7.39E-23 350.5043733 304.2228255 270.1449357 738.37191 735.4945876 597.3709974 
Q2FV98 SAOUHSC_02836 -1.177414999 1.04E-23 1.38E-22 567.193628 533.5600324 492.0130198 247.5405108 232.0016484 207.9851902 
Q2FY13 SAOUHSC_01661 -1.120420293 2.21E-23 2.89E-22 856.1126342 915.4766873 843.3041529 436.6487122 377.1260838 364.3650325 
Q2G218 ldh1 -3.451150803 6.60E-22 8.03E-21 10493.84243 6274.478768 15855.35068 183.7961733 240.8868179 645.8487485 
Q2G2P5 SAOUHSC_00201 -1.215606027 6.95E-22 8.32E-21 697.9674939 586.9160357 753.9406191 252.8525389 280.3764602 328.3976687 
Q2G0P8 ctsR 1.049643434 6.95E-22 8.32E-21 390.8009716 359.4509692 328.6934579 852.0493119 726.6094181 691.1989028 
Q2G2K7 ureF -1.095792072 6.93E-22 8.32E-21 491.9226237 457.7383436 469.4153446 213.5435308 213.2440683 228.3145697 
Q2FZ75 pyrB -1.127525481 8.90E-22 1.05E-20 658.4312089 732.0069217 679.984591 339.9698003 334.6747184 245.5163524 
Q2G1N4 SAOUHSC_00074 1.497489889 1.58E-21 1.84E-20 534.5001615 620.6145641 514.610695 1892.14442 1940.915918 1118.115872 
Q9RQP9 icaA 1.742102391 2.42E-21 2.79E-20 142.9388768 250.8668223 173.5912325 655.5042711 611.1022144 785.0268082 
Q2G1H7 SAOUHSC_00146 -2.005492563 4.43E-20 4.73E-19 694.9262412 401.5741297 978.8902043 154.0488157 154.996846 142.3056565 
Q2FVL5 SAOUHSC_02696 1.188945365 9.59E-20 1.01E-18 231.8955181 204.9993809 214.6779147 588.5727167 523.2377603 409.7151867 
Q2FYV4 SAOUHSC_01320 1.193637431 2.43E-19 2.50E-18 277.5143086 314.5195981 291.7154439 650.192243 598.2680806 835.0683577 
Q2FVB3 SAOUHSC_02821 1.967058009 3.16E-19 3.21E-18 55.50286172 43.99530092 51.3583528 283.6623021 254.7081927 143.8694549 
Q2FV02 SAOUHSC_02942 -1.583819519 9.87E-19 9.72E-18 1227.905776 831.2303663 1489.392231 327.2209328 329.7385131 453.5015426 
Q2G185 essB 1.006744918 1.97E-18 1.91E-17 233.4161445 213.424013 206.4605782 438.7735235 455.1181273 444.118752 
Q2FYJ3 tdcB -2.723152309 4.51E-18 4.33E-17 342.9012416 162.8762204 572.1320502 28.6849519 27.6427496 48.4777511 
322 
 
Q2G0Q6 SAOUHSC_00490 1.10511917 4.61E-18 4.41E-17 149.0213821 196.5747488 175.6455666 376.0915915 381.0750481 387.8220088 
Q2FYL4 SAOUHSC_01425 1.036906285 5.02E-18 4.78E-17 629.5393083 707.6690957 628.6262382 1497.991932 1545.032254 1057.127734 
Q2FZL3 sspB 1.032609257 5.78E-18 5.44E-17 206.8051834 203.1272404 238.302757 478.0825316 479.7991538 384.694412 
Q2FZU1 argG -1.282363233 2.62E-16 2.17E-15 425.0150644 411.8709022 581.3765537 177.4217395 210.2823452 168.8902296 
Q2G201 SAOUHSC_00940 1.105113574 5.02E-16 4.11E-15 163.4673325 189.0861869 183.862903 431.3366841 395.8836639 351.8546451 
Q2FVW5 ureA -1.884746529 1.05E-15 8.41E-15 139.8976241 121.6891302 122.2328797 28.6849519 26.65550854 35.96736372 
Q2G273 ureG -1.067796229 1.05E-15 8.41E-15 753.4703557 668.3541459 602.9470618 287.9119246 270.5040497 394.0772025 
Q2FZC0 flr 1.858367368 2.26E-15 1.73E-14 42.57753776 34.6345986 24.65200934 168.9224945 103.660311 168.8902296 
Q2FYS2 SAOUHSC_01363 1.256765565 2.38E-15 1.81E-14 144.4595031 152.5794479 128.395882 395.2148928 416.6157261 243.9525539 
Q2FVM3 SAOUHSC_02679 -2.5336764 5.35E-15 4.01E-14 208.3258097 99.22344463 217.7594159 16.99849001 14.80861586 28.14837161 
Q2G0E3 SAOUHSC_00662 -1.127294108 1.57E-14 1.14E-13 434.8991357 357.5788288 374.9159754 167.8600889 170.7927029 181.400617 
Q2FYV3 SAOUHSC_01321 1.065099726 1.79E-14 1.29E-13 174.8720301 218.1043641 225.9767523 428.1494672 395.8836639 506.6706889 
Q2G1N5 SAOUHSC_00072 1.165216166 4.42E-14 3.08E-13 199.9623648 228.4011367 241.3842581 572.6366323 619.0001428 358.1098388 
Q2G057 SAOUHSC_00765 1.488515537 4.54E-14 3.14E-13 45.61879045 32.76245813 42.11384929 145.5495707 128.3413374 95.39170378 
Q2G0D1 sarX -1.634369425 6.35E-14 4.34E-13 560.3508094 451.185852 411.8939894 186.9833901 132.2903017 90.70030851 
Q2G0Y5 SAOUHSC_00376 1.533614925 1.32E-13 8.79E-13 50.94098267 35.57066883 35.95084696 147.674382 138.213748 107.9020912 
P02976 spa 1.671905569 1.72E-13 1.13E-12 1646.078022 2958.918004 3718.344743 10118.35118 9027.332227 11251.52965 
Q2G177 SAOUHSC_00270 1.31517469 1.95E-13 1.27E-12 325.4140386 264.9078758 180.7814018 839.3004444 654.5408209 542.6380526 
Q2FVK5 sbi 1.655001421 4.06E-13 2.59E-12 517.7732717 505.4779255 543.3713726 1518.177639 1403.856783 2736.64724 
Q2FXE9 SAOUHSC_01900 1.414631271 4.55E-13 2.88E-12 58.54411442 40.25101999 48.27685163 162.5480608 147.0989175 115.7210833 
Q2FZL2 sspA 1.072579556 2.39E-12 1.44E-11 139.8976241 153.5155181 155.1022254 379.2788084 346.5216111 242.3887555 
Q2G140 mepA -1.064400596 4.92E-12 2.86E-11 217.4495678 201.2551 192.0802395 96.67891195 92.80065937 93.82790536 
Q2G0G1 adh -2.152283134 5.77E-12 3.32E-11 798.3288329 520.4550492 1676.336635 161.4856551 148.0861586 154.8160438 
Q2FZB8 SAOUHSC_01114 1.851170997 9.94E-12 5.62E-11 42.57753776 55.22814371 57.52135513 165.7352776 140.1882301 420.6617757 
Q2FYJ4 SAOUHSC_01450 -1.764986993 1.18E-11 6.58E-11 369.5122027 190.0222572 532.072535 92.42928945 85.88997197 90.70030851 
Q2G2K8 ureE -1.08513213 1.52E-11 8.40E-11 206.8051834 232.1454176 218.7865829 106.2405626 96.7496236 95.39170378 
Q2FWH6 SAOUHSC_02315 1.207758283 3.07E-11 1.67E-10 54.74254854 39.31494976 82.17336448 151.9240045 132.2903017 146.9970517 
Q2FV03 SAOUHSC_02941 -1.605216526 3.52E-11 1.88E-10 202.2433043 117.008779 213.6507476 49.93306441 44.42584757 60.98813848 
Q2FUQ8 SAOUHSC_03046 2.233828393 4.37E-11 2.31E-10 123.9310474 87.99060184 128.395882 475.9577204 589.3829111 1804.62338 
Q2FVW6 SAOUHSC_02557 -1.256584738 6.91E-11 3.56E-10 229.6145786 248.9946818 162.2923948 73.30598818 95.76238254 82.8813164 
Q2G2W8 SAOUHSC_00456 -1.030366051 1.02E-10 5.19E-10 208.3258097 210.6158023 212.6235806 97.74131758 100.6985878 100.083099 
Q2G0X2 SAOUHSC_00401 1.944107646 1.23E-10 6.19E-10 25.85064792 18.72140465 23.62484229 75.43079943 87.86445409 226.7507713 
Q2FYJ2 ald1 -2.305316732 1.63E-10 8.04E-10 323.8934122 147.8990967 582.4037207 30.80976315 25.66826749 46.91395268 
Q2FVL9 SAOUHSC_02683 -2.379018343 1.68E-10 8.26E-10 64.62661981 21.52961534 66.76585864 4.249622503 3.948964229 1.563798423 
323 
 
Q2G2K6 ureB -1.378486671 2.36E-10 1.15E-09 120.8897947 135.7301837 126.3415479 46.74584754 45.41308863 42.22255741 
Q2FYJ5 norB -1.395928155 3.63E-10 1.73E-09 253.9446002 146.9630265 307.1229497 81.80523319 89.8389362 70.37092902 
Q2G2Y3 SAOUHSC_01919 -1.126042303 3.76E-10 1.79E-09 904.0123642 1127.96463 1127.829427 388.8404591 327.764031 669.3057249 
Q2FWP0 SAOUHSC_02241 -1.174754559 1.62E-09 7.28E-09 215.9289415 191.8943976 310.2044509 89.24207257 93.78790043 118.8486801 
Q2G1H3 rocD 1.054210079 2.16E-09 9.64E-09 79.83288329 101.0955851 108.8797079 237.9788602 234.9633716 148.5608501 
Q2G0V2 metN1 1.060066376 2.45E-09 1.09E-08 55.50286172 75.82168882 73.95602803 148.7367876 160.9202923 134.4866643 
Q2G2G0 SAOUHSC_00717 1.405479612 3.46E-09 1.52E-08 86.67570186 92.670953 104.7710397 199.7322577 197.4482114 464.4481315 
Q2G017 SAOUHSC_00810 1.342014122 3.45E-09 1.52E-08 48.66004315 40.25101999 35.95084696 139.175137 129.3285785 81.31751798 
Q2FZC2 SAOUHSC_01110 1.331828857 1.40E-08 5.78E-08 60.06474076 68.33312696 55.46702102 127.4886751 129.3285785 272.1009255 
Q2G1E3 SAOUHSC_00182 1.44403546 2.07E-08 8.33E-08 74.51069107 49.61172232 45.19535046 234.7916433 155.984087 148.5608501 
Q2FZ03 SAOUHSC_01268 1.321880164 2.18E-08 8.71E-08 25.09033475 20.59354511 26.70634345 66.93155443 69.106874 68.80713059 
Q2FWG0 tenA 1.164968586 2.74E-08 1.08E-07 36.49503236 40.25101999 42.11384929 88.17966694 91.81341832 109.4658896 
Q2G1K9 SAOUHSC_00113 -1.848441963 6.95E-08 2.66E-07 1208.897947 823.7418045 3701.91007 322.9713103 341.5854058 323.7062735 
Q2FV35 SAOUHSC_02904 -1.000558027 1.07E-07 4.05E-07 124.6913606 140.4105349 118.1242114 64.80674318 65.15790977 50.04154952 
Q2FV55 ssaA -1.234311336 2.20E-07 8.12E-07 2691.508637 2892.457018 2131.371641 794.6794081 728.5839002 1427.74796 
Q2FZB9 SAOUHSC_01113 1.352370554 3.08E-07 1.11E-06 98.84071265 45.86744139 32.86934579 226.2923983 167.8309797 140.741858 
Q2G1N1 SAOUHSC_00077 1.003402951 3.68E-07 1.31E-06 100.361339 87.05453161 78.06469625 225.2299927 222.1292379 112.5934864 
Q2FVA8 SAOUHSC_02825 1.033805107 6.65E-07 2.29E-06 53.2219222 45.86744139 43.14101635 103.0533457 103.660311 106.3382927 
Q9RQP7 icaB 1.055746153 2.32E-06 7.55E-06 62.34568029 110.4562874 73.95602803 173.172117 145.1244354 236.1335618 
Q2G2N7 SAOUHSC_02250 -1.463097518 3.41E-06 1.09E-05 63.86630664 34.6345986 47.24968457 19.12330127 10.85965163 6.25519369 
Q2G1U4 SAOUHSC_00936 1.00853617 5.10E-06 1.58E-05 41.05691141 37.44280929 47.24968457 121.1142413 85.88997197 62.5519369 
Q2FVC8 SAOUHSC_02785 -1.179719423 1.32E-05 3.88E-05 49.42035633 71.14133766 60.6028563 25.49773502 25.66826749 15.63798423 
Q2G2Y4 SAOUHSC_01918 -1.077426855 3.93E-05 1.09E-04 903.252051 997.8508677 996.3520443 288.9743302 276.427496 656.7953375 
Q2G1N2 SAOUHSC_00076 1.031050574 5.49E-05 1.49E-04 42.57753776 32.76245813 35.95084696 106.2405626 107.6092752 39.09496057 
Q2FZZ3 SAOUHSC_00841 1.326768677 6.12E-05 1.66E-04 20.5284557 10.29677256 12.32600467 75.43079943 48.3748118 26.58457318 
Q2G1H0 SAOUHSC_00153 1.025580601 6.15E-05 1.67E-04 715.454697 838.7189282 882.3365011 1272.76194 1336.724391 2930.558244 
Q2FWH9 kdpA -1.067136599 6.28E-05 1.70E-04 53.2219222 42.12316046 65.73869158 21.24811252 23.69378537 21.89317792 
Q2FYW3 SAOUHSC_01311 1.25174263 1.07E-04 2.83E-04 19.76814253 5.616421394 8.217336448 41.43381941 42.45136546 28.14837161 
Q2G1N3 sbnA 1.03520173 1.43E-04 3.70E-04 24.33002158 21.52961534 20.54334112 48.87065879 77.99204352 28.14837161 
Q2FUT6 hisZ -1.273753007 2.83E-04 7.09E-04 24.33002158 24.33782604 31.84217873 6.374433755 8.885169514 6.25519369 
Q2FX92 SAOUHSC_01985 -1.248729001 3.08E-04 7.67E-04 26.6109611 19.65747488 19.51617406 7.436839381 5.923446343 3.127596845 
Q2FV37 SAOUHSC_02902 -1.020016469 5.36E-04 1.29E-03 44.85847728 43.05923069 39.03234813 26.56014065 13.8213748 10.94658896 














A0A0H2WXF8  mecA -11.19053714 0 0 44124.77507 47471.86576 51286.4511 1.734166628 2.044613367 
Q2FVM2 SAOUHSC_02680 -3.2674026 6.31E-35 7.07E-32 1107.776295 554.1535776 1119.612091 67.63249848 75.65069458 
Q2FVL8 SAOUHSC_02684 -3.397071392 6.1E-34 4.56E-31 2032.317115 1169.15172 2443.630426 121.3916639 122.676802 
Q2FVM0 SAOUHSC_02682 -2.74387631 4.29E-33 2.41E-30 1368.563714 743.2397645 1520.207243 148.2712467 159.4798426 
Q2FZU6 rocD -1.294875629 9.18E-30 4.12E-27 710.8928179 671.1623566 719.0169392 254.0554109 301.5804716 
Q2FVM1 SAOUHSC_02681 -3.668054464 2.44E-28 9.13E-26 3190.274079 1802.871268 3775.866098 101.4487477 117.5652686 
Q2G1V2 SAOUHSC_02685 -3.261430989 1.15E-24 3.69E-22 528.4176561 202.1911702 530.0182009 25.1454161 25.55766709 
Q2FVN1 narT -3.060561318 1.49E-24 4.18E-22 3046.574889 1449.97279 3345.483101 209.8341619 190.1490431 
Q2G1D7 pflA -3.149490191 2.19E-23 4.92E-21 1361.720895 869.6092459 2208.40917 117.9233307 92.00760151 
Q2G172 SAOUHSC_00281 -2.404198772 2.19E-23 4.92E-21 681.2406041 381.9166548 813.5163083 104.0499977 93.02990819 
Q2FVQ4 SAOUHSC_02648 -1.72109518 4.73E-22 8.16E-20 3530.894381 2070.587354 3848.794959 895.6970631 906.7860282 
Q2FYJ3 tdcB -3.113870405 6.43E-21 1.03E-18 342.9012416 162.8762204 572.1320502 20.80999953 20.44613367 
Q2G218 ldh1 -3.395844092 2.32E-20 3.46E-18 10493.84243 6274.478768 15855.35068 334.6941591 294.4243248 
Q2G1D8 pflB -3.054025031 1.55E-19 2.17E-17 4923.027803 2706.179042 7712.997423 365.9091584 297.4912449 
Q2FVM3 SAOUHSC_02679 -3.026421587 7.40E-19 9.76E-17 208.3258097 99.22344463 217.7594159 6.069583197 14.31229357 
P02976 spa 1.904774705 1.16E-14 1.30E-12 1646.078022 2958.918004 3718.344743 11032.76808 13696.86494 
Q2FUY2 clfB 1.058383329 1.49E-14 1.52E-12 10957.63347 14898.49382 16536.36243 25295.42151 35113.16766 
Q2FV74 clpL -1.704882045 4.67E-14 4.36E-12 2242.163551 1653.10003 3191.408043 629.5024858 634.8524504 
Q2FV02 SAOUHSC_02942 -1.457552043 1.05E-13 9.09E-12 1227.905776 831.2303663 1489.392231 421.4024905 384.387313 
Q2FYJ4 SAOUHSC_01450 -2.057641362 2.31E-13 1.92E-11 369.5122027 190.0222572 532.072535 61.56291528 74.62838789 
Q2G0G1 adh -2.339169751 1.28E-12 9.91E-11 798.3288329 520.4550492 1676.336635 125.7270805 119.609882 
Q2G1K8 SAOUHSC_00114 -1.583903953 2.59E-12 1.90E-10 206.0448702 197.510819 191.0530724 58.96166534 56.22686759 
Q2G1K5 SAOUHSC_00117 -1.419527589 2.63E-12 1.90E-10 549.706425 421.2316046 551.588709 182.0874959 165.6136827 
Q2FZM6 SAOUHSC_00974 1.049197175 4.81E-12 3.37E-10 503.3273213 598.1488785 691.2834287 1188.771223 1369.890956 
Q2G1K6 SAOUHSC_00116 -1.557499567 5.62E-12 3.82E-10 231.135205 162.8762204 202.35191 65.89833185 52.13764086 
Q2FYJ2 ald1 -2.503171243 1.03E-11 6.61E-10 323.8934122 147.8990967 582.4037207 29.48083267 14.31229357 
Q2FVL9 SAOUHSC_02683 -2.404815004 9.27E-11 5.47E-09 64.62661981 21.52961534 66.76585864 0.867083314 4.089226734 
Q2G1K7 SAOUHSC_00115 -1.559349268 1.10E-10 6.34E-09 185.5164145 144.1548158 195.1617406 51.15791551 50.09302749 
Q2G1K0 SAOUHSC_00122 -1.3586866 1.50E-10 8.19E-09 248.622408 239.6339795 216.7322488 77.17041493 92.00760151 
Q2G1K2 SAOUHSC_00120 -1.272402782 2.38E-10 1.27E-08 250.1430343 226.5289962 236.2484229 91.04374795 92.00760151 
325 
 
Q2FV03 SAOUHSC_02941 -1.601493144 7.26E-10 3.62E-08 202.2433043 117.008779 213.6507476 56.3604154 44.98149407 
Q2G1H7 SAOUHSC_00146 -1.424560745 1.28E-09 6.23E-08 694.9262412 401.5741297 978.8902043 219.3720784 253.5320575 
Q2G0L4 sdrD 1.230590993 6.29E-09 2.88E-07 2267.253886 3223.82588 3855.985128 7021.640675 8970.741147 
Q2FVK5 sbi 1.396832969 1.76E-08 7.61E-07 517.7732717 505.4779255 543.3713726 1792.26121 1318.775622 
Q2G1J9 SAOUHSC_00123 -1.000331258 3.41E-08 1.39E-06 208.3258097 189.0861869 199.2704089 107.5183309 82.80684136 
Q9RQP9 icaA -1.191843266 3.67E-08 1.47E-06 142.9388768 250.8668223 173.5912325 91.04374795 52.13764086 
Q2G0G9 SAOUHSC_00599 -1.68540005 1.73E-07 5.86E-06 130.773866 101.0955851 72.92886097 25.1454161 17.37921362 
Q2G1K9 SAOUHSC_00113 -1.776140828 5.78E-07 1.75E-05 1208.897947 823.7418045 3701.91007 329.4916592 338.3835122 
Q2G1K3 SAOUHSC_00119 -1.136489512 6.18E-07 1.85E-05 272.9524295 261.1635948 291.7154439 109.2524975 119.609882 
P72358 lrgA -1.046167479 8.83E-07 2.44E-05 116.3279157 95.4791637 143.8033878 51.15791551 54.18225422 
Q2G021 SAOUHSC_00806 -1.530056936 1.05E-06 2.84E-05 157.3848271 87.05453161 69.8473598 22.54416616 24.5353604 
Q2G1K4 SAOUHSC_00118 -1.056623133 1.22E-06 3.23E-05 285.8777535 268.6521567 288.6339427 126.5941638 125.7437221 
Q2FZC2 SAOUHSC_01110 1.17365998 3.54E-06 8.81E-05 60.06474076 68.33312696 55.46702102 169.0812462 141.0783223 
Q2FYJ5 norB -1.068260094 7.02E-06 1.51E-04 253.9446002 146.9630265 307.1229497 103.1829143 105.2975884 
Q2G1J8 SAOUHSC_00124 -1.143385926 7.15E-06 1.53E-04 164.2276456 110.4562874 87.30919976 52.89208214 46.00380076 
Q2G1T5 SAOUHSC_02802 1.136508188 7.99E-06 1.67E-04 1212.699513 1368.53468 1318.8825 3677.300334 2883.927154 
Q2FW05 SAOUHSC_02515 -1.055100579 1.35E-05 2.74E-04 476.7163602 246.1864711 223.9224182 126.5941638 143.1229357 
Q2G1K1 SAOUHSC_00121 -1.166291642 1.38E-05 2.78E-04 78.31225695 94.54309347 77.0375292 31.2149993 33.73612055 
Q2FXB9 SAOUHSC_01945 -1.080676331 2.00E-05 3.74E-04 99.60102582 76.75775905 71.90169392 38.15166581 32.71381387 
Q9RQP7 icaB -1.081709713 3.42E-05 5.90E-04 62.34568029 110.4562874 73.95602803 35.55041587 28.62458714 
Q2FXD3 SAOUHSC_01930 -1.376840269 1.84E-04 2.17E-03 139.1373109 14.97712372 15.40750584 6.069583197 3.06692005 
Q2FVE0 SAOUHSC_02774 -1.173772407 2.94E-04 3.21E-03 967.8786708 438.0808687 334.8564602 183.8216625 203.43903 
Q2FVE3 SAOUHSC_02771 -1.321418965 3.99E-04 4.14E-03 80.59319647 17.78533441 23.62484229 6.069583197 6.133840101 
Q2G1A1 SAOUHSC_00244 -1.074559324 4.88E-04 4.86E-03 249.3827211 118.8809195 82.17336448 71.96791504 37.82534729 
Q2G2F9 SAOUHSC_00718 -1.248161312 7.57E-04 6.87E-03 1034.025917 413.7430427 217.7594159 97.98041446 121.6544953 
Q2FVB5 SAOUHSC_02819 -1.074668025 3.72E-03 2.37E-02 24.33002158 14.97712372 14.38033878 4.335416569 5.111533417 
Q2FVA1 SAOUHSC_02832 -1.024325094 6.03E-03 3.31E-02 56.26317489 35.57066883 17.46183995 17.34166628 0 





log2FC pvalue padj Untrained-1 Untrained-2 Untrained-3 rpoC-1 rpoC-2 rpoC-3 
Q2FZZ6 SAOUHSC_00838 4.144415201 0 0 517.7732717 486.7565208 547.4800408 9565.72186 9228.916865 9400.106394 
O50581 recG 2.304819608 0 0 1373.125593 1416.274262 1537.669083 7238.655874 7071.189435 7255.714661 
326 
 
Q2FW95 SAOUHSC_02404 3.042994048 0 0 761.8338006 799.4039784 809.4076401 6464.072182 6831.006237 6505.539375 
Q2FZD0 uvrC 2.400842498 5.86E-306 3.35E-303 1212.699513 1296.457272 1273.687149 6623.187805 6842.770312 6743.135084 
Q2G035 SAOUHSC_00792 2.62364448 6.69E-265 3.06E-262 1135.147569 1030.613326 1078.525409 6449.707577 7243.729203 6691.274092 
Q2G253 SAOUHSC_00025 2.413462144 1.00E-241 3.82E-239 636.3821268 558.8339287 655.3325817 3413.251106 3478.244852 3132.162728 
Q2FUQ2 mnmE 1.957401928 3.63E-220 1.18E-217 2361.532719 2505.860012 2464.173767 9959.091039 9466.159045 9304.826896 
Q2FUX4 SAOUHSC_02971 3.176242445 1.55E-211 4.44E-209 275.2333691 207.8075916 219.81375 2310.491441 2207.724748 2133.537107 
Q2FXQ3 SAOUHSC_01782 2.104177415 9.17E-198 2.33E-195 1512.262904 1585.702974 1561.293925 6819.872394 6824.14386 6640.619169 
Q2FUQ1 rnpA 2.529954496 9.86E-193 2.25E-190 226.5733259 243.3782604 258.8460981 1487.289087 1422.47274 1383.361821 
Q2G245 SAOUHSC_01854 1.536158358 3.66E-171 7.60E-169 8751.204635 8536.024449 9052.423264 25521.48294 26839.73719 24461.50345 
Q2FUY3 SAOUHSC_02962 2.233873528 6.65E-171 1.27E-168 432.6181961 463.354765 535.1540362 2224.303812 2307.719386 2297.562571 
Q2G082 SAOUHSC_00738 -2.361671483 4.63E-159 8.14E-157 9509.23687 9677.094062 9875.184076 1814.360089 1819.510272 1889.911049 
Q2FXE2 SAOUHSC_01907 1.814448795 3.46E-149 5.65E-147 528.4176561 497.9893636 509.4748598 1836.459481 1860.684535 1769.30409 
Q2FUQ3 mnmG 1.437298126 8.80E-144 1.34E-141 4497.252426 4757.108921 4780.435478 13117.09417 12497.36905 12599.80902 
Q2FY21 SAOUHSC_01652 1.470849646 6.31E-141 9.01E-139 5467.412036 6190.232447 6218.469357 16859.62621 16548.13222 16427.8739 
Q2FY54 SAOUHSC_01611 -1.233407309 2.13E-140 2.86E-138 6001.912197 6025.484086 6195.871681 2582.313964 2479.278814 2664.207727 
Q2G239 SAOUHSC_00708 -1.219542034 6.16E-135 7.82E-133 10186.67591 10480.24232 10832.50377 4402.198901 4537.991945 4534.821663 
Q2G2B2 sasG 1.57968092 2.89E-134 3.48E-132 1932.716089 2181.979712 2329.614883 6375.674614 6581.999982 6436.793408 
Q2FVX0 SAOUHSC_02553 2.50061713 1.08E-131 1.24E-129 311.7284014 278.9489292 276.3079381 1687.288585 1589.130469 1800.6619 
Q2FVH5 SAOUHSC_02737 1.20120766 1.06E-130 1.15E-128 1588.294221 1622.209713 1597.244772 3699.438233 3761.562992 3630.26947 
Q2FZF0 isdB 2.599397877 3.29E-124 3.42E-122 164.2276456 149.7712372 138.6675526 988.9477954 902.8927589 967.2678121 
Q2FZ77 pyrR -2.496693123 1.75E-109 1.74E-107 2085.539037 1933.9211 1997.839924 339.2256684 340.1778364 344.9359031 
Q2FYK5 thyA -1.564568908 1.88E-109 1.79E-107 1977.574566 2018.167421 2077.958954 660.771823 643.1027686 732.0842419 
Q2FWD4 murA 1.305198263 3.52E-108 3.22E-106 4262.315655 4467.863219 4709.560952 11309.36389 11145.48076 10929.40264 
Q2FXQ4 SAOUHSC_01781 1.973205903 6.67E-98 5.86E-96 1925.87327 1805.679478 1892.041717 7325.948473 7342.743501 7904.580101 
Q2G0Q7 SAOUHSC_00489 1.810273935 6.61E-97 5.60E-95 397.6437901 497.9893636 493.0401869 1692.813433 1680.302051 1563.06619 
Q2FWH6 SAOUHSC_02315 3.547154675 1.97E-95 1.61E-93 54.74254854 39.31494976 82.17336448 779.0035706 720.5495959 829.7758787 
Q2FW76 SAOUHSC_02428 1.712215997 8.18E-95 6.45E-93 670.5962197 784.4268547 700.5279322 2538.11518 2274.38784 2344.599285 
Q2FYM1 odhA 1.369142938 2.49E-91 1.89E-89 1877.97354 1829.081234 2069.741618 5038.661393 4964.439665 5028.104126 
Q2FVE1 SAOUHSC_02773 -1.314055504 6.97E-90 5.14E-88 2761.457449 3031.931483 2939.752114 1135.908753 1142.095618 1209.6878 
Q2G1B7 SAOUHSC_00228 -1.07940121 1.00E-86 7.18E-85 16593.83503 17078.60139 17589.20867 7870.698488 8018.197476 8272.431326 
Q2FY61 SAOUHSC_01604 1.691161243 3.42E-85 2.37E-83 489.6416842 436.2087283 409.8396553 1367.952369 1482.273454 1547.387286 
Q2FY74 xerD 1.328907985 1.25E-82 8.41E-81 1062.917818 1148.558175 1191.513785 2843.08679 2869.453969 2893.360949 
Q2FZZ4 SAOUHSC_00840 2.74793878 1.46E-79 9.56E-78 88.95664139 76.75775905 67.79302569 520.4406834 531.3440557 659.7200664 
Q2G0B2 SAOUHSC_00693 -1.225472925 2.89E-77 1.79E-75 1639.235204 1737.346351 1660.929129 699.4457592 704.8641625 736.9085202 
327 
 
Q2FXT1 obg 1.301584331 4.15E-77 2.49E-75 4190.846216 4574.575226 4558.567394 11397.76146 11108.22785 10588.08494 
Q2G0Y8 SAOUHSC_00373 -1.198510482 5.62E-73 3.21E-71 6036.12629 6543.130924 6643.716518 2861.871274 2709.658616 2748.632598 
Q2FXU3 lytH -1.24446739 1.08E-71 6.01E-70 2611.675753 2699.62655 2555.591635 1121.544148 1099.941016 1073.401936 
Q2G0Y6 guaA -1.184869448 5.62E-71 2.99E-69 14582.04637 16863.30524 17561.47516 7395.561558 7088.835548 6927.663732 
Q2FZT3 SAOUHSC_00907 1.221375358 6.56E-71 3.41E-69 778.5606904 770.3858012 821.7336448 1733.697308 1927.347627 1901.971745 
Q2FUW9 SAOUHSC_02982 -1.087670449 2.56E-70 1.30E-68 7315.733362 7096.348432 7283.641594 3367.947352 3390.994629 3397.498038 
Q2FXT3 ruvA 1.131861124 8.88E-70 4.41E-68 1729.712471 1783.213793 1851.982202 3944.741485 3921.358345 3951.083981 
Q2G033 SAOUHSC_00794 -1.047075444 7.81E-69 3.72E-67 26269.58048 27695.50996 30195.62994 13238.64082 13772.79085 13524.8644 
Q2G0K4 SAOUHSC_00556 -1.218675051 9.26E-68 4.32E-66 11142.38957 12168.91302 10194.63303 4795.56808 4684.062543 4813.423738 
Q2G268 SAOUHSC_01178 1.160214378 7.95E-67 3.56E-65 1047.711554 1133.581051 1175.079112 2566.84439 2429.281495 2544.806837 
Q2FZQ1 SAOUHSC_00949 1.607515415 3.57E-66 1.54E-64 246.3414685 232.1454176 257.818931 763.5339962 734.2743501 786.3573735 
Q2FVL5 SAOUHSC_02696 2.193411924 3.96E-66 1.68E-64 231.8955181 204.9993809 214.6779147 1012.152157 1032.297584 1079.432284 
Q2FYT4 sbcD 1.50383248 4.49E-66 1.87E-64 334.5377967 366.9395311 338.9651285 976.7931297 1045.041999 967.2678121 
Q2FYH5 dinG -1.068844566 2.93E-65 1.20E-63 4450.873322 4122.453303 4020.331857 1889.498022 1979.305625 2108.209645 
Q53726 pcrB 1.138801468 9.19E-65 3.69E-63 970.1596103 967.8966203 947.0480256 2117.121761 2141.061656 2137.155316 
Q2G2K5 ureC -1.315741569 1.50E-61 5.91E-60 1402.777806 1318.922957 1324.018335 533.7003186 548.0098287 528.2584809 
Q2FYZ3 SAOUHSC_01279 1.60180612 2.49E-61 9.64E-60 278.2746218 251.8028925 263.9819334 829.8321724 780.3503106 851.4851314 
Q2FVM0 SAOUHSC_02682 -3.493150125 2.32E-59 8.82E-58 1368.563714 743.2397645 1520.207243 79.55781147 94.11260028 85.63094098 
Q2FW75 SAOUHSC_02430 1.418612434 5.35E-59 2.01E-57 3714.129856 3499.966599 2862.714585 9512.683319 8364.25735 9449.555247 
Q2FVQ4 SAOUHSC_02648 -2.642496617 1.03E-58 3.72E-57 3530.894381 2070.587354 3848.794959 475.1369296 475.4646993 426.9486353 
Q2FZ10 cinA 1.194915402 1.87E-58 6.70E-57 797.5685198 938.8784431 851.5214894 1979.00056 1890.094722 2100.973228 
Q2G0Q9 hslO 1.217657732 3.93E-56 1.36E-54 1614.144869 1761.684177 1710.233148 3982.310452 4054.684529 3893.19264 
Q2FZI6 purH -1.5100095 4.80E-56 1.64E-54 780.0813168 777.8743631 787.8371319 251.9330697 286.2591592 268.9535188 
Q2FZD7 rnhC 1.178772033 5.56E-53 1.76E-51 660.7121484 754.4726073 732.3701109 1588.94629 1587.16979 1723.473446 
Q2FX99 SAOUHSC_01978 1.371239081 4.72E-52 1.44E-50 1234.748595 1098.010383 1042.574562 2987.837809 2822.397669 3053.768205 
Q2G252 rlmH 1.923645816 1.09E-51 3.27E-50 130.0135528 161.9401502 155.1022254 595.5786164 574.4789975 590.9740997 
Q2FYF4 SAOUHSC_01497 1.00150329 1.73E-51 5.12E-50 1294.053023 1458.397422 1431.870876 2775.683645 2878.277025 2759.487225 
Q2FVS3 SAOUHSC_02619 1.216991968 1.81E-51 5.30E-50 789.965388 723.5822896 759.0764543 1829.829664 1701.869522 1807.898317 
Q2FVM2 SAOUHSC_02680 -3.736373715 1.05E-50 3.03E-49 1107.776295 554.1535776 1119.612091 43.09381455 49.9973189 56.68527079 
Q2FVG4 SAOUHSC_02750 -1.026025499 5.27E-50 1.51E-48 1904.584501 1856.227271 1885.878715 923.7545887 889.1680047 945.5585595 
Q2G188 esaA -1.109867818 1.47E-49 4.12E-48 1427.868141 1498.648442 1504.799737 664.0867319 643.1027686 730.8781723 
Q2G145 SAOUHSC_00310 1.552578932 2.51E-49 6.83E-48 211.3670624 221.8486451 232.1397546 664.0867319 660.7488811 666.9564839 
Q2FWH7 SAOUHSC_02314 1.921943271 3.04E-49 8.17E-48 237.9780235 234.0175581 334.8564602 1075.135424 985.2412842 1114.408302 
Q2FV86 SAOUHSC_02849 -1.129227344 7.69E-49 2.04E-47 11351.47569 13062.86009 12786.17551 5513.798323 5820.276123 5526.210867 
328 
 
Q2G0W4 SAOUHSC_00410 -1.677381741 8.51E-49 2.24E-47 603.6886603 717.029798 683.0660922 171.2702886 212.7336902 223.1228744 
Q2FY23 SAOUHSC_01650 1.300571982 9.41E-48 2.39E-46 471.394168 447.4415711 442.7090011 1099.444756 1144.056297 1156.620738 
Q2FZ72 carB -1.065518879 2.15E-47 5.34E-46 3172.786876 3365.172485 3410.194626 1582.316473 1592.071488 1542.563007 
Q2FVL8 SAOUHSC_02684 -3.781072212 2.31E-47 5.69E-46 2032.317115 1169.15172 2443.630426 92.81744672 106.8570149 77.18845384 
Q2G1N5 SAOUHSC_00072 2.181769081 9.57E-47 2.33E-45 199.9623648 228.4011367 241.3842581 1109.389482 1025.435207 1109.584024 
Q2FX96 SAOUHSC_01981 1.0041871 5.56E-46 1.32E-44 681.2406041 696.4362529 738.5331132 1349.167886 1453.843606 1462.962414 
Q2FZ88 SAOUHSC_01152 1.391983391 5.74E-46 1.35E-44 559.5904962 610.3177915 672.7944216 1612.150652 1559.720282 1737.946281 
Q2FWY4 sdcS -1.510691188 1.62E-45 3.78E-44 603.6886603 676.778778 692.3105957 222.0988904 244.104557 207.4439697 
Q2G057 SAOUHSC_00765 2.654715157 1.32E-44 3.02E-43 45.61879045 32.76245813 42.11384929 301.6567018 282.3378008 287.0445627 
Q2FWL3 SAOUHSC_02276 1.271195066 1.51E-44 3.43E-43 487.3607447 489.5647315 462.2251752 1170.16281 1122.488826 1231.397053 
Q2G0D1 sarX -3.242786474 3.58E-44 8.03E-43 560.3508094 451.185852 411.8939894 50.82860177 39.21358345 21.70925264 
Q2G278 SAOUHSC_00773 1.819186091 3.74E-44 8.30E-43 147.5007558 139.4744646 123.2600467 468.507112 537.2260933 505.3431587 
Q2FVX2 SAOUHSC_02551 1.179268756 1.05E-42 2.29E-41 435.6594488 466.1629757 437.5731658 1038.671428 992.1036613 1034.807709 
Q2G2U2 SAOUHSC_00023 -1.131330289 1.71E-42 3.70E-41 2293.104533 2380.426601 2386.109071 1014.362096 1074.452187 1102.347606 
Q2G1D7 pflA -4.102535871 4.32E-42 9.15E-41 1361.720895 869.6092459 2208.40917 34.25405772 46.07596055 54.2731316 
Q2G0E5 SAOUHSC_00661 -1.080866405 4.50E-42 9.44E-41 1119.941306 1090.521821 1088.797079 478.4518384 532.3243953 536.7009681 
Q2FUW8 gtf2 -1.010906258 5.78E-42 1.20E-40 1415.70313 1433.123526 1431.870876 738.1196953 679.3753333 692.2839453 
Q2FUX3 isaB 1.093064647 1.17E-41 2.41E-40 1047.711554 985.6819547 978.8902043 2054.138493 2061.65415 2374.751025 
Q2FZ71 pyrF -1.566322586 1.49E-41 2.99E-40 627.2583687 571.938912 628.6262382 208.8392551 200.9696152 190.5589954 
Q2FWC5 SAOUHSC_02373 -1.168758268 7.28E-41 1.42E-39 752.7100425 743.2397645 760.1036214 342.5405772 328.4137614 320.8145113 
Q2FYS2 SAOUHSC_01363 2.080888588 9.43E-41 1.83E-39 144.4595031 152.5794479 128.395882 640.8823702 633.2993727 653.6897184 
Q2FW77 SAOUHSC_02427 1.362693647 3.31E-39 6.16E-38 665.2740275 706.7330254 593.7025583 1837.564451 1581.287753 1733.122003 
Q2FZL3 sspB 1.52867498 6.03E-39 1.10E-37 206.8051834 203.1272404 238.302757 626.5177653 602.9088455 689.8718062 
Q2FV87 glcB -1.191121788 1.40E-38 2.52E-37 3259.462578 2711.795463 3232.494725 1295.024376 1335.222516 1350.797942 
Q2FVW0 SAOUHSC_02581 -1.579474059 1.94E-38 3.44E-37 1110.057234 1066.183995 1064.14507 337.0157291 360.7649677 353.3783902 
Q2FZ76 SAOUHSC_01165 -1.570746999 1.97E-38 3.46E-37 859.9142001 1015.636202 958.3468632 339.2256684 291.1608571 295.4870498 
Q2FVM1 SAOUHSC_02681 -4.056798477 1.25E-37 2.18E-36 3190.274079 1802.871268 3775.866098 78.45284187 96.07327945 74.77631465 
Q2FVM6 nreB -1.291658908 2.88E-37 4.94E-36 1377.687472 1211.274881 1447.278382 522.6506226 561.7345829 536.7009681 
Q2G0M2 SAOUHSC_00538 1.131217508 4.96E-37 8.34E-36 414.37068 492.3729422 522.8280315 1083.975181 1047.983018 1023.953083 
Q2FYH7 SAOUHSC_01470 1.016434663 6.96E-37 1.16E-35 816.5763491 828.4221556 803.2446378 1665.189193 1616.579978 1712.61882 
Q2G1N4 SAOUHSC_00074 1.985950258 8.03E-37 1.33E-35 534.5001615 620.6145641 514.610695 2689.496016 2117.533506 2258.968344 
Q2G016 SAOUHSC_00811 2.215149211 1.14E-36 1.87E-35 242.5399026 258.3553841 235.2212558 1285.079649 1261.697047 1215.718148 
Q2G0M6 araB 1.215660263 1.49E-36 2.36E-35 415.8913063 431.5283771 420.1113259 961.3235553 1030.336905 992.5952736 
Q2G1N1 SAOUHSC_00077 2.409341133 3.39E-36 5.27E-35 100.361339 87.05453161 78.06469625 558.0096499 489.1894535 548.761664 
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Q2FUS7 SAOUHSC_03024 -1.039881684 1.61E-35 2.47E-34 2524.239738 2736.133289 2545.319965 1287.289588 1235.227879 1238.63347 
Q2G0F2 SAOUHSC_00617 -1.009898872 1.99E-35 3.01E-34 3105.879317 2461.864711 2642.900835 1384.526914 1301.890971 1360.446499 
Q2FZI5 purD -1.429068982 3.50E-35 5.22E-34 798.3288329 787.2350654 873.0919976 329.2809419 294.1018759 265.3353101 
Q2G1M9 SAOUHSC_00079 1.915731792 5.38E-35 7.99E-34 107.2041576 121.6891302 118.1242114 475.1369296 422.5263617 489.664254 
Q2FWC4 SAOUHSC_02374 -1.165108106 1.53E-34 2.19E-33 797.5685198 757.280818 732.3701109 320.4411851 369.588024 314.7841633 
Q2G0Y9 xpt -1.001668132 2.62E-34 3.74E-33 1320.663984 1445.292439 1431.870876 760.2190874 684.2770312 631.9804658 
Q2G0D9 graS -1.091170627 2.84E-34 4.04E-33 991.4483792 992.2344463 953.2110279 440.8828719 482.3270764 439.0093312 
Q2FW63 SAOUHSC_02444 -1.344622537 4.10E-34 5.78E-33 5580.698699 5465.714087 4967.379883 1949.166381 2145.963354 2079.263975 
Q2G1V2 SAOUHSC_02685 -3.70367064 9.03E-34 1.25E-32 528.4176561 202.1911702 530.0182009 15.46957445 17.64611255 19.29711346 
Q2G249 SAOUHSC_00026 1.556219749 1.12E-33 1.54E-32 204.5242439 182.5336953 180.7814018 542.5400754 613.692581 575.295195 
Q2FUQ4 rsmG 1.013517892 2.89E-33 3.96E-32 1541.915117 1743.898843 1798.569515 3650.819571 3370.407497 3328.752072 
Q2G200 SAOUHSC_00941 1.366175539 5.08E-33 6.87E-32 193.1195463 230.2732772 229.0582535 561.3245587 570.5576392 584.9437517 
Q2G261 sodM 1.095868059 1.13E-32 1.52E-31 532.9795351 621.5506343 686.1475934 1289.499528 1400.905269 1278.433767 
Q2FVP4 SAOUHSC_02658 -1.236991186 3.62E-32 4.76E-31 583.1602046 549.4732264 554.6702102 230.9386472 242.1438778 230.3592919 
Q2FXL6 SAOUHSC_01819 1.228269298 1.03E-31 1.33E-30 762.5941138 780.6825738 925.4775174 1956.901168 2027.342264 1893.529258 
Q2G2M2 mprF 1.105571428 1.21E-31 1.57E-30 4210.614359 4066.289089 3812.844112 9123.734018 8121.133132 9103.413274 
Q2G105 SAOUHSC_00356 1.219603137 4.31E-31 5.47E-30 2881.58693 2295.24421 2160.132319 5659.65431 6095.751547 5640.787478 
Q2FVB8 SAOUHSC_02816 -1.062852764 5.26E-31 6.61E-30 1043.909988 994.1065868 952.1838609 423.2033582 503.8945473 488.4581844 
Q2FW50 SAOUHSC_02467 -1.423602171 6.31E-31 7.88E-30 1589.054534 1746.707054 1851.982202 646.4072182 608.790883 624.7440482 
Q2G218 ldh1 -4.13104473 1.17E-30 1.42E-29 10493.84243 6274.478768 15855.35068 140.3311397 150.9722963 136.2858638 
Q2G0A0 SAOUHSC_00705 1.354740135 1.57E-30 1.90E-29 206.0448702 172.2369228 200.2975759 507.1810481 487.2287744 523.4342026 
P0A0M9 SAOUHSC_00995 1.607367216 1.98E-30 2.39E-29 152.0626348 140.4105349 140.7218867 437.5679631 448.9955305 488.4581844 
Q2G1H7 SAOUHSC_00146 -2.53308798 2.11E-30 2.52E-29 694.9262412 401.5741297 978.8902043 104.9721124 100.9749774 92.86735852 
Q2G176 SAOUHSC_00271 1.272116729 4.68E-30 5.52E-29 350.5043733 304.2228255 270.1449357 753.5892698 767.605896 767.06026 
Q2FXP2 SAOUHSC_01794 1.372068255 4.91E-30 5.75E-29 237.2177104 217.1682939 222.8952511 605.5233429 568.59696 627.1561874 
Q2FW66 asp23 -1.128776491 7.74E-30 8.89E-29 18417.82633 19386.01451 18704.71209 8540.310067 8773.058957 8161.472924 
Q2G0Q6 SAOUHSC_00490 1.414351309 2.04E-29 2.32E-28 149.0213821 196.5747488 175.6455666 524.8605618 434.2904367 466.7489318 
Q2FZL2 sspA 1.684200371 3.40E-29 3.81E-28 139.8976241 153.5155181 155.1022254 563.5344979 457.8185868 493.2824628 
Q2G1U4 SAOUHSC_00936 2.356837513 8.75E-29 9.61E-28 41.05691141 37.44280929 47.24968457 245.303252 266.6523675 229.1532223 
Q2FXE9 SAOUHSC_01900 2.118521553 9.22E-29 1.01E-27 58.54411442 40.25101999 48.27685163 208.8392551 235.2815007 272.5717276 
Q2FVN3 sarZ -1.176938395 1.27E-28 1.39E-27 4290.447242 3084.351416 3393.759953 1539.222658 1477.371756 1670.406384 
Q2G1D8 pflB -3.56618182 1.73E-28 1.87E-27 4923.027803 2706.179042 7712.997423 202.2094375 235.2815007 207.4439697 
Q2G0Y5 SAOUHSC_00376 2.234029378 2.14E-28 2.28E-27 50.94098267 35.57066883 35.95084696 217.6790119 200.9696152 244.832127 
Q2G2W1 SAOUHSC_02629 -1.145141226 3.24E-28 3.40E-27 7911.058578 7609.314919 7181.952055 3370.157291 3308.646104 3426.443709 
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Q2FXT2 SAOUHSC_01752 1.159731299 1.20E-27 1.24E-26 586.2014573 546.6650157 574.1863843 1373.477217 1265.618406 1238.63347 
Q2G0U0 SAOUHSC_00437 -1.151729446 6.82E-27 6.87E-26 1310.019599 1189.745265 1454.468551 620.9929173 586.2430726 542.731316 
Q2FVV9 SAOUHSC_02582 -1.154171983 1.35E-26 1.33E-25 14772.88498 14353.70094 15328.41398 6522.635571 6668.269865 6440.411617 
Q2G1M8 SAOUHSC_00080 1.52938539 3.32E-26 3.21E-25 197.6814253 172.2369228 147.9120561 533.7003186 485.2680952 545.1434552 
Q2FW41 SAOUHSC_02476 1.628399796 3.40E-26 3.28E-25 118.6088552 117.9448493 95.5265362 327.0710027 347.0402135 408.8575914 
Q2FVN1 narT -2.960666059 3.50E-26 3.35E-25 3046.574889 1449.97279 3345.483101 238.6734344 244.104557 213.4743176 
Q2G1Y2 SAOUHSC_02923 -1.159007938 1.02E-25 9.51E-25 485.8401183 458.6744139 518.7193633 204.4193767 235.2815007 201.4136217 
Q2G194 SAOUHSC_00251 1.493135955 1.63E-25 1.51E-24 716.2150101 602.8292296 608.0828971 1880.658266 1705.79088 2064.79114 
Q2G155 lip2 1.335750542 4.63E-25 4.23E-24 1091.049405 1100.818593 1311.69233 2970.158295 3252.766747 2880.094184 
Q2FVX1 SAOUHSC_02552 1.249308533 8.57E-25 7.81E-24 222.7717601 238.6979093 202.35191 544.7500147 499.973189 572.8830558 
Q2G2J2 ssaA2 1.01127079 1.11E-24 9.99E-24 23260.26094 27564.46013 28424.79394 53708.15256 56551.86937 51483.49264 
Q2FVM7 nreC -1.195614895 1.49E-24 1.32E-23 824.1794809 703.9248147 918.287348 371.2697869 356.8436094 317.1963025 
Q2G1N2 SAOUHSC_00076 2.52549538 2.38E-24 2.09E-23 42.57753776 32.76245813 35.95084696 312.7063979 237.2421799 265.3353101 
Q2FXJ2 isdH 1.176710214 2.73E-24 2.38E-23 190.8386067 198.4468893 188.9987383 459.6673552 452.9168888 419.7122177 
Q2G0V4 SAOUHSC_00421 1.018595993 4.00E-24 3.46E-23 809.7335306 824.6778747 885.4180022 1665.189193 1833.235026 1669.200314 
Q2G172 SAOUHSC_00281 -2.228088513 5.79E-24 4.98E-23 681.2406041 381.9166548 813.5163083 122.651626 106.8570149 116.9887503 
Q2FZI8 purM -1.402301019 6.35E-24 5.44E-23 294.2411984 262.0996651 290.6882768 91.71247711 112.7390524 102.5159153 
P72360 scdA 1.174231925 7.21E-24 6.13E-23 269.9111769 223.7207855 297.8784462 616.5730389 569.5772996 638.0108137 
Q2FZ75 pyrB -1.177187147 9.12E-24 7.72E-23 658.4312089 732.0069217 679.984591 301.6567018 290.1805175 305.1356066 
Q2G196 SAOUHSC_00249 1.187402738 1.25E-23 1.05E-22 624.9774292 663.6737947 645.0609111 1510.493448 1445.02055 1542.563007 
Q2G1N3 sbnA 2.615095704 1.34E-23 1.12E-22 24.33002158 21.52961534 20.54334112 193.3696807 177.4414651 168.8497428 
Q2FV98 SAOUHSC_02836 -1.15704308 2.15E-23 1.79E-22 567.193628 533.5600324 492.0130198 248.6181608 211.7533506 242.4199878 
Q2FVB4 SAOUHSC_02820 2.176917904 2.26E-23 1.86E-22 42.57753776 66.4609865 55.46702102 303.866641 306.8462905 267.7474492 
Q2G1J4 SAOUHSC_00128 -1.187234036 1.12E-22 9.01E-22 517.0129585 568.194631 572.1320502 239.778404 260.7703299 208.6500393 
Q2FZM6 SAOUHSC_00974 -1.419655702 2.41E-22 1.90E-21 503.3273213 598.1488785 691.2834287 193.3696807 219.5960673 225.5350136 
Q2G1F2 azoR -1.708226208 3.75E-22 2.90E-21 193.8798594 173.172993 212.6235806 49.72363217 52.93833766 59.09740997 
Q2G190 SAOUHSC_00256 -1.14337347 7.84E-22 6.03E-21 428.8166303 471.7793971 545.4257067 216.5740423 205.8713131 215.8864568 
Q2FUZ6 SAOUHSC_02949 -1.141332817 1.76E-21 1.33E-20 511.6907663 530.7518217 518.7193633 199.9994983 234.3011611 258.0988925 
Q2FW43 SAOUHSC_02474 1.046763457 2.88E-21 2.16E-20 279.7952481 303.2867553 321.5032885 611.0481909 639.1814102 645.2472313 
Q2FZI9 purF -1.2883097 3.38E-21 2.53E-20 340.6203021 332.3049325 407.7853212 153.5907749 133.3261837 139.9040726 
Q2G074 SAOUHSC_00746 1.653511638 7.51E-21 5.54E-20 288.9190062 286.4374911 247.5472605 1035.356519 800.9374419 943.1464203 
Q2FV02 SAOUHSC_02942 -1.668074479 1.23E-20 9.04E-20 1227.905776 831.2303663 1489.392231 337.0157291 366.6470052 335.2873464 
Q2FYJ3 tdcB -2.919159849 1.81E-20 1.32E-19 342.9012416 162.8762204 572.1320502 33.14908811 36.27256469 15.67890469 
Q2G013 SAOUHSC_00814 1.652298458 2.20E-20 1.59E-19 85.91538869 72.07740789 78.06469625 240.8833736 268.6130466 289.4567019 
331 
 
Q2G2P8 nnrD 1.057416533 2.82E-20 2.02E-19 506.368574 541.0485943 635.8164076 1247.510683 1154.840033 1157.826808 
Q2FXK4 SAOUHSC_01830 1.409669076 3.85E-20 2.75E-19 120.1294815 120.75306 125.3143808 313.8113675 300.964253 402.8272435 
Q2G226 SAOUHSC_00099 -1.01319202 6.3E-20 4.4E-19 463.7910363 443.6972901 414.9754906 239.778404 201.9499548 203.8257609 
Q2FVM3 SAOUHSC_02679 -2.974165868 1.11E-19 7.67E-19 208.3258097 99.22344463 217.7594159 8.83975683 6.862377104 21.70925264 
Q2FUZ9 SAOUHSC_02945 -1.066179298 1.49E-19 1.02E-18 492.6829369 441.8251497 535.1540362 212.1541639 256.8489716 217.0925264 
Q2FZJ0 purL -1.100204085 3.69E-19 2.47E-18 407.5278614 393.1494976 438.6003329 174.5851974 211.7533506 176.0861603 
Q2G012 emp 1.413751894 4.07E-19 2.72E-18 114.8072893 99.22344463 82.17336448 286.1871274 272.534405 277.396006 
Q2FWG1 SAOUHSC_02330 1.585902832 6E-19 3.95E-18 51.70129585 62.71670557 51.3583528 172.3752582 192.1465589 167.6436732 
A0A0H2WXF8 mecA 0.596431727 9.36E-19 6.04E-18 44124.77507 47471.86576 51286.4511 71586.56075 73360.77192 71785.26207 
Q2G2R8 sspP 1.232152087 9.43E-19 6.07E-18 138.3769977 157.259799 169.4825642 369.0598477 402.9195699 350.966251 
Q2FW49 SAOUHSC_02468 -1.152369488 9.8E-19 6.29E-18 4431.865493 4645.716563 5373.11087 2134.801274 2089.103658 2111.827854 
Q2FZI4 SAOUHSC_01019 -1.061625141 1.61E-18 1.03E-17 408.2881746 462.4186948 430.3829964 202.2094375 212.7336902 194.1772042 
Q2FZU1 argG -1.356779638 3.82E-18 2.41E-17 425.0150644 411.8709022 581.3765537 174.5851974 183.3235026 171.261882 
Q2G1U9 SAOUHSC_02689 1.186691423 6.48E-18 4.05E-17 101.8819653 112.3284279 116.0698773 248.6181608 255.868632 267.7474492 
Q2FV28 SAOUHSC_02911 1.040204823 9.56E-18 5.9E-17 347.4631206 319.1999492 356.4269684 714.9153336 725.4512938 705.5507109 
Q2G195 SAOUHSC_00250 1.29252876 1.39E-17 8.53E-17 520.8145243 469.9072566 444.7633352 1219.886443 1104.842714 1336.325107 
Q2G0E3 SAOUHSC_00662 -1.247945611 1.88E-17 1.14E-16 434.8991357 357.5788288 374.9159754 146.9609573 144.1099192 185.734717 
Q2G2Y3 SAOUHSC_01919 -1.532376593 2.14E-17 1.3E-16 904.0123642 1127.96463 1127.829427 325.9660331 345.0795344 347.3480423 
Q2FWG0 tenA 1.729122117 2.21E-17 1.33E-16 36.49503236 40.25101999 42.11384929 128.176474 162.7363713 143.5222814 
Q2G2H9 mnhG1 -1.207128635 3.55E-17 2.1E-16 886.5251612 732.0069217 623.490403 309.3914891 297.0428946 336.4934159 
Q2FYJ4 SAOUHSC_01450 -2.169129965 1.27E-16 7.31E-16 369.5122027 190.0222572 532.072535 68.50811543 58.82037517 65.12775792 
Q2FZC0 flr 1.93105345 1.3E-16 7.43E-16 42.57753776 34.6345986 24.65200934 135.9112613 147.0509379 180.9104387 
Q9ZNI1 lytN 1.470436246 1.68E-16 9.59E-16 70.7091252 61.78063534 71.90169392 192.2647111 219.5960673 188.1468562 
Q2G0G1 adh -2.574256427 2.04E-16 1.16E-15 798.3288329 520.4550492 1676.336635 106.077082 108.8176941 98.89770648 
Q2G1J7 SAOUHSC_00125 -1.145503873 2.51E-16 1.42E-15 370.2725159 366.9395311 391.3506483 166.8504102 180.3824839 147.1404901 
Q2FZI7 purN -1.477466763 4.37E-16 2.45E-15 189.3179804 187.2140465 161.2652278 56.35344979 72.54512938 49.44885324 
Q2FUS6 pcp 1.075815013 8.32E-16 4.6E-15 199.9623648 182.5336953 177.6999007 432.0431151 397.0375324 383.53013 
Q2FZ70 pyrE -1.082756616 9.33E-16 5.14E-15 362.6693841 452.1219222 393.4049824 173.4802278 198.0285964 183.3225779 
Q2G0B0 SAOUHSC_00695 -1.061949947 1.07E-15 5.83E-15 399.1644165 424.9758855 442.7090011 196.6845895 210.773011 183.3225779 
Q2G0V2 metN1 1.390896785 1.49E-15 8.1E-15 55.50286172 75.82168882 73.95602803 204.4193767 191.1662193 171.261882 
Q2FXQ8 engB 1.29846674 2.77E-15 1.49E-14 421.9738117 322.9442302 273.2264369 843.0918077 787.2126877 1001.037761 
Q2FZU3 SAOUHSC_00897 1.061565696 3.47E-15 1.85E-14 206.0448702 148.8351669 181.8085689 383.4244525 389.1948157 378.7058516 
Q2FZ03 SAOUHSC_01268 1.801379644 5.2E-15 2.75E-14 25.09033475 20.59354511 26.70634345 93.92241632 101.955317 96.4855673 
Q2G0B9 SAOUHSC_00686 -1.206045795 6.26E-15 3.29E-14 264.5889846 236.8257688 240.3570911 93.92241632 115.6800712 98.89770648 
332 
 
Q2G2Q9 SAOUHSC_00274 1.424145474 9.93E-15 5.14E-14 85.91538869 60.8445651 78.06469625 198.8945287 239.202859 205.0318305 
Q2G292 SAOUHSC_01849 1.352589601 1.62E-14 8.21E-14 58.54411442 72.07740789 62.65719041 167.9553798 168.6184088 184.5286475 
Q2G177 SAOUHSC_00270 1.368686029 1.78E-14 9.01E-14 325.4140386 264.9078758 180.7814018 689.5010327 659.7685415 773.090608 
Q2G0W6 SAOUHSC_00408 -1.22187689 3.26E-14 1.62E-13 315.5299673 285.5014209 318.4217873 125.9665348 129.4048254 121.8130287 
Q2G0D2 SAOUHSC_00673 -1.318349223 5.21E-14 2.57E-13 884.2442216 621.5506343 557.7517114 239.778404 256.8489716 287.0445627 
Q2G0S6 SAOUHSC_00468 -1.171479533 5.38E-14 2.65E-13 761.8338006 1130.772841 886.4451693 436.4629935 386.253797 364.2330165 
Q8KQR1 isdC 1.395665123 7.67E-14 3.76E-13 49.42035633 50.54779255 52.38551985 152.4858053 132.3458441 144.7283509 
Q2FVB3 SAOUHSC_02821 1.603469703 3.55E-13 1.68E-12 55.50286172 43.99530092 51.3583528 154.6957445 181.3628235 186.9407866 
Q2G0F7 SAOUHSC_00612 1.455370232 4.51E-13 2.12E-12 50.94098267 38.37887953 43.14101635 127.0715044 124.5031275 144.7283509 
Q2FV03 SAOUHSC_02941 -1.754792798 4.93E-13 2.3E-12 202.2433043 117.008779 213.6507476 47.51369296 43.13494179 45.83064447 
Q2FXG6 SAOUHSC_01881 2.20048848 5.09E-13 2.37E-12 15.20626348 12.16891302 6.163002336 83.97768989 57.84003559 88.04308016 
Q2G140 mepA -1.103687933 5.55E-13 2.58E-12 217.4495678 201.2551 192.0802395 91.71247711 93.13226069 90.45521934 
Q2FXW9 SAOUHSC_01711 1.331373301 9.4E-13 4.33E-12 98.08039948 87.05453161 93.47220209 274.0324617 234.3011611 237.5957095 
Q2FYW3 SAOUHSC_01311 2.217282575 2.55E-12 1.14E-11 19.76814253 5.616421394 8.217336448 86.18762909 69.60411062 97.69163689 
Q2G1H3 rocD 1.220931869 2.62E-12 1.17E-11 79.83288329 101.0955851 108.8797079 229.8336776 234.3011611 244.832127 
Q2FYJ2 ald1 -2.51798807 2.97E-12 1.32E-11 323.8934122 147.8990967 582.4037207 22.09939208 31.37086676 25.32746142 
Q2FWP0 SAOUHSC_02241 -1.36446931 2.98E-12 1.32E-11 215.9289415 191.8943976 310.2044509 86.18762909 86.26988359 86.83701057 
Q2FZB8 SAOUHSC_01114 1.893138429 3.13E-12 1.38E-11 42.57753776 55.22814371 57.52135513 232.0436168 261.7506695 250.862475 
Q2G1N0 SAOUHSC_00078 1.54855651 4.66E-12 2.05E-11 106.4438444 68.33312696 65.73869158 322.6511243 234.3011611 235.1835703 
Q2FVW5 ureA -1.537973551 1.07E-11 4.62E-11 139.8976241 121.6891302 122.2328797 47.51369296 38.23324386 33.76994855 
Q2G1M6 SAOUHSC_00082 1.018212921 2.34E-11 9.95E-11 156.6245139 160.0680097 164.346729 355.8002124 299.0035738 349.7601814 
Q2G1L6 SAOUHSC_00106 1.11353886 3.12E-11 1.32E-10 85.91538869 74.88561859 76.01036214 188.9498022 158.815013 189.3529258 
Q2FWJ9 ilvA 1.115706055 5.34E-11 2.22E-10 77.55194377 87.05453161 71.90169392 163.5355014 190.1858797 180.9104387 
Q2FVL9 SAOUHSC_02683 -2.414612186 8.84E-11 3.64E-10 64.62661981 21.52961534 66.76585864 3.314908811 4.901697931 1.206069591 
Q2FWG2 thiM 1.393580263 8.94E-11 3.67E-10 40.29659823 58.03635441 59.57568925 125.9665348 152.9329755 174.8800907 
Q2G1J5 SAOUHSC_00127 -1.017181648 1.25E-10 5.06E-10 320.8521595 264.9078758 296.8512792 145.8559877 134.3065233 142.3162118 
Q2FXF1 SAOUHSC_01898 1.072946282 1.84E-10 7.36E-10 179.4339091 139.4744646 118.1242114 308.2865194 312.728328 340.1116247 
Q2G0X2 SAOUHSC_00401 1.901486427 2.98E-10 1.18E-09 25.85064792 18.72140465 23.62484229 121.5466564 135.2868629 114.5766112 
Q2G0L4 sdrD -1.222131365 3.08E-10 1.22E-09 2267.253886 3223.82588 3855.985128 1190.052263 1185.23056 1362.858638 
Q2FV70 SAOUHSC_02866 -1.521816008 5.24E-10 2.04E-09 1724.390279 1957.322856 1679.418136 553.5897715 532.3243953 517.4038546 
Q2G1K0 SAOUHSC_00122 -1.189207722 6.53E-10 2.51E-09 248.622408 239.6339795 216.7322488 93.92241632 84.30920442 114.5766112 
Q2G2G0 SAOUHSC_00717 1.463007366 7.17E-10 2.73E-09 86.67570186 92.670953 104.7710397 314.9163371 307.8266301 270.1595884 
Q2G225 SAOUHSC_00102 1.102254396 1.39E-09 5.2E-09 67.66787251 71.14133766 93.47220209 181.215015 166.6577297 172.4679515 
Q2G2Y4 SAOUHSC_01918 -1.584166813 1.62E-09 6.03E-09 903.252051 997.8508677 996.3520443 230.9386472 273.5147446 299.1052586 
333 
 
Q2FVK5 sbi 1.3758671 1.66E-09 6.16E-09 517.7732717 505.4779255 543.3713726 1450.82509 1688.144767 1420.749978 
Q2FWN9 SAOUHSC_02243 -1.304402679 1.84E-09 6.81E-09 162.7070193 131.0498325 217.7594159 59.6683586 72.54512938 56.68527079 
Q2FY63 SAOUHSC_01602 1.068484318 2.22E-09 8.12E-09 66.14724616 58.97242464 63.68435747 135.9112613 133.3261837 147.1404901 
Q2G2K6 ureB -1.272000114 2.75E-09 9.97E-09 120.8897947 135.7301837 126.3415479 51.93357138 58.82037517 34.97601814 
Q2G056 SAOUHSC_00766 1.602824259 4.69E-09 1.67E-08 22.80939523 22.46568558 13.35317173 69.61308504 59.80071476 89.24914975 
Q2G1M7 SAOUHSC_00081 1.011859852 8.33E-09 2.91E-08 91.99789408 74.88561859 81.14619742 187.8448326 170.579088 164.0254644 
Q2FV53 SAOUHSC_02886 1.967934213 8.48E-09 2.96E-08 22.04908205 5.616421394 13.35317173 72.92799385 90.19124193 107.3401936 
Q2G2A2 SAOUHSC_01044 1.933160819 1.28E-08 4.41E-08 3.801565871 5.616421394 15.40750584 68.50811543 44.11528138 43.41850528 
Q2FV35 SAOUHSC_02904 -1.054159669 1.84E-08 6.26E-08 124.6913606 140.4105349 118.1242114 60.77332821 59.80071476 54.2731316 
Q2FV74 clpL -1.149556589 2.52E-08 8.48E-08 2242.163551 1653.10003 3191.408043 935.9092544 1035.238603 1007.068109 
Q2FZZ3 SAOUHSC_00841 1.819282916 2.97E-08 9.95E-08 20.5284557 10.29677256 12.32600467 55.24848019 83.32886483 92.86735852 
Q2FZC2 SAOUHSC_01110 1.294367224 3.34E-08 1.11E-07 60.06474076 68.33312696 55.46702102 170.165319 162.7363713 174.8800907 
Q2FZK9 SAOUHSC_00992 1.221395472 3.41E-08 1.14E-07 34.21409284 42.12316046 33.89651285 91.71247711 102.9356566 85.63094098 
Q2FXN1 SAOUHSC_01804 1.485670025 0.0000001 3.23E-07 25.85064792 16.84926418 18.48900701 69.61308504 67.64343145 69.95203629 
Q9EYW6 sspC 1.528459093 1.04E-07 3.35E-07 15.96657666 25.27389627 16.4346729 75.13793306 57.84003559 77.18845384 
Q2G0V1 SAOUHSC_00424 1.332247004 0.00000011 3.53E-07 29.6522138 32.76245813 23.62484229 77.34787226 78.4271669 94.07342811 
Q2G1K9 SAOUHSC_00113 -1.80264562 1.44E-07 4.56E-07 1208.897947 823.7418045 3701.91007 352.4853036 325.4727426 358.2026686 
Q2FUX7 arcA -1.51362298 1.57E-07 4.94E-07 83.63444917 68.33312696 174.6183995 24.30933128 27.44950841 38.59422692 
Q2G1I1 SAOUHSC_00142 1.091035845 1.59E-07 5.03E-07 93.51852043 101.0955851 171.5368983 270.7175529 300.964253 253.2746142 
Q2FVI8 SAOUHSC_02722 -1.226358369 1.61E-07 5.08E-07 136.0960582 90.79881254 94.49936915 37.56896653 49.01697931 37.38815733 
Q2FZB9 SAOUHSC_01113 1.338971927 3.87E-07 0.00000118 98.84071265 45.86744139 32.86934579 160.2205925 183.3235026 186.9407866 
Q2G1K4 SAOUHSC_00118 -1.003301246 4.73E-07 0.00000143 285.8777535 268.6521567 288.6339427 106.077082 152.9329755 138.698003 
Q2FUX9 SAOUHSC_02967 -1.071408738 5.39E-07 0.00000162 145.9801295 136.6662539 205.4334112 50.82860177 88.23056276 75.98238425 
Q2G1J6 SAOUHSC_00126 -1.012910008 0.00000057 0.0000017 141.4182504 149.7712372 164.346729 66.29817623 87.25022317 57.89134038 
Q2G1J8 SAOUHSC_00124 -1.163273174 0.00000085 0.00000249 164.2276456 110.4562874 87.30919976 50.82860177 49.01697931 48.24278365 
Q2G1W1 SAOUHSC_02576 1.294622068 0.00000126 0.0000036 1402.017493 1680.246067 1501.718236 4322.64109 4323.297575 4476.930323 
Q2FWG3 thiE 1.086937438 0.00000139 0.00000395 31.17284014 47.73958185 43.14101635 101.6572035 87.25022317 90.45521934 
Q2G187 SAOUHSC_00259 -1.053689154 0.0000014 0.00000399 79.83288329 96.41523393 91.41786798 34.25405772 41.17426262 43.41850528 
Q2G132 SAOUHSC_00324 -1.083791675 0.00000246 0.0000068 107.2041576 88.92667207 89.36353387 40.88387534 49.01697931 32.56387896 
Q2FXB9 SAOUHSC_01945 -1.086262496 0.00000392 0.0000106 99.60102582 76.75775905 71.90169392 33.14908811 38.23324386 36.18208774 
Q2FXW8 SAOUHSC_01712 1.114256841 0.00000448 0.000012 81.35350964 75.82168882 78.06469625 198.8945287 174.5004463 189.3529258 
Q2FYW2 SAOUHSC_01312 1.086783598 0.00000703 0.0000185 36.49503236 31.8263879 34.9236799 76.24290266 81.36818566 84.42487138 
Q2FZS6 SAOUHSC_00914 1.320304785 0.00000715 0.0000188 19.76814253 31.8263879 16.4346729 57.4584194 85.289544 63.92168833 
Q2FXX0 SAOUHSC_01710 1.141760941 0.00000804 0.0000211 38.01565871 43.05923069 40.05951518 118.2317476 94.11260028 86.83701057 
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P02976 spa 1.011597074 0.00000829 0.0000217 1646.078022 2958.918004 3718.344743 5986.725313 6267.310975 6011.050843 
Q9RQP7 icaB -1.04248055 0.0000167 0.0000423 62.34568029 110.4562874 73.95602803 39.77890574 31.37086676 34.97601814 
Q2FW51 SAOUHSC_02466 -1.237651627 0.000032 0.0000783 60.06474076 55.22814371 78.06469625 19.88945287 24.50848966 21.70925264 
P31337 SAOUHSC_01763 1.127595232 0.0000993 0.00023103 25.09033475 19.65747488 18.48900701 58.563389 54.89901683 48.24278365 
Q2FXE3 SAOUHSC_01906 1.409912334 0.00011289 0.00026146 7.603131742 4.680351162 5.13583528 28.7292097 24.50848966 27.7396006 
Q2FUX8 argF -1.130361298 0.00012627 0.0002904 79.07257012 64.58884603 168.4553972 27.62424009 43.13494179 48.24278365 
Q2G1L9 SAOUHSC_00103 1.00467535 0.00016994 0.00038502 27.37127427 31.8263879 35.95084696 71.82302424 86.26988359 54.2731316 
Q2G0G9 SAOUHSC_00599 -1.115090231 0.00021142 0.00047422 130.773866 101.0955851 72.92886097 41.98884494 32.35120635 44.62457487 
Q2FUR2 SAOUHSC_03041 -1.101836683 0.00027051 0.00059747 88.95664139 47.73958185 53.41268691 26.51927049 20.58713131 26.53353101 
Q2FZM7 SAOUHSC_00973 -1.271171244 0.00027602 0.00060847 101.1216522 49.61172232 27.73351051 17.67951366 4.901697931 22.91532223 
Q2FVY9 sarV -1.225773809 0.00029616 0.00065036 145.2198163 38.37887953 50.33118574 25.41430089 14.70509379 31.35780937 
Q2FYX0 SAOUHSC_01303 1.020857984 0.00036454 0.0007914 15.96657666 23.40175581 14.38033878 44.19878415 41.17426262 41.0063661 
Q2FVR2 SAOUHSC_02639 -1.261913855 0.00075842 0.00158623 36.49503236 15.91319395 18.48900701 3.314908811 4.901697931 6.030347956 
Q2FZB7 SAOUHSC_01115 1.020789873 0.00177697 0.00354264 19.76814253 14.04105349 8.217336448 47.51369296 37.25290428 26.53353101 
Q2FV43 SAOUHSC_02896 -1.025855223 0.00207244 0.00409827 28.89190062 37.44280929 15.40750584 6.629817623 9.803395862 13.2667655 
Q2FUT6 hisZ -1.064286594 0.00218713 0.00429903 24.33002158 24.33782604 31.84217873 15.46957445 6.862377104 6.030347956 
Q2FVE3 SAOUHSC_02771 -1.016410671 0.00613419 0.01124519 80.59319647 17.78533441 23.62484229 11.04969604 6.862377104 20.50318305 










A0A0H2WXF8 mecA -12.30828595 0 0 99804.5093 100391.5559 111770.9285 1.734166628 2.044613367 
Q2FZZ6 SAOUHSC_00838 -3.005175298 1.25E-294 1.43E-291 4921.062859 4877.958063 4524.068837 620.8316527 532.6217821 
Q2G253 SAOUHSC_00025 -2.249989343 6.18E-172 4.71E-169 3716.294879 3916.385274 3821.923345 824.5962314 748.3284923 
Q2G035 SAOUHSC_00792 -2.290219433 1.62E-156 9.24E-154 4926.374887 5062.572141 4317.647445 993.6774776 910.875255 
O50581 recG -1.608259941 1.28E-127 5.86E-125 4454.666789 4428.763382 4173.77799 1415.947051 1412.827837 
Q2FVH5 SAOUHSC_02737 -1.349989637 1.58E-126 6.02E-124 3729.043747 3825.559096 3651.469317 1420.282468 1497.679291 
Q2FXV8 recD2 1.291418593 5.51E-110 1.80E-107 2097.188705 2122.568273 2078.288104 5201.632799 5135.046471 
Q2FZ64 SAOUHSC_01187 1.139194721 1.82E-108 5.19E-106 4340.989387 4557.10472 4366.125196 9627.226033 9933.754043 
Q2G239 SAOUHSC_00708 1.150421385 1.63E-97 4.13E-95 4879.629039 4605.479532 4943.166814 10656.45393 10778.17936 
Q2G0Y8 SAOUHSC_00373 1.545982585 2.43E-97 5.55E-95 2794.126796 2553.992615 2597.46918 7976.299404 7664.233206 
Q2FY54 SAOUHSC_01611 1.104248758 6.45E-93 1.34E-90 3063.977825 2933.093181 2922.739252 6513.529853 6328.078371 
Q2G105 SAOUHSC_00356 -2.379971635 4.16E-91 7.92E-89 9017.698952 9264.27008 9437.52348 1800.932043 1594.798426 
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Q2FZ77 pyrR 2.254404673 1.83E-76 3.23E-74 489.7689935 478.8119127 364.3650325 1960.475372 2501.584454 
Q2G2J9 SAOUHSC_01412 1.431983508 5.04E-75 8.22E-73 745.8087493 764.1245782 800.6647924 2056.72162 2137.643275 
Q2G0Y7 guaB 1.087521659 5.36E-68 7.94E-66 8795.656176 9132.96702 9027.808294 19270.05957 19130.42497 
Q2G0Y6 guaA 1.290512932 5.56E-68 7.94E-66 7692.879137 7762.676432 7643.84669 19003.86499 19022.06046 
Q2FY14 SAOUHSC_01660 1.259476832 5.65E-66 7.60E-64 898.7951595 865.8104071 967.9912236 2244.011616 2138.665582 
Q2FY61 SAOUHSC_01604 -1.700942815 6.85E-66 8.70E-64 1307.821325 1433.474015 1279.18711 398.8583243 407.9003667 
Q2G0E5 SAOUHSC_00661 1.507177354 1.76E-63 2.02E-61 443.023146 417.6029672 409.7151867 1261.606222 1185.875753 
Q2G2N5 SAOUHSC_01354 1.109413257 2.24E-63 2.43E-61 2932.239527 2884.718369 2760.104216 6051.374447 6371.015251 
Q2FZU6 rocD -1.846596032 4.24E-59 4.10E-57 989.0996377 950.713138 1169.72122 254.0554109 301.5804716 
Q2G245 SAOUHSC_01854 -1.002780358 4.30E-59 4.10E-57 15840.46788 17199.7137 15326.78834 8001.44482 8008.750558 
Q2FZD0 uvrC -1.184514378 5.81E-59 5.31E-57 3228.650697 3234.201703 2813.273362 1312.764137 1389.314783 
Q2G171 SAOUHSC_00282 1.198691271 8.10E-58 7.12E-56 759.6200225 712.7880433 700.5816933 1648.32538 1711.341388 
Q2FVE1 SAOUHSC_02773 1.136675118 1.34E-57 1.14E-55 1582.984382 1670.411869 1490.299897 3450.124506 3570.917245 
Q2FUQ2 mnmE -1.108378442 1.88E-57 1.54E-55 6433.92847 6416.07963 5615.600136 2901.260768 2770.451112 
Q2FZD3 mutS2 1.222250122 6.44E-56 4.90E-54 1982.448898 1974.482114 1874.994309 4786.299892 4374.450299 
Q2G2J8 SAOUHSC_01413 1.260455685 8.03E-55 5.92E-53 462.1464472 450.1819221 487.9051079 1156.689141 1093.868151 
Q2G0Y9 xpt 1.406644665 9.64E-54 6.89E-52 652.3170543 650.5918567 591.1158037 1728.097044 1679.649881 
Q2G019 SAOUHSC_00808 -1.512842833 2.43E-53 1.68E-51 1867.70909 1726.684609 1609.148577 639.0404023 552.0456091 
Q2FUQ1 rnpA -1.517683167 3.48E-53 2.34E-51 799.9914363 797.6907742 760.0060334 269.6629106 267.8443511 
Q2FXE2 SAOUHSC_01907 -1.213174666 2.17E-52 1.38E-50 1384.31453 1330.800945 1244.783544 574.0091537 554.0902224 
Q2FXW6 udk 1.10144833 2.47E-52 1.52E-50 2083.377432 2075.180702 1884.377099 4411.719901 4308.000364 
Q2G1S4 SAOUHSC_00018 1.360596407 1.73E-50 1.04E-48 3046.979335 3187.801374 3764.062803 8843.382717 8496.390846 
Q2FUX4 SAOUHSC_02971 -1.757339969 1.12E-46 6.22E-45 698.0004962 701.9283916 673.9971201 218.5049951 171.7475228 
Q2G0Q7 SAOUHSC_00489 -1.378996178 2.07E-45 1.10E-43 1324.819815 1415.703676 1382.397806 523.7183215 514.2202618 
Q2G170 SAOUHSC_00284 -1.378936559 2.17E-44 1.08E-42 2274.610445 2341.735788 2108.000274 908.7033129 785.1315329 
Q2FVI5 SAOUHSC_02725 1.099845164 5.65E-44 2.75E-42 1103.839445 1085.965163 1130.62626 2224.0687 2560.878242 
Q9RQP9 icaA -2.933945657 4.06E-43 1.89E-41 655.5042711 611.1022144 785.0268082 91.04374795 52.13764086 
Q2G1W4 metK 1.203743499 8.56E-43 3.84E-41 3228.650697 3324.040639 2677.2229 7287.835252 7080.49609 
Q2FYF4 SAOUHSC_01497 -1.002979565 8.02E-42 3.40E-40 2986.422214 3005.161778 3334.018237 1520.864132 1555.950772 
Q2FZ65 SAOUHSC_01186 1.006379128 1.65E-41 6.84E-40 1026.283835 1098.799297 991.4481999 2120.885786 2091.639474 
Q2FYM1 odhA -1.019571751 9.00E-41 3.67E-39 3625.990401 3759.413946 4086.205278 1927.526207 1809.48283 
Q2FXL6 SAOUHSC_01819 -1.541069431 4.16E-39 1.64E-37 1887.894797 1930.056267 2505.205073 684.1287346 719.7039052 
Q2FYI3 SAOUHSC_01464 -1.349506098 9.38E-38 3.58E-36 1110.213879 1002.049673 1057.127734 395.3899911 418.1234335 
Q2FWX1 SAOUHSC_02150 -1.409778776 1.09E-37 4.10E-36 4389.860046 4820.698082 5912.721836 1967.412039 1739.965975 
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Q2FZ76 SAOUHSC_01165 1.679553487 1.03E-36 3.58E-35 351.6562622 360.3429859 298.6854987 1004.082477 1253.347994 
Q2G023 smpB 1.054869081 7.22E-36 2.43E-34 576.8862548 624.9235892 680.2523138 1343.112053 1275.838741 
Q2FYZ3 SAOUHSC_01279 -1.410261136 1.01E-35 3.35E-34 699.0629018 610.1149733 619.2641754 235.8466614 236.1528439 
Q2FXM0 SAOUHSC_01815 -1.07865466 7.13E-35 2.20E-33 3031.043251 2997.26385 3549.822419 1508.724966 1478.255464 
P72360 scdA -1.624964411 3.78E-34 1.14E-32 664.0035161 707.851838 664.6143296 226.3087449 195.2605765 
Q2G2J3 SAOUHSC_02573 1.111391757 4.56E-33 1.32E-31 1277.011562 1188.638233 1044.617346 2604.718275 2525.097508 
Q2FYZ0 SAOUHSC_01282 -1.006909424 1.86E-30 4.83E-29 2198.11724 2371.353019 2314.421665 1176.632057 1083.645084 
Q2FZ74 pyrC 1.175800792 1.91E-30 4.90E-29 683.1268174 679.2218473 525.43627 1409.010385 1499.723905 
Q2G2K5 ureC 1.051124564 2.93E-30 7.37E-29 437.7111178 433.3988241 417.5341788 917.374146 885.3175879 
Q2FZ71 pyrF 1.422523242 9.18E-30 2.26E-28 224.1675871 247.7975053 234.5697634 585.2812368 717.6592918 
Q2FWL3 SAOUHSC_02276 -1.165580207 1.21E-29 2.87E-28 1122.962747 1098.799297 935.1514567 491.6362389 432.4357271 
Q2G0M5 SAOUHSC_00535 1.106624567 1.63E-27 3.54E-26 348.4690453 381.0750481 356.5460404 795.9824821 788.1984529 
Q2G200 SAOUHSC_00941 -1.377709571 2.47E-27 5.23E-26 632.1313474 684.1580526 580.1692148 259.2579108 212.6397902 
Q2FZZ4 SAOUHSC_00840 -1.760031922 2.59E-26 5.30E-25 321.9089046 330.7257541 293.9941035 85.84124807 86.89606809 
Q2FZ75 pyrB 1.351514282 8.48E-26 1.67E-24 339.9698003 334.6747184 245.5163524 753.4953997 875.094521 
Q2G1G0 SAOUHSC_00164 -1.181281302 1.32E-24 2.48E-23 606.6336124 618.0129018 689.6351044 295.67541 252.5097508 
Q2G176 SAOUHSC_00271 -1.287957371 4.53E-24 8.22E-23 738.37191 735.4945876 597.3709974 279.200827 271.9335778 
Q2G0P8 ctsR -1.238832836 1.23E-23 2.16E-22 852.0493119 726.6094181 691.1989028 323.422076 302.6027783 
Q2FVN8 SAOUHSC_02664 -1.033136625 1.58E-23 2.76E-22 1226.016092 1061.284136 1171.285019 535.8574879 575.5586628 
Q2G012 emp -1.73179278 2.11E-23 3.63E-22 365.4675353 337.6364415 472.2671236 108.3854142 109.3868151 
Q2FV87 glcB 1.01617885 2.10E-23 3.63E-22 1291.885241 1309.081642 1618.531367 2837.963686 2913.574048 
Q2FWB1 SAOUHSC_02387 -1.035012929 1.98E-22 3.19E-21 1408.74986 1470.989175 1488.736098 684.1287346 714.5923717 
Q2G145 SAOUHSC_00310 -1.164328815 2.60E-22 4.12E-21 553.5133311 572.5998131 459.7567362 225.4416616 238.1974572 
Q2FY36 SAOUHSC_01630 -1.113879439 2.70E-22 4.25E-21 1132.524397 1019.820012 936.7152551 473.4274893 461.0603142 
Q2G177 SAOUHSC_00270 -1.942700618 4.02E-22 6.25E-21 839.3004444 654.5408209 542.6380526 163.011663 149.2567758 
Q2G252 rlmH -1.352986385 3.01E-21 4.46E-20 414.3381941 429.4498599 514.489681 186.4229125 151.3013892 
Q2FW52 SAOUHSC_02465 -1.034980263 6.16E-21 8.86E-20 665.0659218 598.2680806 672.4333217 306.0804098 312.8258451 
Q2G1F9 SAOUHSC_00166 -1.25650025 2.04E-20 2.87E-19 424.9622503 392.9219407 491.0327047 185.5558292 165.6136827 
Q2G2E9 SAOUHSC_00030 -1.075221862 1.06E-19 1.44E-18 1945.264701 1556.879147 1566.926019 844.5391476 726.8600519 
Q2FVG2 SAOUHSC_02752 1.006249499 1.73E-19 2.27E-18 1145.273265 1083.990681 827.2493656 2017.702871 2157.067102 
Q2G0W4 SAOUHSC_00410 1.051446014 3.45E-19 4.42E-18 420.7126278 391.9346997 426.9169694 887.02623 856.6930007 
Q2FUZ9 SAOUHSC_02945 1.110100873 2.09E-18 2.56E-17 303.848009 264.5806033 279.9199176 616.4962361 633.8301437 
Q2G249 SAOUHSC_00026 -1.250853891 4.63E-18 5.58E-17 446.2103629 491.6460465 581.7330132 187.2899958 221.8405503 
Q2FVL5 SAOUHSC_02696 -1.252717292 1.41E-17 1.64E-16 588.5727167 523.2377603 409.7151867 178.6191626 233.0859238 
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Q2FVB4 SAOUHSC_02820 -2.001039423 1.66E-17 1.92E-16 480.2073429 392.9219407 222.059376 71.10083173 81.78453468 
Q2FY13 SAOUHSC_01661 1.033636346 8.72E-17 9.72E-16 436.6487122 377.1260838 364.3650325 832.3999812 812.7338133 
Q9RQP7 icaB -2.137455866 1.14E-16 1.25E-15 173.172117 145.1244354 236.1335618 35.55041587 28.62458714 
Q2FYV4 SAOUHSC_01320 -1.218913188 1.97E-16 2.10E-15 650.192243 598.2680806 835.0683577 307.8145764 266.8220444 
Q2FZC0 flr -2.135104769 3.78E-16 3.96E-15 168.9224945 103.660311 168.8902296 23.41124947 26.57997377 
Q2FWF6 SAOUHSC_02335 -1.142805294 7.99E-16 8.05E-15 507.8298891 455.1181273 423.7893725 203.7645787 202.4167233 
Q2G194 SAOUHSC_00251 -1.288794636 1.31E-15 1.30E-14 1326.944627 1221.217188 802.2285908 466.4908228 402.7888333 
Q2G185 essB -1.015088988 3.86E-15 3.65E-14 438.7735235 455.1181273 444.118752 228.0429115 203.43903 
Q2G196 SAOUHSC_00249 -1.055176264 4.77E-15 4.46E-14 1096.402606 1181.727545 774.0802192 503.7754053 450.8372474 
Q2G0L5 sdrC 1.007749484 7.42E-15 6.87E-14 1012.472561 997.1134677 1124.371066 2004.696621 2290.989278 
Q2G201 SAOUHSC_00940 -1.165511529 2.53E-14 2.23E-13 431.3366841 395.8836639 351.8546451 187.2899958 150.2790825 
Q2G1T3 SAOUHSC_00831 -1.643953877 3.31E-14 2.89E-13 161.4856551 152.0351228 217.3679807 48.55666557 52.13764086 
Q2FY81 SAOUHSC_01584 -1.002177115 5.82E-14 4.96E-13 738.37191 738.4563108 794.4095987 414.465824 318.9596852 
Q2G155 lip2 -1.064764183 8.43E-14 7.09E-13 3120.285323 3227.291016 4719.543639 1850.355792 1573.329986 
Q2FUQ8 SAOUHSC_03046 -2.464046344 2.78E-12 2.00E-11 475.9577204 589.3829111 1804.62338 62.42999859 77.69530794 
Q2FYT5 SAOUHSC_01340 -1.171882968 6.02E-12 4.23E-11 1094.277795 913.1979779 764.6974287 377.1812415 404.8334466 
Q2G0E3 SAOUHSC_00662 1.105234695 6.52E-12 4.57E-11 167.8600889 170.7927029 181.400617 435.2758235 337.3612055 
Q2G1N4 SAOUHSC_00074 -1.186251596 7.41E-12 5.18E-11 1892.14442 1940.915918 1118.115872 683.2616513 695.1685448 
Q2FWH7 SAOUHSC_02314 -1.027890366 1.03E-11 7.12E-11 436.6487122 436.3605473 511.3620842 215.9037451 218.7736303 
Q2G021 SAOUHSC_00806 -2.104680421 1.76E-11 1.18E-10 229.4796152 133.2775427 143.8694549 22.54416616 24.5353604 
Q2FW05 SAOUHSC_02515 -1.584296953 6.09E-11 3.88E-10 619.3824799 393.9091818 406.5875899 126.5941638 143.1229357 
Q2G0F7 SAOUHSC_00612 -1.559343159 1.20E-10 7.39E-10 98.8037232 81.94100774 89.13651009 24.27833279 26.57997377 
Q2G0Y5 SAOUHSC_00376 -1.451727906 1.93E-10 1.17E-09 147.674382 138.213748 107.9020912 38.15166581 47.02610744 
Q2FXE9 SAOUHSC_01900 -1.363296171 2.87E-10 1.68E-09 162.5480608 147.0989175 115.7210833 49.42374889 50.09302749 
Q2FZB9 SAOUHSC_01113 -1.820829621 2.94E-10 1.72E-09 226.2923983 167.8309797 140.741858 34.68333255 38.84765397 
Q2G195 SAOUHSC_00250 -1.052965044 5.79E-10 3.29E-09 941.2913845 914.1852189 586.4244085 425.7379071 324.0712187 
Q2G140 mepA 1.0321159 8.33E-10 4.64E-09 96.67891195 92.80065937 93.82790536 197.6949955 204.4613367 
Q2G057 SAOUHSC_00765 -1.322486676 9.63E-10 5.30E-09 145.5495707 128.3413374 95.39170378 39.01874912 50.09302749 
Q2G1K6 SAOUHSC_00116 -1.39569134 1.00E-09 5.50E-09 144.4871651 154.996846 236.1335618 65.89833185 52.13764086 
Q2FXK4 SAOUHSC_01830 -1.072376994 1.19E-09 6.51E-09 248.6029164 246.8102643 214.2403839 121.3916639 92.00760151 
Q2G1T5 SAOUHSC_02802 1.549663114 1.21E-09 6.60E-09 742.6215325 697.9794274 1390.216798 3677.300334 2883.927154 
Q2FY39 SAOUHSC_01627 -1.070586639 1.66E-09 8.86E-09 1286.573213 1075.105511 1038.362153 540.1929045 489.6849014 
Q2FV35 SAOUHSC_02904 1.210756578 2.27E-09 1.20E-08 64.80674318 65.15790977 50.04154952 152.6066632 149.2567758 
Q2FY63 SAOUHSC_01602 -1.223281053 2.58E-09 1.36E-08 143.4247595 133.2775427 109.4658896 53.75916546 48.04841412 
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Q2FZZ3 SAOUHSC_00841 -2.082156438 3.27E-09 1.71E-08 75.43079943 48.3748118 26.58457318 5.202499883 1.022306683 
Q9F0R1 sarR -1.437144776 4.34E-09 2.25E-08 362.2803184 268.5295675 200.1661981 114.4549974 65.42762774 
Q2FVB3 SAOUHSC_02821 -1.37609477 4.56E-09 2.35E-08 283.6623021 254.7081927 143.8694549 92.77791458 63.38301437 
Q2G016 SAOUHSC_00811 -1.112018866 6.56E-09 3.29E-08 1129.33718 1086.952404 545.7656495 401.4595743 402.7888333 
Q2FXQ8 engB -1.076456908 6.88E-09 3.44E-08 650.192243 483.748118 415.9703804 235.8466614 226.9520837 
Q2G1N1 SAOUHSC_00077 -1.277110574 7.1E-09 3.54E-08 225.2299927 222.1292379 112.5934864 73.70208167 64.40532106 
Q2FWH6 SAOUHSC_02315 -1.15576589 9.8E-09 4.83E-08 151.9240045 132.2903017 146.9970517 58.96166534 58.27148096 
Q2G2Y3 SAOUHSC_01919 1.113828946 1.65E-08 7.94E-08 388.8404591 327.764031 669.3057249 987.6078944 1132.715805 
Q2G1K8 SAOUHSC_00114 -1.286637599 2.04E-08 9.7E-08 122.176647 139.2009891 222.059376 58.96166534 56.22686759 
Q2FX11 SAOUHSC_02096 -1.361016472 2.5E-08 1.17E-07 195.4826352 125.3796143 153.2522454 43.35416569 64.40532106 
Q2G017 SAOUHSC_00810 -1.324035112 1.06E-07 4.69E-07 139.175137 129.3285785 81.31751798 41.61999906 40.89226734 
Q2G1K7 SAOUHSC_00115 -1.292382362 1.27E-07 5.59E-07 109.4277795 125.3796143 200.1661981 51.15791551 50.09302749 
Q2G1A1 SAOUHSC_00244 -1.622928728 1.35E-07 5.92E-07 307.0352259 227.0654431 176.7092218 71.96791504 37.82534729 
Q2FXB3 SAOUHSC_01952 -1.10977957 2.04E-07 8.65E-07 162.5480608 142.1627122 143.8694549 68.49958179 59.29378764 
Q9RQP6 icaC -1.443641274 0.00000024 0.00000101 241.1660771 138.213748 145.4332533 59.82874865 44.98149407 
Q2FV74 clpL -1.164706866 2.71E-07 0.00000112 1393.876181 1408.792989 1920.344463 629.5024858 634.8524504 
Q2FVA8 SAOUHSC_02825 -1.189432691 3.05E-07 0.00000125 103.0533457 103.660311 106.3382927 38.15166581 43.95918739 
Q2G0W9 SAOUHSC_00405 -1.066591565 4.15E-07 0.00000167 483.3945598 309.0064509 353.4184435 199.4291622 139.033709 
Q2G1K5 SAOUHSC_00117 -1.034575811 4.27E-07 0.00000171 288.9743302 323.8150667 542.6380526 182.0874959 165.6136827 
Q2G0M0 SAOUHSC_00540 -1.346586355 9.42E-07 0.0000036 456.8344191 259.644398 198.6023997 105.7841643 97.11913493 
Q2FYI5 gpsB -1.22788072 9.51E-07 0.00000362 183.7961733 132.2903017 129.7952691 63.29708191 48.04841412 
Q2FWG0 tenA -1.108407358 0.00000155 0.00000578 88.17966694 91.81341832 109.4658896 45.95541563 33.73612055 
Q2FZ03 SAOUHSC_01268 -1.19875322 0.00000303 0.000011 66.93155443 69.106874 68.80713059 30.34791598 20.44613367 
Q2G1U4 SAOUHSC_00936 -1.134214364 0.00000372 0.0000134 121.1142413 85.88997197 62.5519369 33.81624924 38.84765397 
Q2G2N7 SAOUHSC_02250 1.517097175 0.0000046 0.0000163 19.12330127 10.85965163 6.25519369 57.22749871 49.07072081 
Q2G1I2 SAOUHSC_00141 -1.081521362 0.00000666 0.000023 164.672872 118.4689269 175.1454233 69.3666651 59.29378764 
Q2FWX0 SAOUHSC_02151 -1.049838491 0.00000707 0.0000244 531.2028129 387.9857355 364.3650325 199.4291622 175.8367496 
Q2FV70 SAOUHSC_02866 1.175501365 0.00000865 0.0000294 818.0523319 869.7593714 1834.33555 3192.600761 2947.310168 
Q2FYV5 SAOUHSC_01319 -1.081336017 0.0000103 0.0000346 103.0533457 88.85169514 89.13651009 45.08833232 33.73612055 
Q2G132 SAOUHSC_00324 1.070196842 0.000012 0.0000398 58.43230942 57.25998131 32.83976687 109.2524975 125.7437221 
Q2FXN1 SAOUHSC_01804 -1.372038606 0.0000145 0.0000475 43.55863066 46.40032969 29.71217003 10.40499977 11.24537352 
Q2FV53 SAOUHSC_02886 -1.546038223 0.0000169 0.0000546 66.93155443 23.69378537 37.53116214 9.537916452 2.044613367 
Q2FZ85 SAOUHSC_01155 -1.084084226 0.0000254 0.0000802 521.6411623 288.2743887 254.8991429 147.4041633 149.2567758 
Q2FZM7 SAOUHSC_00973 -1.494104072 0.0000286 0.0000894 219.9179645 86.87721303 95.39170378 28.61374936 31.69150719 
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Q2FWA5 SAOUHSC_02393 -1.029207923 0.0000337 0.00010461 310.2224427 209.2951041 184.5282139 99.71458109 109.3868151 
Q2G1E3 SAOUHSC_00182 -1.145574991 0.0000343 0.00010634 234.7916433 155.984087 148.5608501 98.84749777 42.93688071 
Q2G1N3 sbnA -1.213267377 0.0000429 0.00013075 48.87065879 77.99204352 28.14837161 15.60749965 18.4015203 
Q2G1N2 SAOUHSC_00076 -1.127618086 0.0000509 0.00015351 106.2405626 107.6092752 39.09496057 32.08208261 31.69150719 
Q2G2Y4 SAOUHSC_01918 1.136778125 0.0000553 0.00016574 288.9743302 276.427496 656.7953375 978.069978 1129.648885 
Q2FV37 SAOUHSC_02902 1.241405944 0.0000642 0.00019007 26.56014065 13.8213748 10.94658896 52.02499883 53.15994754 
Q2FVC8 SAOUHSC_02785 1.148310173 0.0000721 0.00021186 25.49773502 25.66826749 15.63798423 65.03124853 55.20456091 
Q2G0X2 SAOUHSC_00401 -1.237383075 0.0000911 0.00026355 75.43079943 87.86445409 226.7507713 52.02499883 31.69150719 
Q2FXE0 SAOUHSC_01923 -1.055802167 0.00010362 0.00029537 110.4901851 76.0175614 65.67953375 28.61374936 41.91457402 
Q2FVE0 SAOUHSC_02774 -1.252200217 0.00011297 0.00031962 640.6305924 472.8884664 752.1870413 183.8216625 203.43903 
Q2G0V1 SAOUHSC_00424 -1.074539716 0.0001138 0.00032155 48.87065879 85.88997197 54.73294479 26.01249941 24.5353604 
Q2FZL0 SAOUHSC_00991 -1.240841072 0.00029866 0.00078206 1461.870141 917.1469421 548.8932463 266.1945773 302.6027783 
Q2G0G9 SAOUHSC_00599 -1.139753374 0.00047116 0.00118455 103.0533457 49.36205286 40.65875899 25.1454161 17.37921362 
Q2FZS7 SAOUHSC_00913 -1.006207333 0.00079698 0.0019444 54.18268692 51.33653497 37.53116214 22.54416616 17.37921362 
Q2FVE3 SAOUHSC_02771 -1.246993595 0.00084624 0.00205799 61.6195263 21.71930326 31.27596845 6.069583197 6.133840101 
Q2G2F9 SAOUHSC_00718 -1.208685793 0.00111015 0.00266297 875.4222357 435.3733062 289.3027082 97.98041446 121.6544953 
Q2FYG3 SAOUHSC_01489 -1.205738433 0.00119155 0.00284033 11.68646188 11.84689269 15.63798423 2.601249941 0 
Q2FY44 SAOUHSC_01622 -1.049966658 0.00155146 0.00362271 744.7463437 432.411583 461.3205347 194.2266623 206.5059501 
Q2FYW8 SAOUHSC_01305 -1.093828521 0.00186941 0.0043036 77.55561069 16.78309797 9.382790536 0.867083314 2.044613367 
Q2FW59 SAOUHSC_02458 -1.096491801 0.00239056 0.00541072 14.87367876 6.9106874 7.818992113 0.867083314 0 
Q2FZN9 SAOUHSC_00961 -1.011684026 0.00477113 0.01021902 22.31051814 19.74482114 17.20178265 7.803749824 4.089226734 
Q2G2B1 sarT -1.039547532 0.00516104 0.010975 29.74735752 21.71930326 17.20178265 7.803749824 4.089226734 





log2FC pvalue padj rpoB-1 rpoB-2 rpoB-3 rpoC-1 rpoC-2 rpoC-3 
Q2FW95 SAOUHSC_02404 1.857663103 3.73E-207 8.05E-204 1881.520363 1848.115259 1681.083304 6464.072182 6831.006237 6505.539375 
Q2G2J8 SAOUHSC_01413 1.72921063 7.55E-123 8.14E-120 462.1464472 450.1819221 487.9051079 1528.172962 1588.15013 1563.06619 
Q2FWD4 murA 1.390780982 1.08E-120 7.79E-118 4253.872126 4491.94681 3893.858072 11309.36389 11145.48076 10929.40264 
Q2FW76 SAOUHSC_02428 1.944538281 2.15E-114 1.16E-111 635.3185642 630.8470355 555.14844 2538.11518 2274.38784 2344.599285 
Q2G025 SAOUHSC_00802 1.226602946 8.64E-111 3.73E-108 2037.69399 2078.142425 1893.75989 4752.474266 4690.92492 4712.113893 
Q2G2J9 SAOUHSC_01412 1.584307468 7.88E-110 2.83E-107 745.8087493 764.1245782 800.6647924 2169.055332 2437.124211 2378.369234 
Q2FXT4 ruvB 1.172828624 1.56E-95 4.79E-93 3239.274753 3334.900291 2989.982584 7184.512364 7482.932062 7021.73716 
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Q2FXU7 SAOUHSC_01735 1.137243931 3.28E-94 8.85E-92 1942.077484 2098.874488 1961.003222 4408.828719 4377.216252 4485.37281 
Q2G024 rnr 1.095793805 9.59E-88 2.30E-85 6992.753829 7078.51838 7037.092902 15813.22 14952.13937 14535.55071 
Q2G082 SAOUHSC_00738 -1.72370508 6.08E-85 1.31E-82 5846.418159 5431.800296 7304.502432 1814.360089 1819.510272 1889.911049 
Q2FVX0 SAOUHSC_02553 1.960318613 3.89E-83 7.62E-81 448.3351741 451.1691631 367.4926293 1687.288585 1589.130469 1800.6619 
Q2FZD0 uvrC 1.113624604 4.52E-71 7.50E-69 3228.650697 3234.201703 2813.273362 6623.187805 6842.770312 6743.135084 
Q2FXT5 queA 1.125988391 1.89E-70 2.92E-68 3369.950645 3268.75514 2928.994446 6774.568641 7118.245736 7135.107702 
Q2G2M9 SAOUHSC_02003 1.033992741 2.38E-69 3.43E-67 2110.999979 2092.951041 2362.899417 4384.519388 4499.758701 4589.094795 
Q2FUX4 SAOUHSC_02971 1.65608146 5.37E-67 6.81E-65 698.0004962 701.9283916 673.9971201 2310.491441 2207.724748 2133.537107 
Q2FXT3 ruvA 1.109864246 1.37E-65 1.65E-63 1882.582769 1902.413517 1645.115941 3944.741485 3921.358345 3951.083981 
Q2FZF0 isdB 1.802811256 1.68E-65 1.91E-63 278.350274 269.5168086 251.771546 988.9477954 902.8927589 967.2678121 
Q2FXW4 SAOUHSC_01717 1.210870698 2.94E-64 3.17E-62 2317.10667 2489.821946 2201.828179 5331.478338 5574.210887 5462.289179 
Q2FXT1 obg 1.170979213 2.07E-62 2.12E-60 5102.734221 5136.61522 4339.540623 11397.76146 11108.22785 10588.08494 
Q2FW77 SAOUHSC_02427 1.693778895 1.09E-56 1.02E-54 571.5742267 545.9443046 428.4807678 1837.564451 1581.287753 1733.122003 
Q2G2J3 SAOUHSC_02573 1.314934394 1.59E-55 1.43E-53 1277.011562 1188.638233 1044.617346 2932.589328 2965.527248 2960.900846 
Q2G184 essC -1.043990035 8.40E-51 6.97E-49 1521.364856 1526.274674 1526.26726 703.8656376 767.605896 730.8781723 
Q2FZM6 SAOUHSC_00974 -2.129975092 1.42E-48 1.05E-46 876.4846413 876.6700588 1236.964552 193.3696807 219.5960673 225.5350136 
Q2FWH6 SAOUHSC_02315 2.339396392 6.91E-48 4.81E-46 151.9240045 132.2903017 146.9970517 779.0035706 720.5495959 829.7758787 
Q2FXQ3 SAOUHSC_01782 1.001596727 1.17E-47 7.89E-46 3583.494176 3532.348502 2939.941035 6819.872394 6824.14386 6640.619169 
Q2G188 esaA -1.097507495 2.09E-47 1.33E-45 1460.807736 1441.371943 1491.863695 664.0867319 643.1027686 730.8781723 
Q2FZ43 trmD 1.074059068 2.10E-47 1.33E-45 1603.170089 1667.450146 1538.777648 3481.759221 3409.621081 3320.309585 
Q2FXW3 SAOUHSC_01718 1.301060171 3.91E-47 2.35E-45 1445.934057 1287.362339 1086.839904 3013.252109 3076.305622 3478.304701 
Q2FXW5 SAOUHSC_01716 1.158437351 2.12E-46 1.24E-44 3467.691963 3442.509566 3172.946999 7865.17364 7511.36191 7359.436645 
Q2FX99 SAOUHSC_01978 1.291044686 1.21E-45 6.86E-44 1328.007032 1135.327216 1107.169283 2987.837809 2822.397669 3053.768205 
Q2FXL7 ald2 1.14790158 3.58E-43 1.98E-41 492.9562104 523.2377603 536.382859 1205.521838 1104.842714 1159.032877 
Q2FY23 SAOUHSC_01650 1.249027553 1.94E-42 1.05E-40 427.0870616 475.8501895 516.0534795 1099.444756 1144.056297 1156.620738 
Q2FXY9 SAOUHSC_01686 1.062287502 2.87E-42 1.51E-40 570.5118211 573.5870542 553.5846416 1228.726199 1129.351203 1222.954565 
Q2FUY3 SAOUHSC_02962 1.014640504 6.37E-40 3.27E-38 1063.468031 1151.123073 1144.700445 2224.303812 2307.719386 2297.562571 
Q2FZU7 SAOUHSC_00893 -1.00906718 4.81E-37 2.16E-35 1979.261681 2182.789977 1774.91121 1004.41737 989.1626425 938.322142 
Q9RQP9 icaA -2.386511441 2.25E-36 9.70E-35 655.5042711 611.1022144 785.0268082 133.7013221 107.8373545 106.134124 
Q2G2C1 SAOUHSC_01064 -1.181907697 1.17E-35 4.95E-34 14289.35567 14017.83577 11229.63647 5937.001681 5687.930279 5573.247581 
Q2FYV4 SAOUHSC_01320 -1.710553305 1.96E-35 8.14E-34 650.192243 598.2680806 835.0683577 196.6845895 207.8319923 202.6196913 
Q2FVX2 SAOUHSC_02551 1.085993056 4.08E-35 1.66E-33 495.0810216 474.8629485 456.6291394 1038.671428 992.1036613 1034.807709 
Q2G0I4 SAOUHSC_00581 1.017720074 2.59E-31 8.87E-30 516.3291342 536.071894 500.4154952 1091.709969 1025.435207 1063.753379 
Q2G0J2 SAOUHSC_00572 1.113037191 7.29E-30 2.38E-28 429.2118728 437.3477883 380.0030167 874.0309566 945.0473611 925.0553764 
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Q2FVG2 SAOUHSC_02752 1.142818266 7.45E-30 2.40E-28 1145.273265 1083.990681 827.2493656 2405.518827 2174.393202 2297.562571 
P0A0M9 SAOUHSC_00995 1.628704809 1.65E-29 5.17E-28 138.1127314 146.1116765 142.3056565 437.5679631 448.9955305 488.4581844 
Q2G2G3 mntH 1.076192827 9.87E-26 2.54E-24 402.6517322 356.3940216 293.9941035 767.9538746 746.0384251 757.4117033 
Q2FYQ2 SAOUHSC_01383 -1.120125694 3.87E-25 9.49E-24 5249.346197 5267.918281 7446.808088 2703.86062 2716.520993 2699.183745 
Q2FWZ8 ftnA -1.033337659 1.47E-23 3.48E-22 2268.236011 2498.707116 2204.955776 1085.080151 1205.817691 1067.371588 
Q2G1F2 azoR -1.781985998 1.68E-23 3.93E-22 199.7322577 179.6778724 236.1335618 49.72363217 52.93833766 59.09740997 
Q2FV72 SAOUHSC_02864 1.087132223 2.06E-23 4.78E-22 223.1051814 222.1292379 228.3145697 483.9766864 460.7596055 510.1674371 
Q2FYV3 SAOUHSC_01321 -1.423931837 4.63E-23 1.04E-21 428.1494672 395.8836639 506.6706889 156.9056837 144.1099192 174.8800907 
Q2G190 SAOUHSC_00256 -1.164522068 4.44E-22 9.13E-21 464.2712585 462.0288147 544.2018511 216.5740423 205.8713131 215.8864568 
Q2FWY4 sdcS -1.05642676 7.49E-22 1.51E-20 475.9577204 445.2457168 514.489681 222.0988904 244.104557 207.4439697 
Q2FWN0 SAOUHSC_02258 -1.158045935 1.18E-20 2.19E-19 423.8998447 439.3222704 475.3947205 182.3199846 197.0482568 205.0318305 
Q2G1M8 SAOUHSC_00080 1.351618108 2.21E-20 4.07E-19 220.9803702 215.2185505 148.5608501 533.7003186 485.2680952 545.1434552 
Q2FWH7 SAOUHSC_02314 1.168278146 1.04E-19 1.74E-18 436.6487122 436.3605473 511.3620842 1075.135424 985.2412842 1114.408302 
Q2G1M9 SAOUHSC_00079 1.39140592 1.65E-19 2.69E-18 172.1097114 200.4099346 129.7952691 475.1369296 422.5263617 489.664254 
Q2FVX1 SAOUHSC_02552 1.110864853 2.32E-19 3.74E-18 267.7262177 241.874059 220.4955776 544.7500147 499.973189 572.8830558 
Q9RQP7 icaB -2.098226702 1.40E-18 2.15E-17 173.172117 145.1244354 236.1335618 39.77890574 31.37086676 34.97601814 
Q2G1T3 SAOUHSC_00831 -1.75943506 2.34E-18 3.56E-17 161.4856551 152.0351228 217.3679807 48.61866257 47.05630014 44.62457487 
Q2G185 essB -1.025965962 2.44E-18 3.68E-17 438.7735235 455.1181273 444.118752 228.728708 221.5567465 194.1772042 
Q2FZM5 SAOUHSC_00975 -1.178590427 4.58E-18 6.82E-17 1931.453428 1956.711775 2541.172437 946.9589504 869.561213 939.5282115 
Q2FV66 SAOUHSC_02871 -1.143675946 6.70E-18 9.83E-17 348.4690453 333.6874773 290.8665066 144.7510181 141.1689004 144.7283509 
Q2FYV2 thrB -1.333794554 7.91E-18 1.15E-16 381.4036197 327.764031 439.4273568 143.6460485 154.8936546 135.0797942 
Q2FZJ0 purL -1.060855818 2.04E-17 2.91E-16 406.9013547 367.2536733 434.7359615 174.5851974 211.7533506 176.0861603 
Q2G1C4 tarJ' -1.013286112 2.07E-17 2.94E-16 552.4509254 514.3525908 616.1365785 282.8722186 285.2788196 246.0381966 
Q2G2W4 SAOUHSC_02631 -1.203771031 2.19E-17 3.09E-16 627.8817249 503.4929391 444.118752 230.9386472 204.8909735 229.1532223 
Q2FXX1 SAOUHSC_01709 1.132832424 2.37E-17 3.31E-16 161.4856551 148.0861586 200.1661981 358.0101516 399.9785512 373.8815733 
Q2FZI8 purM -1.191390503 6.64E-17 8.89E-16 246.4781052 222.1292379 264.2819334 91.71247711 112.7390524 102.5159153 
Q9ZNI1 lytN 1.503247753 3.94E-16 5.01E-15 71.18117693 62.1961866 65.67953375 192.2647111 219.5960673 188.1468562 
Q2FVL5 SAOUHSC_02696 1.004466559 4.23E-16 5.33E-15 588.5727167 523.2377603 409.7151867 1012.152157 1032.297584 1079.432284 
P60647 cidA -1.270036519 4.55E-16 5.70E-15 484.4569654 550.8805099 642.7211517 246.4082216 199.9892756 219.5046656 
Q2FZI9 purF -1.107331528 1.68E-15 2.03E-14 299.5983865 290.2488708 364.3650325 153.5907749 133.3261837 139.9040726 
Q2G136 SAOUHSC_00319 -1.161348642 2.33E-15 2.78E-14 313.4096596 308.0192098 398.7685978 131.4913828 157.8346734 148.3465597 
Q2G0L4 sdrD -1.523435156 4.31E-15 5.02E-14 3689.734739 3464.22887 4550.65341 1190.052263 1185.23056 1362.858638 
A0A0H2WXF8 mecA -0.521317089 1.05E-14 1.18E-13 99804.5093 100391.5559 111770.9285 71586.56075 73360.77192 71785.26207 
Q2G1N1 SAOUHSC_00077 1.405938182 6.13E-14 6.51E-13 225.2299927 222.1292379 112.5934864 558.0096499 489.1894535 548.761664 
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Q2FUS6 pcp 1.0207799 7.35E-14 7.58E-13 182.7337676 233.9761305 161.0712375 432.0431151 397.0375324 383.53013 
Q2G1M6 SAOUHSC_00082 1.168060115 1.03E-13 1.06E-12 163.6104664 158.9458102 101.6468975 355.8002124 299.0035738 349.7601814 
Q2G2Q9 SAOUHSC_00274 1.381516989 2.27E-13 2.24E-12 82.86763882 81.94100774 65.67953375 198.8945287 239.202859 205.0318305 
Q2G074 SAOUHSC_00746 1.233652692 2.74E-12 2.54E-11 471.7080979 412.6667619 231.4421665 1035.356519 800.9374419 943.1464203 
Q2G1N5 SAOUHSC_00072 1.016552915 8.55E-12 7.35E-11 572.6366323 619.0001428 358.1098388 1109.389482 1025.435207 1109.584024 
Q2FXW9 SAOUHSC_01711 1.283537554 1.43E-11 1.20E-10 84.99245007 75.03032034 134.4866643 274.0324617 234.3011611 237.5957095 
Q2G0D1 sarX -1.608417048 1.63E-11 1.35E-10 186.9833901 132.2903017 90.70030851 50.82860177 39.21358345 21.70925264 
Q2G1I1 SAOUHSC_00142 1.438805317 1.71E-11 1.42E-10 82.86763882 81.94100774 117.2848817 270.7175529 300.964253 253.2746142 
Q2G057 SAOUHSC_00765 1.16619962 2.01E-11 1.65E-10 145.5495707 128.3413374 95.39170378 301.6567018 282.3378008 287.0445627 
Q2G1U4 SAOUHSC_00936 1.348301343 3.69E-11 2.92E-10 121.1142413 85.88997197 62.5519369 245.303252 266.6523675 229.1532223 
Q2FXF1 SAOUHSC_01898 1.134672186 4.20E-11 3.29E-10 169.9849001 127.3540964 120.4124785 308.2865194 312.728328 340.1116247 
Q2FUQ8 SAOUHSC_03046 -2.192085645 1.03E-10 7.66E-10 475.9577204 589.3829111 1804.62338 121.5466564 106.8570149 126.6373071 
Q2G1N3 sbnA 1.579893974 3.85E-10 2.71E-09 48.87065879 77.99204352 28.14837161 193.3696807 177.4414651 168.8497428 
P60643 lrgB 1.042861736 4.73E-10 3.28E-09 188.0457958 193.4992472 193.9110044 426.518267 405.8605887 398.0029651 
Q2G1N2 SAOUHSC_00076 1.494444806 6.46E-10 4.45E-09 106.2405626 107.6092752 39.09496057 312.7063979 237.2421799 265.3353101 
Q2FWH9 kdpA 1.62530423 7.85E-10 5.36E-09 21.24811252 23.69378537 21.89317792 78.45284187 90.19124193 78.39452343 
Q2FZM7 SAOUHSC_00973 -2.141307125 8.19E-10 5.57E-09 219.9179645 86.87721303 95.39170378 17.67951366 4.901697931 22.91532223 
Q2G225 SAOUHSC_00102 1.151505098 8.54E-10 5.78E-09 72.24358256 66.14515083 86.00891324 181.215015 166.6577297 172.4679515 
P72358 lrgA 1.15652628 1.23E-09 8.23E-09 72.24358256 77.99204352 60.98813848 161.3255621 172.5397672 168.8497428 
Q2G1P1 norG -1.064549375 2.32E-09 1.49E-08 184.8585789 144.1371943 162.635036 65.19320662 87.25022317 69.95203629 
Q2FZJ1 purQ -1.191948541 4.05E-09 2.52E-08 112.6149963 100.6985878 129.7952691 36.46399692 51.95799807 49.44885324 
Q2FX92 SAOUHSC_01985 1.995383853 5.95E-09 3.65E-08 7.436839381 5.923446343 3.127596845 28.7292097 41.17426262 56.68527079 
Q2G1M7 SAOUHSC_00081 1.047928325 7.16E-09 4.34E-08 94.5541007 69.106874 78.18992113 187.8448326 170.579088 164.0254644 
Q2FWX7 SAOUHSC_02144 1.200508941 3.40E-08 1.91E-07 52.05787567 40.47688334 51.60534795 89.5025379 130.385165 138.698003 
Q2FXX2 SAOUHSC_01708 1.13846179 6.15E-08 3.33E-07 53.12028129 60.22170449 106.3382927 182.3199846 164.6970505 160.4072556 
Q2FXN0 SAOUHSC_01805 1.062550862 9.31E-08 4.85E-07 70.11877131 90.82617726 57.86054164 160.2205925 166.6577297 164.0254644 
Q2G1N0 SAOUHSC_00078 1.1750574 1.58E-07 8.07E-07 122.176647 124.3923732 73.49852586 322.6511243 234.3011611 235.1835703 
Q9F0R1 sarR -1.080792704 1.30E-06 5.94E-06 362.2803184 268.5295675 200.1661981 135.9112613 119.6014295 109.7523328 
Q2FXG6 SAOUHSC_01881 1.333340569 7.36E-06 3.07E-05 27.62254627 30.60447277 17.20178265 83.97768989 57.84003559 88.04308016 
Q2G1L8 phnC 1.166249408 9.75E-06 3.98E-05 19.12330127 27.6427496 26.58457318 57.4584194 68.62377104 60.30347956 
Q9RQP6 icaC -1.128738536 1.21E-05 4.87E-05 241.1660771 138.213748 145.4332533 85.08265949 65.68275228 62.71561874 
P31337 SAOUHSC_01763 1.256883255 2.43E-05 9.22E-05 13.81127314 23.69378537 18.76558107 58.563389 54.89901683 48.24278365 
Q2G1X0 hly -1.034609545 1.57E-04 5.20E-04 83.93004444 79.96652563 175.1454233 56.35344979 50.97765848 34.97601814 
Q2G056 SAOUHSC_00766 1.022214198 1.58E-04 5.22E-04 31.87216878 33.56619594 31.27596845 69.61308504 59.80071476 89.24914975 
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Q2FXE4 SAOUHSC_01905 1.226912348 2.96E-04 9.30E-04 5.312028129 17.77033903 17.20178265 36.46399692 53.91867724 36.18208774 
Q2G2A2 SAOUHSC_01044 1.023759581 2.21E-03 5.62E-03 26.56014065 18.75758009 17.20178265 68.50811543 44.11528138 43.41850528 










Q2FZZ6 SAOUHSC_00838 -3.974491153 0 0 9565.72186 9228.916865 9400.106394 620.8316527 532.6217821 
Q2FW95 SAOUHSC_02404 -2.624581142 0 0 6464.072182 6831.006237 6505.539375 1062.177059 1048.886657 
A0A0H2WXF8  mecA -11.78696886 0 0 71586.56075 73360.77192 71785.26207 1.734166628 2.044613367 
O50581 recG -2.327214562 6.48E-270 3.70E-267 7238.655874 7071.189435 7255.714661 1415.947051 1412.827837 
Q2G035 SAOUHSC_00792 -2.795292377 4.99E-234 2.28E-231 6449.707577 7243.729203 6691.274092 993.6774776 910.875255 
Q2FZD0 uvrC -2.298138981 8.59E-223 3.27E-220 6623.187805 6842.770312 6743.135084 1312.764137 1389.314783 
Q2FUX4 SAOUHSC_02971 -3.413421429 3.55E-180 1.16E-177 2310.491441 2207.724748 2133.537107 218.5049951 171.7475228 
Q2G245 SAOUHSC_01854 -1.666455598 1.02E-160 2.91E-158 25521.48294 26839.73719 24461.50345 8001.44482 8008.750558 
Q2G253 SAOUHSC_00025 -2.059425365 3.56E-144 9.05E-142 3413.251106 3478.244852 3132.162728 824.5962314 748.3284923 
Q2FUQ2 mnmE -1.74073277 1.77E-140 4.05E-138 9959.091039 9466.159045 9304.826896 2901.260768 2770.451112 
Q2FXQ3 SAOUHSC_01782 -1.967430917 9.04E-139 1.88E-136 6819.872394 6824.14386 6640.619169 1702.084545 1706.229855 
Q2FUQ1 rnpA -2.372802854 7.18E-134 1.37E-131 1487.289087 1422.47274 1383.361821 269.6629106 267.8443511 
Q2FY54 SAOUHSC_01611 1.312027684 1.20E-129 2.10E-127 2582.313964 2479.278814 2664.207727 6513.529853 6328.078371 
Q2FVH5 SAOUHSC_02737 -1.334551958 2.65E-124 4.32E-122 3699.438233 3761.562992 3630.26947 1420.282468 1497.679291 
Q2G082 SAOUHSC_00738 2.262569086 5.04E-119 7.68E-117 1814.360089 1819.510272 1889.911049 8858.990217 9268.232392 
Q2G239 SAOUHSC_00708 1.247664914 1.74E-114 2.49E-112 4402.198901 4537.991945 4534.821663 10656.45393 10778.17936 
Q2FUY3 SAOUHSC_02962 -1.964612523 1.65E-107 2.22E-105 2224.303812 2307.719386 2297.562571 587.0154034 557.1571425 
Q2FVE1 SAOUHSC_02773 1.58022337 5.82E-107 7.39E-105 1135.908753 1142.095618 1209.6878 3450.124506 3570.917245 
Q2FZ77 pyrR 2.632612299 1.94E-101 2.33E-99 339.2256684 340.1778364 344.9359031 1960.475372 2501.584454 
Q2FXE2 SAOUHSC_01907 -1.672637172 5.00E-101 5.71E-99 1836.459481 1860.684535 1769.30409 574.0091537 554.0902224 
Q2FVX0 SAOUHSC_02553 -2.301991003 3.64E-90 3.97E-88 1687.288585 1589.130469 1800.6619 318.2195762 346.5619657 
Q2G0Y8 SAOUHSC_00373 1.480599024 4.74E-90 4.92E-88 2861.871274 2709.658616 2748.632598 7976.299404 7664.233206 
Q2FZ64 SAOUHSC_01187 1.018955691 4.21E-88 4.18E-86 4851.92153 4830.133141 4744.677772 9627.226033 9933.754043 
Q2FY21 SAOUHSC_01652 -1.281694763 1.21E-86 1.16E-84 16859.62621 16548.13222 16427.8739 7024.241925 6552.985841 
Q2FZF0 isdB -2.386169713 1.59E-84 1.45E-82 988.9477954 902.8927589 967.2678121 185.5558292 164.591376 
Q2FWD4 murA -1.275012748 6.22E-83 5.47E-81 11309.36389 11145.48076 10929.40264 4557.389897 4585.045475 
Q2FYK5 thyA 1.484301344 1.46E-81 1.24E-79 660.771823 643.1027686 732.0842419 1852.957042 1982.252659 
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Q2G0Y6 guaA 1.399105885 1.34E-79 1.09E-77 7395.561558 7088.835548 6927.663732 19003.86499 19022.06046 
Q2FXQ4 SAOUHSC_01781 -1.958746834 8.33E-78 6.56E-76 7325.948473 7342.743501 7904.580101 2011.633288 1757.345189 
Q2FYM1 odhA -1.407769613 6.43E-77 4.90E-75 5038.661393 4964.439665 5028.104126 1927.526207 1809.48283 
Q2FY61 SAOUHSC_01604 -1.826759309 2.02E-76 1.49E-74 1367.952369 1482.273454 1547.387286 398.8583243 407.9003667 
Q2FWD1 pyrG 1.096471427 2.33E-76 1.67E-74 7135.893701 7224.122411 7215.914364 15244.19174 15665.82762 
Q2FWH6 SAOUHSC_02315 -3.495162282 7.45E-74 5.01E-72 779.0035706 720.5495959 829.7758787 58.96166534 58.27148096 
Q2G077 SAOUHSC_00743 1.044371693 4.13E-73 2.69E-71 4205.514312 4022.333322 4217.62536 8660.428138 8523.993127 
Q2FUQ3 mnmG -1.125406709 5.75E-72 3.65E-70 13117.09417 12497.36905 12599.80902 5904.837367 5709.582827 
Q2FV86 SAOUHSC_02849 1.515562676 2.69E-70 1.66E-68 5513.798323 5820.276123 5526.210867 15436.68424 17141.01616 
Q2FW76 SAOUHSC_02428 -1.647085377 3.41E-70 2.05E-68 2538.11518 2274.38784 2344.599285 749.1599831 752.417719 
Q2G1B7 SAOUHSC_00228 1.071844842 3.28E-69 1.92E-67 7870.698488 8018.197476 8272.431326 17476.06419 16549.10059 
Q2G033 SAOUHSC_00794 1.145324016 2.54E-66 1.45E-64 13238.64082 13772.79085 13524.8644 29502.50975 30647.73206 
Q2G2B2 sasG -1.220801291 6.99E-66 3.90E-64 6375.674614 6581.999982 6436.793408 2708.768272 2797.031086 
Q2G0Y7 guaB 1.063611244 2.86E-65 1.56E-63 9285.05958 9239.7006 8882.702539 19270.05957 19130.42497 
Q2G0Q7 SAOUHSC_00489 -1.636385891 4.37E-64 2.32E-62 1692.813433 1680.302051 1563.06619 523.7183215 514.2202618 
Q2FXU3 lytH 1.291446585 2.35E-63 1.22E-61 1121.544148 1099.941016 1073.401936 2689.692439 2739.781912 
Q2G0W4 SAOUHSC_00410 2.049038456 1.17E-61 5.93E-60 171.2702886 212.7336902 223.1228744 887.02623 856.6930007 
Q2FZI6 purH 1.713725175 5.05E-61 2.51E-59 251.9330697 286.2591592 268.9535188 872.2858137 938.4775354 
Q2FXT1 obg -1.244885163 4.85E-57 2.36E-55 11397.76146 11108.22785 10588.08494 4505.364898 4727.146104 
Q2FZZ4 SAOUHSC_00840 -2.586883753 4.97E-57 2.37E-55 520.4406834 531.3440557 659.7200664 85.84124807 86.89606809 
Q2FY74 xerD -1.222573233 2.02E-56 9.43E-55 2843.08679 2869.453969 2893.360949 1191.372473 1246.191847 
Q2FYZ3 SAOUHSC_01279 -1.755529314 8.77E-56 4.01E-54 829.8321724 780.3503106 851.4851314 235.8466614 236.1528439 
Q2FVL5 SAOUHSC_02696 -2.25718385 2.72E-55 1.22E-53 1012.152157 1032.297584 1079.432284 178.6191626 233.0859238 
Q2FUW9 SAOUHSC_02982 1.065903236 6.21E-55 2.68E-53 3367.947352 3390.994629 3397.498038 7109.21609 7151.035251 
Q2FZM6 SAOUHSC_00974 2.468852877 6.36E-55 2.69E-53 193.3696807 219.5960673 225.5350136 1188.771223 1369.890956 
Q2FXT3 ruvA -1.110754989 7.03E-54 2.92E-52 3944.741485 3921.358345 3951.083981 1764.514544 1862.642777 
Q2FZT3 SAOUHSC_00907 -1.186966368 2.64E-53 1.08E-51 1733.697308 1927.347627 1901.971745 776.9066492 839.3137871 
Q2G0B2 SAOUHSC_00693 1.117436632 4.00E-53 1.60E-51 699.4457592 704.8641625 736.9085202 1564.218298 1553.906159 
Q2FUS7 SAOUHSC_03024 1.408733337 1.53E-52 6.04E-51 1287.289588 1235.227879 1238.63347 3192.600761 3568.872632 
Q2FZU6 rocD -1.710665855 5.93E-51 2.22E-49 934.8042848 906.8141173 975.7102993 254.0554109 301.5804716 
Q2G019 SAOUHSC_00808 -1.463928694 3.50E-50 1.29E-48 1731.487369 1611.67828 1692.115636 639.0404023 552.0456091 
Q2FWH7 SAOUHSC_02314 -2.196168512 8.24E-50 2.99E-48 1075.135424 985.2412842 1114.408302 215.9037451 218.7736303 
Q2FX99 SAOUHSC_01978 -1.494302401 3.83E-49 1.37E-47 2987.837809 2822.397669 3053.768205 1101.195809 958.9236691 
Q2FVS3 SAOUHSC_02619 -1.333729525 1.91E-48 6.61E-47 1829.829664 1701.869522 1807.898317 704.0716508 689.0347046 
345 
 
Q2G2L4 SAOUHSC_02814 -1.449128367 1.89E-48 6.61E-47 1510.493448 1634.22609 1576.332956 546.2624877 587.826343 
Q2G105 SAOUHSC_00356 -1.721010324 2.15E-48 7.34E-47 5659.65431 6095.751547 5640.787478 1800.932043 1594.798426 
Q2FUX3 isaB -1.316460576 5.72E-47 1.89E-45 2054.138493 2061.65415 2374.751025 877.4883136 835.2245604 
Q2FZQ1 SAOUHSC_00949 -1.511349023 1.14E-46 3.66E-45 763.5339962 734.2743501 786.3573735 250.5870777 272.9558845 
Q2FZ72 carB 1.163029948 5.57E-46 1.77E-44 1582.316473 1592.071488 1542.563007 3460.529505 3653.724087 
Q2G0Y9 xpt 1.279439041 8.88E-46 2.78E-44 760.2190874 684.2770312 631.9804658 1728.097044 1679.649881 
Q2G0E5 SAOUHSC_00661 1.229660219 3.66E-45 1.13E-43 478.4518384 532.3243953 536.7009681 1261.606222 1185.875753 
Q2G268 SAOUHSC_01178 -1.056693381 7.23E-45 2.20E-43 2566.84439 2429.281495 2544.806837 1186.169973 1214.50034 
P60639 cidB 1.188315309 2.50E-44 7.42E-43 1602.205925 1597.953526 1481.053458 3403.302007 3786.623956 
Q2FW75 SAOUHSC_02430 -1.362711034 3.06E-44 8.96E-43 9512.683319 8364.25735 9449.555247 3348.675758 3625.0995 
Q2FZ76 SAOUHSC_01165 1.809056137 2.78E-42 7.67E-41 339.2256684 291.1608571 295.4870498 1004.082477 1253.347994 
Q2FZ10 cinA -1.113768891 5.12E-41 1.36E-39 1979.00056 1890.094722 2100.973228 915.6399794 904.7414149 
Q53726 pcrB -1.00239031 7.53E-41 1.96E-39 2117.121761 2141.061656 2137.155316 1081.252892 1031.507444 
Q2G188 esaA 1.10452336 1.44E-40 3.65E-39 664.0867319 643.1027686 730.8781723 1532.136215 1409.760916 
Q2FVH8 SAOUHSC_02733 1.051384452 3.65E-40 9.18E-39 1211.046686 1185.23056 1180.74213 2457.314111 2525.097508 
Q2FZI5 purD 1.663651758 1.37E-39 3.38E-38 329.2809419 294.1018759 265.3353101 907.8362295 1037.641284 
Q2FUW8 gtf2 1.078341405 2.23E-39 5.42E-38 738.1196953 679.3753333 692.2839453 1487.914966 1508.924665 
Q2G0Q9 hslO -1.1256787 5.18E-39 1.23E-37 3982.310452 4054.684529 3893.19264 1741.103294 1868.776617 
Q2FZ71 pyrF 1.650091599 7.30E-39 1.70E-37 208.8392551 200.9696152 190.5589954 585.2812368 717.6592918 
Q2FWL3 SAOUHSC_02276 -1.317196418 7.95E-38 1.78E-36 1170.16281 1122.488826 1231.397053 491.6362389 432.4357271 
Q2G2U2 SAOUHSC_00023 1.175280839 1.43E-37 3.17E-36 1014.362096 1074.452187 1102.347606 2358.466614 2506.695988 
Q2FZ88 SAOUHSC_01152 -1.397243638 3.46E-37 7.61E-36 1612.150652 1559.720282 1737.946281 636.4391523 580.6701962 
Q2FYT4 sbcD -1.234265209 4.51E-37 9.82E-36 976.7931297 1045.041999 967.2678121 395.3899911 442.6587939 
Q2G194 SAOUHSC_00251 -2.011946472 4.14E-36 8.59E-35 1880.658266 1705.79088 2064.79114 466.4908228 402.7888333 
Q2G145 SAOUHSC_00310 -1.480042197 6.36E-36 1.31E-34 664.0867319 660.7488811 666.9564839 225.4416616 238.1974572 
Q2G1N1 SAOUHSC_00077 -2.683048756 1.81E-35 3.68E-34 558.0096499 489.1894535 548.761664 73.70208167 64.40532106 
Q2G1W4 metK 1.076489714 9.49E-35 1.90E-33 3486.1791 3274.334218 3348.049185 7287.835252 7080.49609 
Q2FXL6 SAOUHSC_01819 -1.440779632 2.04E-34 4.02E-33 1956.901168 2027.342264 1893.529258 684.1287346 719.7039052 
Q2FUW7 gtf1 1.004613029 2.66E-34 5.20E-33 723.7550905 739.176048 697.1082237 1417.681218 1499.723905 
Q2G252 rlmH -1.725604702 2.72E-34 5.27E-33 595.5786164 574.4789975 590.9740997 186.4229125 151.3013892 
Q2FY23 SAOUHSC_01650 -1.208770125 2.01E-33 3.85E-32 1099.444756 1144.056297 1156.620738 502.908322 464.1272343 
Q2G196 SAOUHSC_00249 -1.595376987 8.04E-33 1.52E-31 1510.493448 1445.02055 1542.563007 503.7754053 450.8372474 
Q2G057 SAOUHSC_00765 -2.488686296 1.37E-32 2.55E-31 301.6567018 282.3378008 287.0445627 39.01874912 50.09302749 
Q2G278 SAOUHSC_00773 -1.731286526 2.54E-32 4.64E-31 468.507112 537.2260933 505.3431587 137.8662469 152.3236958 
346 
 
Q2FZI8 purM 1.741327242 1.83E-31 3.19E-30 91.71247711 112.7390524 102.5159153 349.4345755 374.1642461 
Q2G1U8 SAOUHSC_02690 1.124857085 3.81E-31 6.49E-30 1071.820516 1050.924036 1111.996163 2361.067863 2401.398399 
Q2G0L4 sdrD 2.452722358 7.91E-31 1.31E-29 1190.052263 1185.23056 1362.858638 7021.640675 8970.741147 
Q2G1F2 azoR 2.168380175 8.18E-31 1.34E-29 49.72363217 52.93833766 59.09740997 250.5870777 293.4020182 
Q2FZ74 pyrC 1.175046114 1.12E-30 1.83E-29 623.2028565 636.2403915 641.6290225 1409.010385 1499.723905 
Q2G0U5 SAOUHSC_00431 1.002064538 4.91E-30 7.91E-29 532.595349 555.8525454 498.1067412 1080.385809 1061.154337 
Q2FZI3 SAOUHSC_01021 1.0408508 2.04E-29 3.24E-28 1026.516762 961.7131341 1058.929101 2115.683286 2107.996381 
Q2G176 SAOUHSC_00271 -1.423737679 2.35E-29 3.70E-28 753.5892698 767.605896 767.06026 279.200827 271.9335778 
Q2FWY4 sdcS 1.30899576 8.63E-29 1.35E-27 222.0988904 244.104557 207.4439697 556.6674875 585.7817296 
Q2FWC5 SAOUHSC_02373 1.065388706 1.89E-28 2.85E-27 342.5405772 328.4137614 320.8145113 696.267901 705.3916116 
P72360 scdA -1.467609995 3.98E-28 5.83E-27 616.5730389 569.5772996 638.0108137 226.3087449 195.2605765 
Q2FWC4 SAOUHSC_02374 1.145744563 6.51E-28 9.38E-27 320.4411851 369.588024 314.7841633 726.615817 784.1092262 
Q2FUZ9 SAOUHSC_02945 1.403477513 6.52E-28 9.38E-27 212.1541639 256.8489716 217.0925264 616.4962361 633.8301437 
Q2FZ75 pyrB 1.401175948 8.94E-28 1.27E-26 301.6567018 290.1805175 305.1356066 753.4953997 875.094521 
Q2FZI9 purF 1.611345367 9.27E-28 1.31E-26 153.5907749 133.3261837 139.9040726 447.4149899 463.1049276 
Q2FV87 glcB 1.094789548 6.01E-27 8.08E-26 1295.024376 1335.222516 1350.797942 2837.963686 2913.574048 
Q2FW77 SAOUHSC_02427 -1.240050182 1.03E-26 1.36E-25 1837.564451 1581.287753 1733.122003 689.3312345 741.1723455 
Q2FYS2 SAOUHSC_01363 -1.818924875 2.92E-26 3.82E-25 640.8823702 633.2993727 653.6897184 168.2141629 171.7475228 
Q2FW41 SAOUHSC_02476 -1.861704261 3.01E-26 3.90E-25 327.0710027 347.0402135 408.8575914 79.77166487 105.2975884 
Q2G0A0 SAOUHSC_00705 -1.412234701 4.04E-26 5.18E-25 507.1810481 487.2287744 523.4342026 177.7520793 191.1713498 
Q2G1U4 SAOUHSC_00936 -2.482515706 1.19E-25 1.49E-24 245.303252 266.6523675 229.1532223 33.81624924 38.84765397 
Q2G1N5 SAOUHSC_00072 -1.723556979 4.56E-25 5.51E-24 1109.389482 1025.435207 1109.584024 300.0108266 316.9150719 
Q2FZL3 sspB -1.3351558 1.02E-24 1.22E-23 626.5177653 602.9088455 689.8718062 240.1820779 252.5097508 
Q2G0M6 araB -1.101637059 1.23E-24 1.46E-23 961.3235553 1030.336905 992.5952736 446.5479066 467.1941543 
Q2FW50 SAOUHSC_02467 1.379152669 3.98E-24 4.64E-23 646.4072182 608.790883 624.7440482 1642.255796 1727.698295 
Q2FVP4 SAOUHSC_02658 1.165684619 4.58E-24 5.29E-23 230.9386472 242.1438778 230.3592919 508.9779052 566.3579026 
Q2FXP2 SAOUHSC_01794 -1.36896424 4.82E-24 5.52E-23 605.5233429 568.59696 627.1561874 233.2454114 216.7290169 
Q2G249 SAOUHSC_00026 -1.441170367 9.31E-24 1.05E-22 542.5400754 613.692581 575.295195 187.2899958 221.8405503 
Q2G2M2 mprF -1.051996722 1.54E-23 1.72E-22 9123.734018 8121.133132 9103.413274 4253.043654 4094.338267 
Q2G177 SAOUHSC_00270 -1.996211957 2.49E-23 2.77E-22 689.5010327 659.7685415 773.090608 163.011663 149.2567758 
Q2G1Y2 SAOUHSC_02923 1.200846352 3.33E-23 3.65E-22 204.4193767 235.2815007 201.4136217 489.034989 519.3317952 
Q2G1M9 SAOUHSC_00079 -1.681110169 9.33E-23 1.01E-21 475.1369296 422.5263617 489.664254 127.4612471 145.1675491 
Q2FXQ8 engB -1.799846272 1.54E-22 1.63E-21 843.0918077 787.2126877 1001.037761 235.8466614 226.9520837 
Q2FXE9 SAOUHSC_01900 -2.067186453 1.67E-22 1.76E-21 208.8392551 235.2815007 272.5717276 49.42374889 50.09302749 
347 
 
Q2G1N3 sbnA -2.793161351 2.41E-22 2.54E-21 193.3696807 177.4414651 168.8497428 15.60749965 18.4015203 
Q2G1N4 SAOUHSC_00074 -1.674711965 3.22E-22 3.37E-21 2689.496016 2117.533506 2258.968344 683.2616513 695.1685448 
Q2G200 SAOUHSC_00941 -1.232910091 3.44E-22 3.59E-21 561.3245587 570.5576392 584.9437517 259.2579108 212.6397902 
Q2G1N2 SAOUHSC_00076 -2.622062892 5.08E-22 5.24E-21 312.7063979 237.2421799 265.3353101 32.08208261 31.69150719 
Q2FY81 SAOUHSC_01584 -1.275634552 6.18E-22 6.33E-21 866.2961693 909.755136 979.3285081 414.465824 318.9596852 
P0A0M9 SAOUHSC_00995 -1.503640124 6.33E-22 6.46E-21 437.5679631 448.9955305 488.4581844 156.0749965 154.3683092 
Q2G0Y5 SAOUHSC_00376 -2.15214236 6.4E-22 6.48E-21 217.6790119 200.9696152 244.832127 38.15166581 47.02610744 
Q2FZL2 sspA -1.595685406 1.26E-21 1.25E-20 563.5344979 457.8185868 493.2824628 149.13833 165.6136827 
Q2G190 SAOUHSC_00256 1.241326844 1.64E-21 1.63E-20 216.5740423 205.8713131 215.8864568 540.1929045 491.7295147 
Q2G195 SAOUHSC_00250 -1.608693615 1.75E-21 1.72E-20 1219.886443 1104.842714 1336.325107 425.7379071 324.0712187 
Q2FVW0 SAOUHSC_02581 1.281787836 1.98E-21 1.94E-20 337.0157291 360.7649677 353.3783902 876.6212302 878.1614411 
Q2FZJ0 purL 1.256696518 7.54E-21 7.24E-20 174.5851974 211.7533506 176.0861603 447.4149899 478.4395279 
Q2G0Q6 SAOUHSC_00490 -1.300444427 1.66E-20 1.57E-19 524.8605618 434.2904367 466.7489318 190.758329 181.9705897 
Q2G0D1 sarX 2.334852193 1.96E-20 1.84E-19 50.82860177 39.21358345 21.70925264 265.327494 222.862857 
Q2FXT2 SAOUHSC_01752 -1.088059979 4.94E-20 4.5E-19 1373.477217 1265.618406 1238.63347 595.6862366 600.0940232 
Q2G2L5 SAOUHSC_02813 -1.283889203 1.21E-19 1.06E-18 553.5897715 585.262733 622.3319091 251.454161 214.6844035 
Q2FXK4 SAOUHSC_01830 -1.565750729 1.8E-19 1.57E-18 313.8113675 300.964253 402.8272435 121.3916639 92.00760151 
Q2FWZ8 ftnA 1.015862679 5.61E-19 4.79E-18 1085.080151 1205.817691 1067.371588 2432.168695 2168.312476 
P60643 lrgB -1.656210304 1.34E-18 1.12E-17 426.518267 405.8605887 398.0029651 109.2524975 130.8552555 
Q2FY24 SAOUHSC_01649 -1.12287651 1.39E-18 1.15E-17 1039.776397 1087.196601 1209.6878 503.7754053 493.7741281 
Q2FXF1 SAOUHSC_01898 -1.701572293 1.5E-18 1.24E-17 308.2865194 312.728328 340.1116247 91.04374795 89.96298814 
Q2G0F7 SAOUHSC_00612 -2.081322484 1.85E-18 1.51E-17 127.0715044 124.5031275 144.7283509 24.27833279 26.57997377 
Q2G2W1 SAOUHSC_02629 1.005394078 3.29E-18 2.66E-17 3370.157291 3308.646104 3426.443709 6724.231098 7030.403062 
Q2FZU3 SAOUHSC_00897 -1.333567842 4.49E-18 3.6E-17 383.4244525 389.1948157 378.7058516 158.6762464 132.8998688 
Q2G1I1 SAOUHSC_00142 -2.05851571 5.34E-18 4.27E-17 270.7175529 300.964253 253.2746142 52.02499883 59.29378764 
Q2FW43 SAOUHSC_02474 -1.05811166 1.55E-17 1.21E-16 611.0481909 639.1814102 645.2472313 325.1562427 267.8443511 
Q2FVX1 SAOUHSC_02552 -1.148675103 2.32E-17 1.78E-16 544.7500147 499.973189 572.8830558 219.3720784 256.5989775 
Q2FW49 SAOUHSC_02468 1.22187115 2.62E-17 1.99E-16 2134.801274 2089.103658 2111.827854 4740.344476 5447.872316 
Q2FZC0 flr -2.207790851 2.88E-17 2.18E-16 135.9112613 147.0509379 180.9104387 23.41124947 26.57997377 
Q2G2Q9 SAOUHSC_00274 -1.755118157 5.93E-17 4.43E-16 198.8945287 239.202859 205.0318305 54.62624877 60.31609432 
Q2FY17 SAOUHSC_01657 -1.003125449 6.01E-17 4.48E-16 1150.273358 1036.218943 1237.427401 557.5345708 561.2463692 
Q2G1T5 SAOUHSC_02802 2.097977043 2.06E-16 1.49E-15 605.5233429 696.0411062 535.4948985 3677.300334 2883.927154 
Q2FV70 SAOUHSC_02866 2.161524406 3.31E-16 2.38E-15 553.5897715 532.3243953 517.4038546 3192.600761 2947.310168 
Q2G101 SAOUHSC_00359 -1.07032264 4.04E-16 2.89E-15 755.799209 632.3190331 693.4900149 317.3524928 329.1827521 
348 
 
Q2FY64 SAOUHSC_01601 -1.041788042 4.64E-16 3.31E-15 502.7611697 472.5236806 432.9789832 226.3087449 219.7959369 
Q2FZI7 purN 1.590202855 5.33E-16 3.77E-15 56.35344979 72.54512938 49.44885324 175.1508294 219.7959369 
Q2FZM5 SAOUHSC_00975 1.215256954 5.52E-16 3.89E-15 946.9589504 869.561213 939.5282115 2310.777031 2098.795621 
Q2FZI4 SAOUHSC_01019 1.072648563 6.41E-16 4.48E-15 202.2094375 212.7336902 194.1772042 467.3579061 407.9003667 
Q2G1M8 SAOUHSC_00080 -1.286694248 6.78E-16 4.73E-15 533.7003186 485.2680952 545.1434552 198.5620789 213.6620968 
Q2FWF6 SAOUHSC_02335 -1.136341498 9.49E-16 6.52E-15 455.2474767 397.0375324 534.2888289 203.7645787 202.4167233 
Q2G016 SAOUHSC_00811 -1.530154739 1.17E-15 7.98E-15 1285.079649 1261.697047 1215.718148 401.4595743 402.7888333 
Q2G0L5 sdrC 1.02234049 2.74E-15 1.84E-14 1019.886944 1019.55317 1058.929101 2004.696621 2290.989278 
Q2FZ70 pyrE 1.158905186 4.12E-15 2.76E-14 173.4802278 198.0285964 183.3225779 396.2570744 460.0380076 
Q2G2Y3 SAOUHSC_01919 1.520163235 1.63E-14 1.07E-13 325.9660331 345.0795344 347.3480423 987.6078944 1132.715805 
Q2G0E3 SAOUHSC_00662 1.225886197 2.63E-14 1.7E-13 146.9609573 144.1099192 185.734717 435.2758235 337.3612055 
Q2FYT5 SAOUHSC_01340 -1.293901203 2.71E-14 1.74E-13 994.4726434 905.8337777 1133.705416 377.1812415 404.8334466 
Q2G1Z0 SAOUHSC_00655 -1.113648194 1.07E-13 6.64E-13 266.2976745 248.0259153 262.9231709 120.5245806 110.4091218 
Q2FWG0 tenA -1.672560889 1.24E-13 7.58E-13 128.176474 162.7363713 143.5222814 45.95541563 33.73612055 
Q2FZZ3 SAOUHSC_00841 -2.574670676 1.81E-13 1.1E-12 55.24848019 83.32886483 92.86735852 5.202499883 1.022306683 
Q2G012 emp -1.266559087 4.72E-13 2.8E-12 286.1871274 272.534405 277.396006 108.3854142 109.3868151 
Q2FVB4 SAOUHSC_02820 -1.70082684 5.02E-13 2.97E-12 303.866641 306.8462905 267.7474492 71.10083173 81.78453468 
P72358 lrgA -1.520998716 6.58E-13 3.84E-12 161.3255621 172.5397672 168.8497428 51.15791551 54.18225422 
Q9ZNI1 lytN -1.423753971 7.05E-13 4.1E-12 192.2647111 219.5960673 188.1468562 65.89833185 74.62838789 
Q2FVF5 SAOUHSC_02759 -1.181247662 7.67E-13 4.44E-12 1916.017293 1834.215366 1933.329555 839.3366477 755.4846391 
Q2G292 SAOUHSC_01849 -1.416327486 8.47E-13 4.89E-12 167.9553798 168.6184088 184.5286475 65.89833185 54.18225422 
Q2G1U9 SAOUHSC_02689 -1.088599226 1.3E-12 7.45E-12 248.6181608 255.868632 267.7474492 113.5879141 120.6321886 
Q2G013 SAOUHSC_00814 -1.369853453 2.31E-12 1.31E-11 240.8833736 268.6130466 289.4567019 72.83499836 121.6544953 
Q2G074 SAOUHSC_00746 -1.344468448 3.98E-12 2.2E-11 1035.356519 800.9374419 943.1464203 319.0866595 367.0080994 
Q2G097 SAOUHSC_00724 1.053466496 1.41E-11 7.43E-11 141.4361093 130.385165 164.0254644 311.2829097 310.7812318 
Q2FXF2 sigS -1.600596425 1.69E-11 8.85E-11 226.5187688 204.8909735 267.7474492 71.96791504 62.36070769 
Q2FV53 SAOUHSC_02886 -2.38852682 2.13E-11 1.1E-10 72.92799385 90.19124193 107.3401936 9.537916452 2.044613367 
Q2FZ03 SAOUHSC_01268 -1.678252699 2.56E-11 1.31E-10 93.92241632 101.955317 96.4855673 30.34791598 20.44613367 
Q2FWG1 SAOUHSC_02330 -1.296960948 2.55E-11 1.31E-10 172.3752582 192.1465589 167.6436732 71.96791504 63.38301437 
Q2G056 SAOUHSC_00766 -2.006340443 3.64E-11 1.85E-10 69.61308504 59.80071476 89.24914975 11.27208308 13.28998688 
Q2FXN1 SAOUHSC_01804 -2.052838562 3.73E-11 1.89E-10 69.61308504 67.64343145 69.95203629 10.40499977 11.24537352 
Q2FXW9 SAOUHSC_01711 -1.363027408 4.56E-11 2.3E-10 274.0324617 234.3011611 237.5957095 91.04374795 88.94068146 
Q2FY63 SAOUHSC_01602 -1.315254886 1.09E-10 5.37E-10 135.9112613 133.3261837 147.1404901 53.75916546 48.04841412 
Q2G2Q6 SAOUHSC_00277 -1.043523202 1.26E-10 6.19E-10 244.1982824 239.202859 291.8688411 125.7270805 115.5206552 
349 
 
Q2G0V2 metN1 -1.234315573 1.36E-10 6.66E-10 204.4193767 191.1662193 171.261882 80.63874818 69.51685448 
Q2G140 mepA 1.071403237 1.48E-10 7.23E-10 91.71247711 93.13226069 90.45521934 197.6949955 204.4613367 
Q2G0W6 SAOUHSC_00408 1.111339706 3.2E-10 1.54E-09 125.9665348 129.4048254 121.8130287 280.9349937 289.3127914 
Q2FV35 SAOUHSC_02904 1.264358221 3.66E-10 1.73E-09 60.77332821 59.80071476 54.2731316 152.6066632 149.2567758 
Q2FZB9 SAOUHSC_01113 -1.807430994 3.79E-10 1.79E-09 160.2205925 183.3235026 186.9407866 34.68333255 38.84765397 
Q2G1F8 SAOUHSC_00167 1.186624503 6.04E-10 2.79E-09 87.2925987 119.6014295 90.45521934 266.1945773 214.6844035 
Q2G1P1 norG 1.157268709 1.23E-09 5.56E-09 65.19320662 87.25022317 69.95203629 187.2899958 164.591376 
Q2G2Q8 SAOUHSC_00275 -1.244771759 1.58E-09 7.1E-09 232.0436168 264.6916883 268.9535188 82.37291481 118.5875753 
Q2FXG6 SAOUHSC_01881 -1.923589296 1.89E-09 8.4E-09 83.97768989 57.84003559 88.04308016 13.87333302 14.31229357 
Q2G1N0 SAOUHSC_00078 -1.468095853 1.92E-09 8.49E-09 322.6511243 234.3011611 235.1835703 70.23374842 99.1637483 
Q2FV45 SAOUHSC_02894 1.337885109 2.96E-09 1.29E-08 38.67393613 46.07596055 51.86099242 130.9295804 123.6991087 
Q2G0X3 SAOUHSC_00400 1.344718171 3.36E-09 1.45E-08 176.7951366 246.0652361 201.4136217 673.7237348 503.9971949 
Q2G1M6 SAOUHSC_00082 -1.000283654 3.64E-09 1.57E-08 355.8002124 299.0035738 349.7601814 154.3408299 169.7029095 
Q2FYW3 SAOUHSC_01311 -1.950338922 4.01E-09 1.71E-08 86.18762909 69.60411062 97.69163689 9.537916452 18.4015203 
Q2G2Y4 SAOUHSC_01918 1.643518083 5.93E-09 2.48E-08 230.9386472 273.5147446 299.1052586 978.069978 1129.648885 
Q2FWH9 kdpA -1.525741984 4.13E-08 1.62E-07 78.45284187 90.19124193 78.39452343 27.74666604 19.42382699 
Q2FWN6 SAOUHSC_02246 -1.054564516 5.81E-08 2.23E-07 176.7951366 143.1295796 180.9104387 72.83499836 78.71761463 
Q2G132 SAOUHSC_00324 1.329365422 6.89E-08 2.61E-07 40.88387534 49.01697931 32.56387896 109.2524975 125.7437221 
Q2FYH9 SAOUHSC_01468 -1.265540889 1.03E-07 3.84E-07 161.3255621 141.1689004 168.8497428 61.56291528 55.20456091 
Q2G1M7 SAOUHSC_00081 -1.012795543 2.15E-07 7.79E-07 187.8448326 170.579088 164.0254644 84.97416475 79.73992131 
P31337 SAOUHSC_01763 -1.649708789 2.15E-07 7.79E-07 58.563389 54.89901683 48.24278365 14.74041633 9.200760151 
Q2G0V1 SAOUHSC_00424 -1.419900241 0.00000024 8.65E-07 77.34787226 78.4271669 94.07342811 26.01249941 24.5353604 
Q8KQR1 isdC -1.024698671 3.72E-07 0.00000133 152.4858053 132.3458441 144.7283509 68.49958179 64.40532106 
Q2FWX0 SAOUHSC_02151 -1.162673181 6.24E-07 0.00000219 443.0928111 482.3270764 473.9853493 199.4291622 175.8367496 
Q2G2A2 SAOUHSC_01044 -1.703681735 0.00000122 0.0000042 68.50811543 44.11528138 43.41850528 7.803749824 11.24537352 
Q2FW05 SAOUHSC_02515 -1.149565058 0.00000219 0.00000733 337.0157291 329.394101 354.5844598 126.5941638 143.1229357 
Q2G1W1 SAOUHSC_02576 -1.351657273 0.00000251 0.0000083 4322.64109 4323.297575 4476.930323 1288.485804 1513.013892 
Q2G073 SAOUHSC_00747 -1.010854052 0.00000417 0.0000135 435.3580239 386.253797 436.597192 182.9545792 207.5282567 
Q2FZS6 SAOUHSC_00914 -1.44912054 0.00000442 0.0000143 57.4584194 85.289544 63.92168833 22.54416616 15.33460025 
Q2G021 SAOUHSC_00806 -1.440450575 0.00000465 0.000015 110.4969604 67.64343145 115.7826808 22.54416616 24.5353604 
Q2G1H7 SAOUHSC_00146 1.108527235 0.00000494 0.0000158 104.9721124 100.9749774 92.86735852 219.3720784 253.5320575 
Q2FW42 SAOUHSC_02475 -1.152568847 0.00000992 0.0000309 67.40314583 74.50580855 80.80666261 30.34791598 27.60228045 
Q2FWG2 thiM -1.007323324 0.0000138 0.0000421 125.9665348 152.9329755 174.8800907 72.83499836 66.44993442 
Q2FVB3 SAOUHSC_02821 -1.012506465 0.0000174 0.0000523 154.6957445 181.3628235 186.9407866 92.77791458 63.38301437 
350 
 
Q2FYW2 SAOUHSC_01312 -1.127364537 0.0000207 0.0000616 76.24290266 81.36818566 84.42487138 29.48083267 35.78073392 
Q2FYX0 SAOUHSC_01303 -1.310468555 0.0000271 0.0000792 44.19878415 41.17426262 41.0063661 13.87333302 11.24537352 
Q2FXX0 SAOUHSC_01710 -1.131336254 0.0000451 0.00012833 118.2317476 94.11260028 86.83701057 29.48083267 51.11533417 
Q2FV56 crtO -1.043682325 0.000055 0.00015492 67.40314583 71.56478979 71.15810588 25.1454161 35.78073392 
Q2FXW8 SAOUHSC_01712 -1.058246277 0.0000595 0.00016623 198.8945287 174.5004463 189.3529258 67.63249848 95.07452156 
Q9EYW6 sspC -1.194319427 0.0000845 0.0002307 75.13793306 57.84003559 77.18845384 14.74041633 35.78073392 
Q2G0X2 SAOUHSC_00401 -1.194761856 0.00015598 0.00040611 121.5466564 135.2868629 114.5766112 52.02499883 31.69150719 
Q2G0X4 SAOUHSC_00399 1.116179185 0.00048046 0.0011772 36.46399692 34.31188552 34.97601814 110.9866642 82.80684136 
Q2FV37 SAOUHSC_02902 1.064610034 0.00051031 0.00124633 23.20436168 19.60679172 19.29711346 52.02499883 53.15994754 
Q2FV43 SAOUHSC_02896 1.202546982 0.00052478 0.00127894 6.629817623 9.803395862 13.2667655 32.08208261 34.75842724 
Q2FXE3 SAOUHSC_01906 -1.26051598 0.00065551 0.00157571 28.7292097 24.50848966 27.7396006 6.069583197 7.156146784 
Q2FX92 SAOUHSC_01985 -1.167346749 0.00067044 0.00160484 28.7292097 41.17426262 56.68527079 15.60749965 14.31229357 
Q2FYM5 SAOUHSC_01410 -1.260608335 0.00067583 0.00161605 19.88945287 20.58713131 16.88497428 4.335416569 1.022306683 
Q2G293 SAOUHSC_01847 -1.147365425 0.00099136 0.00229378 36.46399692 32.35120635 21.70925264 12.13916639 6.133840101 
Q2FZS5 SAOUHSC_00915 -1.067963835 0.00111441 0.00254245 50.82860177 55.87935641 30.15173978 17.34166628 17.37921362 
Q2FVY9 sarV 1.114597602 0.00157511 0.00351283 25.41430089 14.70509379 31.35780937 71.96791504 77.69530794 
Q2FXF0 SAOUHSC_01899 -1.168050234 0.00164146 0.00364664 165.7454406 117.6407503 212.2682481 41.61999906 30.6692005 
Q2FYR6 trpC 1.047032044 0.00280033 0.00591641 7.734787226 8.823056276 13.2667655 36.41749918 20.44613367 
Q2G2T5 SAOUHSC_00012 1.062661401 0.00298009 0.00626724 6.629817623 6.862377104 9.64855673 26.01249941 21.46844035 
Q2FZN9 SAOUHSC_00961 -1.000973462 0.00513837 0.01036745 15.46957445 20.58713131 22.91532223 7.803749824 4.089226734 
351 
 
 
 
